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ON THE COVER AND THIS PACE 
Joseph Schlessinger’s life has taken 
him from the war-torn Yugoslavia 
of his birth, to Israel where he grew 
up to defend his new home, and 
finally to Yale, where, with his stud¬ 
ies of cells and drugs, he fights 
against disease. 
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!8 The Chase years 
Six years ago, Herbert Chase came to Yale to improve medical 
education. As his tenure ended this summer, he left behind 
a reinvigorated curriculum and a generation of medical students 
who had learned to look for the “edge” of scientific knowledge. 
By Jennifer Kay I in 
24 The long war 
Born in a war-torn mountain village in the former Yugoslavia, 
Yossi Schlessinger went on to fight other battles, including 
one against disease. 
By Marc Wort man 
30 Preserving fertility 
Where once physicians’ only concern was saving lives, new 
techniques under study at Yale can also preserve fertility in 
women undergoing treatment for cancer. 
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important area of study 
I found the article on EcoEpi- 
demiology [‘‘When Animals 
Sound a Warning,” Spring 2006] 
very interesting, l am a d.v.m. 
and received an m.p.h. in the 
section of epidemiology of infec¬ 
tious diseases. My field study 
on arboviral zoonosis was sub¬ 
mitted under the late Professor 
Robert Shope in 1976.1 have 
since worked in the Cameroon 
civil service as a specialist in 
the eradication of tse-tse flies, 
the trypanosomiasis vector, and 
as the director of veterinary 
research. I wish you success in 
your undertakings in this field, 
which is of great importance: 
especially to the developing 
world, where there is very 
close habitation between man 
and animal. 




HOW TO REACH US 
Yale Medicine welcomes news 
and commentary. Please send 
letters (350 words or less) and 
news items to Yale Medicine, 
300 George Street, Suite 775, 
New Haven, CT 06311, or via 
e-mail to ymm@yale.edu, and 
include a telephone number. 
Submissions may be edited for 
length, style and content. 
VISIT US ON THE WEB 
yalemedicine.yale.edu 
Duran-Reynals and the 
viral etiology of cancer 
Jennifer Kaylin’s article,‘‘The 
Virus Behind the Cancer” 
[Spring 2006], unfortunately 
omits mention of Francisco 
Duran-Reynals, whose pioneer¬ 
ing work on viruses as a cause 
of cancer was undertaken for 
the most part in the Depart¬ 
ment of Microbiology at the 
School of Medicine for a period 
of 20 years until his untimely 
death in 1958. In those years 
there were very few scientists 
who worked on viruses as a 
cause of cancer—Oberling in 
France and Duran-Reynals, 
Shope, Bittner, Lucke, Burmeister 
and Nigrelli in the United States. 
A classmate, David J. Nelligan, 
m.d. '55, and I had the great 
privilege of spending some time 
in Duran-Reynal’s laboratory 
during our third and fourth years 
of medical school. We were 
witness to his many extraordi¬ 
nary personal qualities and 
his passionate efforts, despite 
material difficulties, to persuade 
a disbelieving scientific com¬ 
munity of the importance of 
viruses in the genesis of some 
cancers. Unfortunately he 
did not live to see the general 
acceptance of many of his 
theories. 
Ion Cresser, m.d. ’55 
Paris, France 
In the Spring 2006 issue there 
is a lovely article by Jennifer 
Kaylin called "The Virus Behind 
the Cancer." It is not the aim 
of the article to be complete, 
however, and for future endeav¬ 
ors it could be fine to refresh 
the Yale memory about cancer 
and viruses. 
In fact the ‘‘virus theory of 
cancer” came to life at Yale 
with Francisco Duran-Reynals, 
(1899-1958), who wrote more 
than 50 original papers on 
the subject. 
C.Soler-Durall, m.d., m.p.h. ’56, 
dr. PH. '57 
Barcelona, Spain 
New deans at the 
medical school 
This spring Richard Belitsky, M.D., 
associate professor of psychiatry, 
was named deputy dean for edu¬ 
cation, effective July 1. Belitsky, 
the deputy chair for education in 
his department, has had a major 
impact on the teaching of both 
medical students and residents. 
He succeeds Herbert S. Chase Jr., 
M.D., who stepped down at the 
end of the academic year. 
Belitsky has received three 
top teaching awards from Yale 
since 1998, as well as several from 
his colleagues in psychiatry at 
the national level. He was inducted 
into the School of Medicine’s 
Society of Distinguished Teachers 
in 2002. He has a reputation for 
a high level of skill in resolving 
complex clinical problems and is 
one of the persons most fre¬ 
quently consulted by colleagues 
when making a referral. He is also 
a highly effective administrator, 
adept at framing and working 
through issues with colleagues in 
many departments, conceiving 
and launching new programs and 
sorting and extracting the data 
required for good decision making. 
Also this spring, Laura R. Ment, 
M.D., professor of pediatrics 
and neurology, was appointed 
associate dean for admissions and 
chair of the admissions commit¬ 
tee, effective July 1. Ment succeeds 
Thomas L. Lentz, m.d. ’64, who 
retired on June 30 after 38 years in 
admissions at the School of Medi¬ 
cine. She has received numerous 
awards for excellence in teaching 
since 1979. 
Ment is a leading authority on 
injury and recovery in the develop¬ 
ing brain of preterm infants and 
on stroke in children. She is the 
author of more than 150 scholarly 
articles and a member of the 
National Advisory Neurological 
Disorders and Stroke Council, the 
major advisory panel of the 
National Institute of Neurological 
Disorders and Stroke. 
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Fertility, drug discovery and a good-bye 
In our cover story for this issue, Contributing Editor Marc 
Wortman reports on the time he spent with pharmacology 
Chair Joseph Schlessinger, offering a profile of the pioneer in 
drug development who was born under siege in the former 
Yugoslavia during World War II. 
Also in this issue, Contributing Editor Jennifer Kaylin 
examines new methods of preserving fertility in women 
undergoing cancer treatment. These new techniques are 
offering hope to women who might otherwise be unable to 
have children. 
Finally in this issue we say farewell to Herbert S. 
| Chase Jr., m.d., deputy dean for education. We first met 
Herb in 1999, between the announcement of his appoint¬ 
ment and the date of his assuming his new job at Yale. 
Earlier this year he announced his return to Columbia 
University’s College of Physicians and Surgeons. Over the 
years we’ve been struck by Herb’s eloquence in advocating 
improvements in medical education. He’s been a pleasure 
to work with and he will be missed. 
This spring brought us good news in the form of acco- 
1 lades. First we learned that one of our contributors, David 
:! M. Oshinsky, ph.d., the George Littlefield Professor 
of American History at the University of Texas at Austin, 
SECOND OPINION BY SIDNEY HARRIS 
had been awarded the 2006 Pulitzer Prize in History for 
“a distinguished book upon the history of the United 
States” on April 17. Polio: An American Story was featured 
by Time magazine in June as one of five recent books 
that readers should not miss. Oshinsky wrote “Breaking 
the Back of Polio” for the Autumn 2005 issue of Yale 
Medicine about the late Dorothy Millicent Horstmann, m.d., 
fw ’43. Horstmann, the first female professor of medi¬ 
cine at Yale, conducted research that led to a breakthrough 
in the development of polio vaccines. Oshinsky repeated 
his tribute to Horstmann in a talk that he gave to the 
New York Academy of Medicine in January. 
Then we learned that Yale Medicine had received two 
Circle of Excellence Awards from the Council for Advance¬ 
ment and Support of Education (case). We won a silver 
medal in the category of Special Interest Magazines. And 
Contributing Editor Cathy Shufro won a bronze medal 
from case in the category of Best Articles of the Year for 
“The Unseen Wounds of War,” which appeared in the 
Autumn 2005 issue of Yale Medicine. Shufro wrote about 
post-traumatic stress disorder in veterans returning 
from Iraq and the role of Vietnam veterans in providing an 
informal support network for the younger men. 

























4 chronicle NEWS FROM CEDAR STREET 
Meet the new dean 
of public health 
Harvard professor Paul Cleary, a 
medical sociologist, has studied how 
patients relate to health systems. 
At first glance, Paul D. Cleary, ph.d., 
might seem an unorthodox choice to 
be dean of public health. The one-time 
rock and blues pianist started out as 
a medical sociologist, but a look at his 
research projects and publications 
shows that he’s spent his career explor¬ 
ing behaviors that affect health and 
how people interact with the systems 
that provide health care. His work 
has sought better ways to find out how 
patients view their care; he has also 
studied what determines variations in 
the quality of care. He’s traveled the 
world to study hiv/aids, smoking, 
alcohol abuse and mental illness. 
“The things I have focused on are 
health behavior, analytic methods, 
research that people refer to as social 
epidemiology, statistical modeling, 
health policy and behavioral science,” 
Cleary, a member of the Institute of 
Medicine of the National Academy of 
Sciences, said in an interview in 
March, about two weeks after Yale 
President Richard C. Levin and School 
of Medicine Dean Robert}. Alpern, 
m.d., announced his appointment as 
dean of public health and chair of 
the Department of Epidemiology and 
Public Health. 
Cleary, who enjoys bicycling, skiing 
and flying his private plane, began 
his work at Yale in July. He succeeds 
Michael H. Merson, m.d., the Anna 
M.R. Lauder Professor of Public 
Health, who stepped down as dean in 
2005 after 10 years on the job. Brian P. 
Leaderer, m.p.h. ’71, ph.d. ’75, served 
as interim dean for 18 months. 
“My philosophy of organization,” 
Cleary said, “is that I should make 
it easier for the faculty to do their 
job better.” 
Cleary also believes in program¬ 
matic research. “Let’s say you have two 
people, three people, four people who 
want to focus on cancer research. They 
may reinforce each other. You may 
be able to get more support for certain 
programs. You may be more likely to 
have an impact. Young assistant pro¬ 
fessors who want to work in that area 
will have mentors,” Cleary said. “I feel 
very strongly about developing research 
programmatically, fostering multidisci¬ 
plinary collaborations and developing 
excellence in focused areas.” 
Those areas of inquiry, he stressed, 
would be determined by the faculty. 
And his programmatic view would not 
preclude individual scholarship by 
faculty members, he said. “You rely on 
their vision and innovation to do 
things,” he said. 
Cleary’s academic path, also a bit 
unorthodox, began with his graduation 
from the University of Wisconsin in 
1970 with an undergraduate degree in 
physics, a field that still fascinates him. 
Advanced studies in physics seemed 
too abstract at a time when the real 
world of social ferment inspired by the 
Vietnam War and civil rights move¬ 
ment was beckoning. After taking time 
off from school to play in blues and 
rock bands, he chose to study medical 
sociology, also at Wisconsin. 
In 1982 he joined the faculty at 
Harvard, where, at the time of his 
appointment at Yale, he was professor 
Paul Cleary started as the new dean of public 
health in July. Cleary, who specializes in 
studies of interactions between patients and 
health care organizations, believes in pro¬ 
grammatic research, as well as the innovations 
of individual scientists. 
of health care policy in the depart¬ 
ments of health care policy and social 
medicine at Harvard Medical School. 
“I know that many of you, as I do, 
look forward to working with him 
in the years ahead," Levin told a gath¬ 
ering of public health faculty in the 
Winslow Auditorium. “You will find 
that he can be a sympathetic listener, 
someone who can pay attention to peo¬ 
ple and at the same time be capable of 
independent thinking and leadership.” 
Alpern, Ensign Professor of Medi¬ 
cine, said he shares Cleary’s vision 
of programmatic research and multi¬ 
disciplinary collaborations. 
Cleary and his wife, Cynthia 
Barnett, j.d. ’82, a corporate and envi¬ 
ronmental lawyer in Boston, have two 
children, Janet, 19, and Barnett, 14. 
—John Curtis 
Cancer Center moves forward 
after vote by New Haven Board 
of Aldermen 
In a unanimous vote in May, New 
Haven’s Board of Aldermen cleared the 
way for the construction of a new can¬ 
cer facility at Yale-New Haven Hospital 
(ynhh) for patient care and clinical 
research. With groundbreaking for the 
14-story, $450 million structure sched¬ 
uled for this fall, the facility will open 
its doors to patients at the end of 2009. 
The vote followed a marathon 
negotiating session in March in which 
the city, the hospital, a labor union 
and community groups resolved numer¬ 
ous issues surrounding the Yale Cancer 
Center (ycc). Under the agreement the 
city agreed to approve needed zoning 
changes; the hospital increased its 
offer of benefits to the community; and 
the hospital and the Service Employees 
International Union agreed to a nine- 
month organizing period for hospital 
workers, to be followed by a secret- 
ballot election. Mayor John DeStefano 
Jr. called the deal a “win-win-win” for 
all parties. 
For the hospital and medical school, 
the deal means the chance to continue 
improvements in cancer treatment 
and research. 
“The facility will allow us to meet 
our mission of providing exceptional 
care to the most acutely ill patients 
we serve,” said Marna P. Borgstrom, 
m.p.h. ’79, ceo and president of 
ynhh. Richard L. Edelson, m.d. ’70, 
professor of dermatology and director 
of ycc, agreed. “This is a huge step 
forward for the Yale Cancer Center’s 
capacity to provide truly state-of-the-art 
care,” he said. 
The hundreds of physicians, nurses, 
clinical researchers and laboratory 
technicians involved in cancer treat¬ 
ment at Yale are now dispersed 
throughout the hospital and medical 
school. The new building on Park 
Street will bring them together under 
one roof, with immediate benefits 
for patients, said Jose Costa, m.d., 
professor of pathology and deputy 
director of the ycc. “Our current facil¬ 
ities are the result of a cancer center 
that has been in existence for 30 years, 
and with the passage of time they have 
grown and have been remodeled to 
adapt to progress in clinical medicine, 
but in a less-than-ideal fashion,” Costa 
said. “The new building benefits from 
a clean, forward-looking design.” 
One of the biggest advantages of 
the unified facility will be easier access 
to state-of-the-art care for patients and 
families facing a challenging illness, 
Borgstrom said. 
“Cancer care is multidisciplinary, 
involving important input from several 
specialties,” Edelson said. “Bringing 
collaborative physicians together for 
face-to-face discussions—to put their 
heads together to discuss a challenging 
case when it is fresh in their minds, 
rather than simply reading one 
another’s notes in the chart—is simply 
the best way to do it." 
Although it is still three years 
from its scheduled completion date, 
A vote by New Haven’s aldermen and negotiations 
among the city, Yale-New Haven Hospital, com¬ 
munity groups and a labor union have paved the 
way for construction of the Yale Cancer Center. 
Among the specialists who will work in the new 
clinical pavilion are (seated, from left) Lyndsay 
Harris (breast cancer), Gary Friedlaender (sarcoma), 
Edelson said the project has already 
had an impact. Thanks in part to the 
plans for a new building, Edward 
Chu, m.d., the cancer center’s chief 
of medical oncology and director of 
clinical research, was able to recruit 
11 top clinical investigators to Yale in 
just two years. “We have to have the 
best doctors that we can possibly 
have, and we can do a much better 
job attracting them if we have the 
very best facilities,” Edelson said. 
With that new expertise and a new 
building on the way, Yale will be able 
to direct more clinical trials of treat¬ 
ments discovered at the School of 
Medicine, Edelson said. For Costa, the 
building’s advancement of both care 
and research will mark a new era in 
the ycc’s 30-year history. “We want to 
be practicing the medicine of tomor¬ 
row,” said Costa. “Let’s not remodel 
the house; let’s build a new house 
that is ideally suited not just for today, 
but for where we think we will be in 
10 years.” 
—Peter Farley 
Frank Detterbeck (thoracic), Wasif Saif (gastro¬ 
intestinal), Dennis Cooper (lymphoma/bone 
marrow transplant), (standing, from left) Mario 
Sznol (melanoma), Stephan Ariyan (melanoma), 
Donald Lannin (breast cancer), Francine Foss 
(lymphoma/bone marrow transplant) and Jack 























Ugandan doctors visit Yale in 
first steps of collaboration on 
medical education 
In 2002 Majid Sadigh, m.d., associate 
clinical professor of medicine, made 
the first of three trips to the Makerere 
University Medical School in Uganda. 
“1 am stunned,” he said on his return, 
“by the level of scientific elegance in 
that institution.” On his second visit 
two years later, Sadigh taught Ugandan 
medical students and residents. On his 
third trip, in the fall of 2005, he was 
joined by Asghar Rastegar, m.d., asso¬ 
ciate chair of medicine. Their goal this 
time went beyond simply teaching. 
"Makerere was a gold mine for some 
sort of collaboration,” Sadigh said, not¬ 
ing the enthusiasm for a partnership 
on both sides. 
In March three ranking members 
of Makerere’s medical faculty spent a 
week at Yale to pursue that collabora¬ 
tion. “The major areas of interest are 
medical education and the importance 
of clinical care,” said Samuel Luboga, 
m.d., deputy dean of the medical school 
at Makerere. “Under that umbrella 
there will be specific programs.” 
The largest university in Uganda, 
Makerere is the alma mater of several 
presidents of African nations. The 
medical school was recently selected 
by the Academic Alliance for aids 
Care and Prevention in Africa, an 
international public-private partner¬ 
ship, as the site of the Infectious 
Diseases Institute, a regional center of 
excellence for hiv/aids care, training, 
research and prevention in East Africa. 
To be sure, hiv/aids is the country’s 
leading health problem, but not the 
only one. Infectious diseases, malaria 
and maternal morbidity and mortality 
also rank high. Then there is the short¬ 
age of doctors. 
In the best of circumstances, Luboga 
said, there is one physician per 18,000 
people. In the countryside, though, 
only one doctor may be available for 
35,000 to 50,000 people. “If I had my 
way,” Luboga said, “it would be one 
per thousand.” 
While at Yale, Luboga, Harriet 
Mayanga, m.d., chair of medicine, and 
Samuel Kaggwa, m.d., chair of surgery, 
visited colleagues in surgery, infectious 
diseases and medical education. 
As envisioned, the collaboration 
would see a year-round presence by Yale 
attendings, who would rotate through 
the 1,600-bed Mulaga Hospital in 
Uganda. Students and residents would 
also do rotations there. Ugandan fac¬ 
ulty, residents and attendings would 
come to Yale for training. 
The program fits into Yale’s vision 
of its mission as a global university 
and would offer Yale physicians, resi¬ 
dents and students experience with 
diseases not usually seen in the United 
States. Funding is being sought in 
Uganda and the United States. Ideally, 
the program would be sustainable for 
the long term. 
David L. Coleman, m.d. hs ’80, 
professor and interim chair of medi¬ 
cine, said the department is also seek¬ 
ing a partnership with a facility in an 
underserved community in Connect¬ 
icut. “We have taken the responsibility 
to improve public health and health 
care in communities, particularly com¬ 
munities that are underserved or have 
resource constraints.” He hopes to 
have the Ugandan exchange in place 
by the end of the 2006-07 academic 
year. “We want to help improve the 
health of the citizens of Uganda by 
assisting the leadership of Makerere 
University to improve medical educa¬ 
tion. We hope to make an enduring 
contribution while also learning from 
our colleagues in Uganda.” 
—John Curtis 
Students reach out to the 
uninsured at free medical clinic 
in Fair Haven 
The first patient to arrive at the haven 
Free Clinic when it opened its doors 
last November was in serious danger. 
The man had the highest level of 
thyroid-stimulating hormone that both 
the attending physician and medical 
director had ever seen. Although his 
condition could have been easily 
treated, he hadn’t sought help before 
because he has no health insurance. 
Since his visit to haven, however, he 
has had access to medications that keep 
his hyperthyroidism under control. 
haven, a new medical clinic in 
the Fair Haven neighborhood of New 
Haven, was founded with just such 
patients in mind, said Mallika Mendu, 
co-director of the clinic with Margaret 
Samuels-Kalow, a fellow member of 
the medical school’s Class of 2008. 
Organized by students in public health, 
medicine and nursing and in the 
Physician Associate Program (PA), 
haven (an acronym for Health Care, 
Advocacy, Volunteerism, Education 
and Neighborhood) provides an array 
of medical services to uninsured 
patients free of charge every Saturday 
morning. Each patient is seen by a 
team of students and a volunteer 
attending physician, as well as at least 
one of the clinic’s medical directors. 
Medical students, working under the tutelage 
of faculty preceptors, opened a free Saturday 
morning clinic in New Haven’s Fair Haven neigh¬ 
borhood. Students Erica Mintzer (left) and 
Susan Mathai met with a patient at the clinic 
in January. 
A physician or nurse practitioner from 
the Fair Haven Community Health 
Center, which houses haven, acts as 
attending supervisor. In addition, 
faculty from the medical and nursing 
schools and the PA program serve 
as attendings. 
haven differs from the Fair Haven 
Clinic in several ways. The Fair Haven 
Clinic is not free—patients are seen 
on a sliding scale—and it is open only 
on weekdays. And haven incorporates 
Yale faculty, who serve as attendings 
and provide pro bono specialty refer¬ 
rals. In this way haven hopes to reach 
a population for which few medical 
services are available. 
Most patients come in with multi¬ 
ple unmanaged chronic diseases such 
as diabetes and hypertension, said 
education coordinator and medical stu¬ 
dent Corinna Levine. The students run 
an education program that provides 
general information about diseases 
and their management, which supple¬ 
ments the instructions the patient 
receives from the attending physician. 
Patients also receive a social work 
consultation about agencies that pro¬ 
vide assistance with such nonmedical 
issues as housing. Cynthia Correll, the 
clinic’s social work coordinator and a 
second-year medical student, said that 
most patients are unaware that they 
may be eligible for public health insur¬ 
ance programs. Applications are com¬ 
plicated and often not available in 
Spanish, the language spoken by most 
of the clinic’s patients. To overcome 
the language barrier, the clinic staff 
includes student interpreters. 
haven receives funding from all 
the Yale health professions programs 
and is seeking grants from community 
sources. Yale-New Haven Hospital is 
donating laboratory services and clinic 
organizers have built up a stock of 
medicines to give to patients. 
For the students, the clinic is a way 
to help others. “There’s a real need in 
our own community,” said first-year stu¬ 
dent Rachel Solomon. 
—Colleen Shaddox 
YALE JOINS IN AIDS INITIATIVE 
Public health faculty at Yale will work with 
the William J. Clinton Foundation hiv/aids 
Initiative and the Ethiopian Ministry of Health 
to launch the Ethiopian Hospital Manage¬ 
ment Initiative to improve management of 
the public hospital system in Ethiopia. 
Under this initiative, mentors from the 
United States and other countries will work 
with directors of io to 12 public hospitals and 
health bureaus in Ethiopia to identify sys¬ 
temic changes that can improve provision of 
health care to the country’s 76 million people. 
“We want the Yale-Clinton Foundation 
mentors to think outside the box, tell us 
what they see and what they recommend, 
and then we will consider it,” said Adhanom 
Chebeysus m.d., the Ethiopian minister 
of health, who proposed the collaboration. 
Elizabeth H. Bradley, m.b.a., ph.d., asso¬ 
ciate professor of public health, directs the 
project at Yale. The Yale team has completed 
a needs assessment in Ethiopia and has 
recruited the 22 fellows to serve in this effort, 
which began on July 1. 
—J.C. 
CDC FUNDS PREPAREDNESS CENTER 
To ensure a swift, coordinated response to 
disasters, disease outbreaks and acts of 
terrorism, the Department of Epidemiology 
and Public Health received a $4.5 million, 
five-year grant in February from the Centers 
for Disease Control and Prevention to 
establish the Yale Center for Public Health 
Preparedness. 
Staff at the center, one of 52 nationwide, 
will assess the training needs of Connecticut’s 
public health work force, develop curricula 
and ensure that training is provided. The 
center will also expand the public health 
preparedness curriculum available at Yale. 
Brian P. Leaderer, m.p.h. ’71, ph.d. ’75, the 
Susan Dwight Bliss Professor of Public Health, 
is the principal investigator on the grant. 
Linda C. Degutis, m.s.n. ’82, dr.ph. ’94, 
associate professor of surgery (emergency 
medicine) and of epidemiology and public 
health, is the director of the center. 
—J.C. 
Rounds MEDICINE AND HEALTH AT YALE 
Beauty of Botox is 
more than skin deep 
Yale scientists employ botulinum 
toxin, known for its cosmetic uses, 
to treat neurological disorders. 
For centuries, botulinum toxin has 
been known as the cause of the para¬ 
lytic and sometimes fatal illness known 
as botulism. Best known by the brand 
name Botox, the toxin’s type A variant 
has a reputation as a cosmetic and is 
famous for smoothing furrowed brows. 
Bahman Jabbari, m.d., professor of 
neurology, is among a small number of 
clinicians with expertise in the toxin’s 
many therapeutic uses. He and his 
Yale neurology colleagues are using it 
to treat a constellation of neurological 
disorders, migraine headaches and 
other complaints in a growing practice 
that saw 300 patients last year. 
“It is a remarkable drug,” said 
Jabbari, the former chief of neurology 
at Walter Reed Army Medical Center in 
Washington, who was among the first 
Botox, known for its cosmetic uses, is now 
being used for clinical purposes—to treat 
neurological disorders, migraine headaches 
and other complaints. 
researchers to establish the drug’s 
effectiveness in treating pain. “It is 
something that gives very few side 
effects, yet the patient sees results that 
are so dramatic, so sustained.” 
Botulinum A is used to treat mus¬ 
cular symptoms in head trauma, stroke, 
cerebral palsy and multiple sclerosis. 
In these conditions, the relief comes 
from the toxin’s muscle-relaxing prop¬ 
erties—the same properties that make 
it useful to combat wrinkles, said 
Jabbari. But, he added, the drug has a 
range of biochemical actions effective 
in many conditions, including excessive 
sweating and salivation. Botulinum A 
offers a palliative option in many 
cases where other medicines had been 
unable to offer much comfort. 
“It is very satisfying to be able to 
give relief to patients with a chronic 
neurological disorder who previously 
had no hope,” said Jonathan M. 
Goldstein, m.d., associate professor of 
neurology and director of clinical serv¬ 
ices in the department. 
Jabbari’s current investigations 
focus on pain relief, which he believes 
is the greatest area of potential for 
botulinum A. Patient H. Stuart Engar 
volunteered for one of Jabbari’s stud¬ 
ies, hoping for a reprieve from excruci¬ 
ating neck pain. An undiagnosed 
neurological disorder had left Engar 
unable to work or perform such 
simple tasks as bending to unload the 
dishwasher. Though the study is com¬ 
pleted, Engar continues to get botu¬ 
linum A injections every three to four 
months for pain and mobility. He 
called the treatments “life-changing.” 
On a recent visit, Jabbari adminis¬ 
tered a series of injections in carefully 
pinpointed muscles along Engar’s 
neck. In some cases, physicians use 
electromyographic guidance to make 
the injections. Jabbari asked Engar if 
he experienced side effects from the 
treatment. Like most patients, he did 
not. The most common side effects are 
flu-like symptoms and muscle weak¬ 
ness, the latter of which is often pre¬ 
vented by proper dosage, Jabbari said. 
There is no danger to patients who 
take botulinum A long-term, he added, 
because the toxin gets deactivated in 
the body after three months. 
Patients do, nevertheless, express 
misgivings about Botox. When Huned 
S. Patwa, m.d., associate professor 
of neurology, picked up a syringe, the 
patient—a migraine sufferer—asked, 
“Do you know where it came from?” 
She was referring to a Florida 
physician who injected patients with 
a counterfeit version of the drug. The 
unlicensed product contained much 
higher concentrations of the toxin, 
causing patients to contract botulism. 
Ironically, botulinum’s promise as a 
weapon helped to unlock its healing 
potential. Army officer Edward J. 
Schantz, ph.d., first purified botulinum 
toxin type A in a crystalline form in 
1946 when the U.S. military was study¬ 
ing it as a weapon. Schantz later col¬ 
laborated with Alan B. Scott, m.d., who 
used the toxin to relieve strabismus 
(crossed eyes) in monkeys. Over the 
course of 20 years they developed a ver¬ 
sion of the toxin that won fda approval 
for testing on humans. They sold it to 
the pharmaceutical company Allergan, 
which branded the drug Botox. In 
1989, the fda approved it for the treat¬ 
ment of strabismus, blepharospasm 
and hemifacial spasm in patients over 
12 years old. 
Researchers like Jabbari see the 
drug’s future applications as broad and 
promising. For patients like Engar, 
clinical botulinum has already made a 
dramatic difference. “I can hold my 
grandchild,” he said. “That may seem 




a new way to manage blood 
loss in the operating room 
The most common method for track¬ 
ing blood volume during surgery— 
a catheter inserted into the heart that 
transmits information to a monitor—is 
not only invasive, but not very accurate. 
This leads, according to Kirk H. 
Shelley, m.d., ph.d., associate profes¬ 
sor of anesthesiology, to a delicate 
clinical balancing act with very high 
stakes. “Too little fluid can put a 
tremendous amount of stress on the 
kidneys, the cardiovascular system 
and the central nervous system,’’ 
Shelley said. “But if you give too 
much fluid for the heart to pump, it 
backs up, causing bloating and pul¬ 
monary edema.” 
Now Shelley, who as chief of ambu¬ 
latory surgery oversees about 8,000 
surgeries a year at Yale-New Haven 
Hospital, has found a possible solution 
I to this surgical dilemma. By combin¬ 
ing a clinical insight from the 1870s 
with data provided by the modern 
pulse oximeter, a clothespin-like clip 
placed on a fingertip, ear or toe to 
measure the oxygen level in the blood, 
Shelley has discovered a noninvasive, 
precisely quantified method to monitor 
blood loss and guide difficult decisions 
i in the operating room. 
The pulse oximeter has become a 
common sight in hospital hallways 
since it was first introduced in the 
1980s. The clips contain light-emitting 
diodes that shine both visible red and 
infrared light through the skin. Because 
deoxygenated hemoglobin allows 
infrared light to pass but absorbs red 
light, while oxygenated hemoglobin 
allows red light to pass and absorbs 
infrared, the oximeter can detect 
changes in the blood’s oxygen satura¬ 
tion by calculating the relative absorp¬ 
tion of red and infrared light. 
In those early days of the pulse 
oximeter, Shelley discovered that 
oximetry clips generated exceedingly 
complex waveforms that were 
“cleaned up” by oximeter manufac¬ 
turers in favor of clear, simple sig¬ 
nals. But Shelley’s curiosity about the 
wealth of information produced 
by early oximeters prompted him to 
devise software to sift through the 
raw oximetry signal for potentially 
valuable clinical information. 
Shelley found that pulsus para¬ 
doxus—a drop in blood flow after 
a deep breath caused by the mechani¬ 
cal ventilation used in anesthesia— 
could be detected in the raw oximetry 
waveform. 
“There’s all sorts of wild, raw data 
that comes off the pulse oximeter 
that companies have worked hard to 
eliminate, because it has been seen as 
just noise,” said L. Alan Carr, ph.d., 
then a senior licensing associate in 
Yale’s Office of Cooperative Research 
who shepherded the discovery through 
a patent application. “What’s ironic 
is that the background data actually 
had useful information in it.” 
Shelley plans to mine the pulse 
oximeter for even more clinical treasure, 
and he is adapting his method for use 
in nonventilated patients suffering from 
blood loss, such as trauma patients 
arriving at emergency departments. 
—Peter Farley 
WORK, HABITS AND HEALTH 
Researchers in Epidemiology and Public 
Health have received $1.7 million from the 
National Institute on Aging to study the 
interplay of work-life, health habits and 
health over a lifetime. For the study, “Work- 
life, Health Habits and Health: Longitudinal 
Analysis of Aging,” researchers will build 
a life cycle model, covering adolescence to 
late life, that evaluates occupation, smoking 
and drinking and obesity. 
The study began in March and will con¬ 
tinue through February 2010. Jody L. Sindelar, 
ph.d., professor of public health, is the prin¬ 
cipal investigator. “Since much of life is spent 
working, characteristics of work are poten¬ 
tially important risk factors and can be 
viewed in the same vein as health habits,” 
she said. 
—John Curtis 
YALE TO STUDY LEISHMANIASIS 
Yale researchers have received a $5.4 million 
grant from the National Institutes of Health 
for the study of cutaneous leishmaniasis 
(CL), a parasitic disease spread by the female 
sand fly. 
The grant will support three projects in 
Colombia. The first will develop the infrastruc¬ 
ture for clinical trials. The second will identify 
factors responsible for transmission as well as 
vector control measures. The third will study 
immunological responses to the parasite. 
“With over 400 species of sand flies in 
the Americas alone and at least a dozen 
species of CL occurring all over the world, the 
epidemiology of leishmaniasis is complex,” 
said co-principal investigator Leonard E. 
Munstermann, ph.d., senior research scien¬ 
tist in epidemiology (microbial diseases). 
“However, we believe that the current study 
in Colombia can become a sound epidemio¬ 
logical model for other endemic regions.” 
The program is a collaboration with the 
Centro Internacional de Entrenamiento e 
Investigaciones Medicas in Cali, Colombia. 
Diane M. McMahon-Pratt, PH.D., professor of 
epidemiology, is the co-principal investigator 






















10 Findings from the bench 
Can microRNAS put the 
brakes on cancer? 
Between 20 and 25 genetic letters long, 
microRNAS regulate the expression 
of genes involved in development. 
One of the basic premises of biology is 
that our genetic code lies in our dna, 
which, in turn, relies on rna to trans¬ 
mit that code to build the proteins that 
carry out the chemical activities neces¬ 
sary for life. 
In the early 1990s, however, 
scientists at Harvard Medical School 
discovered a genetic switch in the 
microscopic roundworm C. elegans 
that called into question long-held 
beliefs about the role of rna. Lin-4 
was the first of what would become 
known as microRNAS. 
Only 22 genetic letters long, lin-4 
is far shorter than a typical 1,000- 
letter rna message, and rather than 
helping to build proteins, it sticks 
to messenger rna and shuts down 
the expression of genes involved in 
early development. 
It would be seven years before 
Frank Slack, ph.d., showed that lin-4 
was no fluke. In 2000, while a post¬ 
doctoral fellow at Harvard, Slack, 
now associate professor of molecular, 
cellular and developmental biology 
at Yale, identified a second microRNA, 
let-7, that also governs development 
in C. elegans. 
Then the floodgates opened. In 
the past five years, hundreds of gene- 
silencing microRNAS have been 
found in plants and animals, includ¬ 
ing over 200 in humans that may 
regulate more than a third of our 
genes. Because half of the C. elegans 
genome matches our own, including 
the genes for let-y, Slack’s research 
is having an impact on our under¬ 
standing of human development, 
aging and illness, especially cancer. 
According to Slack, one of the pri¬ 
mary roles of microRNAS is to put 
a brake on cell proliferation during 
development. “Initially in the human 
embryo, you’ve got cells just dividing, 
dividing, dividing—to make as many 
cells as possible,” he said. “But at 
some point you want to make an 
organ. MicroRNAS come on to tell cells 
to stop dividing and to start differenti¬ 
ating into organs. And they stay on 
all through life, to keep the cells from 
dividing again.” Slack believes that the 
uncontrolled cell division that is a hall¬ 
mark of cancer might be caused when 
the check on cell growth imposed by 
microRNAS is somehow lifted. “In vari¬ 
ous cancers we’ve looked at, microRNAS 
have been shut off,” he said. “We think 
that causes cells to re-enter their cell 
division program and behave like 
they’re in the embryo.” 
In particular, Slack has found that 
let-y is tamped down in human tumors, 
unleashing Ras, a cell-proliferation 
gene that has long been implicated in 
cancers of the lung and pancreas. 
Slack is collaborating with Joanne 
B. Weidhaas, m.d., ph.d., assistant 
professor of therapeutic radiology, to 
develop microRNA-based diagnostic 
tools and treatments. According to 
Weidhaas, genomic analyses of tumors 
and cancer therapies targeting single 
genes have been largely disappointing, 
because hundreds of genes are faulty 
in any given cancer and it has been 
difficult to discern which mutations 
are most important. The excitement 
surrounding microRNAS, she said, 
stems from their ability to regulate 
entire suites of genes that underlie 
biological pathways. 
A 2005 study published in the 
journal Nature found that measuring 
the levels of just 217 microRNAS 
could generate clearer genetic signa¬ 
tures for tumors than 16,000 probes 
for messenger rna. Encouraged by 
these results, Slack and Weidhaas hope 
within two years to perfect a microRNA- 
based screening device that could help 
tailor cancer treatments to patients’ 
tumor types, and they are in the early 
stages of testing a let-y inhalant 
therapy to rein in uncontrolled cell 
growth in lung cancer. In addition, 
Weidhaas has shown that raising let-y 
levels in C. elegans makes the worm’s 
cells more sensitive to radiation, lead¬ 
ing her to conclude that a let-y treat¬ 
ment could be a powerful adjunct to 
standard radiotherapy. 
—Peter Farley 
Tissue engineering takes 
a leap forward with new 
scaffold design 
Tissue engineering began in the late 
1980s to fill a gap in the treatment 
of certain diseases—those for which 
transplants could offer a cure. There 
j isn’t enough natural human restora¬ 
tive tissue to go around, however, and 
two recent studies at Yale show how 
, clinical applications of tissue engineer¬ 
ing are coming within reach. 
In one study, researchers created 
! a tiny water-soluble “scaffold” that 
provides a framework for the growth 
of new blood vessels; in the other, 
they demonstrated that the technique 
for creating new arteries—manipulat¬ 
ing telomerase to extend cell life-— 
doesn’t necessarily cause cancer, as 
had been feared. Both papers appeared 
in the February 21 issue of the 
| Proceedings of the National Academy 
I of Sciences. 
Ij “A microvascular network is funda- 
a mentally important for tissue engi¬ 
neering,” said Erin Lavik, sc.d., an 
assistant professor of biomedical 
engineering and author of one of the 
studies. She added, however, that the 
“stability of microvascular networks 
has been a challenge.” 
Lavik’s team built scaffolds out of 
gelatin-like, porous hydrogels that can 
be chemically treated to form numer¬ 
ous interconnected internal pores. 
In collaboration with Joseph A. Madri, 
m.d., hs ’76, ph.d., professor of 
pathology and of molecular, cellular 
and developmental biology, Lavik and 
her colleagues seeded the gels with 
blood vessel cells, implanted them 
under the skin of mice and found that 
functional and stable vessel networks 
had formed after six weeks. 
Scientists have been able to create 
new arteries in humans by using the 
patient’s own cells, but one drawback 
has been that these replacements 
haven’t been as effective in older peo¬ 
ple. A second Yale team found a 
way around that problem last year. 
Researchers had previously used 
gene therapy to deliver telomerase, an 
enzyme that extends the cells’ normal 
life span by lengthening their chromo¬ 
somes following cell division. The 
technique worked, even in patients as 
old as 85, said Laura E. Niklason, m.d., 
ph.d., an associate professor of anes¬ 
thesiology and biomedical engineering. 
Telomerase, however, is highly active 
in cancerous cells. “One of the out¬ 
standing questions is, ‘How safe is 
this?’,” she said. 
In the latest study, which involved 
tissue samples from eight elderly 
patients and one young donor, Nikla- 
sorfs team took cells obtained during 
a coronary bypass procedure and 
increased telomerase expression. They 
discovered that they had not produced 
cancerous cells in so doing. “Just 
turning on telomerase by itself is not 
enough to create cancer,” she said. 
Although Niklason said more work 
is needed, her findings may one day 
enable the development of techniques 
for making replacement tissue. 
—John Dillon 
Scaffolds such as these, made of macroporous 
hydrogels, serve as the foundations for creating 
new blood vessels. 
FIGHTING A LETHAL MICROBE 
Scientists at Yale have discerned how the 
immune system fights the bacterium that 
causes Legionnaire’s disease. 
The bacterium, Legionella pneumophila, 
hides from immune defenses by living 
and multiplying in sealed vacuoles inside 
cells. Craig R. Roy, ph.d., associate pro¬ 
fessor of microbial pathogenesis and senior 
author of a study published in Nature 
Immunology in March, and colleagues found 
that a protein called Birc ie is key to detect¬ 
ing Legionella infection. 
Postdoc Dario S. Zamboni, ph.d., lead 
author of the study, showed that when 
bacterial products leave the infected cells, 
Birc ie activates a signaling pathway that 
stimulates a protease called caspase-i. 
The protease degrades other proteins in the 
infected cell, starting a cascade of events 
that results in cell death. 
“Identification of Birc ie and the caspase 
cascade gives us information about the 
process of how the body fights off infection 
by a potentially lethal microbe, as well as 
possible targets for treatments,” said Roy. 
—John Curtis 
GENE LINKED TO SOCIAL AVERSION 
Knocking out a gene in the brains of mice 
can counteract an aversion to social 
interactions, according to researchers at 
Yale and the University of Texas South¬ 
western Medical Center at Dallas. 
The scientists conditioned mice to avoid 
mice they didn’t know by exposing them 
to more aggressive mice. Then, using viral 
technology developed by Ralph J. DiLeone, 
ph.d., assistant professor of psychiatry at 
Yale and a co-author of the report that 
appeared in the journal Science in February, 
the researchers inactivated a gene called 
brain-derived neurotrophic factor (bdnf). 
Mice without bdnf did not develop 
defeated behavior, DiLeone said, suggesting 
that the gene is essential to developing social 
aversion as a response to aggressive behavior. 
“The results have implications for a num¬ 
ber of psychiatric conditions, including 
depression and post-traumatic stress disorder, 
where stressful events can have significant 
and long-lasting consequences for social 





















12 Books & ideas bookshelf 
Chemical warfare during the Cold War 
In a work of fiction, a Yale psychiatrist describes how the 
Army tested agents for use in war. 
Pfc. Don Wheatland sits on his bed babbling, pulse racing, 
occasionally swatting imaginary flies. Capt. Martin Baker, 
m.d., knows what has gone wrong. The soldier is a guinea 
pig in a test of VX; a single drop of this lethal neurotoxin 
can kill a man in 15 minutes by overstimulating the nervous 
system. The year is 1961, and the soldier is one of the “volun¬ 
teers” undergoing tests of potential chemical warfare agents 
at Edgewood Arsenal in Maryland. Wheatland has been 
vomiting, and an Army medical officer has been treating the 
soldier by injecting him with atropine—too much, as it 
turns out. The private is delirious from atropine poisoning. 
But the real problem will not emerge until later, when 
medical officer Baker gets a 10 p.m. phone call: “Wheatland 
has disappeared." 
This scene comes from Men and Poisons: The Edgewood 
Volunteers and the Army Chemical Warfare Research Program, 
a fictionalized account of life at Edgewood Arsenal in Mary¬ 
land by Malcolm Baker Bowers Jr., m.d., hs ’65 (Baker 
in the book). Bowers, now professor emeritus of psychiatry, 
spent three years as a medical officer at Edgewood begin¬ 
ning in 1959. Bowers said he was inspired to write and self- 
publish the book to provide an account of chemical war¬ 
fare research of the era. About 650 men were exposed to 
these nerve agents as part of Army research at Edgewood, 
according to the U.S. Army Medical Research Institute of 
Chemical Defense. 
In one scene that illustrates the vision of chemical 
warfare held at the time, a general tells the research staff: 
“Think of it: LSD-impregnated toilet paper gets delivered to 
the Kremlin.” 
In an interview at his office at 300 George Street, 
where he still sees patients, Bowers described his command¬ 
ing officer, who tested the poisons on himself first. “His 
approach to the feasibility of testing was to insist that he 
take at least twice the dose proposed for a volunteer.” 
Looking back, Bowers was struck by the lack of 
informed consent in that era. The 30 soldiers recruited for 
monthlong rotations had no idea what they were getting 
into, said Bowers, who provided them with medical care. 
Malcolm Bowers wrote a novel 
based on his experiences with 
chemical warfare agents at the 
Edgewood Arsenal. 
“They came to get a break from their bases and to check out 
the infamous bars along the harbor in Baltimore.” 
Before being exposed to nerve gases and hallucino¬ 
gens, the soldiers got only brief verbal explanations of what 
was to happen. They did not really consent, either. They 
signed no forms and, Bowers noted, “There was no question 
that they would participate.” 
Bowers recounted in his book how a seemingly 
healthy volunteer given lsd became psychotic and had to be 
sent to a psychiatric hospital. He was later diagnosed with 
paranoid schizophrenia. Bowers said that seeing such cata¬ 
strophic drug reactions sparked his interest in how drugs 
can trigger psychiatric illness—the subject of another self- 
published book, Abetting Madness: The Role of Illicit and 
Prescribed Drugs in Promoting Psychotic and Manic Disorders. 
Bowers’ account rings true to his colleague George 
K. Aghajanian, m.d. ’58, the Foundations Fund Professor of 
Psychiatry and Pharmacology, who served in the Army at 
Edgewood beginning a year after Bowers left. “It’s not fic¬ 
tion," he said, “Just the names are fictional.” 
Before Bowers and Aghajanian arrived at Edgewood, 
the work there had led to a therapeutic breakthrough: the 
first cancer chemotherapy agent. Two Yale pharmacologists, 
Louis S. Goodman, m.d., and Alfred Gilman, ph.d., showed 
that the World War I gas nitrogen mustard could shrink 
lymphatic tumors. Their study was published in The Journal 
of the American Medical Association in 1946. 
As for the soldier on whom Wheatland was based, he 
was found in New York City two days after he disappeared, 
when he asked a police officer what city he was in. The 
resulting newspaper headlines embarrassed the Army, but 
the soldier recovered. 
—Cathy Shufro 
Bookshelf is a column focusing on books and authors at the School of 
Medicine. Send ideas to Cathy Shufro at cathy.shufro@yale.edu. 
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Volume 1, Theory and Method, 
2nd ed. 
edited by Dante Cicchetti, ph.d., 
and the late Donald ). Cohen, 
m.d. ’66 (Wiley) The topics 
addressed in this volume derive 
from current research on 
developmental psychopathology 
and include cross-cultural per¬ 
spectives, developmental epi- 
1 demiology, self-determination 
1 theory and gender issues. 
Heart Care for Life: 
Developing the Program That 
Works Best for You 
by Barry L. Zaret, m.d., the 
Robert W. Berliner Professor of 
Medicine, and Genell (. Subak- 
, Sharpe, m.s. (Yale University 
I Press) This book outlines charac- 
I teristics common to each form of 
heart disease, from angina and 
heart attacks to high blood pres¬ 
sure and cardiac arrhythmias. 
The authors include instructional 
case histories and guide the 
reader in assessing personal vari¬ 
ables to develop an individual 
treatment and life style program. 
The authors also provide quizzes 
to assess risk factors and suggest 
questions that readers can ask 
their doctors. I Doctor, Can I Ask You a 
Question? Your Health Care 
Questions Answered 
■ by Arthur E. Baue, m.d., former 
I chair and Donald Guthrie Profes- Isor of Surgery (XLibris Corp.) 
This book provides information 
■ that patients need in order to 
be informed about their health 
i care. Baue discusses finding a 
qualified doctor; patient-doctor 
relationships and patient rights; 
disease prevention; and senior 
; health care. 
Another Day in the Frontal Lobe: 
A Brain Surgeon Exposes Life on 
the Inside 
by Katrina S. Firlik, m.d., assist¬ 
ant clinical professor of neuro¬ 
surgery (Random House) Firlik 
provides an inside look at the 
work of a brain surgeon, from 
the basic tools used in brain sur¬ 
gery to the ethical dilemmas 
that neurosurgeons face. She 
describes some of her more 
bizarre cases—such as a man 
with a three-inch nail shot into 
his brain—and the process of 
speedy decision making after 
a patient has suffered a head 
injury or stroke, when time is 
critically important. She also 
predicts what she believes to be 
the future of brain surgery— 
“brainlift” procedures that prom¬ 
ise cognitive enhancement. 
Life Is With Others: Selected 
Writings on Child Psychiatry 
by the late Donald ). Cohen, m.d. 
’66, edited by Andres Martin, 
m.d., m.p.h., and Robert A. King, 
m.d. (Yale University Press) 
Cohen, former director of the 
Child Study Center, made ground¬ 
breaking contributions to the 
study of autism and develop¬ 
mental disabilities,Tourette syn¬ 
drome, developmental psycho¬ 
pathology, child psychoanalysis 
and children’s adaptation to 
trauma.This book addresses top¬ 
ics including childhood psychiat¬ 
ric disorders; research ethics; 
mentorship; and the role of play 
fantasy, aggression and violence 
in childhood. Selections also 
include autobiographical writings. 
Oasis in the Overwhelm: 
60-Second Strategies 
for Balance in a Busy World 
by Millie Grenough, m.s.w., 
clinical instructor in psychiatry 
(social work) (Beaver Hill Press) 
The author shares strategies 
that she designed to balance 
her work and personal life. 
She has developed a process to 
reduce stress and improve pro¬ 
ductivity; manage distractions 
and sharpen focus; and create 
a way of life that increases 
both personal and professional 
satisfaction. 
Out of the Woods: Tales of 
Resilient Teens 
by Stuart T. Hauser, m.d. ’66, 
Joseph P. Allen, ph.d., and Eve 
Golden, m.d. (Harvard University 
Press) Through interviews with 
70 people who had been institu¬ 
tionalized in a psychiatric facility 
during their adolescence, the 
authors investigate why some 
teens bounce back from a trou¬ 
bled adolescence while others 
don’t. The authors observe that 
the subjects who fared best 
had an interest in and capacity 
for reflection, responsibility 
and relationships, as well as a 
positive attitude and the desire 
to change. 
Principles and Practice of 
Geriatric Psychiatry 
edited by Marc E. Agronin. M.D., 
and Gabe J. Maletta, m.d., ph.d. 
(Lippincott Williams & Wilkins) 
This textbook combines the 
insights of psychiatry, medicine 
and neurology by using scien¬ 
tific principles of geriatric psy¬ 
chiatry and clinical practice to 
provide evidence-based guide¬ 
lines for care of the elderly. 
Contributors use case studies to 
illustrate these principles. 
The Medical Interview: 
Mastering Skills for Clinical 
Practice, 5th ed. 
by John L. Coulehan and Marian 
R. Block, m.d. ’71 (F.A. Davis) 
This updated text helps medical 
students and other health- 
professions students learn good 
communication skills, including 
basic history-taking, conveying 
bad news and communicating 
unanticipated adverse out¬ 
comes. The authors also address 
ethical and legal issues relating 
to medical interviews. 
The Secrets of Happily Married 
Men: Eight Ways to Win Your 
Wife’s Heart Forever 
by Scott Haltzman, m.d., hs ’89, 
and Theresa Foy DiGeronimo 
(Jossey-Bass) This book lists 
eight common sense strategies 
for men committed to building 
happy marriages. Among these 
suggestions are: learn to listen, 
make your marriage your job, 
know your wife and aim to 
please. The authors supply to- 
do lists and examples of success¬ 
ful interactions. 
Home Long-Term Oxygen 
Treatment in Italy: 
The Additional Value of 
Telemedicine 
by Allen I Goldberg, m.d., hs ’70 
(Springer) This book describes 
the evolution in the home man¬ 
agement of severe chronic respi¬ 
ratory insufficiency over the 
last two decades in Italy. Gold¬ 
berg covers epidemiological 
aspects, complicating events, 
current systems for oxygen 
delivery, changing approaches 
to the patient-caregiver rela¬ 
tionship, the economic burden 
of home management and the 
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New library software helps find the 
needle in the haystack 
Evidence-Based Psychotherapy: 
Where Practice and Research 
Meet 
edited by Carol D. Goodheart, 
Alan E. Kazdin, ph.d., professor 
of psychology and director of 
and professor in the Child Study 
Center, and Robert J. Sternberg, 
ph.d. (apa Books) The authors 
acknowledge differences 
between the fundamental pur¬ 
poses of research and clinical 
practice in psychology and pre¬ 
sent varying viewpoints on the 
contributions and limitations 
of evidence-based practice. The 
book provides perspectives on 
how to improve psychotherapy 
from leading figures in both 
clinical practice and research. 
Brain and Culture: Neurobiology, 
Ideology, and Social Change 
by Bruce E. Wexler, m.d., profes¬ 
sor of psychology (The mit Press) 
Wexler explores the social impli¬ 
cations of the close relationship 
between an individual’s neural 
and psychological make-up and 
how the individual interacts 
with the social and cultural envi¬ 
ronment. He integrates recent 
neurobiological research with 
major experimental findings in 
cognitive and developmental 
psychology, making reference 
to psychoanalysis, literature, 
anthropology, history and politics. 
Rethinking Substance Abuse: 
What the Science Shows, and 
What We Should Do About It 
edited by William R. Miller and 
Kathleen M. Carroll, ph.d., pro¬ 
fessor of psychiatry (The Guilford 
Press) Leading experts describe 
what substance-abuse treatment 
and prevention would look like if 
they were based on the best sci¬ 
ence available.The writers sum¬ 
marize current thinking about 
the nature and causes of alcohol 
abuse and other drug problems; 
what works at the individual, 
family and societal levels; and 
how to develop more effective, 
humane treatments and serv¬ 
ices. The book incorporates 
developmental, neurobiological, 
genetic, behavioral and social- 
environmental perspectives. 
Understanding Depression in 
Women: Applying Empirical 
Research to Practice and Policy 
edited by Carolyn M. Mazure, 
ph.d., professor of psychiatry, 
and Gwendolyn Puryear Keita 
(American Psychological 
Association) Women are more 
likely to suffer from depression 
than are men, and depression is 
the leading cause of disability 
for women throughout the 
world. The editors survey the 
findings of over 40 experts on 
depression and explore the lat¬ 
est strategies for treatment, 
prevention and service delivery. 
The descriptions above are based on 
information from the publishers. 
SEND NOTICES OF NEW BOOKS TO 
Cheryl Violante, Yak Medicine, 
300 George Street, Suite 775, 
New Haven, CT 06511, or via e-mail 
to cheryl.violante@yale.edu 
Some researchers and clinicians may feel joy when they 
consider that the database PubMed contains 16 million 
citations for journal articles. But for others, the possibilities 
of the information superhighway are overwhelming. 
Fortunately, Charles J. Greenberg, m.l.s., m.ed., can offer 
strategies for finding what’s useful. 
“You have to learn how to confront the large quantity 
of information and make it manageable,” said Greenberg, 
head of Curriculum and Research Support at the Cushing/ 
Whitney Medical Library. 
One useful approach is to use automated systems to 
tailor the flow of information to one’s interests. 
PubCrawler (http://pubcrawler.gen.tcd.ie/). My ncbi 
(http://www.ncbi.nlm.nih.gov/) and BioMail (http://biomail. 
sourceforge.net/biomail/) all automatically search for newly 
indexed articles in PubMed. The user creates search param¬ 
eters and then receives citation alerts about new articles 
via e-mail. Alternatively, PubCrawler and My ncbi can save 
articles in a user’s account on the application website. 
For best-practices, one-stop shopping, Greenberg rec¬ 
ommends UpToDate (www.uptodate.com), which, he says, 
“replaces a shelf of textbooks” and is more current. This 
online compendium supplies regularly revised information 
for 13 clinical specialties and can keep clinicians informed 
about new treatment recommendations. It can also remind 
or update clinicians about ways to treat a problem they 
rarely see—say, when a surgeon gets a question about an 
ear infection. 
Greenberg believes that all computer sophisticates 
need to use rss, or really simple syndication, an alternative 
to e-mail. Users can obtain grant announcements, fda 
alerts and even check their Netflix dvd account queue using 
rss. Users can sign up for an rss “feed” by finding the 
orange xml or similar button on any Web page that offers 
rss feeds. To view the content, one needs an rss reader 
that automatically checks feeds. Examples of readers are 
available at www.bloglines.com and www.feedmaker.com. 
All Yale faculty, staff and students have an Rss-reading portal 
account at www.yale.edu/yaleinfo. 
—Cathy Shufro 
In Circulation is a column focusing on activities at the Cushing/Whitney 
Medical Library. Send ideas to Cathy Shufro at cathy.shufro@yale.edu. 
ON CAMPUS 15 
Public health plans lacking, 
although stakes are high 
Despite the 9/11 attacks and the 
subsequent anthrax scare, the 
United States, said Nicole Lurie, 
m.d., m.s.p.h., has become com¬ 
placent about public health. 
“Just when we were in danger 
of going back to sleep we had 
sars and then the nightmare 
of Hurricane Katrina,” said Lurie, 
a former official in the U.S. 
Department of Health and 
Human Services, and now an 
analyst at the rand Corp. 
In the 9th annual Samuel O. 
Thier Lecture at medical grand 
rounds in January, Lurie said 
public health preparedness lacks 
consistent standards, often has 
insufficient emergency plans 
and has flawed communications 
between health departments 
and providers. To assess local 
responses, Lurie and her col¬ 
leagues phoned in feigned 
emergencies, such as plague 
symptoms, only to be told to call 
back later. They also conducted 
more than 30 table top exercises 
around the country. While some 
responders were "absolutely ter¬ 
rific,” Lurie said, "you see things 
that are really terrifying.” 
Local responses are critical, 
she said.“A weak link is going 
to have major consequences for 
the country and the world." 
Lurie called on the faculty and 
students to make personal pre¬ 
paredness plans, and to become 
involved with their state and 
local health departments in 
preparing for public health 
emergencies. 
—John Curtis 
Contact with nature can 
be therapeutic 
Bringing flowers to a sick friend 
does more than fulfill a social 
convention, according to Stephen 
R. Kellert, ph.d., the Tweedy/ 
Ordway Professor of Social Ecol¬ 
ogy at the School of Forestry 
and Environmental Studies.The 
fact that nearly every hospital¬ 
ized patient has a bedside bou¬ 
quet reflects “a deep-held need” 
for contact with nature, said 
Kellert in a March talk sponsored 
by the Program for the Human¬ 
ities in Medicine. 
Studies have shown that 
proximity to nature, including 
contact with pets, can be thera¬ 
peutic, said Kellert. Until humans 
established the first cities 5,000 
years ago, survival depended 
solely on paying close attention 
to predators, weather and sources 
of food and water, Kellert noted, 
and so humans are evolutionar- 
ily programmed to feel drawn 
to “the organized complexity” 
of nature. 
Kellert said the absence of 
nature and the sterility of most 
of the modern urban built envi¬ 
ronment, including hospitals, 
can be remedied by incorporat¬ 
ing nature into the built envi¬ 
ronment. This, in turn, promotes 
both health and productivity. 
"It’s a design failure that we can 
remediate through good design.” 
A champion of health 
insurance for all 
During his lifetime, Isidore S. 
Falk, ph.d., professor emeritus 
of public health at Yale, was a 
towering figure in public health, 
championing universal health 
insurance as early as the 1930s. 
Now, 20 years after his death, 
although Falk’s work is largely 
forgotten, it remains relevant, 
Ronald T. Rozett, m.d., m.p.h., 
told his audience at the April 
meeting of the Beaumont 
Medical Club. 
"Falk wanted minimum medi¬ 
cal insurance for all Americans, 
not just the old and the sick,” 
said Rozett, director of the Mas¬ 
ter of Health Administration 
Program at Ouinnipiac 
University in Hamden, Conn. 
Among the staunchest oppo¬ 
nents of publicly funded health 
insurance was the American 
Medical Association (ama), 
whose members resented gov¬ 
ernment intrusion in their 
medical practice. When Falk 
worked with President Franklin 
D. Roosevelt to include health 
insurance in the Social Security 
Act, the ama undermined the 
proposal. Roosevelt ultimately 
focused on old age insurance 
alone, eliminating health insur¬ 
ance from the Social Security 
legislation. 
Rozett said the Bush adminis¬ 
tration’s recent social security 
proposal would have horrified 
Falk. “The idea of allowing peo¬ 
ple to opt out of the social 
security system undermines the 
concept of social insurance, 
where people who are healthy 
subsidize those who are not,” 
said Rozett. 
—Lori Ann Brass 
Lessons from a pandemic 
that never was 
In planning for a possible avian 
flu pandemic, said Harvey 
Fineberg, m.d., president of the 
Institute of Medicine, it is 
instructive to look at the recent 
past. Thirty years ago, Fineberg 
noted, the federal government 
began planning for a pandemic 
that never happened. Several 
people died of complications 
from a vaccine for swine flu, and 
that incident, coupled with a 
flawed outreach plan, bred mis¬ 
trust of the program. 
"That program was con¬ 
sidered a fiasco,” Fineberg said, 
addressing the annual meet¬ 
ing in April of the Associates of 
the Cushing/Whitney Medical 
Library.The plan had an unreal¬ 
istic goal of immunizing 95 per¬ 
cent of the American public, and 
the inability to attain this target 
obscured the unprecedented 
achievement of vaccinating 40 
million people, twice as many as 
in any previous year. 
Flu epidemics occur about 
three times a century, Fineberg 
said, denying scientists frequent 
chances to observe them. He 
called such events "low-likelihood, 
high-consequence” occurrences. 
"They are seriously difficult 
for experts and for policy¬ 
makers,” he said. “If you are a 
naysayer and you scoff at the 
prospect of preparation, more 
often than not you are going to 
be proved correct. That doesn’t 
mean it is wise or prudent if 























Rare volumes and a refuge 
from the blacklist 
Deemed a security risk and unable to find work, a psychologist in the McCarthy 
era found a home at Yale. 
By Jill Max 
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John P. Flynn, ph.d., a professor emeri¬ 
tus of psychology (psychiatry) who 
died in 1980 after 26 years on the Yale 
faculty, liked to tell the story of how 
he acquired some neurology books at 
a used bookstore in New York in the 
early 1940s. The owner, unaware of 
their value, sold the rare volumes to 
Flynn for just $10. 
The three-volume set, Textura del 
Sistema Nervioso del Hombre y de los 
Vertebrados, was written between 1897 
and 1899 by the Spanish histologist 
Santiago Ramon y Cajal, m.d., consid¬ 
ered the founder of modern neurosci¬ 
ence (this year is the centennial of the 
Nobel Prize in physiology or medicine 
to Cajal and Camillo Golgi, m.d.). John 
Gach, president of John Gach Books 
far left The gift to the Medical Historical 
Library of neuroscience texts that belonged to 
John Flynn recalled a Cold War tale involving 
Flynn and his wife, Hulda Rees McCarvey Flynn. 
left Flynn found a three-volume set written 
by a Spanish physician in a used bookstore 
in New York City. A lengthy inscription by the 
author, Santiago Ramon y Cajal, added to 
its value. 
above Textura del Sistema Nervioso del 
Hombrey de los Vertebrados is considered one 
of the two greatest books on neuroscience of 
the 20th century. 
17 
and an appraiser specializing in the 
neurosciences, described the set as 
“one of the two greatest neuroscience 
books of the 20th century,” along with 
The Integrative Action of the Nervous 
System, by another Nobel laureate, Sir 
Charles Scott Sherrington, m.d., pub¬ 
lished in 1906. (Sherrington’s book is 
a compilation of the Silliman Lectures 
he gave at Yale in 1904, which were 
originally published by Yale University 
Press in 1906.) Cajal was the first to 
describe the main types of neurons as 
separate cells, which became the basis 
of the neuron theory. He also hypoth¬ 
esized about how neurons interact 
through junctions to form the circuits 
for brain functions. The books, pur¬ 
chased by Flynn in the original 
Spanish edition, are especially prized 
because Cajal himself inscribed 
them, with a lengthy handwritten note 
explaining his reasons for writing 
them, in 1910. “They were my father’s 
most prized material possession,” 
said Flynn’s daughter, Sarah Flynn. 
Flynn came to Yale during the 
McCarthy era, when he was deemed a 
risk to national security. During the 
1930s and early 1940s, his wife, Hulda 
Rees McGarvey Flynn, ph.d., had been 
involved in an early teachers’ union 
and had supported the anti-fascist 
cause in the Spanish Civil War. After 
being called before the House Un- 
American Activities Committee in 
1953, Flynn was told he could keep his 
job as head of the Psychology and 
Statistics Division at the Naval Medical 
Research Institute (nmri) in Bethesda, 
Md., only if he divorced his wife. He 
chose to stay with her. 
Thirteen offers of employment 
came from universities in the ensuing 
months; in all but one case the univer¬ 
sity backed out. The exception was 
Yale, where Flynn was hired in 1954 
and worked with Paul D. MacLean, 
m.d. ’40, a professor of physiology and 
psychiatry who was studying the lim¬ 
bic system, and where he remained for 
the rest of his career. Yale’s president 
at the time, A. Whitney Griswold, 
believed strongly in academic freedom 
and was known for standing up to Sen. 
Joseph McCarthy. In a recent letter to 
Yale President Richard C. Levin, Sarah 
Flynn wrote: “My father was always 
very proud of being a Yale faculty 
member, and many are proud of Yale 
for taking the stand it did during this 
black period in our nation’s history.” 
The beginning of Flynn’s interest in 
psychology is almost as serendipitous a 
tale as that of his acquisition of the Cajal 
volumes. In the early 1940s, while a 
priest in Chicago, Flynn volunteered to 
study psychology in order to be able 
to teach it. He earned a ph.d. in experi¬ 
mental psychology at Columbia in 
1943. A year later he left the priesthood. 
In 1945, while working at the Psycho- 
Acoustics Lab at Harvard, he married 
McGarvey, whom he had met at Colum¬ 
bia and who later became an assistant 
professor of psychology at Yale. One year 
later, he went to nmri, where he began 
his work in physiological psychology. 
While at Yale, Flynn established the 
psychiatry basic science section at the 
Connecticut Mental Health Center and 
became internationally renowned for 
his studies on aggressive behavior and 
neural function. Each year the university 
holds a lecture in his honor. 
Flynn’s legacy at Yale now also 
includes the Cajal volumes, which his 
daughter donated to the Medical 
Historical Library last year. In remarks 
read at the presentation of the set in 
April 2005, Gordon M. Shepherd, m.d., 
ph.d., professor of neuroscience and 
neurobiology, said: “It will not only be 
an ornament in the library’s collection, 
but also a reminder of John Flynn’s own 
distinguished contribution to neurosci¬ 
ence at Yale, and of the generosity and 
thoughtfulness of Sarah Flynn in giving 
it a home in his memory.” 
Jill Max is a writer in Connecticut. 
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Six years ago, Herb Chase came to Yale to improve medical education. 
As he leaves, he and others reflect on his legacy. 
ART MEDICAL DECISION MAKING SCIENCE 
Herbert Chase believes that medical 
decisions lie at the intersection of 
art and science. Doctors must be able 
to access and analyze the outer 
reaches of scientific knowledge— 
what he calls the edge—and possess 
the clinical skills necessary to apply 
this knowledge to benefit the patient. 
Herbert S. Chase Jr., m.d., was living a life in New York City 
that suited him well. He’d been a professor at the Columbia 
University College of Physicians and Surgeons for 22 years, 
where he’d been honored for his teaching skills. His wife and 
two sons were happily engaged in city life, and he enthusiasti¬ 
cally attended the opera whenever his schedule allowed. But 
in 2000, David A. Kessler, m.d., then dean of the School of 
Medicine, asked him to come to Yale as deputy dean for edu¬ 
cation, and Chase felt as though he’d been offered the key to 
the Promised Land. 
What appealed to him about the medical school was 
the Yale System of Medical Education, with its emphasis 
on critical thinking in a nongraded, noncompetitive environ¬ 
ment. Although Yale in many ways adheres to the traditional 
approach to medical education—two years of basic science 
courses followed by two years of clinical training—Yale’s 
educational philosophy encourages students to become inde¬ 
pendent and scientific thinkers and places the responsibility 
for learning and mastering critical thinking on them. That 
philosophy struck Chase as the ideal environment in which 
to teach future doctors. The mandatory thesis, with its focus 
on independent, original research, appealed to Chase’s long- 
held belief that medical students need to learn to think like 
scientists. “The values of the faculty and administration were 
directly compatible with mine,” Chase recalls. 
But when Chase got to Yale, he soon realized that the 
Promised Land had suffered serious incursion's; its inhabi¬ 
tants were restive and outside forces threatened the very quali¬ 
ties that had made it an academic paradise. An ever-expanding 
curriculum was consuming time that students once devoted 
to their theses and the unstructured exploration of medicine— 
posing a direct threat to the Yale System’s commitment to 
self-directed lifelong learning. Meanwhile, the Liaison Com¬ 
mittee on Medical Education (lcme), the accrediting body for 
medical schools, said that students’ clinical skills needed to be 
formally assessed. (The accreditation process is about to get 
under way again at Yale.) In other words, mandatory testing— 
another move at odds with the core values of the Yale System. 
“I didn’t realize how far the actual practice of the Yale 
System had deviated from its philosophy,” Chase says. He 
spent the next six years trying to recast the School of Medicine 
into the place he’d found so enticing. To reduce classroom 
hours and create a more fluid curriculum, Chase merged 
courses in related disciplines and integrated basic and clinical 
sciences. He worked with the anatomy faculty, William B. 
Stewart, ph.d., and Lawrence J. Rizzolo, ph.d., to revamp the 
course for first-year students, turning it into a national model, 
and in a deviation from the traditional distinction between 
science and clinical years, he implemented the Clinical Skills 
Program that provides rigorous instruction and assessment 
during the first two years of medical school. 
These changes generated both angst and accolades 
among faculty and students. The general view, however, is that 
Chase reaffirmed the central importance of teaching at the 
medical school and created a framework on which his succes¬ 
sors could build. 
Last December Chase announced his plans to resign 
at the end of the academic year in June. He has since 
returned to the Columbia campus to explore the role of sci¬ 
entific training in medical decision making and to test his 
long-held theory that doctors who are scientifically trained 
will be more cautious when prescribing drugs or utilizing 
new technologies. Had he stayed at Yale longer, Chase 




















20 The Chase years 
four-year pharmacology curriculum and expanding students’ 
training in the analysis of medical literature. 
Easygoing, but with a clear vision 
Chase, a trim man with bright eyes, has the comfortable 
charm of someone who wears his self-confidence lilce an old 
cardigan. He laces his remarks with self-deprecating humor, 
easily acknowledges what he doesn’t know and is generous 
in his praise of others. At a recent talk, he graciously accepted 
a clarification from the audience, scribbling notes in the mar¬ 
gin of his speech. 
But underneath this easygoing facade, Chase had a 
clear-eyed view of what he wanted to accomplish. He took sug¬ 
gestions and entertained other views, but in the end he did 
what he thought was best, even if it ruffled some feathers. 
“In a job like Herb’s, you need to have a vision, and you 
need to go with it,” says Dean Robert J. Alpern, m.d., Ensign 
Professor of Medicine. “You try to build consensus, and some 
people will agree with you and some people won’t, but you 
need to decide where you’re going to go.” 
“Herb had a difficult job,” says Asghar Rastegar, m.d., 
associate chair and professor of medicine. “He attempted to 
bring a lot of people together.” 
Nancy R. Angoff, m.p.h. ’81, m.d. ’go, hs ’93, associate 
dean for student affairs, says that before Chase came to Yale 
the academic program was more “laissez-faire.” But the fac¬ 
ulty was frustrated by students’ poor attendance in classes and 
small discussion groups. “Herb was the first to say, ‘If they’re 
not coming to class, maybe it’s because the teaching is bad. 
We need to make sure the teaching is good so they have a rea¬ 
son to come to class.’ He was also the first person to say, ‘We 
need learning goals and objectives, so students know what the 
point is they’re supposed to be getting.’ He brought an educa¬ 
tor’s eye to this, not just a doctor’s. That was something that 
really had never been here before.” 
Chase recalls arriving at Yale to be told that people 
were “unhappy” and that he needed to “fix” the curriculum. 
“My diagnosis, which took me a while," he says, “was that 
the curriculum couldn’t be improved upon, but we had 
to get back to the basics—good teaching, good lectures and 
more structured courses.” 
Making sure education matters 
A key part of Chase’s response was the creation of a central¬ 
ized leadership, through a system of committees that would 
empower the faculty to oversee the educational program 
and curriculum development process. His leadership struc¬ 
ture is built around committees overseen by the Educational 
Policy and Curriculum Committee, composed of faculty 
and students. 
Reporting to this committee are three subcommittees: 
a curriculum committee, which oversees what is being taught, 
and two assessment committees, preclinical and clinical, which 
oversee how it’s being taught. “What Herb did was to elevate the 
importance of education in the administration. He created 
an organizational infrastructure to support education,” Alpern 
says. “Yale needed to make this transition, and Herb led it.” 
Historically, the academic departments at Yale and else¬ 
where have decided independently how best to teach their 
disciplines. They derive their autonomy and authority from 
their clinical and research contributions—and they pay the 
professors’ salaries. But Chase determined that the educa¬ 
tional enterprise required a centralized oversight to impose a 
structure of cooperation, standardization and quality control. 
He consolidated and streamlined lectures, cutting them down 
from an hour to 40 minutes so students would have more 
time to pursue independent studies. And he insisted on a les¬ 
son plan for every lecture in tire first two years. 
Some professors opposed these moves—they feared 
students were getting shortchanged on vital information. 
“There’s a natural tendency to want to teach all the new things 
in your discipline,” says Robert H. Gifford, m.d., hs ’67, 
Chase’s predecessor as deputy dean for education. “That’s 
fine, but there aren’t enough hours in the day or days in the 
week. Somewhere, somehow, you’ve got to cut.” 
During his tenure, Gifford also tried to reduce the 
number of hours students spent in class. “ ‘Integration’ 
was what we called it then, but of course the departments 
resisted. It would be easier to move a graveyard than to 
change the curriculum at the medical school.” Gifford says 
department chairs are highly protective of their turf. “The 
departments are very strong and take a lot of pride in what 
they do,” he says. “They don’t want to give up any of the 
accolades or attention by doing anything that would dimin¬ 
ish their standing.” 
But if Chase’s ideas received a cool reception from 
some faculty members, they were warmly embraced by stu¬ 
dents as a welcome return to the ethos of the Yale System. 
Aaron Remenschneider, president of the Medical Student 
Council last year, calls Chase “a dedicated advocate for the 
students.” Referring to the deputy dean’s efforts to reduce 
classroom time, Remenschneider says, “There is so much 
happening on campus, students love that time to go to the 
hospital and shadow a specialist, to take an elective, to 
research their thesis project or to study.” 
Marcus Coe, m.d. ’06, co-president of the Class of 
2006, says he used his free afternoons to take part in two 
research projects. The first looked at the mechanical proper¬ 
ties of human cervical spinal ligaments. For the second 
project, he spent time with the community cardiothoracic sur¬ 
gery department studying what effect, if any, delayed surgery 
has on late presenters with a certain type of aortic dissection. 
“I’m busy, but I also had time to get married, own a 
dog and do other things,” Coe says. “Whether it was intended 
or not, it does free students up to lead a more balanced life, 
both inside and outside medicine.” 
These enthusiastic appraisals stand in sharp contrast to 
students’ initial reaction to Chase’s initiatives. An unintended 
consequence of his early efforts to build more free rime into 
students’ academic schedules was that many of the basic sci¬ 
ence courses were concentrated in the first year. That meant 
that more exams were also concentrated in the first year. And 
,he and the faculty had instituted mandatory qualifying exams 
in the second-year modules. 
Students balked. A group of nine banded together I and, calling themselves the Yale System Preservation 
Initiative, wrote to alumni asking for their support of a 
petition that all self-assessment exams remain optional. 
Chase rescinded the mandatory module exams and 
began a dialogue to find ways to assess students without 
exams. By the time of Chase’s farewell reception in 
May, two members of the initiative joined other students 
in singing Chase’s praises. 
Since then, classroom time has been reduced by 25 
percent, the ratio of small-group sessions to lectures has 
increased, and exams have been placed on the Web, so stu¬ 
dents can take them on their own schedule. Courses are 
now structured with the goal of finding ways for students to 
retain what they’ve learned in class so they can apply it to 
the treatment of patients. 
The molecules-to-systems integrated curriculum, for 
example, coordinates material from the biochemistry, cell 
biology and histology, and physiology courses. Tire three course 
directors work together to decide which course should discuss 
which topics. A lecture on the biochemistry of membrane 
biology might be coordinated with a lecture on the cell biology 
“You want to leave having said that you 
made the school a better place. I think with¬ 
out a doubt there are many, many ways that 
you can say that Herb Chase has done this, 
from organizing the infrastructure of the 
curriculum at a time when many faculty 
were fighting and screaming and not want¬ 
ing to be brought under one umbrella, to 
computerizing the curriculum... to the new 
grand rounds on education.” 
Margaret J. Bia, M.D., professor of medicine, speaking at a 
reception for Chase in May. 
ABOVE left Howard Levitin 
mentored a group of students at 
a cadaver table in the new anato¬ 
my lab in the Anlyan Center. With 
the new lab came a new curricu¬ 
lum and a new approach to teach¬ 
ing anatomy. Led by instructors 
Larry Rizzolo and Bill Stewart, the 
new approach fit in with Chase’s 
philosophy of teaching. 
ABOVE RIGHT In the fall of 
2004 then-first-year students 
Danielle Cuez and April Levin 
used a computer during a 
histology class, which has been 



































22 The Chase years 
“You taught us not only about sodium and 
water and the importance of the kidney, but 
about becoming physician-scientists by‘liv¬ 
ing on the edge,' about recognizing bias in 
medical decision making and about working 
in teams.... When students would come to 
you for advice, you always took the time to 
listen, be thoughtful and give us your honest 
opinion and advice.” 
Ami Parekh, third-year medical student, at the reception in May. 
TOP left From left,first-year 
students Sundeep Bhat, Susan 
Mathai and Oliver Rothschild met 
regularly with Chase (center) as 
members of his journal club. Chase 
encouraged the formation of 
journal clubs to discuss clinical 
research papers. 
top right Linus Sun,a third-year 
student, studies in the Medical His¬ 
torical Library with his ever-present 
laptop computer that allows him 
access to the latest information. 
above First-year student Elizabeth 
Kvach interviewed standardized 
patient Crystal Neuhauser as class¬ 
mates Robert Leone and Youssra 
Marjoua and clinical instructor 
Auguste Fortin observed. 
“You have been a constant proponent 
and protector of the Yale System. You have 
improved the quality and efficiency of 
teaching. You created journal clubs and 
made more time for research. You even 
helped some of us understand the flow of 
free water in the kidney. You showed us 
where the edge was and helped pave the 
path to it. You taught us high New York 
fashion, and let us know that beards and 
balding are “in.” You have been a tremen¬ 
dous teacher, mentor, administrator and 
master clinician. Best of all, you lead by 
example, which is truly the very most any 
of us can hope to do.” 
Douglas Housman, m.d. ’06, and Douglas Walled, m.d. ’06, 
at the reception for Chase. 
of membranes, which will then be linked to a lecture and work¬ 
shop on the transport of ions and solutes across membranes. 
“I like to think we cleaned the jewel that is the Yale 
System,” Chase says. “We dipped the diamond in ammonia 
solution.” 
Assessing clinical skills 
Another major challenge came as a result of the lcme deter- 
: mination that the accrediting authority had no way of knowing 
whether Yale medical students were learning clinical skills. 
Margaret J. Bia, m.d., professor of medicine, who was appointed 
the new director of clinical training in 2001, agrees that the 
clinical skills program needed help. “It was kind of thin. You 
were assigned to a tutor and attended lectures on how to talk 
to patients, but there wasn’t much real practice,” she says. 
Acting on the lcme mandate, Chase provided the 
1 resources and support to Bia to create a program that com¬ 
bines rigorous clinical skills building during the first two years 
with assessments at the end of the third year conducted at the 
University of Connecticut Health Center. At the UConn test 
site students see seven standardized patients and perform a 
focused history and physical on five “patients” and a focused 
history and counseling on two. 
Students are given 20 minutes for each "patient,” then 
have five minutes to write down their top three diagnoses. 
Yale faculty members are on hand to review the cases with 
students and do remediation if needed. Chase took this 
! assessment a step further with the preceptor program, which 
increased student contact with senior faculty for bedside 
teaching, case discussions and student presentations. It 
appears to have worked—in the most recent round of the 
national boards, Yale medical students had a 100 percent pass 
rate on the exam’s clinical skills component. 
In addition to the assessment gap, the lcme found that 
Yale lacked a program for teaching communications skills and 
discussing end-of-life issues. As a result, students now partici¬ 
pate in a workshop on delivering difficult news, offered during 
the internal medicine clerkship, and a behavior modification 
counseling workshop, offered during the psychiatry clerkship. 
A new end-of-life curriculum has been introduced for third- 
year students. 
“The attitude used to be, ‘Just go into the wards and 
you’ll leam something,’ ” says Chase. “We’ve changed it so that 
it doesn’t take any more time, but it’s much more focused.” 
An emerging problem 
Still looming, however, at Yale and medical schools across the 
country, is a challenge with no easy answers. For more than 
a century, clinical education has been based in the inpatient 
environment of teaching hospitals, but diose learning experi¬ 
ences are far less relevant now that hospital stays have become 
shorter and more treatments are done on an outpatient basis. 
“The greatest challenge facing medical schools is learning to 
treat patients with chronic diseases,” says Michael Whitcomb, 
m.d., senior vice president for medical education of the 
Association of American Medical Colleges (aamc) and direc¬ 
tor of the aamc’s Institute for Improved Medical Education. 
“They may go to hospitals for the management of complica¬ 
tions, but the focus needs to be on preventive and post-care. 
We need to shift an awful lot of the educational experience 
out into other sites.” 
According to Whitcomb, 100 million people in the 
United States have one or more chronic diseases, and that 
number grows every year. Moreover, 75 percent of all health 
care spending goes to care for that population. “It just makes 
sense that students get training in caring for those patients.” 
Medical schools know they need to adapt their cur¬ 
ricula, but one overriding obstacle stands in their way: money. 
“Education is the stepchild of academics,” Chase says. “It 
doesn’t bring money in, it only uses it up.” 
“It’s very difficult to sustain this enterprise as a by¬ 
product of whatever else we do,” says Rastegar, who served on 
an education committee convened by former Dean Kessler to 
evaluate the curriculum. “Research money has gotten tighter, 
clinical can barely pay for itself, and there’s no way a clinician 
can make his or her salary and teach at the same time.” 
“Yale has an army of fabulous clinical practitioners who 
basically teach gratis,” Chase says. “But the day of the freebie 
is gone. You get what you pay for, and if you don’t pay for it, 
you devalue the activity and you guarantee no innovation.” 
To reward faculty for teaching, Chase has implemented 
such programs as the Society of Clinical Preceptors and the 
Society of Distinguished Teachers, which recognize and cel¬ 
ebrate faculty whose level of commitment reaches beyond the 
ordinary. Tire Society of Distinguished Teachers has a modest 
endowment, but not enough to support teaching to a sig¬ 
nificant degree. Chase says the most direct solution is the 
creation of an endowed teaching academy. With respect to 
the curriculum, he recommends that his successor develop 
avenues for students to receive more patient-centered and 
longitudinal-care experience. 
Despite the challenges, Chase has confidence in the 
Yale faculty’s deep-seated commitment to preparing students 
to be the best doctors they can possibly be. 
In thinking about the future of medical education at 
Yale, Chase was reminded of the day his older son celebrated 
his bar mitzvah. That morning, when Chase popped his head 
into his son’s bedroom and saw a look of doubt, he began to 
wonder if his son was prepared to get through the ceremony. 
But at the synagogue Chase watched the cantor interact with 
his son and his worries evaporated. “I knew he would never 
let my son fail, and I’ve always held him up as a model for 
what we as teachers should strive for. Our job is to guarantee 
our students’ success.”ym 
Jennifer Kaylin is a contributing editor of Yale Medicine and a freelance 






















At the end of 1964 Joseph 
Schlessinger, on left, was 
commissioned as an officer 




The long war 
Born in a war-torn mountain village in the 
former Yugoslavia, Yossi Schlessinger 
went on to fight other battles, including 
one against disease. 
By Marc Wortman 
On March 26, 1945, in the village of Topusko in the moun¬ 
tains near Zagreb in German-occupied Yugoslavia, Riflca 
Schlessinger went into labor. Gunfire crackled and artillery 
exploded outside the battered house where she delivered 
a baby boy who was given the name Joseph. His parents, 
Jewish partisans fighting the invaders and local fascists, 
swaddled the newborn in silk cut from a British soldier’s 
parachute and grabbed their rifles. With Topusko about 
to fall to German forces, the family boarded a cart and 
retreated into the mountains. The parents of Yossi, as he 
was called, fought on for two more months until the end 
of the war in Europe. 
Their struggles, though, were not over. After Schles- 
singer’s father was jailed for several months for making 
a joke at work about Marshal Josip Tito, the Communist 
leader who had taken control of Yugoslavia, the Schlessingers 
fled to Israel, where Yossi’s parents had family. But as soon 
as the Schlessingers disembarked from their ship, they 




















26 The long war 
its Arab neighbors—battles that continue to this day. For 
their son, a lifetime of war had just begun. 
Just surviving such inauspicious and violent beginnings 
would seem an achievement: Yossi Schlessinger, however, 
would go on to discern some of the most important mecha¬ 
nisms in the life cycle of the cell and make discoveries about 
the causes of cancer that have led to some of the most effec¬ 
tive new treatments for the disease. Now the William H. 
Prusoff Professor of Pharmacology, and chair of the depart¬ 
ment, Schlessinger made one of his frequent trips back to 
Israel last May, where he maintains close scientific ties. This 
visit was an occasion for joy. Schlessinger took the stage in 
a Tel Aviv University auditorium alongside cellist Yo-Yo Ma 
and the Polish journalist and leader in the fight against 
Communist repression, Adam Michnik. The three were 
among the recipients who shared three $1 million Dan David 
Prizes, established in 2001 by David, an inventor of photo¬ 
graphic technologies, to honor cultural, scientific, social 
or technological achievements. Schlessinger’s citation praised 
him “for his critical role in deciphering a new code for 
the flow of information from the cell surface into the cell. 
Dr. Schlessinger epitomizes the scientist that has paved the 
road from basic research in the laboratory, all tire way to 
the patient.” 
Today Schlessinger, who has published almost 500 
papers, is regarded as one of the world’s leading cellular 
biologists and cancer investigators. His studies have helped 
to open a new understanding of the ways in which signals 
from growth factor proteins circulating in the blood reach 
the interior of cells and stimulate them to divide and grow. 
He has also shown how aberrant cellular signals can lead 
In 1946, after World War II, 
Schlessinger, his mother, Rifka, 
his father and grandmother 
settled in the town of Osjek, 
which is now part of Croatia. 
Osjek was severely damaged 
during the war in the mid-1990s 
which led to the breakup of 
Yugoslavia. 
to cancer and has suggested ways to block them. His discov¬ 
eries have led to a new field of cancer therapy research 
that has already produced a new generation of targeted anti¬ 
cancer drugs. 
Along the way, Schlessinger also cofounded two bio¬ 
technology companies and serves as an advisor to several 
others—work that has led to one drug that is extending cancer 
patients’ lives and other agents that are at the testing stage. 
Living at the forefront of the scientific world and 
financially secure beyond the dreams of most academic sci¬ 
entists, Schlessinger seems far removed from the wars that 
dogged his life from the very first moment. But although 
he may no longer fear bombs and bullets striking home, the 
impact of war never goes away. 
A scientist-soldier 
A few months before Schlessinger left for Israel to accept 
the Dan David prize, he sat in his sunlight-filled corner 
office in the new extension of the B-wing of Sterling Hall of 
Medicine. Behind him the window offered a view of down¬ 
town New Haven. He faced out toward the department he 
leads and whose laboratories and offices fill the new build¬ 
ing. He personally hired many of its junior members— 
including six new professors—as part of a wholesale effort 
to revamp one of Yale’s flagship programs. In the five years 
since he arrived at Yale from New York University, he has 
built new facilities for his own laboratory and brought in 
13 new graduate students and postdoctoral fellows. 
Life, it seems, had prepared him for such disruptions 
and new starts. “Our life,” he recalls of his childhood, “had a 
lot of dramatic events.” The most tragic occurred even before 
he was born. Before the war his parents had been married 
to others and his father had had a daughter. Their spouses 
and children, however, as well as nearly all of their parents, 
grandparents, aunts, uncles, sisters, brothers and cousins— 
80 percent of Schlessinger’s extended family—were shot by 
Germans and local fascists or herded into gas chambers. 
The family’s past with its unredeemable losses could 
never be pushed far away from the Schlessinger house¬ 
hold. The war also left them impoverished. “We were in 
pretty bad shape,” he says, recalling his family’s arrival in 
Israel. Although his parents doted on him and his younger 
brother, their sadness about the past and fears for the 
future made home, he recalls, “not a very happy environ- 
ment. It took me many years to figure out how their mood 
influenced me.” 
Schlessinger, who is heavyset and speaks with a thick 
Israeli accent, can look doleful at times. He talks freely 
about his difficult childhood, but when discussing the 
destruction of his parents’ families, a deep sadness comes 
into his eyes. Perhaps that is why John Mendelsohn, m.d., 
president of The University of Texas M.D. Anderson Cancer 
Center in Houston and co-recipient of the David Prize with 
Schlessinger, says, “He’s not one to make small talk. He’s 
interested in serious issues.” Schlessinger, who knows the 
history of World War II intimately, has visited the towns in 
the former Yugoslavia where his family and many other Jews 
once lived, as well as the places where his parents battled 
the Nazis. He admits to a hair-trigger temper in response to 
what he perceives as statements that may harbor anti- 
Semitism. “I’m very sensitive about these things,” he says. 
Growing up in Israel, lie never lived far from a battle¬ 
field. Like most young Israelis in the new nation’s early 
years, he was raised to be “a macho fighter.” He entered the 
military, becoming a captain in the elite Golani Brigade. As 
part of that force, he preceded the regular infantry to lay or 
remove landmines, setting or demolishing thousands of 
explosives in the course of fighting in the 1967 Six-Day War, 
the 1973 Yom Kippur War and the 1982 invasion of 
Lebanon. He claims not to have been scared clearing mine¬ 
fields. “A mine is a task,” he says. “It plays into the scientific 
mind.” He feels differently about enemy fire. “A sniper 
shooting at you is not science.” 
From these early experiences, Schlessinger learned 
that survival in a dangerous world depended upon intuition, 
195OS 
Schlessinger as a young boy in 
Kiryat Amal, in northern Israel, 
in 1950 or 1951, two or three years 
after the Schlessinger family 
left Croatia. 
study and hard work. During World War II his father, cap¬ 
tured by the Gestapo, jumped from a moving train to escape 
certain death in a prison camp. “My father,” Schlessinger 
recalls, “said the only reason he survived was because he 
fought. I knew I would also have to make it on my own. 
1 didn’t have safety nets and had to depend on myself.” 
Despite the disruptions of serving in Israel’s military 
reserve and call-ups for wars, he completed a doctorate in 
biophysics at Israel’s Weizmann Institute of Science in 1974. 
He had been fascinated with science since childhood. “I 
was always interested in addressing fundamental questions,” 
he said. At the institute he studied the dynamic nature of 
proteins by measuring the circular polarization of their fluo¬ 
rescence, a preparation seemingly far removed from his 
later work in cellular biology. After postdoctoral study in the 
United States, at Cornell and the National Institutes of 
Health, he focused on how signals were communicated into 
the interior of the cell. 
In the late 1980s, Schlessinger took a sabbatical from 
his lab in Israel and, after directing a drug research team 
at a pharmaceutical company, returned to academic life at 
the medical school at New York University (nyu). He con¬ 
tinued to elucidate signaling pathways while directing the 
Department of Pharmacology, and, for a time, the Skirball 
Institute of Biomolecular Medicine. His laboratory analyzed 
the mode of action of growth factor receptors on the cell 
surface and the intracellular signaling pathways that are acti¬ 
vated in response to growth factor stimulation. He recog¬ 
nized the critical role played by the components in the 
signaling pathways in the control of many fundamental cel¬ 
lular processes, including cell proliferation, differentiation 
1964 
In 1964 Joseph Schlessinger (right), 
a second lieutenant in the Israeli 
army, planned a military exercise 
with his platoon. He finished his 
compulsory military service in 1965. 
After participating in the Six-Day 
War in 1967 and in the Yom Kippur 
War in 1973 as a reserve officer, 
Schlessinger was promoted to the 




















28 The long war 
and metabolism, as well as cell survival and cell migration— 
and their role in many diseases caused by dysfunctions in 
signaling pathways. 
At the time, Mendelsohn was on the faculty at Mem¬ 
orial Sloan-Kettering Cancer Center. He and Schlessinger 
would regularly drop in on each other. “He’s fun to talk to,” 
Mendelsohn says. “He’s a very creative and rigorous scientist 
who’s willing to try out new ideas. He’s more likely to look 
at something in a new way.” Mendelsohn also points out 
that Schlessinger is “a driven person. He’s driven to use sci¬ 
ence productively. He brings a collaborative spirit and sus¬ 
tained intellectual power to a question and works at it until 
it’s solved." 
Unlocking the signaling pathway 
Irit Lax, ph.d., a faculty member in pharmacology, has been 
working for Schlessinger since she was a graduate student 
in Israel in the early 1980s. They are a couple now. Each 
has two children from a previous marriage. They spend, says 
Schlessinger, “99.8 percent” of their time together, which, 
he adds, “is amazing.” Although he goes to his office seven 
days a week, he rarely steps into the laboratory any longer. 
“He reads,” Lax says. “He has a unique capacity to integrate 
things that at first sight seem not connected. He has an 
instinct for which direction to go.” 
While they were at nyu, Lax recalls Schlessinger say¬ 
ing that once all the signaling pathways have been eluci¬ 
dated, “finding the abnormal, disease-causing pathways will 
be a trivial matter.” In the early 1980s, Schlessinger and his 
colleagues showed how epidermal growth factor (egf) pro¬ 
tein binds and activates a receptor tyrosine kinase (rtk), an 
2006 
Schlessinger and his wife, Irit Lax, 
have been working together since 
the 1980s. 
enzyme located on the cell surface. Schlessinger’s laboratory 
revealed how this coupling launches a cascade of signals that 
eventually reach the cell nucleus and tell the cell either to 
divide and grow, or to ignore checkpoints that would nor¬ 
mally cause it to die. He then demonstrated that genetically 
aberrant forms of EGF-receptors and other rtks can set off 
the rampant cell growth seen in cancer, including malignant 
brain tumors and other human cancers. 
He recognized that drugs that could inhibit EGF- 
receptors or other rtks could also control cancers. And these 
discoveries did in fact lead to a new class of targeted anti¬ 
cancer drugs—tyrosine kinase inhibitors. The approval in 
2001 of the first such inhibitor, Gleevec, a treatment for 
chronic myelogenous leukemia, was celebrated as the begin¬ 
ning of a new era in cancer treatment. Mendelsohn concur¬ 
rently produced an antibody that could block the action of 
EGF-receptors in cancer cells. That antibody was eventually 
developed into Erbitux (cetuximab), a monoclonal antibody 
used for treating colorectal cancer. Other related treatments 
include Herceptin (trastuzumab), a monoclonal antibody 
previously approved for the treatment of breast cancers for 
its action against overexpression of the protein ErbB2; and 
the tyrosine kinase inhibitors Iressa (gefitinib) and Tarceva 
(erlotinib). Pharmaceutical companies are now discovering 
and developing scores of kinase inhibitors. Schlessinger 
also decided to pursue the possibilities for cancer therapy 
that his findings indicated. “I don’t know any basic scientist 
who, if he had the opportunity to develop drugs, would 
ignore it,” he says. “We all want to be Louis Pasteur.” 
In 1991 Schlessinger formed the pharmaceutical 
company Sugen with Axel Ullrich, ph.d., his longtime 
Schlessinger confers with members 
of his lab team, Satoru Yuzawa and 
Valsan Mandiyan. 
collaborator at the Max Planck Institute of Biochemistry 
in Germany. (The “S” and “U” in the company’s name stood 
for the two founders’ last names.) The company was acquired 
by Pharmacia in 1999 in a deal valued at $750 million. 
Pharmacia was subsequently acquired by Pfizer. The head 
of Pharmacia at the time of the Sugen acquisition, Fred 
Hassan, is now chief executive officer and chair of the phar¬ 
maceutical giant Schering-Plough. He recalls Schlessinger 
as “the ‘big science’ presence at Sugen. ... He is one of the 
more insightful science innovators I have encountered.” 
That characterization was borne out in January, when 
i the U.S. Food and Drug Administration (fda) approved 
. SU11248, sold by Pfizer as Sutent, the first drug derived 
{ from work begun at Sugen. Clinical trials of the drug were 
moved quickly through the fda approval process because of 
its obvious effectiveness in treating advanced kidney cancer 
as well as a stomach cancer known as gastrointestinal stro¬ 
mal tumor, or gist. Pfizer is also testing Sutent and other 
drugs based on Sugeris discoveries as treatments for more 
common renal cancers, as well as breast and other cancers. 
When Schlessinger learned in January that the fda 
had approved Sutent, Lax recalls that he shared a bottle 
of champagne with his lab members and then returned to 
work. He will receive royalties from a drug projected to 
bring Pfizer more than $1 billion in annual revenues. “Money 
1 doesn’t speak to him,” says Lax, noting that life went on 
unchanged after Sutent was approved “He didn’t buy three 
more houses or a sports car. He didn’t slow down his work¬ 
ing schedule.” According to Lax, the couple plans to give 
Yale and other organizations most of the money one day. 
I! Schlessinger also intends to give his department part of his 
half share of the $1 million prize he received in Tel Aviv. 
Exploring the darkness 
! With many biotechnology companies pursuing kinase inhibit- 
| ors, Schlessinger realized by the end of the 1990s that the 
same assays were leading to the same drugs with the same 
limitations. He took a counterintuitive approach and began 
1 to study chemical compounds that weakly inhibited rtk and 
other cell surface receptors. Those potential drugs would 
not work as cancer therapies themselves. By using structural 
biology methods, however, investigators could find the 
targets to which they linked and then “reverse engineer” the 
target to design drugs that would bind tightly enough to 
them to inhibit their signals. Schlessinger co-founded 
Plexxikon, a Berkeley, Calif., biotechnology company in late 
2000 together with Peter Hirth, ph.d., the former presi¬ 
dent of Sugen, and Sung-Ho Kim, ph.d., a professor from 
Berkeley. Unusually for an academic scientist, he serves not 
only as a member of its scientific advisory board but also 
as chair of the board of directors. The company already has 
one drug in clinical testing. Its most advanced compound 
and its first to be tested in humans is a treatment for adult- 
onset diabetes and other metabolic disorders. Plexxikon also 
developed a new drug for the treatment of melanomas and 
colon cancer. 
Most successful drugs require 12 to 15 years for dis¬ 
covery, testing and fda approval at a cost that can reach 
hundreds of millions of dollars. Sugen required 15 years for 
its first drug to gain approval. Schlessinger thinks his new 
company may bring its first drug to market by 2009. 
“Chances are not high we succeed,” he says, “but if we do, 
it’s a world record.” 
While pursuing industrial ties, Schlessinger is also 
creating a drug discovery program at Yale. The Center 
for Drug Discovery, a pilot program with one scientist and 
two more soon to be hired, will develop agents based on 
departmental research for so-called “orphan” diseases—those 
with fewer than 200,000 patients in the United States and 
which are of little interest to drug companies. He hopes the 
center will grow to a staff of 20 specialists who will function 
as “an engineering arm of department scientists.” Their 
products will be licensed to industry or serve as the basis for 
new companies to be established by Yale’s Office of 
Cooperative Research. 
Schlessinger has been offered numerous presidencies 
of drug companies but has rejected them all. “I need the 
freedom of academia,” he says. “It’s the freedom that makes 
me work. A true scientist will work harder that way than if 
you tell him how many hours he has to work.” He worries 
that the increasing pressure from various funding agencies 
to move academic research more directly into finding treat¬ 
ments for diseases will undermine the basic scientific 
research culture that led him to his own breakthrough dis¬ 
coveries. “You’ll never be creative if you know the answer 
ahead of time. That’s not science,” he says. “The key thing is 
to let creative people have intellectual fun. I sincerely believe 
you need to let good people think and do what they want if 
you want science to succeed. We are always in the darkness 
exploring a hypothesis. What you think is of no value may 
prove to be of great value. But science takes time. You need 
to be patient.” 
The tide in support of academic science is moving the 
other way these days. But fighting for what he believes has 
never been a question for Schlessinger. “I have tremendous 
anxiety because of what happened to my parents,” he says. 
That anxiety has been transferred from the battlefield to the 
laboratory. “You’re only as good as your last work,” he says. 
"You have to prove yourself again.” That need drives him to 
return to work every day. “The anxiety I did not cure myself 
of is a good thing.” ym 
Marc Wortman is a contributing editor of Yale Medicine. 
Preserving fertility 
Where once physicians' only concern was saving lives, 
new techniques under study at Yale can also preserve 
fertility in women undergoing treatment for cancer. 
by Jennifer Kaylin 
Photographs by Terry Dagradi 
A new method for preserving 
oocytes requires bathing them in 
protective solution, then slow- 
cooling them with liquid nitrogi 
This procedure has more than doi 
bled the success rate to betwi 























or more than two years Tracy 
Urbano endured menstrual periods that were alarmingly 
intense. She suffered heavy bleeding that might last as long 
as six months straight. Once she fainted and had to be taken 
to the hospital because she’d lost so much blood. 
Her doctor tried to regulate her periods with birth 
control pills. When that approach failed, he ordered an ultra¬ 
sound, which revealed that the lining of her uterus was 
unusually thick. Through a sonohysterogram, a procedure 
to check for abnormalities of the uterine cavity that could 
interfere with pregnancy, Urbano’s doctor discovered numer¬ 
ous polyps—benign growths that are usually easily removed 
with dilation and curettage. But when he began the proce¬ 
dure, he made a distressing discovery: endometrial cancer 
had spread throughout her uterus. 
Urbano needed to have a complete hysterectomy as 
quickly as possible. The diagnosis was devastating to the 
27-year-old Northford, Conn., woman, but equally upsetting 
was the realization that the surgery would leave her unable 
to have children. “I grew up in a big Italian family,” says 
Urbano. “Ever since I was a little girl, I’d always dreamed of 
being a mother, but they told me there was nothing they 
could do.” 
A conversation among colleagues brings hope 
Shortly after Urbano’s diagnosis, her doctor, Peter E. Schwartz, 
m.d., hs ’70, the John Slade Ely Professor of Obstetrics, 
Gynecology and Reproductive Sciences, ran into a colleague 
in the department, Pasquale Patrizio, m.d., m.b.e., professor 
of obstetrics, gynecology and reproductive sciences, described 
his patient’s predicament. Patrizio, the director of the Yale 
Fertility Center and the OncoFertility program, had recently 
begun using a new egg-freezing technique known as slow 
oocyte cryopreservation to enhance women’s fertility options. 
He thought he might be able to help Urbano. 
Patrizio is one of several doctors at Yale in a variety of 
specialties who are working on solutions for patients whose 
cancer treatments could compromise their fertility. From 
oocyte preservation to radical vaginal trachelectomies (exci¬ 
sion of the cervix and surrounding parametria without 
removing the uterus) for some cervical cancers to progestin 
treatment in early-stage endometrial cancers, innovative 
methods for fertility preservation are being explored and 
refined at Yale in response to growing patient demand. 
Patrizio has recently received a grant from the pharmaceuti¬ 
cal company Serono to study with Dagan Wells, ph.d., 
an assistant professor in the department, changes in gene 
expression of eggs during the freezing/thawing process 
in order to recognize—at the molecular level—and avoid 
potential cryotoxic events. 
In the past two decades, the rate of cancer survival in 
the United States has improved dramatically. Earlier detec¬ 
tion coupled with improved treatment options has increased 
survival rates for all cancers. According to the National 
Cancer Institute (nci), for females under 45 (an age near the 
end of the childbearing years for most women) the survival 
rate rose from 72.8 percent in the late 1970s to 81 percent 
in the late 1990s. For men, the survival rate increased from 
59.8 percent to 69.8 percent during the same period. 
With many women deferring childbearing until their 
mid-30s and beyond, oncologists are treating a growing 
number of women for whom fertility remains a major prior¬ 
ity. In the past these patients would have had to choose 
between survival and fertility, but new surgical techniques 
and hormonal treatments have made it possible for an 
increasing number of cancer survivors to have children. 
“It’s an elegant commentary on where we stand with 
respect to cancer treatment,” says Charles J. Lockwood, m.d., 
the Anita O’Keefe Young Professor of Women’s Health 
and chief of obstetrics and gynecology at Yale-New Haven 
Hospital. “The focus used to be on survival. ... We can now 
focus on quality of life.” 
“Ten years ago, the term fertility preservation didn’t 
exist,” says Kutluk Oktay, m.d., director of the Fertility 
Preservation Program at the Weill Medical College of Cor¬ 
nell University in New York City and president of the 
Fertility Preservation Special Interest Group of the American 
Society of Reproductive Medicine. “Now, we’re slowly see¬ 
ing these procedures becoming a standard part of care.” 
In Urbano’s case, Patrizio recommended that she con¬ 
sider freezing both embryos and unfertilized eggs. During 
a four-hour consultation and evaluation with Patrizio’s staff, 
Urbano learned how to inject herself with fertility drugs. 
These medications contain hormones that increase a woman’s 
natural egg production from just one ovum per cycle to as 
many as 15. Every other day Urbano went to Patrizio’s office 
for an ultrasound to track the growth of the egg follicles. 
The procedure took about three weeks, forcing Urbano to 
postpone her surgery by a week. 
“My doctor was a little concerned (about the delay), 
but I really wanted this done,” recalls Urbano, who is single. 
“I couldn’t have dealt with the surgery aspect if I thought 
I couldn’t have children.” 
Patrizio harvested 16 eggs. Six weren’t mature enough 
to work with, but six others were fertilized with the sperm 
of an anonymous donor and frozen as embryos. The 
other four ova were frozen using the new method of oocyte 
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cryopreservation. “It was just the biggest blow, being told 
I wouldn’t be able to have my own children,” Urbano says. 
“Now that’s not a concern. It’s just made everything a little 
bit easier for me.” 
Understanding at the molecular level 
Oocyte freezing is just one of many clinical innovations and 
research initiatives being explored and fine-tuned by medical 
school faculty. 
“We can’t preserve fertility in every woman, but we 
now have things to offer them,” says Emre U. Seli, m.d., 
assistant professor of obstetrics, gynecology and reproduc¬ 
tive sciences. Seli is a member of the gamete biology 
; core, a group of six Yale researchers from different back- 
;j grounds who work together to develop innovative thera- 
\ peutic options for women with reproductive problems. 
| One team member, Joshua Johnson, ph.d., an assistant 
| professor in the department, recently reported the genera- 
I tion of eggs from bone marrow stem cells in a mouse 
[ model. This controversial discovery challenges the long- 
Iheld belief that female mammals are born with a finite 
number of eggs and opens up new possibilities for the 
development of treatments for infertility. 
Seli says that reproductive therapies have traditionally 
been developed with very little understanding of what was 
occurring on the molecular level. “Our group’s main inter¬ 
est,” he says, “is using cutting-edge scientific techniques to 
understand the development of the egg and embryo and 
what can go wrong, so we can offer all available techniques 
in an evidence-based manner.” 
About 120,000 people in the United States under the 
age of 45 are diagnosed with cancer annually, the nci reports. 
It is often difficult for oncologists to guide patients who 
wish to preserve their fertility. According to Seli, oncologists 
are not always aware of the available options and there 
is no well-structured referral system between clinicians 
and researchers. 
Sperm and embryo cryopreservation are the fertility 
preservation techniques most familiar to the public. They 
are now widely available and considered standard practice. 
Other methods show promise but are considered investiga¬ 
tional. Oocyte cryopreservation is among the most promis- 
When Tracy Urbano was diagnosed 
with endometrial cancer, she chose 
to preserve her fertility before 
undergoing a hysterectomy. She 
took hormones to increase her 
egg production and Pasquale 
Patrizio, head of the Yale Fertility 
Center, harvested 16 eggs, four 























ing of the new methods. The American Society of Reproduc¬ 
tive Medicine classifies it as an experimental procedure, but 
last December the School of Medicine’s institutional review 
board approved use of the technique. Patrizio says that his 
office has already handled 10 cases, including three in which 
the patients had cancer. 
“One of my goals is to put Yale on the map as a pre¬ 
mier fertility preservation center. That’s why we’re putting 
together this program,” says Patrizio. 
Although variations of the cryopreservation technique 
have been tried for 15 years, damage to the eggs by freezing 
resulted in a disappointing track record of only about two 
babies for every 100 eggs frozen. The new method—bathing 
eggs in protective solutions, slow-cooling them with liquid 
nitrogen and thawing them—has doubled the success rate 
to five or six babies per 100 eggs. The procedure’s success is 
also dependent on the age of the patient. Harvesting eggs 
when the woman is under 35 increases the odds of a future 
successful pregnancy. 
A ban leads to a new technique 
The latest freezing method was developed by Veronica 
Bianchi, ph.d., and Andrea Borini, m.d., at Tecnobios 
Procreazione, a private fertility clinic in Bologna, Italy, in 
response to a 2004 Italian law that bans the freezing of 
human embryos. Egg preservation is allowed because the 
eggs are unfertilized. Bianchi is now working with Patrizio 
at Yale to further refine the methods and improve the 
success rate. This technique is appealing to women who 
don’t have a partner and don’t want to use sperm from 
an anonymous donor. Patients who have ethical objections 
to embryo freezing also find oocyte preservation an 
acceptable alternative. “You don’t have frozen embryos— 
just eggs, so you have a lower ethical barrier to leap,” 
says Lockwood. 
Fertility preservation almost always centers on women, 
whose reproductive biology is far more complex than 
men’s. “Sperm is easy. It can be readily stored in high vol¬ 
umes and frozen with minimal preparation. Men in 
their 80s produce perfectly good sperm,” says Lockwood. 
“The big issue is the egg.” 
As the field of fertility preservation advances, oncolo¬ 
gists and fertility experts agree that there needs to be 
more communication and cooperation between disciplines. 
The American Society of Clinical Psychologists reports 
that approximately half of oncologists do not initiate fertility 
discussions with patients at the time of diagnosis. 
Dennis L. Cooper, m.d., hs ’82, professor of medicine 
(medical oncology) and clinical director of the hematopoietic 
stem cell transplant program, says he understands doctors’ 
reluctance to address fertility issues. “When we talk to 
patients, we always tell them there’s a possibility this treat¬ 
ment will knock out their fertility, but I can’t say that I’ve 
had a single patient who has actually gone through with egg 
or embryo freezing,” he says. The problem, Cooper says, 
is that often patients are too sick to delay treatment long 
enough to go through an egg retrieval cycle. “I’m not trying 
to be negative, but it places the patient in a very difficult 
position: Do you delay therapy for the possibility of having 
kids, when the odds of that procedure being successful 
are not very good? It puts additional stress on an already 
stressful situation.” 
To provide oncologists with better guidance, a panel 
convened by the American Society of Clinical Oncology 
in February 2005 developed the first guidelines to address 
fertility preservation options for people living with cancer. 
The guidelines were published in the June 20, 2006, issue 
of the Journal of Clinical Oncology. Patrizio, who served on 
the panel as both a bioethicist and a reproductive endocrinol¬ 
ogist, says he’s encouraged by the response he’s received 
from oncologists. “It became obvious to me a few years ago, 
when I talked with colleagues who treat cancer patients, 
that we were completely apart.” 
“Until now,” says Oktay, the senior author of the 
guidelines, “there’s been no clear guidance for discussing 
and initiating fertility preservation with cancer patients.” 
Already there are signs that the lines of communica¬ 
tion are opening. Jessica Dorey, R.N., coordinator of Yale’s 
gestational carrier and egg donation program, says that 
patient referrals from oncologists have gone up in recent 
years. “Everyone seems to be much more aware of the 
options,” she says. And now that more cancer patients are 
seeking Yale’s reproductive services, Yale is trying to expe¬ 
dite the process so they can resume cancer treatment as 
quickly as possible. “It all happens very quickly, and it can 
be extremely overwhelming,” Dorey says. “We try to make 
it as easy for them as possible.” 
Around the world, as many as 40,000 women a year 
who are diagnosed with cancer while they are pregnant choose 
to continue the pregnancy rather than submit to a treatment 
that might jeopardize the fetus or their future fertility. 
This number doesn’t surprise Lockwood at all. “The 
drive to reproduce is palpable and common to all animals. 
It’s the primary drive,” he says. “We see the faces of desper¬ 
ate couples all the time. If you told them they had to climb 
Mount Everest to have a baby, they’d gladly do it. Those of 
us who see that kind of longing just really want to help.” ym 
Jennifer Kaylin is a contributing editor of Yale Medicine and a freelance 









New methods to 
preserve fertility 
Besides oocyte cryopreservation, 
researchers are exploring other 
methods to preserve female fertil¬ 
ity. For women with early-stage 
cervical cancer, a more conserva¬ 
tive, but technically challenging 
surgery called radical vaginal trach- 
electomy has been found to pre¬ 
serve fertility in some patients. A 
recent study found that of 319 
women who had the surgery, 147 
pregnancies were recorded, includ¬ 
ing 99 live births (67 percent). 
Charles J. Lockwood, m.d., the 
Anita O’Keefe Young Professor of 
Women’s Health and chief of 
obstetrics and gynecology at Yale- 
New Haven Hospital, says this pro¬ 
cedure still needs improvement. 
It is used only for the “absolutely 
desperate,” because of the high 
rate of subsequent preterm deliv¬ 
eries associated with it. 
Younger patients diagnosed 
with some borderline ovarian 
tumors can undergo a more con¬ 
servative surgery, in which the sur¬ 
geon removes only the affected 
ovary, leaving the unaffected 
ovary and uterus intact. So far, 
data show that the outcome after 
this surgery is comparable to 
that of the more radical approach 
of removing both ovaries and 
the uterus. 
And patients with early-stage 
endometrial cancer can opt for 
progesterone therapy instead of 
an immediate hysterectomy. After 
the cancer has been diagnosed, 
the patient begins hormone 
therapy, which temporarily sup¬ 
presses the cancer. The aim is to 
buy the patient enough time to 
conceive and carry the pregnancy 
to term. Once the baby is born, 
the patient stops taking the hor¬ 
mones and has a hysterectomy. 
"This is a reasonable course of 
action for many early-stage endo¬ 
metrial cancers, but it requires 
careful monitoring,” says Lockwood. 
“We’ve cared for three patients 
using this approach, and they’ve 
all done fabulously well.” 
A woman’s fertility can be 
compromised by any treatment 
for cancer that interferes with 
the functioning of the ovaries, 
fallopian tubes, uterus or cervix, or 
that causes a hormonal imbal¬ 
ance. Surgery is the most obvious 
way in which fertility can be lost, 
but other causes include the 
patient’s response to the chemo¬ 
therapy or radiation, the method 
of administration (oral or intra¬ 
venous), the dose intensity and 
the size and location of the radia¬ 
tion field. 
For patients who need pelvic 
radiation, a surgical technique 
called ovarian transposition is 
sometimes used to reposition the 
ovaries at a safe distance from 
the radiation field.This approach, 
which is relatively simple and mini¬ 
mally invasive, is most commonly 
used in patients with Hodgkin’s 
disease, cervical and vaginal can¬ 
cers and pelvic sarcomas. 
Other therapies being explored 
include administration of 
gonadotropin-releasing hormone. 
This hormone temporarily puts 
the body in a menopausal state, 
which is believed to result in less 
damage to reproductive organs 
during chemotherapy. Another 
technique, still experimental, is 
ovarian tissue cryopreservation. 
Ovarian tissue is removed from 
the cancer patient prior to treat¬ 
ment, and frozen if it is found to 
be free of metastatic disease. 
Once the patient is cured and 
wants to get pregnant, the cryo- 
preserved ovarian tissue is thawed 
and placed back in the ovary or 
another body part that is more 
easily accessible, such as the sub¬ 
cutaneous tissue of the abdomen, 
and that can accommodate the 
tissue and allow it to function. It 
has been shown that ovarian tis¬ 
sue removed prior to the initiation 
of cancer treatment is functional 
following the thawing process, but 
only for a short time. Worldwide, 
two babies, in Belgium and in 
Israel, have been born using this 
option when the ovarian tissue 
was placed back in the pelvis where 
the ovary is normally located. This 
fall Pasquale Patrizio, m.d., m.b.e., 
professor of obstetrics and gynecol¬ 
ogy, the director of the Yale Fertility 
Center and the oncofertility pro¬ 
gram, is starting a new project to 
perfect the method of ovarian 
preservation. Instead of freezing 
sliced tissue, he plans to freeze 
the entire ovary, which he believes 
will better survive the freezing 
and thawing process. 
—J.K. 
Veronica Bianchi, left, developed 
the slow cooling technique for 
oocyte preservation at a private 
fertility clinic in Bologna, Italy. 
She is now at Yale, working with 
Pasquale Patrizio, right, at the 
Yale Fertility Center to improve 





















Joan Steitz Thomas Pollard 
Two Yale biologists 
receive Gairdner 
International Award 
Two Yale biologists were among 
five scientists to win 2006 
Gairdner International Awards, 
among the most prestigious 
in science. The awards will be pre¬ 
sented in October in Toronto. 
JOAN A. STEITZ, PH.D., 
Sterling Professor of Molecular 
Biophysics and Biochemistry and a 
Howard Hughes Medical Institute 
investigator, is being honored 
for her discovery of snRNPs (pro¬ 
nounced “snurps”), complexes of 
protein and rna that edit and 
splice other rna strands to form 
messenger rna, the genetic 
recipe used by the cell’s protein¬ 
making machinery. 
THOMAS D. POLLARD, M.D., 
chair and Sterling Professor of 
Molecular, Cellular and Develop¬ 
mental Biology, is being recognized 
along with his colleague Alan 
Hall, ph.d., of Memorial Sloan- 
Kettering Cancer Center in New 
York, for discovering the molecular 
basis of cellular motility and 
the mechanism of its regulation. 
This fundamental knowledge is 
required to understand embryonic 
development, defense against 
infections and the spread of 
malignant tumors in the body. 
Founded in 1959, the Gairdner 
International Awards recognize 
achievements in medical science. 
In 2004, another Yale scientist 
received a Gairdner Award. Arthur 
L. Horwich, M.D., hs ’78, the Eugene 
Higgins Professor of Genetics and 
Pediatrics and a Howard Hughes 
Medical Institute investigator, was 
honored for his findings on pro¬ 
tein folding and its relevance to 
neurodegenerative diseases. 
Curtis Patton 
William Prusoff and Dean Robert Alpern 
Prusoff is awarded 
Parker Medal for role in 
discovery of aids drug 
WILLIAM H. PRUSOFF, PH.D., 
professor emeritus and senior 
research scientist in pharmacol¬ 
ogy, received the Peter Parker 
Medal, which honors service to 
the university, on April 17. Prusoff 
and his colleague Tai-Shun Lin, 
ph.d., discovered the antiviral 
properties of d4T, or stavudine, in 
1986. Marketed by Bristol-Myers 
Squibb as Zerit, it became one of 
the leading drugs used to treat 
hiv/AIDS. Dean Robert J. Alpern, 
m.d., presented the medal to 
Prusoff at the ceremony held at 
the Union League Cafe. 
Curtis Patton retires 
from research and 
international health 
When curtis l. patton, ph.d., 
professor of epidemiology (micro¬ 
biology) and director of interna¬ 
tional medical studies at the 
School of Public Health, describes 
his career in public health, his 
memory goes back to his boyhood 
in Birmingham, Ala., when he 
contracted malaria. He can’t prove 
it after so many years, but he 
suspects he got the disease at a 
waterhole near his home, where 
he and his friends caught tadpoles 
and crawfish. The water was 
stagnant and dirty, but that 
didn’t seem to matter to the boys. 
"Pushing one another into the 
water was a wonderful game,” he 
recalled in a recent interview. 
“I found out after I was in college 
that this was an open sewer.” 
Patton has spent his career 
studying tropical diseases, specifi¬ 
cally the trypanosomes that cause 
malaria. Among his most memo¬ 
rable experiences, both profes¬ 
sional and personal, were trips to 
the Brazilian Amazon to protect 
indigenous tribes from the diseases 
that followed civilization, to Kenya 
to study trypanosomes and tsetse 
flies, and to Senegal to study 
the public health implications of 
damming the Senegal River. 
Patton retired in July after 36 
years at Yale. Along with his 
research he will also be remem¬ 
bered for steering the Downs 
International Health Student 
Travel Fellowship program that 
has sent more than 400 students 
in medicine, public health, nurs¬ 
ing and the Physician Associate 
Program abroad since it began in 
1966. Students are expected to 
travel to a region of the world that 




population, but is also one where 
they haven’t lived or worked 
before. “We decided it would be 
a better experience if students 
went to places that would stretch 
them culturally, underserved areas 
where there really was a need to 
find out what the problems were, 
not just in public health, but in 
medicine,” Patton said. One of his 
retirement projects is a study of 
the effects of the Downs program 
on participants. Anecdotally, he 
observes, “They come back more 
mature. They come back more 
committed.” 
Patton believes this is an impor¬ 
tant program for students. “This 
is a formative period of their lives,’ 
he said. “It’s not just about get¬ 
ting a Nobel Prize for studying 
malaria. It is about developing as 
an individual, as a student who is 
going to go ahead and make the 
kind of progress we want students 
to make.” 
NOTES 37 
Alison Calvani Nigel Crindley 
Kelly D. Brownell, ph.d., professor 
and chair of psychology, pro¬ 
fessor of epidemiology and 
director of the Rudd Center for 
Food Policy and Obesity, has 
been named in Time magazine’s 
list of 100 "People Who Shape 
Our World.” Brownell, one of the 
list’s scientists and thinkers, 
was cited for his efforts to 
reduce obesity in the United 
States. Also on the list are 
President Bush, actor George 
Clooney, model Tyra Banks, Iraqi 
Shiite leader Muqtada al-Sadr 
and rap artist Sean Combs. 
Elizabeth B. Ciaus, M.D. ’94, PH.D. 
’94, associate professor of public 
health (biostatistics), has been 
awarded a five-year, $9.5 million 
grant from the National Insti¬ 
tutes of Health, for the first large 
national effort to study risk fac¬ 
tors associated with a diagnosis 
of meningioma, the most fre¬ 
quently reported of primary 
intracranial neoplasms. This 
study is important because of 
the lack of information about 
the disease, the large number of 
patients with this diagnosis and 
this tumor's frequent association 
with neurological complications 
and decreased quality of life. 
John A. Elefteriades, M.D. ’76, 
hs ’8i, fw ’83, professor and 
chief of cardiothoracic surgery, 
received the prestigious Socrates 
Award for Excellence in teaching 
and mentoring of residents at 
the 42nd annual meeting of the 
Society of Thoracic Surgeons in 
Chicago in January. Elefteriades 
also received the Program 
Director Award for the best resi¬ 
dent paper, titled "What Is 
the Optimum Treatment for Late 
Presenters With Acute Type A 
Aortic Dissection?”The paper 
was presented by Ryan R. Davies, 




m.d. ’01, who carried out the 
research while he was the 
Winchester Fellow in Cardio¬ 
thoracic Surgical Research at 
Yale-New Haven Hospital. 
Alison Calvani, ph.d., assistant 
professor in the School of Public 
Health’s Division of Epidemiol¬ 
ogy of Microbial Diseases, has 
been named a recipient of a 
Guggenheim Foundation Fellow¬ 
ship. Guggenheim Fellows are 
appointed on the basis of past 
achievements and on the prom¬ 
ise of future achievements. 
Galvani was awarded the fellow¬ 
ship based on her research on 
the public perception of 
influenza vaccination policies. 
Nigel D.F. Grindley, PH.D., profes¬ 
sor of molecular biophysics 
and biochemistry, has been 
elected to the Royal Society of 
the United Kingdom. Fellows 
are chosen for their contribu¬ 
tions to basic science and for 
advancing progress in research 
and industry. Grindley studies 
dna transposition and site- 
specific recombination. 
Charles J. Lockwood, m.d., the 
Anita O’Keefe Young Professor 
of Women’s Health and chair 
of obstetrics, gynecology and 
reproductive sciences, and Errol 
R. Norwitz, m.d., ph.d., associate 
professor of obstetrics, gynecol¬ 
ogy and reproductive sciences, 
are among six scientists who 
will share $2.4 million from the 
March of Dimes for research 
into premature births. The three- 
year prematurity research 
initiative grants will fund efforts 
to predict and prevent prema¬ 
ture births. 
Alexander Neumeister, M.D., asso¬ 
ciate professor of psychiatry, was 
awarded the cinp 2006 Bristol- 
Myers Squibb Max Hamilton 
Memorial Prize in July.The cinp, 
Collegium Internationale Neuro- 
psychopharmacologicum, is an 
international group of scientists 
interested in neuropsychophar¬ 
macology, basic science and 
clinical issues such as treatment. 
The $10,000 award is given to 
scientists under the age of 
41 who have made important 
research contributions to the 
field in the area of depression. 
Peter J. Novick, PH.D., professor 
of cell biology, has been elected 
to the American Academy of 
Arts and Sciences. Novick, an 
expert on vesicle trafficking and 
cell polarity in yeast, joins more 
than 130 other Yale faculty as a 
fellow of the Cambridge, Mass.- 
based academy. 
Jody L. Sindelar, ph.d., professor 
of public health, has been named 
the inaugural president-elect 
and current vice president of the 
newly formed American Society 
of Health Economists (ashe). 
Sindelar, who studies the eco¬ 
nomics of smoking, alcohol 
and illicit drugs, is a founding 
member of ashe, a profes¬ 
sional organization dedicated 
to promoting excellence in 
health economics research in 
the United States. 
Scott Strobel, ph.d., was named 
chair of the Department of 
Molecular Biophysics and Bio¬ 
chemistry (mb&b) for a three- 
year term that began July 1. 
Strobel succeeds Nigel D. F. 
Grindley, ph.d., who has led the 
department since 2003. Also 
this spring, the Howard Hughes 
Medical Institute (hhmi) named 
Strobel as one of its new hhmi 
professors chosen for the quality 
of their teaching, inspiration 
and mentoring. Strobel will 
receive $1 million over four years 
to implement innovative science 
teaching ideas, hhmi will pro¬ 
vide the resources for Strobel 
to take undergraduates "bio¬ 
prospecting” for promising natu¬ 
ral products in the world’s rain 
forests. The students will then 
purify and analyze the com¬ 
pounds they collect and test 
them for potentially beneficial 
activity. 
Richard Torres, M.D. ’99, M.P.H., 
assistant clinical professor 
of medicine and chief medical 
officer of Optimus Health 
Care, which includes Bridgeport, 
Stratford and Stamford Com¬ 
munity Health centers, was 
selected to the National Health 
Leadership Fellowship Program 
by the Robert F. Wagner Gradu¬ 
ate School of Public Service 
at New York University and the 
National Hispanic Medical 
Association. Torres was one of 
only 10 physicians selected in 
America, and the only physician 
from New England. 
Barry Wu, M.D., HS '92, associate 
clinical professor of medicine, 
received the Herbert S. Waxman 
Award for Outstanding Medi¬ 
cal Student Educator from the 
American College of Physicians 
on April 6 in Philadelphia. 
SEND FACULTY NEWS TO 
Claire M. Bessinger, Yale Medicine, 
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38 students commencement 2006 
Use Larson awaits the procession to Old Campus 
on the morning of Commencement. 
39 
Always put the 
patient first 
Doing what’s best for the patient 
will require courage, education dean 
says at Commencement. 
The pressures of the real world will 
challenge their graduation-day idealism, 
Herbert S. Chase Jr., m.d., told the ioi 
members of the Class of 2006 in his 
Commencement address. Speaking 
on Harkness Lawn on a flawless spring 
day, the deputy dean for education 
offered a cautionary tale. 
At another institution Chase 
reviewed a colleague’s research pro¬ 
posal: the trial would replace a known 
diabetes medicine with an experimen¬ 
tal drug. Half the elderly patients in 
the study would get the new medicine 
and half would get a placebo. Chase 
rejected the proposal, disturbed that 
a respected physician would propose 
a plan that could cause harm. Later, 
remorseful, the doctor called to explain. 
The pharmaceutical company behind 
the experimental drug was subsidizing 
his salary. “He had let it blind him 
to the obvious fact that taking elderly 
patients off their diabetes medicine was 
unambiguously unacceptable,” Chase 
said. “He had opted to protect himself 
rather than his patient.” 
Chase urged the graduates to adopt 
“a mantra, a talisman in the face of the 
challenges you will inevitably encounter. 
‘Do what is best for the patient.’ ” That 
will require the courage to resist 
pressures to rush, to save money, to 
discharge patients quickly. “You 
will sometimes have to take some risk 
to do what is right for the patient.” 
Dean Robert J. Alpern, m.d., 
Ensign Professor of Medicine, honored 
Howard Levitin, m.d., professor emeri¬ 
tus and senior research scientist in 
medicine, for 50 years of service to the 
School of Medicine. Alpern also hon¬ 
ored Thomas L. Lentz, m.d. ’64, pro¬ 
fessor of cell biology and associate 
dean for admissions, noting that as a 
member of the admissions committee 
since 1968, Lentz had read more than 
100,000 applications. 
The Bohmfalk Teaching Prize went 
to Chase for basic science teaching, 
and to Andre N. Sofair, m.d., m.p.h. 
’97, assistant professor of internal medi¬ 
cine, for clinical teaching. Mark D. 
Siegel, m.d., fw ’95, associate professor 
of internal medicine, won the Leonard 
Tow Humanism in Medicine Award. 
Two people won the Leah M. 
Lowenstein Prize for promoting 
humane and egalitarian medical edu¬ 
cation: Nancy R. Angoff, m.p.h. ’81, 
m.d. ’90, hs ’93, associate dean for 
student affairs; and, for the second 
year, Catherine Chiles, m.d., hs ’86, 
associate clinical professor of psychia¬ 
try. The Francis Gilman Blake Award 
for outstanding teacher of the medical 
sciences went to Interim Chair of 
Internal Medicine David L. Coleman, 
m.d. ’76, hs ’79; and the Betsy Winters 
House Staff Award went to Robert W. 
Chang, m.d., chief surgical resident. 
Professor of Medicine Fred S. Gorelick, 
m.d., fw ’79, received the Alvan R. 
Feinstein Award for outstanding 
teacher of clinical skills. The graduat¬ 
ing class presented $6,000 to the 
Society of Distinguished Teachers, 
which supports faculty in educational 
initiatives and development. 
—Cathy Shufro 
to p In one of his last acts as deputy dean 
for education, Herbert Chase delivered the 
Commencement address to the Class of 2006. 
MIDDLE Todd Ebbert, Natalie Guerrier 
and Calvin Barnes before the procession to 
Old Campus. 
BOTTOM Khoonyen Tay, Sarah Doernberg, 
Eliza Meade and Travis Maak waited for the 
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Calls for morality, justice 
and passion at Epidemiology 
and Public Health ceremony 
With a child under five dying some¬ 
where in the world every 3 seconds and 
a child born into poverty in the United 
States every 35 seconds, “our global and 
our nation’s moral compass and our 
nation’s priorities need resetting,” said 
Marian Wright Edelman, j.d., founder 
and president of the Children’s Defense 
Fund and the speaker at the 2006 
Department of Epidemiology and Public 
Health Commencement. “We are the 
wealthiest nation on earth. The fact that 
we still do not choose to ensure healthy 
children, a healthy start for all of our 
children, is simply wrong and foolish,” 
she said. 
Addressing the 123 graduates, fac¬ 
ulty and staff gathered in Battell 
Chapel on May 22, Edelman cited the 
German cleric Dietrich Bonhoeffer’s 
belief that the test of a society’s moral¬ 
ity is its treatment of its children. 
“We flunk Bonhoeffer’s test every hour 
of every day,” Edelman said. 
In this country, Edelman said, 
nearly 9 million children whose par¬ 
ents work and “follow the system” 
are without health coverage. “Wealth,” 
she said, “should not dictate good 
health. ... It is time for every child in 
this country and their parents—in fact, 
every American—to have national 
health and mental health coverage.” 
Edelman concluded with an anec¬ 
dote about Sojourner Truth, who once 
had a white man tell her that her anti¬ 
slavery efforts meant no more to him 
than a flea bite. She told the man that 
she would keep him “scratching.” In 
that spirit, Edelman said, “We need big 
changes. Enough committed fleas bit¬ 
ing strategically can make very big 
dogs uncomfortable. And I hope every¬ 
one in this audience is determined that 
you are going to be a flea for justice, 
for children, for health care for all 
Americans. Believe it. You can do it.” 
Aliya Jiwani, m.p.h. ’06, who gave 
the student address, urged her fellow 
graduates to “question everything ... 
notions, ideas and even the most popu¬ 
lar theories of the day.” Above all, she 
encouraged her peers to “follow your 
passion—whatever it may be.” 
Brian P. Leaderer, m.p.h. ’71, ph.d. 
’75, the Susan Dwight Bliss Professor 
of Epidemiology, who served as interim 
dean of public health and interim chair 
of the Department of Epidemiology 
and Public Health until July, urged this 
year’s graduates to be leaders “from 
the smallest neighborhood clinic to the 
largest of the nih’s institutes. Your 
work will, directly or indirectly, 
improve people’s lives. ... No matter 
what path you take, hold on to the 
ideals that brought you here, and move 
forward with confidence and courage.” 
Trace Kershaw, ph.d., assistant pro¬ 
fessor of epidemiology in the Division 
of Chronic Disease Epidemiology and 
in the Social and Behavioral Sciences 
Program, received the Award for Excel¬ 
lence in Teaching. Dean’s Prizes for 
Outstanding m.p.h. Theses were given 
to Heather Brown, Jessica Clague and 
Ann Liu. The Henry J. Chauncey Jr. 
Inspiration Award was given to Katrina 
Van Gerpen, and the Cortlandt Van 
Rensselaer Creed Award was presented 
to Erica Jackson. Christine Malino 
received the Wilbur G. Downs Inter¬ 
national Health Prize. 
—Mar tie Foley 
TOP Marion Wright Edelman,founder and 
president of the Children’s Defense Fund, called 
for national health coverage for all in her 
Commencement address. 
middle Lisa Bono-Corredor, Nadia Abuzaineh 
and Roberta Horth at Cross Campus. 
bottom Lisa Houston, Anita Makkenchery 
and Laquesha Andrews leaving Battell Chapel 
after Commencement ceremonies. 
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Obesity, AIDS and a shark’s 
gland are among the topics of 
Student Research Day 
In the 1990s, Jeffrey M. Friedman, 
m.d., ph.d., director of the Starr Center 
for Human Genetics at Rockefeller 
University, wondered why humans tend 
to keep their weight stable over years. 
“There must be some biological system 
that counts our calories for us,” said 
Friedman during his keynote speech at 
Student Research Day in May. His 
questioning led him to leptin, a hor¬ 
mone secreted in the blood that regu¬ 
lates food intake and energy expendi¬ 
tures. But food intake remains a com¬ 
plex process that is not completely 
understood. “We don’t know how this 
information is processed. We don’t 
know where it is processed.” 
UnderRated skewers 
rankings and—as ever— 
the med school faculty 
When the School of Medicine dropped 
to number n in the annual U.S. News 
and World Report rankings in 2005, the 
news was perfect fodder for the second- 
year show presented in February by 
the Class of 2008, and produced by 
Carolyn Avery, Chris Gibson, Lars 
Grimm, Mary Hatcher, David Merrick 
and Jen Voorhees. UnderRated was 
chock-full of vignettes, video pieces and 
song-and-dance numbers woven into 
a tongue-in-cheek plot about student 
protest over Yale’s lowered ranking and 
the faculty’s response to the “crisis.” 
The show did justice to the tradition 
of impersonations of faculty members, 
In patients who are deficient in 
leptin, he said, there is no signal to the 
hypothalamus that the body has ade¬ 
quate stores of fat. “This is a major 
medical problem,” Friedman said. “For 
reasons we don’t understand, obesity 
increases the risk for a host of diseases.” 
Sixty-six students presented posters 
of their research and five students 
gave oral presentations of their award¬ 
winning theses: Jennifer Greenwold 
discussed doctors who wrote about the 
early days of the aids pandemic; Lauren 
Kernochan studied a gene linked to 
spinal muscular atrophy; Khoonyen Tay 
studied ways to reduce the overuse of 
antibiotics; Connor Telles investigated a 
potassium channel in the shark rectal 
gland; and Jaehyuk Choi described hiv 
replication in certain cells. 
—John Curtis 
with Kristina Zdanys as Nancy R. 
Angoff, m.p.h. ’81, m.d. ’90, hs ’93, 
associate dean for student affairs, 
who urged a baffled Dean Robert J. 
Alpern, m.d., played by Shane Lloyd, to 
take charge of the rebellious students. 
In the finale, “Walk Like a Physi¬ 
cian,” sung to the tune of the Bangles’ 
“Walk Like an Egyptian,” the Class of 
2008 came to the conclusion that a 
magazine’s rankings don’t matter—it’s 
the quality of education that students 
get at Yale that really counts. Perhaps 
U. S. News editors were in the audi¬ 
ence: a month later Yale bounced back 
to number nine in the rankings. 
—Jill Max 
Erin Kiehna described her thesis, Changes in 
attentional performance in children and young 
adults with localized primary brain tumors 
requiring radiation therapy, at Student Research 
Day in May. 
Mary Air with Danny Balkin portraying Herbert 
Chase, the deputy dean for education, in a 
scene from UnderRated, the second-year show 
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Match Day 2006 
2006 residency placements 
for Yale medical students 
The Office of Student Affairs has pro¬ 
vided the following list, which outlines 
the results of the National Resident 
Matching Program for Yale’s medical 
graduates. Some names appear twice 
because the graduate is entering a one- 
year program before beginning a specialty 
residency. The transitional designation 
is a one-year program with three-month 
rotations in different specialties. 
California 
Alameda County Medical Center, 
Oakland 
Stacy UyBico, transitional 
California Pacific Medical Center, San 
Francisco 
Sunanda Pejavar, medicine-preliminary 
Santa Clara Valley Medical Center, 
San Jose 
Janet Kim, transitional 
Scripps Mercy Hospital, San Diego 
Kendra Klang,transitional 
Stanford University Programs 
Powell Jose, internal medicine 
Kendra Klang, diagnostic radiology 
Gregory Magee, general surgery 
UCLA Medical Center, Los Angeles 
Ayonija Maheshwari, emergency 
medicine/internal medicine 
Andrew Nerlinger, emergency 
medicine 
Stacy UyBico, diagnostic radiology 
University of California, Davis 
Janet Kim, radiation oncology 
University of California, San Diego 
Jenli Waters, surgery-preliminary, 
neurosurgery 
University of California, San Francisco 
Thomas Dewland, internal medicine 
Sarah Doernberg, internal medicine 
Natalie Guerrier, pediatrics/primary 
Use Larson, pediatrics 
Meg Pearson, internal medicine/ 
primary 
Sunanda Pejavar, radiation oncology 
Hyman Scott, internal medicine/ 
primary 
Dana Weiss, surgery-preliminary, 
urology 
Colorado 
University of Colorado School of 
Medicine, Denver 
Lindsey Sukay, pediatrics 
Connecticut 
Greenwich Hospital 
Calvin Barnes, medicine-preliminary 
Griffin Hospital, Derby 
Karina Lund, medicine-preliminary 
Hospital of Saint Raphael, New Haven 
Amichai Erdfarb, medicine-preliminary 
Jane Gwira, medicine-preliminary 
Andrew Nerlinger, medicine¬ 
preliminary 
Robert Schonberger, transitional 
Douglas Walled, transitional 
St. Vincent’s Medical Center, 
Bridgeport 
Scott Degregorio, transitional 
Margaret Rose, transitional 
Yale-New Haven Hospital 
Teeb Al-Samarrai, internal medicine 
Jaehyuk Choi, dermatology, medicine¬ 
preliminary 
Brittiny Epperson, medicine¬ 
preliminary 
Jorge Galvez, anesthesiology, 
medicine/primary-preliminary 
Brendon Graeber, pediatrics 
Ryan Huffman, ophthalmology 
Igor Latic, diagnostic radiology 
Kirsten Menn, diagnostic radiology 
Benjamin Noonan, orthopaedic 
surgery 
Ali Ozturk, neurosurgery, surgery¬ 
preliminary 
Michael Reel, obstetrics and 
gynecology 
Amar Rewari, medicine-preliminary 
Margaret Rose, anesthesiology 
Robert Schonberger, anesthesiology 
Jennifer Smith, medicine-preliminary 
Connor Telles, orthopaedic surgery 
Tamara Vanderwal, psychiatry- 
adult/child 
Florida 
Jackson Memorial Hospital, Miami 
Joyce Kaufman, general surgery 
University of Miami-Bascom Palmer 
Eye Institute 
Anil Vedula, ophthalmology 
Georgia 
Emory University School of Medicine, 
Atlanta 
Odicie Fielder, internal medicine/ 
primary 
Illinois 
McGaw Medical Center of 
Northwestern University, Chicago 
Eliza Meade, obstetrics and 
gynecology 
Northwestern University, Chicago 
Jane Gwira, ophthalmology 
Rush University Medical Center, 
Chicago 
A.J. Valenson, orthopaedic surgery 
Iowa 
University of Iowa Hospitals and 
Clinics, Iowa City 
Todd Ebbert, diagnostic radiology 
Maine 
Maine Medical Center, Portland 
Stephen Ward, internal medicine 
Maryland 
Johns Hopkins Hospital, Baltimore 
Simon Best, otolaryngology 
Michelle Zikusoka, internal medicine 
National Naval Medical Center, 
Bethesda 
Huy Phun, internal medicine 
University of Maryland Medical 
Center, Baltimore 
Samantha Wood, emergency 
medicine/internal medicine 
Massachusetts 
Beth Israel Deaconess Medical Center, 
Boston 
Jason Knight, obstetrics and 
gynecology 
Boston University Medical Center 
Dara Arons, family medicine 
Karina Lund, ophthalmology 
Brigham and Women’s Hospital, 
Boston 
Marwah Abdalla, internal medicine/ 
primary 
David Enis, medicine-preliminary 
Pavlos Kaimakliotis, internal medicine 
Jessica Kattan, internal medicine/ 
primary 
Rahul Rajkumar, internal medicine 
Shari Rogal, internal medicine 




Jennifer Greenwold, psychiatry 
Children’s Hospital Boston 
Kira Bona, pediatrics 
Massachusetts General Hospital, 
Boston 
Michele Buragas, pediatrics 
Davender Khera, medicine-preliminary 
Sadhna Vora, internal medicine/primary 
Massachusetts General Hospital/ 
Brigham and Women’s Hospital, 
Boston 
Davender Khera, neurology 
Massachusetts General Hospital 
(Harvard Combined), Boston 
Natasha Archer, medicine/pediatrics 
Alyssa Letourneau, medicine/pediatrics 
Missouri 
Barnes-Jewish Hospital, St. Louis 
Calvin Barnes, diagnostic radiology 





J Marcus Coe, orthopaedic surgery 
New Jersey 
UMDNJ-Robert Wood Johnson 
Medical School, Piscataway 
|i Nora Cheung, general surgery 
New York 
Albert Einstein College/Montefiore 
' Medical Center, Bronx 
f Sadiqa Edmonds-Myies, pediatrics/ 
primary 
[I Amichai Erdfarb, diagnostic radiology 
j Lisa Millman, internal medicine/ 
■ primary 
i Hospital for Special Surgery/Cornell 
i(, Medical Center, New York City 
I Travis Maak, orthopaedic surgery 
i Memorial Sloan-Kettering Cancer 
Center, New York City 
I Douglas Housman, radiation 
B oncology, transitional 
t| Igor Latic, transitional 
lij Akash Shah, transitional 
1 Anil Vedula, transitional 
Mount Sinai Hospital, New York City 
I] Sarah Adams, research medicine 
I Richard Crockett, plastic surgery 
Mount Sinai School of Medicine/ 
Cabrini Medical Center, New York City 
I Trushar Patel, medicine-preliminary 
: New York Methodist Hospital, 
ai Brooklyn 
|| Juliana Capatosto, emergency 
medicine 
/ New York-Presbyterian Hospital- 
i Columbia, New York City 
l Connie Chung, anesthesiology, 
1 medicine-preliminary 
I Ameya Kulkarni, internal medicine 
A Brenda Ritson, pediatrics 
New York-Presbyterian 
Hospital-Cornel!, New York City 
Joseph Cousin, psychiatry 
Mariel Focseneanu, obstetrics 
and gynecology 
David Liska, general surgery 
Trushar Patel, diagnostic radiology 
Akash Shah, diagnostic radiology 
New York University School of 
Medicine, New York City 
Renu Chundru, ophthalmology 
Scott Degregorio, diagnostic 
radiology 
Anna Yusim, psychiatry 
St. Vincent’s Hospital-New York 
Medical College, New York City 
Kirsten Menn, transitional 
Ohio 
Cleveland Clinic Foundation 
Shlomo Koyfman, radiation oncology 
Mary Turell, ophthalmology 
Pennsylvania 
Children’s Hospital of Philadelphia 
Khoonyen Tay, pediatrics 
Hospital of the University of 
Pennsylvania, Philadelphia 
David Enis, dermatology 
Melissa Knauert, internal medicine 
Meghan Lane, anesthesiology 
Katya Rubinow, internal medicine 
Pennsylvania Hospital, 
University of Pennsylvania Health 
System, Philadelphia 
Renu Chundru, medicine-preliminary 
Tennessee 
University of Tennessee College of 
Medicine Chattanooga 
Ryan Huffman, transitional 
Vanderbilt University Medical Center, 
Nashville 
Heather McKee, medicine¬ 
preliminary, neurology 
Texas 
University of Texas Southwestern 
Medical School, Dallas 
Justin Heller, plastic surgery 
Virginia 
University of Virginia, 
Charlottesville 
Erin Kiehna, surgery-preliminary, 
neurosurgery 
Washington 
University of Washington Affiliated 
Hospitals, Seattle 
Lauren Kernochan, pathology 
Tong Yang, surgery-preliminary, 
neurosurgery 
Wisconsin 
Cundersen Lutheran Medical 
Foundation, La Crosse 
Todd Ebbert, transitional 
Three students have chosen career 
options other than residency. Rachel 
Light will remain in New Haven as a 
freelance book writer and birth 
assistant to a home birth midwife. 
Sara Nayeem will be an investment 
banking associate at Merrill Lynch 
Global Healthcare Group in New 
York City. And Jeffrey Hoschander 
will be an associate at Simpson, 
Thacher & Bartlett, a law firm in 
New York City. 
opposite Although happy with 
her match, a transitional residency 
at Scripps Mercy Hospital in San 
Diego before she begins a diag¬ 
nostic radiology program at 
Stanford, Kendra Klang, at left, 
was overcome with emotion. 
left Renu Chundru,at left, 
celebrated her match in medicine 
at Pennsyl-vania Hospital with 
Rajeshvari Patel, a friend from the 
Class of 2008. 
top Anil Vedula is heading for 
Miami and a residency in ophthal¬ 
mology, while Trushar Patel 
will pursue diagnostic radiology 
in New York City. 
middle Eliza Meade shared the 
news of her match in obstetrics 
and gynecology at Northwestern 
with friend Jason Griffiths, an 
m.d./ph.d. student in the Class 
of 2008. 
bottom Sarah Doernberg will 




















Back on Cedar Street 
Hundreds of alumni, spanning 60 years, returned to the 
medical school in June to reunite with classmates, 
learn about changes at the school and enjoy the Friday 
evening clambake. 
Photographs by Terry Dagradi and John Curtis 
TOP Dean Robert Alpern brought alumni up to 
date on the state of the school. 
bottom Frank Lobo, president of the 
Association of Yale Alumni in Medicine, opened 
the business meeting on Saturday morning. 
This year’s reunion kicked off on the 
evening of Friday, June 2, in the Medi¬ 
cal Historical Library with welcoming 
remarks from Dean Robert J. Alpern, 
m.d., Ensign Professor of Medicine. 
“This is a special time for me. I 
came here two years ago on June 1. 
Right after I arrived, the first special 
occasion was the alumni reunion 
weekend. As I came here and was 
absorbing the complexity of the medi¬ 
cal school, it was very invigorating to 
see all the alumni and see how enthu¬ 
siastic everyone was about their experi¬ 
ence at Yale, how much they loved it 
and how much they love coming back 
here. It was really uplifting. I look for¬ 
ward to experiencing that again and 
seeing everyone come back and hear¬ 
ing nothing but compliments,” he 
said, before concluding, to laughter 
from alumni, “The faculty is not that 
kind to me.” 
By the time of the reception in the 
library, reunion activities were well 
under way. Events began the day before, 
with a presentation from the Yale 
Surgical Society, and continued earlier 
on Friday with Alumni Day at Epidemi¬ 
ology and Public Health at the New 
Haven Lawn Club, and two presenta¬ 








The state of the school 
The next morning, at the business meet¬ 
ing of the Association of Yale Alumni 
in Medicine (ayam), Alpern brought 
alumni up to date on the state of the 
medical school. A new deputy dean of 
education, Richard Belitsky, m.d., asso¬ 
ciate professor of psychiatry, has been 
appointed, as has a new associate dean 
of admissions, Laura R. Ment, m.d., 
professor of pediatrics and neurology. 
Sharon Bonney, second from left, and Frank 
Coughlin, right, received the Distinguished 
Alumni Service Award at this year’s reunion 
from Dean Robert Alpern and ayam President 
Frank Lobo. 
“The educational program is outstand¬ 
ing,” Alpern reported, “but there are 
always ways to improve it, especially dur¬ 
ing the third and fourth years.” 
The medical school ranks in seventh 
place in total funding from the National 
Institutes of Health, and about 30 bio¬ 
tech startups affiliated with the medical 
school have begun operations. “We have 
become a major engine of the local 
economy,” Alpern said. 
He also cited the formation of a 
translational research center at the medi¬ 
cal school, a new stem cell center with 
I potential funding from the state of 
1 Connecticut, a center for clinical investi- 
I; gation and the start of construction of 
1 a new 14-story addition to ynhh for 
I; cancer care. 
Honors for alumni 
i Francis R. Coughlin Jr., m.d. ’52, and 
I Sharon L. Bonney, m.d. ’76, each 
I received the Distinguished Alumni 
I- Service Award. 
Coughlin was honored for his serv¬ 
ice to the medical school, including a 
i term as president of the ayam. His 
I citation noted that Coughlin went to 
! law school in 1985 and has since 
served on medical and legal commis¬ 
sions in New York and Connecticut. 
Bonney’s citation traced her career 
path from clinical work to clinical 
research and development in the phar¬ 
maceutical industry. She served on the 
alumni executive committee twice and 
is currently the medical school repre¬ 
sentative to the Association of Yale 
Alumni (aya). 
At the business meeting, members 
elected a new secretary, new board 
members and a new representative to 
the aya. Robert W. Lyons, m.d. ’64, was 
elected to a three-year term as secretary, 
replacing Christine A. Walsh, m.d. ’73, 
who was named ayam representative to 
the aya, along with Irving G. Raphael, 
m.d. ’71. Carol }. Amick, m.d. ’59, 
Arthur C. Crovatto, m.d. ’54, hs ’61, 
and Richard D. Kayne, m.d. ’76, hs ’79, 
were elected to the ayam executive com¬ 
mittee as members at large. 
Working across disciplines 
Alumni began the day with a sympo¬ 
sium on a new model for interdiscipli¬ 
nary research. 
In order to break barriers in medi¬ 
cine, Yale is knocking down intramural 
walls that tend to confine researchers 
within their own disciplines. Why keep 
some of the world’s best scientists 
cooped up in their specialized fields, the 
thinking goes, when they can conquer 
diseases by sharing their expertise? 
This synergistic model recently 
took the form of the Interdepartmental 
Program in Vascular Biology and 
Transplantation, whose work was out¬ 
lined at a forum during the School of 
Medicine’s Alumni Weekend in June. 
Bringing together experts from many 
fields is “bridging the taxonomies of 
science and medicine,” said Francis M. 
Lobo, m.d. ’92, president of the ayam. 
“The walls are coming down.” Lobo 
spoke in a literal as well as metaphori¬ 
cal sense. The loosely knit vascular 
biology and transplantation team will 
work together in the Amistad Building 
under construction on Amistad Street. 
The interdepartmental program was 
established in 2000 and now has 36 
faculty members from a range of disci¬ 
plines, including surgery, medicine, 
dermatology, anesthesiology, cardiol¬ 
ogy, immunobiology, pharmacology, 
genetics, pathology and biomedical 
engineering. 
Jordan S. Pober, m.d. ’77, ph.d. ’77, 
director of the program since its incep¬ 
tion, said he “had a personal epiphany” 
in 1996 at a meeting of vascular biolo¬ 
gists. Vascular biologists examine the 
cellular structure of the vessels that feed 
every organ in the body and whose fail¬ 
ure lies at the root of many deadly dis¬ 
eases. Although vascular biology had 
been a specialty only since the 1980s, 
“the field had matured,” Pober said. “We 
understood the basic principles. What 
we didn’t know was how we could use 
this stuff to treat patients.” 
Pober convinced former Dean David 
A. Kessler, m.d., to launch the multidis¬ 
ciplinary program even though there 
was no blueprint for it. Team members 
acknowledged that the “translational” 
aspect of the program would involve 
more research than actual therapy in its 
early stages. If something works in 
mice, “most of the time it doesn’t work” 
in humans, Pober said. “We decided 
that we couldn’t cure everything.” The 
researchers focused on a few targets: 
arteriosclerosis, alleviating organ short¬ 




















46 Alumni REUNION 2006 
sue engineering, and regeneration—or, 
as Pober put it, “How do you get new 
blood vessels to grow?” 
Pober, a professor of pathology, 
immunobiology and dermatology, spe¬ 
cializes in the role of blood vessel cells 
in immunology. Working with his late 
colleague, Jeffrey S. Schechner, m.d. 
’91, Pober used his knowledge of blood 
vessel cells to grow vascularized 
synthetic skin. He studies the role of 
endothelial cells, which form the 
inside layer of blood vessels. William 
C. Sessa, ph.d., deputy director of the 
program and professor of pharmacol¬ 
ogy, said that researchers want to solve 
the problem of endothelial dysfunction 
and the peripheral artery disease (pad) 
that it causes, pad appears in 20 per¬ 
cent of patients over age 55 and has a 
25 to 30 percent mortality rate within 
five years. Sessa said that a key to 
pad appears to be the inability of the 
cells to produce nitric oxide or use it 
efficiently, and that his lab is working 
on injections of an enzyme called 
endothelial nitric oxide synthase. This 
enzyme protects against disease by 
improving blood flow through the ves¬ 
sels by relaxing vascular tissue. 
George Tellides, m.d., hs ’93, ph.d., 
associate professor of cardiothoracic 
surgery, said that the goal of his research 
is to find the immune mechanisms 
behind vascular injury and remodeling 
—specifically, the effects of interferon- 
gamma following injury. Interferon- 
gamma appears to stimulate an over¬ 
growth of muscle cells in the wall of 
the arteries, which eventually causes 
narrowing of the arterial lumen. 
And Laura E. Niklason, m.d., ph.d., 
associate professor of anesthesiology 
and biomedical engineering, said her 
role is to create new blood vessels 
through tissue engineering “so that we 
might one day have an endless supply.” 
The formation of these vessels comes 
through biodegradable scaffolds that 
contain enough space for the vascular 
cells to develop a new artery, she said. 
Innovations in the classroom 
The patient had missed her dialysis and 
was steadily deteriorating as a group 
of medical students debated treatment 
options. Thankfully, she was in no dan¬ 
ger—the patient was a high-fidelity 
patient simulator, a mannequin capable 
of physiological responses that is used 
to train third-year medical students. 
The simulation program presented 
by the Society of Distinguished Teachers 
to alumni at reunion on Friday, June 2, 
and one of six programs funded by the 
society during the last academic year, 
is part of the society’s effort to develop 
innovative teaching methods. Leigh V. 
Evans, m.d., hs ’02, assistant profes¬ 
sor of surgery (emergency medicine), 
showed a video of the simulation pro¬ 
gram and explained that students use 
partial task trainers to practice such 
procedures as airway management, as 
well as more sophisticated mannequin 
simulators to unravel complex cases. 
In another program funded by 
the society, amistad (Advanced 
Methods of Interactive Simulations 
Through Academic Design), stu¬ 
dents work with standardized adoles¬ 
cent patients, a component often 
lacking in medical school programs, 
according to Karen Santucci, m.d., 
associate professor of pediatrics 
(emergency medicine). 
This program trains 14- to 17-year- 
olds as standardized patients. The stu¬ 
dents interview each patient to arrive 
at a diagnosis. This approach allows the 
students to develop a level of comfort 
interviewing members of an age group 
with whom they might otherwise come 
into contact only after graduation. 
Bugs—they’re not always bad 
Later Friday afternoon alumni learned 
what happens when pathogens interact 
with the human body. Most of the 
time, nothing, according to Jorge E. 
Galan, d.v.m., ph.d., professor and 
chair of microbial pathogenesis. But in 
a presentation to alumni at reunion in 
the Hope Building, “Bacterial Type II 
Secretion: Not Your Average Needle 
Stick,” Galan explained what happens 
when pathogens interact with human 
cells and how this interface can be 
used to fight disease. 
Pathogens are designed not to 
cause disease but to replicate, and in 
so doing they have developed an ele¬ 
gant “machine” to enter cells. Galan 
described this mechanism as a nano- 
At a reunion talk Jorge Galan described the ni 




Neurosurgeons honored their mentor, William 
Collins, second from left, at the annual 
meeting of the Yale Surgical Society. Joining 
syringe that injects proteins into cells. 
It can theoretically be used as a delivery 
platform to transport vaccines or anti¬ 
gens that could provoke the immune 
system into destroying tumors. In the 
lab, Galan has shown that orally admin¬ 
istered Salmonella engineered to express 
a tumor antigen can destroy tumors 
in mice. He hopes to conduct trials in 
human subjects next year. 
Surgical society honors a mentor 
On Thursday, June i, the Yale Surgical 
Society paid tribute to William F. 
Collins, m.d. ’47, the Harvey and Kate 
Cushing Professor Emeritus of 
Neurosurgery, who served as chief of 
neurosurgery at the medical school 
and as chair of surgery from 1984 to 
1994. Retired and dividing his time 
between San Diego and Guilford, 
Collins were, from left, Chair of surgery 
Robert Udelsman, Chair of neurosurgery Dennis 
Spencer, Walter Longo and Richard Bucholz. 
Conn., Collins has been writing short 
stories, novels and murder mysteries 
during the past few years. He was in 
town for the reunion and listened as 
the surgeons he trained recalled what 
they learned from him. 
“The things we learned on the rota¬ 
tion in neurosurgery were the impor¬ 
tance of the accountability of being a 
physician, a passion for patients— 
many with devastating spinal injuries 
—and the fact that you embraced inno¬ 
vation,” said Walter E. Longo, m.d., 
m.b.a., hs ’87, chief of the section of 
gastrointestinal surgery at the medical 
school. “You were always available 
to listen to us. You always looked for 
ways to increase our clinical experi¬ 
ence. You made sure that we were edu¬ 
cated, that we were mentored and that 
we were inspired.” 
Dennis D. Spencer, m.d., hs ’77, the 
Harvey and Kate Cushing Professor 
of Neurosurgery and chair of neurosur¬ 
gery, recalled meeting Collins when he 
came to Yale in the 1970s. “It was pal¬ 
pable,” Spencer said. “I felt this passion 
he had for training not just neurosur¬ 
geons, but all young surgeons.” 
Richard D. Bucholz, m.d. ’77, hs 
’83, director of neurosurgery at the 
Saint Louis University School of 
Medicine, said Collins encouraged him 
on an unusual career path. Bucholz had 
a longstanding interest in computers 
and believed they could help to improve 
surgery and surgical outcomes. By 
coupling computers to new imaging 
technologies the surgeon can perform 
a “virtual” surgery to help reduce mis¬ 
takes in the subsequent real procedure. 
“With these systems you can do the pro¬ 
cedure ... before you even get into the 
operating room,” Bucholz said. Then, 
by using navigational computers that 
track instruments during the operation, 
surgery can be simplified and made 
safer. “Surgery takes on aspects of a 
video game—which may appeal to our 
younger surgeons,” Bucholz said. 
He envisioned a system in which all 
operating room devices are connected 
and provide real-time data about the 
patient. That information can be trans¬ 
mitted to consultants outside the oper¬ 
ating room so that they can offer the 
benefits of their clinical experience. “In 
a very real way we can share and record 
experiences and use them to enhance 
outcomes,” Bucholz said. 
Also at the society's meeting was 
Charlotte Ariyan, m.d., ph.d., an oncol¬ 
ogy surgeon, who received the fifth 
annual Samuel Harvey Award as an 
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In her keynote speech at Alumni Day at Epi¬ 
demiology and Public Health, Cynthia Gomez 
said an inequitable health system will have 
serious effects on the future of the country. 
Public health—from disparity to equity 
With 46 million people uninsured and 
an equal amount underinsured, our 
health care system is broken, Cynthia 
A. Gomez, ph.d., told the audience 
at Alumni Day at the Department of 
Epidemiology and Public Health, on 
(une 2. “A weak and inequitable health 
system is going to create poor health 
in our nation. We have a nation and a 
world in which health is deteriorating 
to the degree that it is definitely going 
to affect the future of this country 
and the world,” said Gomez, director 
of Health Equity Initiatives at San 
Francisco State University. 
Her keynote speech, “Separate and 
Unequal: Confronting Disparities in 
Health,” kicked off a discussion on one 
of the biggest challenges in health care 
today. Many of the diseases confronting 
society, such as obesity, diabetes and 
cardiovascular disease, can be prevented 
by changes in behavior, Gomez said. 
People of color suffer disproportionately 
from these chronic diseases, but the 
nation spends more money on treat¬ 
ment titan on prevention, she said. 
Gomez urged alumni to shift the 
conversation from disparities to health 
equities, which concerns justice. “When 
the water rises, all boats rise,” she said. 
“Do we as a society care if there’s a 
future? If we do, how do we make a 
society not so burdened by disease?” 
Panelists at this year’s reunion sym¬ 
posium, moderated by Jeannette R. 
Ickovics, ph.d., associate professor of 
epidemiology and psychology, explored 
the complexities of health disparities 
and suggested new approaches. The 
Yale School of Nursing is working to 
achieve equity by creating a partnership 
with the Howard University Division 
of Nursing, said Marjorie Funk, m.s.n. 
’84, ph.d. ’92, professor of nursing 
and director of the Yale-Howard Part¬ 
nership Center on Health Disparities. 
In 2000, Yale and Howard created a 
partnership to enhance the research 
capacity of minority nursing students 
and faculty. Since then, Yale has brought 
34 undergraduate nursing students 
from Howard to New Haven for sum¬ 
mer research internships. Today, more 
than half of those students have com¬ 
pleted or are completing graduate 
work, increasing research in health dis¬ 
parities at both universities. 
Beth A. Jones, m.p.h. ’86, ph.d. ’93, 
associate professor of epidemiology, 
studied disparities in the mammogra¬ 
phy process: do African-American 
women receive the same benefit from 
mammography? She found disparities 
in three areas: adherence to guidelines 
for frequency of mammography, differ¬ 
ences in follow-up care for abnormal 
screenings, and communication and 
understanding of the results. 
“We know that even at the same 
stage of diagnosis, the mortality rate 
among African-American women is 
greater,” said Jones. “We’ve made 
huge progress in terms of treatment 
and early detection, but it’s time to 
start thinking about strategies to 
ensure that all groups benefit from 
these advances, so that we can elimi¬ 
nate the disparities in outcomes. 
When it comes to cardiovascular dis¬ 
eases, said Harlan M. Krumholz, m.d., 
the Harold H. Hines Jr. Professor of 
Medicine, professor of epidemiology 
and public health and co-director of 
the Robert Wood Johnson Clinical 
Scholars Program, studies have shown 
that African-Americans undergo dis- 
proportionately fewer procedures— 
cardiac catheterization, angioplasty and 
bypass surgery—than whites. There is 
no evidence, however, that these proce¬ 
dures improve outcomes. 
“When you find something like this 
disparity, you have to decide. Is it a dif¬ 
ference without a consequence? Is it 
a difference with a consequence? Then 
we can call it a disparity. Is it a differ¬ 
ence with a consequence that we can¬ 
not attribute to anything else but pure 
bias against a certain group?” he said. 
The final panelist was Curtis L. 
Patton, ph.d., professor of epidemiol¬ 
ogy (microbiology) and director of 
international medical studies, who 
retired in July after 36 years. Patton, 
who is African-American, spoke 
about the ability of African-Americans 1 
to survive. 
“We know that when we look at the < 
medical literature published in the 
19th century, experts predicted that j j i 
nobody who looks like me is supposed f 
to be here. We were supposed to have $ 
disappeared a long time ago, and at r 
several points in history—from tuber- a 
culosis, syphilis, starvation—you name j it 
it,” he said. “In some ways, people who j j 
look like us are monuments, not just al 
to slavery, but to survival and excep¬ 
tional competency.” 
Race, ethnicity and genetics 
As work on the human genome shifts 
from sequencing to understanding how 
dna affects health, the roles of race and 
ethnicity also come into play, said Vence 
Bonham Jr., j.d., the National Human 
Genome Research Institute’s senior 
advisor to the director on the societal 
implications of genomics. 
“This conversation is not ending,” 
Bonham said in his special address to 
public health alumni. “It is only be¬ 
ginning and that is why it is so impor¬ 
tant to public health professionals.” 
Acknowledging that race and eth¬ 
nicity are social and political con¬ 
structs, he discussed the complexities 
of race-based medicine. And he cited 
BiDil, a drug that was approved by the 
fda in 2005 to treat congestive heart 
failure. A retrospective study found 
that the drug, which was first tested in 
the 1980s and 1990s, seemed to ben¬ 
efit blacks more than whites. In 2005 
the fine print on the label noted that 
the drug was indicated for use by “self- 
identified blacks.” 
“It is the first drug in the history of 
the United States to be approved for 
only one racial group," Bonham said. 
“Who is a self-identified black? What 
does that mean?” 
The implications of race and ethnic¬ 
ity for public health and health care 
practitioners center on how research 
studies are designed, as well as how the 
results of such research are interpreted, 
according to Bonham. “Race and ethnic¬ 
ity are important components of health 
in our society, but we have to be careful 
about how we use them.” 
Awards and the state of eph 
This year’s Distinguished Alumni Award 
went to Irene Trowell-Harris, ed.d., 
m.p.h. ’73, director of the Northeast 
Regional Office of Healthcare Inspec¬ 
tions, Office of the Inspector General, 
Department of Veterans Affairs. 
The Eric W. Mood Award was given 
to Elisabeth Schauer, m.p.h. ’96, 
director of vivo international, a founda¬ 
tion that deals with mental health 
issues in communities affected by vio¬ 
lence and conflict. 
Katrina Clark, m.p.h. ’71, executive 
director of the Fair Haven Community 
Health Center in New Haven, received 
the Emerging Majority Affairs Commit¬ 
tee’s (emac) Health Equity Award 
for her leadership in promoting com¬ 
munity health in New Haven, emac, 
a committee of the Association of Yale 
Alumni in Public Health, strives to 
increase the representation of African- 
Americans, Latinos and other under¬ 
represented groups in the student body. 
Curtis L. Patton, ph.d., received 
the 2006 Award for Excellence for his 
service to the department and to the 
university (see related article p. 36). 
Matthew Lopes, m.p.h. ’77, director 
of aids Care for New Haven’s health 
department, and Judith Stavisky, m.ed., 
m.p.h. ’80, who developed public 
health programs for low-income popu¬ 
lations in Pennsylvania, were inducted 
into the 2006 Alumni Public Service 
Honor Roll. 
Brian P. Leaderer, m.p.h. ’71, 
ph.d. ’75, the Susan Dwight Bliss 
Professor of Epidemiology, who 
served for 18 months as interim dean, 
gave a brief report on the state of 
the school. Recent accomplishments 
included the implementation of a five- 
year joint program with Yale College 
that will allow undergraduates to take 
public health courses 
during and after their undergraduate 
education and earn an m.p.h. one 
year following receipt of their under¬ 
graduate degree. Five new faculty 
members will start in September, 
Leaderer said, in biostatistics, envi¬ 
ronmental health, health policy and 
social and behavioral science. The 
school is also undergoing a self-study 
as part of the accreditation process, 
he said. 
Leaderer introduced the new dean 
of public health, Paul D. Cleary, 
ph.d., whom he called “the best of 
all applicants.” 
Cleary said he hopes to create “the 
best possible educational experience” 
in the department. “I am hoping I can 
rely on your advice and counsel as 
I try to do that over the next several 
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1946 
60th reunion 
Short of a conference call to 
the entire class, let this synopsis 
serve to update our svho 
(sometimes vigorously healthy 
octogenarians). We stand in awe 
of the returnees, who included 
the following: Molly Albrink, still 
the scholarly professor enlight¬ 
ening students and the universe 
as a true pioneer in all things 
regarding triglycerides and 
serum fatty acids. Bill Banfield— 
watch the litigation dramas of 
raising sheep, researching 
unknowns and remaining an 
nih alumnus. Tim [Aaron] Beck, 
receiving more monetary 
awards than Tiger Woods while 
continuing to reap accolades 
from colleagues around the 
planet.To think he hated 
Psychiatry 101! Sandy [Sanfurd] 
Bluestein—the # i-seeded U.S. 
senior tennis player, who spends 
more time on the clay courts 
than on Wall Street. He has been 
most generous in supporting 
(anonymously) many Yale proj¬ 
ects and scholarships for stu¬ 
dents and radiology residents. 
Sandy continues to serve as a 
board member of the New York 
City Opera. Tickets anyone? Tom 
Doe—his kiddie patients are 
now all grandparents and call 
him at midnight about their 
own grandchildren. Ho hum. He 
and Bert [Lambert] Filer learned 
the virtue of "tincture of time” 
from the Daniel Darrow/Grover 
Powers dynasty and are now 
both “coasting.” Bert was 
recently honored for his ongoing 
work in St. Raphael’s Pediatric 
Clinic. Marty Gordon and partner- 
for-life Evelyn are now living in 
a North Branford, Conn., retire¬ 
ment community where the 
swimming pool dip in the a.m. is 
88 degrees Fahrenheit, unlike 
the frigidity of Linsley Lake. The 
Cushing/Whitney Medical 
Library continues to be Marty’s 
home away from home. The 
Peabody Museum contributed 
all the avian specimens for his 
current exhibit, “The Flu and 
You—Old and New Threats," 
posted on the Medical Library 
website. Jack Neville and Laura 
White are the most unchanged, 
youthful couple, even register¬ 
ing early for our reunion. They 
bask in and on the Cape, where 
they are active in the commun¬ 
ity and with their kids. 
Jim Kleeman is still seeing 
patients in between his appoint¬ 
ments for renal dialysis.The 
class graduation plaudits now 
are continuing for staunch forti¬ 
tude. Linus Cave lost our Dusty to 
renal failure and the aberrant 
cerebral beta protein. Six daugh¬ 
ters watch over him in New 
Jersey now. Eli Wing continues to 
be a civic leader and fulfills the 
role of internist to the Rhode 
Island masses. He also finds time 
to treat the sugar cane workers 
in the Caribbean islands. 
There are many who wanted 
to come but were thwarted 
by unavoidable reasons. Bill and 
Midori Wedemeyer send their 
very best. They joined the 
Gordons during the International 
Medical Film Awards in Los 
Angeles. A hilarious mini-class 
reunion per Bill’s wit and 
Midori’s docent guidance were 
typical and valued. Bob Cooper 
and Linda now live in Florida, 
enjoying the perks of retirement 
from the Air Force. Subdural 
decompressions for injured 
flight deck pilots were done per 
Harvey Cushing’s mentoring. 
The Coopers may move from 
their usual Delaware home¬ 
stead. Vinny and Rosina Longo 
were unable to attend due to ill¬ 
ness. Vinny was a Pfizer consult¬ 
ant during the early Viagra era 
and can describe the patho¬ 
physiology of erectile dysfunc¬ 
tion in the classic manner for 
those whose current focus 
requires his fund of knowledge. 
Vinny and June Pepe continue 
to enjoy the benefits of their 
gynecology dynasty while joined 
by son—guess who signs out to 
whom when not in Florida? They 
send their regrets to the class. 
Dick and Mitzi Sisson had to 
cancel their reunion plans due 
to sudden illness. Her recovery 
from surgery has been greatly 
successful. Dick has recently 
retired from an outstanding sur¬ 
gical career, teaching students 
and house officers at Washington 
University Medical Center and 
running his own private prac¬ 
tice. The Sissons are closely 
united with their children and 
hope to visit on the way to 
Boston. Don Shedd has been the 
constant caregiver for wife 
Charlotte; both have just been 
honored as founders of Hospice 
Buffalo by a special endowment 
of half a million dollars in their 
honor. Kudos to them both! 
Hal King and Betty have 
yearned for this reunion. Retired 
as cardiovascular surgeon 
and professor emeritus of the 
Indiana University Medical 
Center, Hal’s impact on that 
institution continues. Tom 
Coleman, always warm and gen¬ 
erous to others, and Babette 
send their best for “this historic 
reunion event.” Ruth S. Kempe 
and her late husband Henry pio¬ 
neered the profession’s long- 
needed attention to child abuse. 
Ruth continues to lecture as 
associate professor emerita at 
the University of Colorado. 
Sixteen grandchildren require 
her to manage an Excel birthday 
flow sheet and tons of balloons. 
Julie Sack’s vision and other 
impairments precluded his com¬ 
ing to New Haven. Greg Flynn’s 
fabulous ophthalmology prac¬ 
tice has been closed for several 
years while Peggy and he enjoy 
the benefits of a retirement 
community. We’re too late to ask 
for cataract treatment with pro¬ 
fessional courtesy. Greg’s recent 
illness precluded the long- 
awaited trip to New Haven. 
Elaine Yudkin managed to join 
us, since the class has always 
been so treasured by Jerry dur¬ 
ing his long neurological illness. 
She freely discussed her coping 
with the family Huntington’s 
gene, helped by Dean Alpern’s 
characteristic attentive empathy. 
Mary Wagner and Norma 
Whelan, along with our other 
endearing class widows, have 
each expressed their warmest 
wishes to all. Mary Judd called 
from Hawaii, "thinking of us 
fondly on this day.” Susan Owens 
emphasized how important the 
Class of ’46 has always been to 
Bob’s life. The extended ’46M 
camaraderie continues, and all 
await our 
next reunion in 2011! 
Marty Gordon, SVHO 
1951 
55th reunion 
Although only four of us made it 
to the reunion, our meeting was 
marvelous, exciting, thrilling, 
nostalgic and touching. Our 
small group, which had little 
contact with one another during 
our years at Yale, spoke warmly 
and intimately during the two 
days. We parted sadly but hop¬ 
ing that we will meet again at 
our 60th. All of us had been 
back to New Haven in recent 
years and were familiar with the 
changes in the buildings. Old 
St. John’s Church is gone, and 
several skywalks join the major 
buildings. Entering the main 
wing of the School of Medicine, 
one passes the reception desk as 
before. I spent many a lunch 
hour there covering for the regu¬ 
lar attendant, thus earning 
enough for a quick supper at 
Dudow’s on Congress Avenue. 
Walking down the hall to the 
library, one passes the familiar 
antique medical photos and 
etchings.The Historical Library 
was exactly as it was half a 
century ago, except that the 
comfortable chairs have been 
replaced with newer ones. In 
memory of days long gone, 
I snatched a brief nap. 
5i 
Upstairs on the long corridor 
leading past the anatomy labs, 
I found the tables all gone and 
their place taken by many small 
labs for researchers.The anatomy 
labs had moved across the street 
to the new Anlyan Center, which 
was erected at the site of the 
former nurses’ dorm. The new 
anatomy wing is a palace, a 
whited sepulcher where the 
departed give all their help to 
the living. Exhaust fans assure 
fresh air for the weary, and video 
j screens above each table help 
" the lost find missing parts. I Everything everywhere was 
spic and span, and the staff was 
• wonderfully accommodating. 
1 No question or request was too 
I much—ask a question and you 
j were taken by the hand (almost!) 
| to where you could find the 
j answer to your problem.The 
I meals were superb, and at sev¬ 
eral locations were containers 
of iced soft drinks including (sur¬ 
prise!) “Yale Water”—nectar of 
the gods, and a delightful relief 
i from the heat on a muggy New 
England day. 
My three companions had 
each lost their spouse in recent 
years. I am still blessed with 
mine, Deo gratias. Jocelyn Malkin 
is still practicing psychiatry; she I makes several trips to Yale each 
year to attend meetings of the 
Association of Yale Alumni in 
Medicine. Lowell Goodman, Al 
Mowlem and I are all retired. I 
learned for the first time that 
Al had served in Korea in a 
m.a.s.h. unit, where his life was 
much like that of the physician 
portrayed by Alan Alda on the 
television show—except that 
quite often Al was the only doc¬ 
tor on hand to take care of 
dozens of casualties. 
I received nearly a dozen 
letters from classmates, far 
too long to repeat here (from 
Straatsma, Adams, Pava, Anderson, 
Merritt, Sterling, Nik Nevin, 
Small, Katz, Groel and Hamburger). 
Send me a business-size self- 
addressed envelope; a stamp is 
not needed. I will forward any 
letter (one or more) to anyone 
who wishes. 
Sad to say, there is no news 
from Jane Swartz. Never have I 
met a classmate without asking 
“Any news from Jane?” and then, 
“Remember I’affaire du rideau?” 
Al Mowlem told me that he heard 
of the display, surreptitiously 
walked by her table and took a 
peek—which Jane noticed—and 
asked (probably the first and 
only words spoken to any class 
member), "What did you expect, 
jelly beans!?” 
Write! I shall respond—but I 




For those returning to New 
Haven, it was a weekend of remi¬ 
niscence, rekindled friendships, 
and now, with the perspective of 
time, an even greater apprecia¬ 
tion of the Yale System. Seeing 
the growth of the campus and 
learning of Yale’s pre-eminent 
role in the advancement of sci¬ 
ence left us feeling proud. 
Our 50th reunion was spread 
over three days. The opening 
event was an elegant private 
party hosted by John Gardner on 
Thursday. On Friday night there 
was an equally elegant party 
hosted by the Downings (the 
fifth in 25 years). As a measure 
of the spirit and good feeling 
toward Yale, more than 50 per¬ 
cent of the class came back. 
Those coming back included Cal 
and Phyllis Bigler, Gloria and Leo 
[Levon] Boyajian, Tom and Joyce 
Brown, Rosalie Burns and hus¬ 
band Herb Goldberg, Georgiann 
and John Carroll, Barbara and Ed 
Child, Tina and Jim Collias, Paula 
and Chandler Dawson, Helen and 
Steve Downing, Janet and Mitch 
Edson, Rona and Gil Eisner, John 
Gardner, Shayna and Sumner 
Gochberg, Charmian and Alan 
Gurwitt, Susan and Bill Hindle, 
Joan and Chuck Hopper, Marie- 
Louise and Ken Johnson, Linda 
and Jerome Klein, Gloria and Bill 
Lewit, Pres [Preston] Manning, 
Carol and Dwight Miller, Don 
Nalebuff, Jane and Fred North, 
Beverly and Jim Patrick, Ruth and 
George Paulson, Denise and Bob 
Scheig, Ruth and Jim Scheuer, and 
Bruce Trembly. Suzanne (Supplee) 
Becker, Joe Cerny, Jack Love and 
Bill Narva sent regrets but could 
attend only in spirit. 
Thanks to the efforts of Mitch 
Edson, reunion gift chair, and 
those generous classmates, 
especially the Hindles, for their 
remarkable gift, a scholarship 
was established. Also, thanks to 
Mary Meehan and her alumni 
office staff, who made the 





Our class reunion dinner at the 
Graduate Club went on well into 
the night. Attendees included 
David Brook and wife Judith, 
Christopher Durham and wife 
Susan, Joseph Jasaitis, Marguerite 
Lederberg, George and Christa 
Lordi, James Lurie, Vincent 
Marchesi, Anoush Miridjanian, 
Roland and Grazina Paegle, 
Roy Ronke, Warren and Myra 
Widmann, and Donald and 
Alice Young. 
We exchanged e-mail 
addresses, anecdotes about for¬ 
mer professors,family stories 
and continued appreciation of 
the Yale School of Medicine 
(ysm) experience. Joe’s first 
impression of ysm was the wel¬ 
coming address by Dean Vernon 
Lippard: “When I came here this 
morning, a young man asked, 
‘Hey, Mac, where is the medical 
school?’We at Yale do not 
address anyone as Mac.” 
In an attempt to tap the wis¬ 
dom accumulated during our 
long and active careers, a mini¬ 
survey circulated among the 
members of the class asked for 
definitions of happiness. Our 
Declaration of Independence 
lists “the Pursuit of Happiness” 
as one of our inalienable rights. 
Jim noted that "accomplishment 
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evanescent. Happiness is playing 
chamber music regularly; seeing 
children for psychiatric treat¬ 
ment and having them improve 
and be successful; watching my 
own children grow up and 
become interesting and crea¬ 
tive.” For Roy, happiness is “lov¬ 
ing those around you and the 
work you do.” For Marguerite, it’s 
"learning to let go of fixed 
expectations and taking satis¬ 
faction in the present moment." 
Anoush’s definitions changed: 
“When younger I viewed happi¬ 
ness as caught up with lots of 
accomplishments and being a 
useful person. Happiness now is 
peace with yourself and what 
you are, time and enough 
means to do what you want to 
do.”“It used to be beer and 
pizza,” but now George finds 
happiness “wrestling with 
grandchildren and having your 
children develop into mature 
adults with secure careers.” 
David's definition also changed 
to becoming “more flexible and 
accepting, reviewing more of 
the possibilities, fewer of the 
limitations.” Roland defined it as 
"dating adorable women and 
finding and keeping the one. 
The right spouse will create a 
wonderful family.” Don Young 
liked “remembering the good 
stories we experienced as medi¬ 
cal students. There is a bond 
that develops that you retain for 
a lifetime. Great teachers like 
Averill Liebow and Harry Greene 
leave memories that never 
leave.” 
Warren found happiness to 
be "a moving target. In youth 
happiness assumed a safe 
home; in medical school it was 
success in preparation for life as 
a doctor.‘Life’assumed a sup¬ 
portive marriage, healthy chil¬ 
dren and then a successful 
career. Retirement did not equal 
happiness to me. I felt that my 
career was too much a part of 
what defined me for me to just 
walk away from it—and I lucked 
into a full-time academic posi¬ 
tion with summers off. Happi¬ 
ness is seeing our children 
happy; but now, what was not 
even really on the radar screen 
before, are the issues of health 
and impending inevitable 
decline, and the hope that con¬ 
tentment can prevail without 
undue decline of function until 
death. Happiness is seeing 
grandchildren grow up healthy, 
achieving well, making the 
right choices and hoping that 
we can live long enough to see 
them well on their way in life.” 
I agree with Jim that "this 
reunion was fun.” Hope to see 




Classmates present were in good 
spirits and looked well. Not a sin¬ 
gle tattoo or male earring was 
seen. 1966 was the year Medicare 
was enacted, and we were gun 
fodder for that program. 
Stuart Kotler is active in radi¬ 
ology in New Jersey. His future 
looks rosy—he owns a gas 
station. Investors take note: 
through convoluted boilerplate, 
Stuart personally guarantees the 
solvency of British Petroleum. I 
introduced my wife of 40 years 
to Mary Alice Bernet Houghton. 
For some reason M.A. was sur¬ 
prised, and said she thought I 
had Invisible Wife Syndrome. I 
hope she sends more informa¬ 
tion about it. Are invisible wives 
silent? Can they see each other? 
M.A. is active in general psychia¬ 
try practice in Milwaukee with 
husband Bill, m.d. ’64. Of ail the 
people my wife met that week¬ 
end ("They’re all wonderful”), 
her favorite was Mary Alice. 
I inadvertently sat at the bad 
boys’ table at the class dinner. 
There were reflections on long- 
ago mischief. Joe Baron’s bar and 
beer were mentioned. Kindly 
campus police used to herd rev¬ 
elers to Harkness beds and were 
less judgmental than Mom. Back 
then there were some half-assed 
fraternities. They threw an occa¬ 
sional half-assed dance. At one 
such soiree, a classmate brought 
a hooker in signature street 
dress. This made for social ana¬ 
phylaxis with the wives and 
dates who were present. One 
innominate classmate claims he 
doesn't remember the occasion 
but admits he might have been 
the culprit. 
Ed O’Keefe is retired from 
academic dermatology in North 
Carolina. He now does wood¬ 
working there in the winter and 
in Maine in the summer. Bob 
Gunn is semiretired after 30 
years at the cdc—something 
about condoms; he is now in 
San Diego and has taken up golf. 
The class dinner was held 
in the library of the Graduate 
Club. As the room heated up, 
Arne Youngberg, retired radiolo¬ 
gist from Cheshire, Conn., and 
class secretary, turned on a 
window air conditioner. It was 
white with pigeon droppings. 
We may all be gone by the time 
you read this. Dick Bookman 
professes medicine at Weill 
Medical College of Cornell Uni¬ 
versity in New York City. He 
arranged a memorial gathering 
for Donald Cohen. 
John Howard does internal 
medicine on the elbow of Cape 
Cod. He sails. He also has a 
company for staffing nursing 
homes and jails, and serves as 
the local medical examiner. By 
Massachusetts tradition this 
office confers immunity from 
prosecution for misdemeanors. 
I mentioned to him that in my 
bailiwick, although they try to 
hang this office on a patholo¬ 
gist, I do not care for forensics 
and was delighted to have a 
psychiatrist fill the role. 
Wilbur Kukes, native of 
Montana, was also in town for 
the reunion. Contrary to class 
legend, he rode into New Haven 
by iron horse. He arrived at 
Harkness Hall clutching one 
small suitcase. Sharpie upper¬ 
classmen spotted equine prod¬ 
uct on his boots and immedi¬ 
ately hustled him for used text¬ 
books. They promised Hamm’s 
Histology would read like a Louis 
LAmour novel. Wilbur no longer 
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mends the bones of cowpersons 
in Big Sky country but walks an 
Old English sheepdog on a 
beach in the state of Washington. 
Larry Toder and wife Susan 
came from Missoula, Mont., 
where Larry is a retired ortho¬ 
paedic surgeon. 
Jon and Joan Wayland joined 
us from Klamath Falls, Ore., 
where she has retired from child 
psychiatry and he is a retired 
urologist. 
Looking back at our class, 
formed 44 years ago, we decided 
diversity is nothing new. Wilbur 
was two standard deviations 
from the mean, and the South¬ 
erners one SD. 
Lynne Lipton Levitsky is head 
of pediatric endocrinology at 
Mass General. She was at the 
class dinner with her husband 
Sidney, a cardiac surgeon. During 
the dinner Sid confessed they 
started dating when he was a 
resident and she was still a stu¬ 
dent. The assembly groaned in 
horror but decided it was too 
late to give our chief resident 
emeritus the hot water treat¬ 
ment. The bad boys wanted to 
know what the problem was. 
Stuart Hauser and I met at 
the new Child Study Center, the 
legacy of our classmate, the late 
Donald Cohen. The center and 
several other buildings proved 
that Donald had a powerful edi¬ 
fice complex and was a master 
fundraiser, a skill much cher¬ 
ished in academe. Stuart said 
that fundraising is one of his 
duties as head of a Boston child 
psychiatry clinic, but romancing 
donors is not his favorite thing. 
He runs a long-term program in 
adolescent development. 
Jimmy Brown is working part- 
time in oncology in Middle- 
town, Conn. He also knows all 
the verses of “Amazing Grace," 
useful in that specialty. Phil 
Bernstein is pounding out ortho¬ 
paedics in the San Francisco 
area. When I mentioned my 
imperfect knees, he said 90 per¬ 
cent of his patients are happy 
with his joint replacements. I 
asked if he were flying back on 
the 90 percent airline. 
Mac Griffiss came in from 
San Francisco, where he toils in 
microbiology pathogenesis. He 
is also a retired bird-colonel in 
the Army Reserves. For all your 
military needs, give Mac a call. 
Why fight with lawyers when 
you can get the infantry 
cheaper? 
David Fox is working in 
Fresno as a child psychiatrist. 
A beloved avocation is playing 
the cello in a string quartet. 
When I mentioned that I had 
recently bought the six-disc 
complete Shostakovich series by 
the Emerson Quartet, he was a 
fount of information on the 
topic but, alas, I could have done 
better. Incidentally, if you are fed 
up with hip-hop noise at your 
gym, lob one back and stick 
some string quartets in the CD 
player. But be prepared to out¬ 
run vulgarians a third our age. 
Me? Pathologist emeritus in 
Marshalltown, Iowa. I read a lot, 
take solo road trips and follow 
my wife around giving helpful 
housekeeping tips. 
Spouses of our classmates 
should consider themselves 
assimilated into the class. [Caveat: 
The bad boys, in denial re: Club 
Prostate, still have lots of life, 
so certain conditions and restric¬ 
tions may apply.] 
Other classmates spotted but 
not engaged: Clarence Sasaki and 
Robert McRoberts 
There were reports of bad 
breaks and sorrows for some 
classmates, but this report is like 
that garden ornament that her¬ 
alds only sunny hours. 
Eugene P. Cassidy 
1971 
35th reunion 
How different the conversation 
was when 23 members of the 
Class of’71 gathered at the 
Quinnipiack Club for their class 
dinner than it had been 30 years 
ago, when they met for their 
fifth reunion. At that time the 
talk was of residencies and fel¬ 
lowships being completed and 
careers and families being 
started. At this reunion the talk 
was of careers winding down, 
children’s accomplishments, 
grandchildren and plans for 
retirement, as well as of three 
members who died over the 
past five years. Irv Raphael, who 
served as master of ceremonies, 
remembered Robert Mackey, 
Jerry Haber and Richard Helgerson 
with a moment of shared 
silence before moving into a 
round of self-deprecatory humor 
and remarks. David Lippman 
did a wonderful job arranging 
the dinner and bringing Yale 
Med ’71 treats. 
Privately, Irv mentioned how 
proud he was that his son is fol¬ 
lowing him into orthopaedics. 
Expected, not attending and 
missed was retired Barbara 
Kinder, whose daughter Caitlin 
was part of the 2006 United 
States women’s Olympic ice 
hockey team. Steve Moffic, who 
has been honored by the 
American Psychiatric Association 
for his work in ethics, has a son 
close to ordination as a rabbi. 
While John Foster Jr. was the first 
of the attendees to retire, he’d 
been preceded by Barbara and 
Doug Schmidt. Al Weihl spoke 
eagerly of splitting his time 
between Hawaii and Colorado 
once he retires. Richard Moggio 
has left cardiac surgery and now 
does corporate health care work. 
He also takes off for Ireland to 
golf when he can. 
Others continue to balance 
work, family and avocation. 
Stuart Kleeman practices pediat¬ 
rics, enjoys Zachery, his new 
grandson, and builds miniatures. 
Fred Cohn practices ob/gyn and 
enjoys his family, with kids rang¬ 
ing in age from 9 to 27. Sherry 
Loo and Wally Matthews Jr. 
traveled from Hawaii for the 
reunion and a family Harvard 
graduation. William Krinsky, our 
class entomologist, attended 
with his new wife, Suzanne. Sten 
Lofgren came with his partner, 
Sally Lopez. Lenny Eisenfeld 
described the painful years after 
the loss of his son and noted 
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two grandsons,"our family num¬ 
bers are again going in the right 
direction.” Barry Perlman, coerced 
into writing this report, has 
recently completed 25 years as 
director of psychiatry at Saint 
Joseph’s Medical Center in 
Yonkers. He has served as presi¬ 
dent of the New York State 
Psychiatric Association and as 
chair of the New York State 
Mental Health Services Council. 
He delights in having his chil¬ 
dren living nearby on the Upper 
West Side of nyc. 
Barry B. Perlman 
1976 
30th reunion 
The weekend was a little wet (!), 
but that did not prevent us 
from having a great time greet¬ 
ing old friends and sharing our 
news. Present at the class dinner 
on Saturday night at Chow, 
the Friday night clambake in 
Harkness courtyard, or both, 
were the following: 
Sarah Auchindoss: She is busy 
practicing psychiatry in New 
York City and raising her chil¬ 
dren. Alfredo Axtmayer and wife 
Pat: Alfredo is practicing ortho¬ 
paedic surgery in Wallingford, 
Conn., and is also heavily into 
golf. Sharon Bonney (referred 
to below as me/I) and husband 
James A. Beattie Jr.: Sharon 
retired in 2005 after 20-plus 
years of designing and running 
investigational drug clinical tri¬ 
als for first Wyeth, then Miles 
(now called Bayer) and then 
Pfizer (10 years). She received a 
Distinguished Alumni Service 
Award from the a yam (Associa¬ 
tion of Yale Alumni in Medicine) 
on June 3. Roger Boshes and wife 
Meredith: They brought Dr. and 
Mrs. William Konigsberg as 
guests to the class dinner. Bill is 
still teaching molecular biology 
to the Yale medical students as 
he did to us 35 years ago. Bill 
looks exactly the same, except 
he now has silver hair instead 
of pepper-and-salt. Roger is a 
psychiatry professor at Harvard. 
He no longer looks like John 
Lennon. Charles Swenson: He is 
practicing psychiatry and teach¬ 
ing trainees in Northampton, 
Mass. He now looks like Stephen 
Spielberg. Frank Watkins: He is 
an orthopaedic surgeon in New 
Rochelle, N.Y. He and I are huge 
fans of Hillary Clinton. He 
reminded me that she audited 
the Class of 1975’s first-year psy¬ 
chiatry lecture course at cmhc 
in 1971-72 with Frank, Todd 
Estroff, George Knowles and me. 
Todd Estroff: He is practicing 
adult and child psychiatry in 
Atlanta. He has written a book— 
the Manual of Adolescent 
Substance Abuse Treatment, pub¬ 
lished by American Psychiatric 
Publishing in August 2001. It is 
available on Amazon.com. 
Candace Corson: She is a consult¬ 
ant and national marketing 
director for usa Integrative 
Med/Juice Plus in Granger, Ind. 
She is enthusiastically spreading 
the word about the benefits 
of nutriceuticals. Her husband 
is George Knowles, m.d. ’75. 
Florence Comite: She is practicing 
in New Haven and teaching at 
Yale. Her son Jon just finished 
his first year of medical school 
at Yale. Vin Dicola: He is a cardi¬ 
ologist in private practice in 
New Haven. His son John is 
attending Stanford University; 
his daughter Laura just gradu¬ 
ated from Choate and will be 
attending Harvard University in 
the fall. Vin is subspecializing 
in golf and in winning contests. 
Ken Dobuler and wife Susan: 
Ken is the chief of medicine at 
Griffin Hospital in Derby, Conn. 
He and Susan live in Branford, 
Conn., not too far from the 
Sound. Ken is building a sailboat 
(seriously!). Chris Jolles and Katie 
Reeder: Chris is in private prac¬ 
tice in special gynecology and 
oncology in Salt Lake City, Utah. 
Richard Kayne and wife Maria: 
Rich is in solo practice (endo¬ 
crinology and internal medicine) 
in Cheshire, Conn. He is on 
the board of directors for Paul 
Newman’s Hole in the Wall 
Gang Camp in Ashford, Conn., 
for children with cancer and 
serious blood diseases. Maria is 
on the board of the Creative Arts 
Workshop in New Haven. Many, 
many thanks to Rich and Maria 
for once again serving as the 
social chairpersons for this 30th 
reunion, as they did for our 25th!!! 
Norman Kohn: He is practicing 
psychiatry and neurology in 
Chicago. Bill levy and wife Karen 
Kelly, M.D. ’77: Bill and Karen 
recently relocated from Abington, 
Pa., to Williamstown, Mass., 
where they are employed (Bill as 
the hospital cardiologist, Karen 
in internal medicine/geriatrics) 
at the local hospital. They are 
enjoying their seven-acre rmoun- 
taintop spread and getting to 
know their neighbors. Eventual 
retirement to that gorgeous 
region was the motivation for 
their move from Philly, but they 
are having so much fun that 
retirement looks a long way off! 
Cindy Mann: She is practicing 
pediatric and adolescent medi¬ 
cine in Hamden, Conn., and is a 
major supporter of women’s 
health research at Yale. Doug 
Mann: He recently moved to 
Cape Cod (Falmouth), where he 
is in solo practice in otolaryn¬ 
gology and loving it. He recently 
joined an a cappella singing 
group called Notescape.cod. Rick 
Morin: He is a professor and 
pediatrician/neonatologist at 
the University of Buffalo School 
of Medicine and is serving as 
its interim dean. Peter Swanson: 
He is associated with Family 
Health Care Associates in 
Shelton, Conn. John Wiles: He is 
practicing dermatology in 
New London, Conn. 
News from those unable to 
attend the reunion but who 
send greetings to all: 
Randy Cebul is professor of 
medicine at Case Western 
Reserve Medical School in Cleve¬ 
land, Ohio. He and wife Mary 
Scott Cebul live in Hunting 
Valley, Ohio. Avi Hettena and his 
wife live in San Francisco. He is 
practicing medicine and they are 
raising their five children. Jon 
Lederer (m.d./ph.d.) is a profes¬ 
sor doing basic research and 
teaching at the University of 
Maryland Biotechnology Insti¬ 
tute. Richard Neubauer is prac¬ 
ticing internal medicine in 
Anchorage, Alaska. He has been 
appointed to the Board of 
Regents of the American College 
of Physicians. 
Many, many thanks to all for 
coming and for contributions 
to this newsletter! See you all, 
we hope, for our 35th in 2011. 
Sharon L. Bonney 
1981 
25th reunion 
Our reunion had strong compe¬ 
tition from parental duties and 
academic obligations. Appropri¬ 
ately, high school and college 
graduations, final exams, and a 
national oncology meeting took 
precedence for most of us. 
Nevertheless, more than a dozen 
of our intrepid classmates and 
their guests journeyed to rainy 
New Haven for a most enjoyable 
reunion weekend. We settled 
down to a wonderful get- 
together on Saturday night at 
the Ouinnipiack Club. It was a 
great opportunity to share our 
memories of Yale, renew friend¬ 
ships and recount our experi¬ 
ences over the past two and a 
half decades. 
David Lebwohl drove from 
Madison, N.J., where he is 
involved in clinical development 
of new cancer drugs for Novartis. 
When not traveling overseas, 
David is in his garden, at con¬ 
certs, near the ocean or on the 
tennis court. Jonah (Kalu) Odim 
was accompanied by wife Tracy 
and adorable young sons— 
Jonathan, 5, and Emmanuel, 2. 
Now with an m.b.a. to comple¬ 
ment his m.d./ph.d., Jonah is 
crossing the continent and relo¬ 
cating his cardiac surgery prac¬ 
tice at ucla to the nih, where 
his duties will combine his clini¬ 
cal and business skills. It was a 
treat to see Bernie Lew in and 
wife Terri Haberman, who is an 
optometrist. With their oldest 
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son Craig at Penn State, Bernie’s 
"harem” includes 13-, 14-, and 
16-year-old daughters. Bernie is 
in private practice in radiology 
near Philadelphia. We enjoyed 
hearing about his exploits on his 
motorcycle and other adven¬ 
tures. Dovelet Shashou, accompa¬ 
nied by husband Jonathan 
Trambert with camera in hand, 
snapped plenty of pictures and 
spoke about her most recent 
avocation: tango lessons!! 
Dovelet continues to practice 
pediatric ophthalmology in New 
York City. 
Class agent Anthony Urbano 
and wife Camille M.C. Oualtere 
are living in Bethlehem, Pa., 
where Tony is doing interven¬ 
tional cardiology as part of a 
nine-person cardiology group. 
They have three teenagers at 
home who keep them quite 
busy. Tony has been involved in 
successful thoroughbred breed¬ 
ing and racing. He enjoys gar¬ 
dening, which affords him the 
time to relax and solve prob¬ 
lems. Mike Nerenberg was 
accompanied by wife Lynne, 
who is an internationally 
renowned Arabic dancer! Mike 
is a biotech executive in La Jolla, 
Calif. His hobbies include riding 
his Harley, welding, archery 
and puffing on Cuban cigars. 
It was great to see Mark 
Kasper and wife Donna. Mark is 
in private practice in internal 
medicine in East Haven, Conn. 
Together they share their pas¬ 
sion for antiquing, such as 
collecting Murano glass, as well 
as exploring ethnic restaurants 
locally and in Manhattan. 
Worldwide traveler, radio 
celebrity and wine connoisseur 
Christine Duranceau was accom¬ 
panied by husband Richard 
Zakrzewski. Christine has moved 
from California to the resort 
area of Galena, III. When not 
practicing emergency medicine 
in Platteville, Wis., she is politi¬ 
cally active, both as president of 
the Wisconsin chapter of the 
American College of Emergency 
Physicians and the Northern 
Illinois chapter of the American 
Cancer Society. She travels to 
Washington periodically to con¬ 
sult and testify on health care 
issues. A Congressional run has 
not been ruled out! 
Fresh from high school and 
college graduation parties, Lisa 
Babitz, geriatrician, and husband 
Stewart Creisman, rheumatolo¬ 
gist, live on the West Side of 
Manhattan, where they share an 
office. We offer their daughter 
Laura, 22, a Cornell graduate, our 
best wishes as she travels to 
Melbourne on a Fulbright schol¬ 
arship to spend a year on venom 
research! Daughter Jill, 18, is 
heading to Cornell, while son 
Jack, 14, will be attending 
Stuyvesant High School. Neil 
Gross, formerly in Atlanta, is now 
living in Boston. Charged with 
enthusiasm, Neil is enjoying 
"the single life” while practicing 
ophthalmoplasty. He continues 
to play guitar. Steve Konstadt, 
accompanied by wife Jody, a der¬ 
matologist, entertained with 
his tales of extreme snowboard¬ 
ing, windsurfing, sailing and 
eclectic gourmet cooking. In 
between enjoying life with Jody 
and his two daughters, Steve has 
squeezed in the time to be a 
professor and chair of anesthesi¬ 
ology at Maimonides Hospital in 
Brooklyn, edit several textbooks, 
and train hundreds of residents 
and fellows during his 20-year 
academic career. Marilyn 
Merker, ph.d. ’83, and our class¬ 
mate Rob Goldman shared pic¬ 
tures and stories of their life 
near Milwaukee, Wis. They have 
a son and daughter. Rob is in pri¬ 
vate practice in neurology, and 
Marilyn is a professor of phar¬ 
macology at the Medical College 
of Wisconsin. 
Speaking of Wisconsin, reun¬ 
ion social chair Steven Brown 
and wife Amy are also living 
near Milwaukee, where he has 
been in private practice in pul¬ 
monary critical care and sleep 
medicine since 1988. Steve’s two 
sons are in college, while his 
daughter, a nationally ranked 
junior tennis player, is in high 
school. Steve is in demand 
nationally as a lecturer on copd, 
asthma, respiratory infections 
and insomnia. Cosmetic and 
hand surgeon Ines Carrasquillo 
has moved from Brooklyn to a 
private group practice in 
Rochester, N.Y. She has stayed in 
touch with a number of our 
classmates. Barb Roach traveled 
all the way from Hamden, Conn., 
with her husband, who is a local 
attorney. Their son and daughter 
are teenagers. Barb remains in 
private practice in rheumatology. 
Although not able to attend 
the reunion, I’ve had wonderful 
communications with many 
who send their best wishes and 
fond regards. They include: 
Lesley Levine, Louann Brizendine, 
Mark Shoag, Nancy Ross-Ascuitto 
and Bob Ascuitto, Mark Koruda, 
Pat Burke, Paula Fracasso, Peter 
Arvan, Donald Ingber, David 
Goldfarb, David Paly, Ramona 
Fung, Richard Kravitz, Stephen 
Harrison, Alicia Barela, Steve 
Fugaro, Victor Vaisbort, David 
Weiss, Francis Chui, Erik Fisher, 
Annette Guido, Chris Attinger, 
Dave Gendelman, Brian Kobilka, 
Elliot Lach and Aziz Laurent. 
A PowerPoint presentation of 
our class is being prepared and 
will be distributed to our class¬ 
mates. Please send biographical 
information as well as any jpeg, 
bmp, mp3, wav, gif, tif, mim, mov, 





The wet weather failed to 
dampen our spirits at the 20th 
reunion of the Class of 1986. 
On Friday evening we gathered 
under the tents to eat clams 
and lobster with Roberto Lewis- 
Fernandez, who continues his 
research in the department of 
psychiatry at Columbia Univer¬ 
sity. We also saw Ben Li, chief of 
the division of surgical oncology 
at Louisiana State University 
Health Sciences. Dan Fierer 
showed up looking dashing in 
a suit. He continues his work on 
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infectious disease and plays 
oboe with the Musica Bella 
Orchestra of New York. Dae Song 
joined us from his private oph¬ 
thalmology practice in 
Birmingham, Ala. 
Samir Bhatt and his wife 
came to the clambake. He has a 
private practice in otolaryngol¬ 
ogy in Boston; she is an ophthal¬ 
mologist. Mike Miller is repairing 
our health care system from 
Cambridge, Mass., where he is a 
consultant. John Detre is on the 
faculty of the University of 
Pennsylvania department of 
neurology and directs the 
Center for Functional Imaging. 
Lee Bailey flew out from 
California, where he specializes 
in interventional and consulta¬ 
tive cardiology. Paul Wang is 
working in developmental and 
behavioral pediatrics for Pfizer 
Global Research in New London, 
Conn. Paul Chang is chief medical 
officer for Tengion, a biotech 
company in King of Prussia, Pa., 
involved in tissue regeneration. 
The dinner on Saturday was 
at my house in Ridgefield, Conn., 
with entertainment provided by 
Catfish, a local band. We saw 
Dave Atkins, who coordinates 
the Clinical Preventive Services 
Agency for Healthcare Policy and 
Research, and chairs the 
Subcommittee on Health 
Promotion and Maintenance in 
Washington. Amanda Dill flew 
out from her new home in 
California. She recently moved 
from Connecticut and is putting 
down new roots, both personal 
and professional. Tim McCowen 
joined us from Winston-Salem, 
N.C., where he specializes in 
spinal surgery and scoliosis and 
builds things in his spare time. 
Brad Reich is at McLean Hospital 
in Belmont, Mass., the largest 
psychiatric hospital in the 
Harvard system. He does 
research in post-traumatic stress 
disorder, dissociative disorders 
and personality disorders. 
Barbara Harvey joined us from 
her solo internal medicine prac¬ 
tice in Pennsylvania. We also had 
the pleasure of seeing Gail 
Mizner and her son Matt. She is 
practicing internal medicine and 
hiv care in Prescott, Ariz., and he 
just finished middle school. I 
continue to practice retinal and 
vitreous surgery in Danbury, 
Conn. I can’t help noticing that 
everyone seems to grow more 
accomplished, attractive, charm¬ 
ing and articulate with each 





The Class of 1991 marked its 15th 
reunion on June 2 and 3. It was 
an occasion to reflect on the 
joys of our accomplishments 
and on the unspeakable sorrow 
of our losses. Arriving on Friday 
evening for the Dean’s reception 
and clambake were Colleen Foy, 
Funda Meric and James Stanislaw 
with guest Brandy Settlemyre, 
and our class’s dear friend 
Cynthia Carver-Smith. Later 
Friday arrivals included Carl 
Henningson, Liz Holt, Jane 
Minturn and Dan Saal (Carl and 
Dan graciously accepted hospi¬ 
tality from Chateau Leaubeau). 
After the clambake, the party 
rolled on into New Haven’s old 
reliable, Viva Zapata’s, where 
nachos and sangria fueled a few 
more hours of revelry. 
On Saturday morning the 
crowd swelled with the arrivals 
of David Frankfurter with wife 
Lisa Tillman and children, and 
Bob Spillane with wife Annette 
and new bundle of joy, just in 
time for the class photo. 
Saturday afternoon saw a log 
phase, prompted by the trans¬ 
porting reading of Doris larovici. 
Doris had been invited by her 
publisher to read at the Yale 
Bookstore from her most recent 
collection of short stories, 
American Dreaming and Other 
Stories. Arriving at the reading 
were Marc Butler and companion 
Chris Yulo, Eleanor Poliak, Kathy 
Ryder and Marc Potenza. A little 
afternoon diversion and then 
dinner—more log phase growth. 
Gaetane Francis and Larry Hirsch, 
Peter Bernstein and wife Cathleen 
Barnhart, were there. We were 
also treated to a whirlwind visit 
from Robin Smith and special 
guest Dr. Morris Dillard. Colleen 
Foy opened wines she brought 
from her husband’s family vine¬ 
yard—Esterlina 2003 Zinfandel 
(14.7% alcohol!), 2003 Pinot Noir, 
and 2004 Chardonnay—sub¬ 
lime—hurry and buy. I must say 
that everyone with the excep¬ 
tion of yours truly looked great. 
After dinner the fireplace lit 
up, while I tried to find music to 
keep the party a-rockin’. Frankly, 
I failed in that endeavor, which 
prompted Doris to move the 
party to Bar, one of New Haven’s 
hip night spots, where the age¬ 
less wonders of ’91 showed the 
kids how it’s done. At some 
point, I and the Saturday night 
Chateau guests, Colleen Foy and 
Dan Saal, got home. Late the 
next morning I awoke to the 
fetching aroma of baking (huh?!) 
in the Chateau’s kitchen. It was 
Dan, back at the bench with a 
new experiment—scones. A true 
eureka moment—there’s noth¬ 
ing better than a good scone. As 
the first scones were being bro¬ 
ken, Liz Holt and Jane Minturn 
careened around the corner in 
Liz’s garnet-red Lotus Elise 
(which later shuttled Jane and 
Dan to the train, one at a time— 
two-seater, you know). After a 
few hours of scones, coffee, bub¬ 
bly and mimosas, ’91 adjourned 




The rain did not dampen the 
spirits of the members of the 
Class of 1996 who returned for 
their 10th reunion. Attempting 
to bring a little sunshine to New 
Haven were the Californians, 
including Owen Garrick, who is 
coo of hov, a clinical research 
company in Oakland. Owen 
attended with wife Jocelyn, an 
ER physician, and their chil¬ 
dren—Owen Jr., 3, and Evan, 
13 months. Peter Ferren is a child 
psychiatrist at ucsf and was 
accompanied by partner John 
Prigeon.a successful Silicon 
Valley type. Susan Wolf, a derma¬ 
tologist in San Mateo, came with 
husband Bill Greene, a recover- Iing radiologist and venture capi¬ 
talist, and 8-year-old daughter 
Corynn. Representing SoCal were 
neuro-ophthalmologist Peter 
Ouiros, a member of the use 
faculty and resident of Venice 
Beach and Palm Springs, and 
plastic surgeon Jane Kim and 
husband Paul Maggio, a surgeon. 
Traveling just a little less 
distance to the Elm City were 
Monica Escarzaga and husband 
Cyrus Cramer of Albuquerque, 
N.M. Monica is a cardiologist and 
Cyrus is a high school English 
teacher. Newlyweds Kathleen 
Figaro and businessman Alan 
Rice journeyed from Nashville, iTenn., where Kathleen is on the 
Vanderbilt faculty. Double Yalie 
Chris Muntzel is a pediatrician in 
greater Atlanta. 
From our nation’s capital 
came Matt Poggi, a radiation 
oncologist at the National Naval, 
Medical Center in Bethesda, 
Md., and Sarah Hougen Poggi, a 
perinatologist in Alexandria, 
Va. They were accompanied by 
daughters Eliza, a veteran of the 
fifth-year reunion, 5, and Julia, 3. 
Closer to our Eli home, Pfizer 
i executive Yin Ho and plastic 
' surgeon Henry Hsia, M.D.’95, 
traveled from New York City with 
daughters Thalia and Viola. Anil 
Panackel and fiancee Jennifer 
, Gribskor made time for the 
reunion with their wedding only 
two weeks away. Anil is an infec¬ 
tious disease specialist in Boston 
and Jennifer is graduating from 
business school. Best wishes 
to them! Simon Cornelissen and 
Rebecca Crichton are living in 
Providence, R.I., with Simon com¬ 
muting to his private orthopae¬ 
dics practice near Boston and 
Rebecca working locally as a 
gynecologic endoscopist. They 
have two children—Ross, 5, and 
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Anneke, 3. Also visiting from 
Providence were child psychia¬ 
trist Karyn Horowitz and husband 
Michael Robbins, a psychologist. 
They also have two children, 
Simon and Asher. From the 
shade of the Charter Oak were 
Helena Nolasco, a rheumatolo¬ 
gist, and Dr. Victor Chang of 
Hartford, Conn. 
Representing New Haven 
were Yale-New Haven infectious 
disease attending Krystn Wagner 
and infant daughter, as well as 
Lisa Sanders, who continues to 
work as an internist at Water- 
bury Hospital and as a journalist 
and mother to daughters 
Tarpley and Yancey. 
We enjoyed the clambake 
and the chance to add to our 
collection of Yale Medical School 
beer mugs. For those of you 
who did not make it back, Hark- 
ness Hall kind of looks like a 
Starbucks and is much improved 
from our days.The elegant din¬ 
ner at the Ouinnipiack Club on 
Saturday was appreciated by all 
who attended. We heard second¬ 
hand that the cme was very 
informative, but it was not struc¬ 
tured around our nap times 
so we were unable to attend. 
One excused absence was 
perinatologist Eleanor Rhee, 
enjoying bed rest in Durham, 
N.C. Her twins may be delivered 
by press time! We are grateful to 
all our classmates who attended 
our 10th reunion and hope to 
see even more of you at our 15th. 
Sarah and Matthew Poggi 
2001 
5th reunion 
On Friday afternoon, the gradu¬ 
ates of the Class of 2001 met at 
the reception in the Historical 
Library, where we mingled 
with current faculty, including 
former Special Assistant to the 
Dean Larry Cohen and Director 
of Admissions Richard Silver- 
man, as well as with many of 
our reuniting classmates. After¬ 
ward we came together for 
seafood delights and musical 
fun at the New England clam¬ 
bake held at Harkness dormi¬ 
tory. We were happy to hear that 
"Club Med,” the weekly social 
event started by our class 
almost eight years ago, is still a 
popular gathering point for stu¬ 
dents and faculty colleagues. 
For most of the crew, 
Saturday began with a tour of 
the Anlyan Center for Medical 
Research and Education. The 
construction of this building 
during our latter days at Yale 
certainly seems to be worth the 
investment. For many, the high¬ 
light of the tour was a visit to 
the anatomy laboratory, hosted 
by none other than Bill Stewart, 
ph.D.The new anatomy teach¬ 
ing format is truly an interactive 
experience, featuring computer 
stations alongside each cadaver. 
The stations are equipped to 
guide students through clinical 
vignettes, radiographic correla¬ 
tive images and the anatomical 
dissection from a surgical per¬ 
spective. We really have come a 
long way from our days of using 
just a Grant’s dissector! 
The fun continued that 
evening at the alumni gathering 
held at the Graduate Club, 
where we mingled and recalled 
our Yale experiences and memo¬ 
ries alongside graduates of 
decades ago. Having our own 
room in the back, we turned it 
into a makeshift Mory’s night 
and celebrated with great food, 
stories of past and present and 
jokes about a guy named Pedro. 
Hany Bedair is currently 
entering his penultimate year in 
orthopaedic surgery in 
Pittsburgh. Carmit and George 
Archibald traveled from New 
York City, where Carmit is an 
attending physician in obstetrics 
and gynecology. Fred Aslan just 
graduated from Harvard 
Business School and is moving 
to New York City to work for a 
medical venture capital firm.The 
Boston group included Dan Hoit, 
who is in his fifth year of a six- 
year neurosurgery residency; 
Brian Lester, who just joined a 
busy dermatology practice; and 
Andrea Ciaraneilo, who is doing 
a fellowship in infectious dis¬ 
eases. Also representing Boston 
was Jessica Mega and her hus¬ 
band, Nick Walsch, j.d., and 
Sandeep Bansal and wife Ruby. 
Jessica is doing a cardiology 
fellowship, and Sandeep is per¬ 
forming research prior to start¬ 
ing fellowship training in 
cardiology. Sharon Chekijian and 
Aaron Covey made the short trip 
to the reunion Friday night. Both 
are residents in New Haven, in 
emergency medicine and ortho¬ 
paedics, respectively. 
Those coming from far, far 
away included Jose J. Miranda, 
who is entering his chief resi¬ 
dency year in orthopaedic 
surgery with the U.S. Army in 
Augusta, Ga., and M. Vaughn 
Emerson, who is about to enter 
his second year of a two-year 
fellowship in retinal care in 
Portland, Ore. 
Jose J. Miranda 
PA Program 
About two dozen alumni of the 
Physician Associate Program 
attended a reunion reception on 
June l at the Graduate Club. 
Mary L. Warner, m.m.sc., pa-c, 
assistant dean and director of 
the program, told the gathering 
that the program is expanding 
from 25 to 27 months. The longer 
schedule is designed to accom¬ 
modate accreditation require¬ 
ments and to give students more 
time for work on thesis projects. 
There will be a site visit for the 
program’s accreditation in the 
spring of 2007. 
Warner said she and her staff 
have been working with medical 
schools in Uganda and England, 
and may help to start physician 
associate programs there. Also 
on the international front, four 
students have gone abroad 
for clinical rotations in England, 
Costa Rica, Belize and Nicaragua, 
while two students received 
funding from the Wilbur Downs 
International Health Travel 
Fellowship Program to travel to 
Brazil and South Africa to com¬ 
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Crossing the country to 
promote global health 
A 1997 alumna bicycles through 13 
states to raise awareness of the links 
between poverty and disease. 
Karen Kiang, m.d. ’97, approached the 
podium at the public library in 
Telluride, Colo., with an enthusiasm 
and none of the weariness you might 
expect from someone who had pedaled 
her bike 77 miles over a io,ooo-foot 
mountain pass the previous day. Slim, 
with a luminous smile that dominates 
her round face, Kiang came to 
Telluride with a single goal—to 
awaken others to the urgency of world 
health issues she has seen firsthand. 
Kiang has no desire to lecture—she 
designed her presentation, dubbed 
Global Health 101, as a conversation 
starter. “What do you know about 
malaria?” she asked a high school stu¬ 
dent in the audience. When he replied 
that it’s a blood disease, she nodded 
her head. Like so many other diseases 
facing the developing world, malaria is 
largely preventable with low-cost inter¬ 
ventions, she told the audience. Kiang 
has seen malaria’s damage with her 
own eyes, and it’s the senselessness of 
it that bothers her most. “These are 
treatable diseases, but it takes money 
to get things done,” she said. 
Just 18 days earlier, she had left San 
Francisco with 20 other bicyclists to 
begin the Ride for World Health, a 
3,700-mile journey across the United 
States to raise awareness and money 
for global health issues. Along the way, 
Kiang and the other riders, most of 
them medical students, slept in school 
gyms, in churches and in the homes of 
gracious local hosts. In the evenings 
the riders led lectures and discussions 
about issues like malaria, hiv, tuber¬ 
culosis and the poverty that drives 
these diseases in the developing world. 
Kiang and her companions sought to 
raise $250,000 for Partners in Health, 
a nonprofit global health program 
aimed at providing basic health care to 
underserved people in Haiti, Rwanda, 
Guatemala, Mexico, Russia, the United 
States and other parts of the world. 
“Just $50 can provide testing and treat¬ 
ment for seven tuberculosis patients,” 
said Kiang. “You also prevent each 
patient from spreading it to 10 to 15 
other people.” 
Kiang signed up for the ride after 
receiving a notice about it via e-mail. “I 
couldn’t resist,” she said. Already an 
avid bicyclist, she owns no car and bikes 
about 10 miles each day to her job at 
The Northern Hospital in Melbourne, 
Australia. “I loved the idea that such a 
humble vehicle could carry such an 
important message,” she said. The ride 
also appealed to her sense of adventure. 
But Kiang is not just on a ride— 
she’s on a mission. “I grew up in a 
safe, well-to-do suburb of Minneapolis. 
I never worried about whether I could 
eat or not,” she said. Her parents, 
both physicians, fled China to escape 
Communism and never allowed her to 
take prosperity for granted. “My father 
lived for years on rice porridge,” said 
Kiang. “I understood from an early age 
how fortunate I was, and I felt I should 
pay something back.” 
During medical school she teamed 
up with renowned medical parasitolo¬ 
gist Peter J. Hotez, m.d., ph.d., to 
study chronic hookworm in China and 
Thailand. She noticed that one village 
had fewer cases of parasitic disease 
than the others. “It was the richest vil¬ 
lage, and that realization was part of 
my public health awakening,” said 
Kiang. “Poverty is the root of disease.” 
She saw it on American Indian reser¬ 
vations and in the villages of China 
and Thailand—poverty leads to malnu¬ 
trition, which boosts the probability of 
Karen Kiang bicycled across the country to raise 
awareness of global health issues. She pedaled 
77 miles the day she arrived in Telluride, Colo. The 
San Juan Mountains are in the background. 
infection, in turn increasing the risk of 
early death. 
Kiang has spent her career trying to 
stop the cycle. As a resident at Duke, 
she traveled to Tanzania to work with 
hiv patients. While there, she met her 
partner, Tim Fricke, m.sc., a pediatric 
optometrist. After two years as an 
Epidemic Intelligence Service Officer at 
the Centers for Disease Control and 
Prevention in Atlanta, Kiang moved to 
Australia, where she is now the equiva¬ 
lent of a fellow in the emergency room 
at The Northern Hospital. 
In November, she will embark on 
her next project, a stint with Doctors 
Without Borders, which will likely take 
her back to Africa. But in April she still 
had a ride to finish. By the time she 
reached Washington, on May 21, Kiang 
had crossed 11 states and given her 
Global Health 101 presentation to hun¬ 
dreds of people. “Once people realize 
these problems exist, they open them¬ 




When numbers matter: 
an epidemiologist improves 
health care for the homeless 
Can statistics help the health of New 
York City’s homeless? Bonnie Kerker, 
ph.d. ’oi, is convinced that they can. 
Over the last two years, Kerker, the 
city’s assistant commissioner for epi¬ 
demiology services, and her colleagues 
have analyzed data from more than 
100,000 clients of the city’s vast shel¬ 
ter system. 
Her research—based on data from 
everyone who spent a night in the shel¬ 
ter system from 2001 through 2003 
that were matched to Health Depart¬ 
ment registries—has created a picture 
of the health of this population. Now 
this information underpins a plan to 
augment health care resources avail¬ 
able to shelter residents. 
Among her findings—single adults 
who use New York’s shelter system 
are diagnosed with hiv infection 16 
times more often than the city’s gen¬ 
eral population. And the death rate 
among the homeless is twice as high. 
These facts helped influence the new 
plan, scheduled to be fully operational 
by December 2006. 
The new plan enhances both medi¬ 
cal screenings and treatment options. 
Expanded services will range from 
shelter-based ambulatory detox services 
to greater assistance for pregnant 
women. Progress will be monitored 
against new performance indicators 
that will track the implementation of 
each step. Deaths due to exposure 
to natural elements or extreme weather 
will also be analyzed. 
Lead author of a report, “The Health 
of Homeless Adults in New York 
City,” which was released in January 
2006, Kerker is particularly pleased 
that the plan will “expand rapid hiv 
testing and increase the identification 
and treatment of alcohol and drug 
abuse at shelters—all of which the city 
said it would do in response to the 
findings. It’s the bright side of some 
dark data.” 
Participation in the new health pro¬ 
grams is voluntary, and eligible candi¬ 
dates will receive information to 
explain what’s being offered and how 
they can benefit. The city’s ultimate 
goal is to find homes for as many shel¬ 
ter users as possible. “We think that 
improving people’s health can improve 
their chances to acquire and maintain 
adequate housing,” Kerker said. “But 
the big elephant in the room is really 
homelessness.” 
Kerker’s concern for underserved 
populations began at age 10, when 
she imagined herself as a Peace Corps 
volunteer helping malnourished 
African kids. She and her two sisters 
grew up in New City, a suburb north 
of New York City, where their father 
was a lawyer and their mother a for¬ 
mer teacher. Kerker, now 37, did join 
the Peace Corps after graduating 
from Tufts in 1990 with a degree in 
American studies. During two years 
in the Dominican Republic, she 
developed community health and edu¬ 
cation programs in Sabana Alta, a 
small town of 8,000 people. 
Hired as an epidemiologist and data 
analyst for the New York City Depart¬ 
ment of Health and Mental Hygiene in 
1995, Kerker left in 1997 to pursue 
a doctorate at Yale. “I was always inter¬ 
ested in the translation of data into 
action. My two amazing advisors— 
Mark Schlesinger and Sally Horwitz— 
gave me much hands-on opportunity 
to see how data can actually be used in 
real life. Dr. Horwitz was evaluating 
the health effects of Connecticut’s new 
Welfare to Work program. Being 
involved in that process helped me 
understand how to analyze and 
present data in a way that makes them 
useful to policy-makers.” 
Her doctoral program yielded an 
unexpected professional reward. After 
18 months at a child welfare agency in 
Connecticut, Kerker heard through a 
classmate about a new Department of 
Health bureau in New York established 
by another Yale alumnus, Farzad 
Mostashari, m.d. ’96. He hired her in 
Bonnie Kerker, assistant commissioner for 
epidemiology services at the New York City 
Department of Health, recently completed 
a study of the health of the 100,000 people 
who use the city’s homeless shelters. 
late 2003. When Mostashari left in 
2005 to head another project, Kerker 
was promoted to his former position. 
Today, she runs a department with 
25 employees and clearly loves her 
work. “Everybody really relies on data 
in the Bloomberg administration. So 
you feel like you’re needed, and that 
the work you do is actually being used 
in policy decisions,” Kerker reflected. 
“That’s why I went into this field in 
the first place.” 
—Carol Milano 
Familiar Faces 
Do you have a colleague who is making 
a difference in medicine or public 
health or has followed an unusual path 
since leaving Yale? We’d like to hear 
about alumni of the School of Medicine, 
School of Public Health, Physician 
Associate Program and the medical 
school’s doctoral, fellowship and 
residency programs. Drop us a line at 
ymm@yale.edu or write to Faces, 






















Aaron Beck Milton Hamilt Augustus 
White III 
1940s 
Aaron T. Beck, m.d. ’46, received 
a 2006 Distinguished Investiga¬ 
tor Award this spring from 
narsad: the Mental Health 
Research Association. The one- 
year $100,000 award supports 
experi enced investigators con¬ 
ducting neurobiological research. 
Beck also received the Adolf 
Meyer Award from the American 
Psychiatric Associa-tion in April. 
195QS 
Leonard Cook, PH.D. '51, who 
directed central nervous system 
research at DuPont Merck Phar¬ 
maceutical Co. starting in 1983, 
was the winner of the 2006 
P.B. Dews Lifetime Achievement 
Award in Behavioral Pharmacol¬ 
ogy. The award was presented 
in April in San Francisco. Cook is 
recognized as a pioneer in behav¬ 
ioral pharmacology who has 
contributed substantially to the 
discovery and evaluation of 
psychotherapeutics. 
Milton W. Hamilt, M.P.H. ’54, 
writes to say that he has been 
retired since 1989 and that he 
and his wife live in a retirement 
community in Pennsylvania. 
After his graduation from Yale 
he spent two years as an admin¬ 
istrative resident at Grace-New 
Haven Community Hospital, 
spending his last year as the 
first administrator of the Yale 
Psychiatric Institute. In 1969 he 
became a professor at Temple 
University, where he taught 
hospital administration. 
196OS 
John A. Parrish, M.D. ’65, profes¬ 
sor, chair and chief of the 
Department of Dermatology 
and director of the Center for 
Integration of Medicine and 
Innovative Technology at 
Harvard Medical School, has 
been elected to the board of 
directors for the National Space 
Biomedical Research Institute 
(nsbri). nsbri, funded by NASA, 
is a consortium of institutions, 
including Harvard, that study 
the health risks related to long- 
duration space flight. 
Dennis J. Rudzinski, M.D. ’69, 
assumed a part-time position at 
Commonwealth Anesthesia 
Associates in January. A former 
partner in the Richmond, Va., 
group, he works every other 
week. During his weeks off, he 
enjoys gardening and cruising 
the Chesapeake Bay. 
Augustus A. White III, M.D., PH.D., 
hs ’66, received the 2006 Diver¬ 
sity Award in March at the 73rd 
annual meeting of the American 
Academy of Orthopaedic Sur¬ 
geons in Chicago. The award rec¬ 
ognizes fellows of the academy 
who have significantly con¬ 
tributed to advancing diversity 
in orthopaedics through recruit¬ 
ing, mentoring, leadership and 
treating diverse populations. 
197QS 
Richard D’Aquila, M.P.H. ’79, has 
been appointed executive vice 
president and chief operating 
officer (coo) at Yale-New Haven 
Hospital and executive vice 
president of Yale New Haven 
Health System. D’Aquila previ¬ 
ously served as senior vice 
president and coo of New York- 
Presbyterian Hospital/Weill 
Cornell Medical Center and 
executive vice president and 
coo of St. Vincent’s Medical 
Center in Bridgeport, Conn. 
Allen I. Goldberg, M.D., HS ’70, 
has spent his career focused on 
home health, mobile health 
and telemedicine/eHealth. In 
the 1990s, as president of the 
American College of Chest 
Physicians, Goldberg invited for¬ 
mer U.S. Surgeon General C. 
Everett Koop, m.d., to help begin 
a series of dialogues about 
improving health care. 
Lee Goldman, m.d. ’73, M.P.H. ’73, 
chair of the Department of 
Internal Medicine at the 
University of California San 
Francisco, was named in May as 
Columbia University’s new 
executive vice president for 
Health and Biomedical Sciences 
and dean of the Faculties of 
Health Sciences and Medicine. 
Goldman, who assumed his post 
at Columbia in late June, also 
has appointments as the Harold 
and Margaret Hatch Professor of 
the University, professor of 
medicine in the College of 
Physicians & Surgeons and pro¬ 
fessor of epidemiology in 
Columbia’s Mailman School of 
Public Health. 
David H. Lippman, M.D. ’71, writes 
to say that his 15-year-old son 
Daniel appeared in the Talk of the 
Town section of The New Yorker 
last October. Daniel visits Ask the 
White House, a forum on the 
White House website, to ask 
questions of Bush Administration 
bureaucrats.The exchanges are 
posted on the site. Daniel’s father 
is medical director of River Valley 
Counseling Center in Holyoke, 
Mass. 
Robert J. Schechter, M.D. ’74, 
received in May the Department 
of Ophthalmology Senior Honor 
Award of the Jules Stein Eye 
Institute of the ucla School of 
Medicine for "distinguished 
service” and "contributions 
extending over many years.” 
Schechter is a clinical professor 
of ophthalmology at ucla. 
1980s 
Peter Diffley, PH.D., fw ’80, an 
associate dean of the graduate 
school at the University of Notre 
Dame, became the first full-time 
dean of graduate studies at the 
University of Hartford on July 1. 
Diffley is an executive commit¬ 
tee member, past chair and cur¬ 
rent treasurer of the Association 
of Graduate Schools in Catholic 
Colleges and Universities. He 
is also an executive committee 
member and past chair of the 
Midwest Association of Gradu¬ 
ate Schools. He received his 
ph.d. in zoology from the Uni¬ 
versity of Massachusetts and 
was a postdoctoral fellow at the 
School of Medicine before join¬ 
ing the faculty at the University 
of Notre Dame in 1984. 
William N. Hait, M.D., PH.D., 
hs ’82, fw ’83, director of The 
Cancer Institute of New Jersey, 
became president-elect of the 
American Association for Cancer 
Research, effective April 3, at 
the group’s 97th annual meet¬ 
ing in Washington in April. The 
president, president-elect and 
past president serve terms of 
one year. Hait’s research inter¬ 
ests include breast cancer, drug 
development, calcium-mediated 
signal transduction, multidrug 
resistance, translational research 
and clinical pharmacology. 
199OS 
Michael J. Davidson, M.D. ’96, a 
cardiac surgeon at Brigham and 
Women’s Hospital in Boston, will 
6i 
be among the first cimit- 
Johnson & Johnson Young 
Clinician Research Recipients.The 
funding, made possible through 
Johnson & Johnson’s Corporate 
Office of Science and Technology, 
will allow Davidson to mentor 
other cardiac surgical trainees 
and continue his work develop¬ 
ing techniques for heart valve 
repair, cimit is a Boston-based 
research consortium of major 
teaching hospitals and engineer¬ 
ing schools dedicated to advanc- 
! ing the standard of patient care. 
Jordan (Sink) Creenbaum, /VI.D. 
'89, and Laurence A. Creenbaum, 
m.d. ’90, ph.d. ’94, recently 
joined Children’s Healthcare of 
Atlanta. Jordan joined the 
Children’s Healthcare of Atlanta 
Child Protection Center as its 
first full-time medical director. 
Laurence joined the Kidney 
Transplant, Dialysis and cri 
Clinic team and will serve as 
chief of pediatric nephrology 
i and associate professor of 
pediatrics at Emory University 
School of Medicine. 
Bruce K. Lin, m.p.h. ’97, was mar¬ 
ried to Kathryn Anne O’Brien, 
m.p.h., m.b.a. ’05, in January. Lin 
! is an epidemiologist for the 
March of Dimes, and O’Brien is 
an associate with Roche 
Pharmaceuticals.They live in 
New York City. 
John P. Sanchez, m.p.h. ’98, gradu¬ 
ated from the Albert Einstein 
College of Medicine this spring 
and started a residency in 
emergency medicine at Jacobi 
Medical Center in the Bronx in 
June. He was recently featured 
on the pbs program In the Life 
for his work addressing the 
health care needs of minorities 
and gay and lesbian individuals. 
Jonathan Erulkar, 
Deirdre Carroll and 
Samuel 
Noah S. Scheinfeld, m.d. ’97, J.D., 
was married to Jacqueline M. 
Didier in New York City in 
December. Scheinfeld is a der¬ 
matologist on the staff of St. 
Luke’s-Roosevelt Hospital Center 
and Beth Israel Medical Center, 
both in New York. Didier is a vice 
president and lawyer at Lehman 
Brothers, the New York invest¬ 
ment bank. 
Elizabeth R. Roth, m.d. ’92, was 
married in November 2005 to 
Albert Lafarge in Vineyard 
Haven, Mass. Roth, a 1984 gradu¬ 
ate of Yale College, practices 
internal medicine in Boston. 
Lafarge runs an independent lit¬ 
erary agency in Boston, where 
the couple lives. 
20005 
Jonathan Erulkar, m.d. ’01, and 
Deirdre Carroll, RN ’00, welcomed 
a healthy baby boy named 
Samuel Jonathan on October 11, 
2005. Samuel was 22 inches 
long and 8 lbs, 13 oz! After nearly 
10 years at Yale, Dede, Jonathan 
and their new little one are 
moving to Boston. 
Barbara (Latunik) Esders, M.M.SC. 
’03, and her husband, Theodore 
Esders Jr., write to announce 
the birth of their first child, 
Ella Victoria, on November 8, 
2005. Barbara is a physician 
assistant in the emergency 
department at Rochester Gen¬ 
eral Hospital, N.Y. 
Gretchen Fredericks, PA ’05, 
and Michael Myre were mar¬ 
ried in March in La Crosse, 
Wis. She is employed at 
Independent Medical Associ¬ 
ates in Bangor, Maine. He is 
employed by AstraZeneca/PDi 
in Saddle River, NJ. 
Devesh S. Gandhi, M.D. ’02, was 
married in May to Rinaa S. 
Punglia, m.d., m.p.h., in San Jose, 
Calif. Gandhi is the senior 
health analyst at Sonar Capital, 
a hedge fund in Boston. Punglia 
is an assistant professor of 
radiation oncology at Harvard 
Medical School and a radiation 
oncologist at the Dana-Farber 
Cancer Institute. 
Joseph M. Harburger, M.D. ’04, 
and Lauren J. Levy, M.s. ’04, 
were married in March in Old 
Greenwich, Conn. Harburger is a 
resident in internal medicine at 
Yale-New Haven Hospital. Levy 
is a doctoral candidate in behav¬ 
ioral neuroscience at Yale. 
Marion C.W. Henry, m.d., M.P.H. 
’05, was married in April to 
Andrew Joseph Colyer, a portfo¬ 
lio manager and research 
analyst at Sands Capital Man¬ 
agement. Henry is a fifth-year 
resident in general surgery 
at Yale-New Haven Hospital. 
Katherine M. Marshall, M.P.H. '02, 
and David Purviance, d.m.d., 
were married in September in 
New Hampshire. Marshall 
is an epidemiologist with the 
Connecticut Department of 
Public Health. Purviance is a 
dental resident in periodontics 
at the University of Connecticut. 
Hilary F. Ryder, M.D. ’04, was 
married in December 2005 to 
Matthew J. Henken, j.d. ’04, 
in New Hampshire. Ryder is a 
resident in internal medicine at 
Dartmouth-Hitchcock Medical 
Center in Hanover, N.H. Henken 
is an associate at Boies, Schiller 
and Flexner in Hanover. 
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Thomas T. Amatruda Jr., M.D. ’78, 
former chief of medicine at the 
VA Connecticut Health Care 
System in West Haven and direc¬ 
tor of clinical services at Water- 
bury Hospital, died on April 22 at 
his home in Woodbridge, Conn., 
after a short illness. He was 79. 
Amatruda developed an interest 
in medicine during his service in 
the U.S. Army during World War 
II. He started his career at the 
School of Medicine and became 
Waterbury Hospital’s director of 
clinical services in 1971, a post he 
held for 17 years. Many of his 
publications are considered clas¬ 
sics in the field of endocrinology 
and metabolism. In 1989 he 
received the Laureate Award 
from the American College of 
Physicians, Connecticut Chapter. 
The Thomas T. Amatruda Visiting 
Lecture Series in Endocrinology 
was established in his honor at 
Waterbury Hospital in 1990. 
John E. Borowy, M.D. ’50, died in 
Stamford, Conn., on February 13 
after a brief illness. He was 84. 
Borowy came to the medical 
school after serving in North 
Africa in the U.S. Air Force during 
World War II. After residencies 
at Kings County Hospital Center 
in New York and the Veterans 
Administration hospitals in West 
Haven and Newington, Borowy 
opened a private practice in 
internal medicine and diseases 
of the heart in Stamford. He 
retired in 1999. 
Lawrence M. Brass, M.D., profes¬ 
sor of neurology and of epi¬ 
demiology and public health, 
died of cancer on March 8. Brass, 
a nationally recognized expert 
who devoted his professional 
life to improving care and out¬ 
comes for patients with stroke, 
was 49. He received his medical 
degree from Tufts Medical 
School. He completed an intern¬ 
ship at Newton-Wellesley 
Hospital in Massachusetts and 
a residency and chief residency 
in neurology, as well as a stroke 
fellowship, at the Neurological 
Institute of New York at 
Columbia University. In 1987 he 
was recruited by Yale to estab¬ 
lish a stroke program. He was 
also chief of neurology at the VA 
Connecticut Healthcare System 
in West Haven and co-director of 
the Yale Cerebro-vascular Center. 
He was an active lecturer, and 
authored more than 100 articles 
and 20 books and book chap¬ 
ters. One of his legacies is the 
first complete database of 
stroke among the elderly in the 
United States; another is the 
Women’s Estrogen for Stroke Trial. 
William B. Bucher, M.D. ’50, died 
on March 19 in Ventura, Calif. 
He was 83. While serving in the 
Air Force in World War II, Bucher 
received shots infected with 
encephalitis and spent 20 
months recovering from paraly¬ 
sis. After the war he went to 
medical school on the Gl Bill. 
He was a pediatric resident in 
the University of Southern 
California's program at Childrens 
Hospital Los Angeles. 
Walter J. Burdette, PH.D., M.D. ’42, 
hs ’46, died on April 18 in Hous¬ 
ton, Texas. He was 91. Prior to 
coming to Yale, Burdette earned 
a ph.d. from the University of 
Texas at Austin in 1938. While at 
Yale he was a member of Alpha 
Omega Alpha and the Nathan 
Smith Club and served on the 
editorial board of the Yale Journal 
of Biology and Medicine. During 
his career he was on the surgical 
faculty at Louisiana State Uni¬ 
versity, the University of Mis¬ 
souri, Saint Louis University 
School of Medicine, the Univer¬ 
sity of Utah, the University of 
Texas M.D. Anderson Cancer 
Center and the University of 
Texas School of Medicine at 
Houston. His research interests 
included genetics and cancer 
treatment; his most recent book, 
The Basis for Gene Therapy, was 
published in 2001. He was hon¬ 
ored by the Yale Club of Houston 
with a special Tercentennial 
Award in 2001. 
Thomas B. Caldwell III, M.D. '65, 
died on April 20 in Nashville, 
Tenn. He was 66. Caldwell 
taught anesthesiology at the 
University of Miami and 
Vanderbilt University and pub¬ 
lished journal articles and text¬ 
book chapters on anesthesiology. 
Frank W. Countryman, M.D. ’44, 
died on February 14 in Indian¬ 
apolis. He was 85. Countryman 
was a superintendent of 
Kentucky State Hospital and was 
on the staff of Winter Veterans 
Hospital and the Menninger 
Foundation in Topeka, Kan. He 
also served as assistant profes¬ 
sor of psychiatry at Indiana 
University School of Medicine 
and consultant to the Social 
Security Administration’s hear¬ 
ing and appeals committee. 
Thomas W. Ferguson, M.D. ’77, 
died on April 14 in Little Rock, 
Ark., where he was under¬ 
going treatment for multiple 
myeloma. He was 62. A writer, 
physician and researcher, 
Ferguson studied and wrote 
about the empowered medical 
consumer and online health 
resources. In 1993 he organized 
the world’s first conference 
devoted to computer systems 
designed for medical con¬ 
sumers. Born in Ross, Calif., 
Ferguson attended Reed College 
and earned a master’s degree in 
creative writing from San 
Francisco State University before 
coming to Yale. He then launched 
a career in consumer-focused 
medical writing as founder of 
Medical Self-Care magazine. 
From 1980 to 1996 he authored 
or co-authored over a dozen 
books and was section editor for 
health, medicine and self-care 
for the Whole Earth Catalog. 
Lucian S. Lapinski, M.D. ’50, died 
on January 15 in Los Angeles, 
Calif. He was 85. A native of 
Bridgeport, Conn., Lapinski prac¬ 
ticed medicine there before mov¬ 
ing to California 23 years ago. 
Preston L. Leslie, M.D. ’53, died on 
November 10,2005, at his home 
in Fremont, Calif. He was 81. 
Leslie enrolled at the School of 
Medicine following service in 
the U.S. Air Force during World 
War II. He practiced radiology 
and was an associate professor 
at Stanford University Medical 
Center for several years. 
Leo Lutwak, m.d. ’56, ph.d., died 
on February 23 in Bethesda, Md., 
from complications of lung 
disease. He was 77. Born in the 
Bronx, N.Y., Lutwak received a 
ph.d. from the University of 
Michigan in Ann Arbor in 1951 
before beginning his medical 
studies at Yale. Lutwak was a 
biochemist and endocrinologist 
specializing in obesity who, 
while a medical officer for the 
Food and Drug Administration, 
raised warnings about health 
risks from the use of fenflu¬ 
ramine and dexfenfluramine 
(Fen-Phen) as dietary aids in 
treating obesity. Despite his 
warnings the drugs were 
‘I approved in 1996. Two formula¬ 
tions, Redux (dexfenfluramine) 
and Pondimin (fenfluramine), 
were taken off the market a year 
later when they were linked to 
[ hypertension and heart valve 
1 problems. Lutwak’s 50-year 
career included research, teach¬ 
ing and patient care. 
! Benjamin E. Lyons, m.d. ’38, died 
on March 18 at his home in 
Meadow Ridge, Conn. Lyons 
practiced ophthalmology in 
0 Norwalk, Conn., and at the New 
|( York Eye and Ear Infirmary until 
he retired in 1989. He collected 
I art from local artists and during 
his travels with his wife. He also 
played the violin in local sym¬ 
phony orchestras. 
; George F. Mahl, ph.d. ’48, profes¬ 
sor emeritus of psychiatry and 
. psychology, died on March 11 at 
his home in North Haven, Conn. 
He was 88. Mahl’s graduate work 
in psychology at Yale was inter¬ 
rupted by four years of military 
\ service during World War II. He 
was a member of the Yale faculty 
from 1947 until his retirement 
in 1988, with joint appointments 
in psychiatry and psychology. 
He received the Distinguished 
Service Award in 1995 from the 
I Yale Psychiatric Alumni Associat¬ 
ion. His major research contribu- 
! tion dealt with the expression of 
emotions and thought in speech 
and body movements during 
'j. psychotherapeutic and psychoan- 
h, alytic interviews.The author 
or co-author of over 50 major 
: papers, Mahl also served on the 
faculty of the Western New 
; England Institute for Psycho- 
i analysis for 25 years and was its 
(president from 1972 to 1974. The 
Western New England Psycho¬ 
analytic Society awarded him its 
Founder Teaching Prize in 2002. 
Sally L. Marchesi, M.D. ’63, died 
on February 13 in Essex, Conn., 
after a long struggle with 
Alzheimer’s disease. She was 69. 
A faculty member in the Depart¬ 
ment of Internal Medicine since 
1972, and later in the Department 
of Laboratory Medicine, Marchesi 
retired in 1997. She met her hus¬ 
band, Vincent T. Marchesi, m.d. 
’63, at Yale. After graduation, 
Sally Marchesi spent several 
years at the National Institutes 
of Health, where she was one of 
the first researchers to isolate 
and study the blood factor 
responsible for hemophilia. An 
avid outdoorswoman and ath¬ 
lete, she ran races, coached soc¬ 
cer teams, hiked, biked, swam 
and windsurfed. 
Jean M. Maynard, M.D., m.p.h. ’63, 
died on January 16 in Warwick, 
R.l. He was 91. Maynard received 
his medical degree from Uni¬ 
versity Laval in Quebec City, 
Quebec. After an internship in 
Maine and work as night super¬ 
intendent at Rhode Island 
Hospital, he enlisted in the U.S. 
Army as a medical corps captain. 
He served in Europe during 
World War II, including the 
Battle of the Bulge, where he 
earned five battle stars. He prac¬ 
ticed medicine with his wife in 
West Warwick, R.L, for 20 years. 
Harry L. McClelland, M.D. ’50, died 
on April 17 in Tracy, Calif. He was 
80. A native of Madras, India, 
where his parents were mission¬ 
aries, McClelland also lived in 
Calcutta and attended Kodaikanal 
International School. He served 
in the U.S. Army as a physician 
and as a U.S. Air Force flight sur¬ 
geon. Until illness forced him 
to end his medical practice in 
March, McClelland was an active 
internist for 50 years. He was 
also a volunteer physician in 
Honduras following an earth¬ 
quake, and in Nepal and India. 
F. Patrick McKegney, m.d. '58, died 
on February 3 in the Bronx, N.Y., 
after a brief illness. He was 73. 
McKegney worked at the Public 
Health Service in Washington, 
D.C., and taught psychiatry at 
Yale and at the University of 
Vermont College of Medicine, 
where he was department chair 
for four years. In 1983 he moved 
to Albert Einstein College of 
Medicine in New York. He was 
regarded as a leader in the field 
of psychosomatic medicine and 
consultation-liaison psychiatry. 
Richard K. Root, M.D., who in 
the 1970s headed the medical 
school’s department of infec¬ 
tious diseases and briefly served 
as acting chair of internal medi¬ 
cine, died on March 19 during a 
trip to Botswana when a croco¬ 
dile attacked him. He was 68 
and lived in Seattle. Root, a pro¬ 
fessor emeritus at the University 
of Washington medical school 
and an expert in infectious dis¬ 
eases, had gone to Botswana in 
March to train hospital staff at 
Princess Marina Hospital in 
Gaborone in the management 
of hiv/aids. He and his wife, 
Rita O’Boyle, were visiting a 
clinic in Tuli, a remote district in 
the northeast, when they took 
a wildlife tour of the Limpopo 
River. Root was in the lead canoe 
when a crocodile leaped out 
of the river, grabbed him and 
pulled him under the water. 
Root came to Yale in 1971 as a 
professor of medicine and was 
appointed the first Paul Beeson 
Professor of Medicine in 1980. 
He was voted "teacher of the 
year” by the Yale house staff in 
1982. He was former president of 
the American Federation of 
Clinical Research, editor-in-chief 
of a textbook, Clinical Infectious 
Diseases: A Practical Approach, 
and director of the National 
Institutes of Health’s aids 
Advisory Committee from 1986 
to 1991. 
Norman J. Siegel, M.D., HS ’70, 
founding director of the Section 
of Pediatric Nephrology, former 
vice chair and interim chair of 
pediatrics and physician-in-chief 
at Yale-New Haven Children’s 
Hospital, died on April 28 while 
attending a meeting of the 
Pediatric Academic Societies in 
California. He was 63. A native of 
Texas, he received his m.d. from 
the University of Texas Medical 
Branch in Galveston. Siegel, one 
of the world’s leading pediatric 
nephrologists, came to Yale in 
1968 as an intern in pediatrics. 
He joined the faculty in 1972 and 
became a tenured professor 
in 1982. He was elected to the 
American Society of Clinical 
Investigation in 1983 and held 
leadership positions in the 
American Society of Pediatric 
Nephrology, the National Kidney 
Foundation and other national 
and international organizations. 
SEND OBITUARY NOTICES TO 
Claire M. Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 





















64 F0ll0W-Up Archives 50 and 25 years ago 
Yale innovation in art of observation has 
worldwide reach 
In 1997, worried that physicians’ observational skills might be 
waning in an era of laboratory tests, electronic monitors 
and medical imaging, Irwin M. Braverman, m.d., professor of 
dermatology, in collaboration with Linda K. Friedlaender, m.s., 
curator of education at the Yale Center for British Art (ycba), 
offered an unusual approach to training doctors. 
"Physicians were losing this ability that they all had, 
and all used, 50 years ago,” Braverman said. At about the same 
time, Friedlaender had a disappointing experience when she 
saw that a resident examining a friend of hers prior to surgery 
failed to notice obvious signs that the patient was agitated. 
Friedlaender told this story to her friend Braverman, and the 
program, Enhancing Observational Skills, was born. 
Each spring, Yale medical students visit the museum 
for three hours to study and describe paintings, and they then 
apply their enriched observational vocabulary to images of 
human skin lesions they are likely to encounter in the clinic. 
The program, now required of all first-year students, has 
proven so successful that two dozen other medical schools 
have adapted it. The Frick Collection & Frick Art Reference 
Library in New York is offering a variation on the program for 
about 200 medical students a year drawn from Weill Medi¬ 
cal College of Cornell University, Albert Einstein College of 
Medicine of Yeshiva University, Mount Sinai School of Medi¬ 
cine and New York University School of Medicine. 
And educators in professions from business to law 
enforcement are following suit. Yale School of Management 
Dean Joel M. Podolny, ph.d., thought business students also 
could learn how to size up a situation by looking at art, so as 
part of their orientation last August newly arrived Yale busi¬ 
ness students paid a visit to the ycba. Two years ago mem¬ 
bers of the New York City Police Department were invited to 
take part in similar training. 
New Haven and Yale police officers have also taken the 
course. According to Friedlaender, the New Haven police will 
apply their new descriptive skills to photos of street scenes, 
not skin lesions. “This exercise may encourage officers to con¬ 
sider how the museum looking experience might impact their 
professional duties,” Friedlaender says, adding,"I'm sure they 
could teach me a thing or two.” 
—Cathy Shufro 




“Since 1953, special alumni pro¬ 
grams and class reunions have 
been arranged annually in 
September for the 10th, 15th, 20th, 
and 25th year medical classes. 
These programs were planned to 
supplement the annual February 
22 Alumni Day and allow the spe¬ 
cial classes to meet as individual 
groups ten years or more follow¬ 
ing graduation. In 1954 and 1955, 
the 30th year classes also were 
included; however, the 10th year 
classes preferred to hold their 
reunions in June. 
“Although the September pro¬ 
grams have been enthusiastically 
received by the reunion classes, 
attendance by some classes has 
been poor. After careful considera¬ 
tion of the problem of scheduling 
these reunions, the executive com¬ 
mittee of your Association of Yale 
Alumni in Medicine has decided 
that a June program offers defi¬ 
nite advantages. Beginning this 
year, special alumni reunions for 
10th, 15th, 20th, 25th, and 30th 
year classes will be held annually 
in June.” 
YALE MEDICINE_ 
Yale and New Haven Area Health 
Professionals Appeal for 
the Prevention of Nuclear War 
—Yale Medicine 
Spring/Summer 1981 
“In a full page advertisement in 
local newspapers, almost 500 Yale- 
New Haven Medical Center and 
New Haven area health profession¬ 
als issued a ‘warning from health 
professionals for the prevention of 
nuclear war.’ The ad urged readers 
to join its authors in appealing to 
President Reagan and Chairman 
Brezhnev to defuse the current ten¬ 
sions between our countries; to ban 
the use of all nuclear weapons; and 
to recognize the threat posed by 
the very existence of our enormous 
nuclear arsenals. ... 
“In a letter to his colleagues, 
urging them to support the 
appeal, Dean Robert W. Berliner 
wrote,‘Although nuclear war 
has been a possibility for three 
decades, recent world events 
have made that possibility even 
more likely. We who concern 
ourselves with human health have 
a unique stature and responsibil¬ 
ity in our society. As physicians and 
health professionals, therefore, 
we have an important opportunity 
to emphasize to our fellow citi¬ 
zens the magnitude and immedi¬ 
acy of this very grave public 
health danger.’..." 
Stay connected 
Yale Medicine can help you stay connected with fellow alumni 
of the School of Medicine, School of Public Health, Physician 
Associate Program and the medical school’s doctoral, fellowship 
and residency training programs. Share your personal and pro¬ 
fessional news for publication in the Alumni Notes department 
of Yale Medicine and on the Web, using this card or the online 
form at info.med.yale.edu/ayam. 
□ _ 
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House Staff (hs) 
□  
Other Yale degree(s) and year(s) 
Share your news on the reverse of this card and mail to: 
Claire M. Bessinger 
Institutional Planning and Communications 
Yale School of Medicine 
300 George Street, 7th floor 
New Haven, CT 06511 
Please include a photograph. 
























































































































































































































































































A NEW DEGREE CELEBRATES RESEARCH 
Since early in the 19th century, when students were first required 
to submit a thesis for graduation, the medical school has placed a 
high value on the scientific method. In December the Yale 
Corporation approved a new program that further celebrates and 
recognizes the importance of training physician-scientists. Fellows 
in the Robert Wood Johnson Clinical Scholars program and medi¬ 
cal students who spend a fifth year on research are now eligible to 
receive a new degree, the master’s in health sciences research. 
To be eligible, students must have a fully funded fellow¬ 
ship in either laboratory or clinical research. “The key ingredient is 
the research training on a hypothesis-driven topic worked out 
between the student and a faculty mentor,” said John N. Forrest 
Jr., m.d., hs ’67, director of the Office of Student Research. 
Students and fellows must also provide a written summary of 
their research, take courses in their concentration and participate 
in a seminar series. 
Harlan M. Krumholz, m.d., m.sc., the Harold H. Hines Jr. 
Professor of Internal Medicine, professor of epidemiology and 
public health and director of the clinical scholars program, said all 
fellows who complete the two-year program, which includes 
classes, research and service, will receive the new degree. The ulti¬ 
mate goal of the program is to prepare future physician leaders 
who can advance knowledge and improve people’s lives, he said. 
“The degree is an acknowledgement that what they achieve here 
is substantial.” 
—John Curtis 
Jennifer Dominguez, right, is among the first 
medical students eligible for a new master’s 
degree in health sciences research. She will 
spend a fifth year studying the neuroen¬ 
docrinology of postpartum depression in the 
laboratory of faculty mentor Neill Epperson. 
“The idea of the program is to promote a struc¬ 
tured environment for students interested in 
training in research methods,” Dominguez said. 
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Little mpuse, big science 
\ Genfetiqi^ Tian Xu has found a way to make knockout 
quickly and cheaply. By finding genes dnd discerning t 
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ON THE COVER 
Takat and Aminata, Tuareg girls 
from Camp Tantigellay Teckniwen, 
fetch water from a marsh contam-/ 
inated with animal and human 
waste, and load it into a bag on i 
a donkey. Water flows only a few, 
months of the year in the Azawak 
plains of Niger in western Africa. 
During the dry season inhabitants 
spend most days in search of water. 
he hopes to find cures,for genefrelated disease, i 
\\ ' ! / M A 
Water is life i 1 J t ”f i j 
An eph alumna works to bring water to the remote Azawak 
region of Niger, where drought is devastating a traditional, N 
nomadic wpy of life'! y 
By Ariane Kirtley, m.p.h. ’04 
BACKGROUND I i 
Aminata, a Tuareg girl, fetches 
water from a marsh. 
Fever, internal medicine and Paul Beeson 
During his 13 years as chair of internal medicine, Paul Beeson 
turned the department into one of the best in the country 
and cemented his reputation as a physician and teacher^ 
By Richard Rapport, m.d. 
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This just in 
HOW TO REACH US 
Yale Medicine welcomes news 
and commentary. Please send 
letters (350 words or less) and 
news items to Yale Medicine, 
300 George Street, Suite 773, 
New Haven, CT 06511, or via 
e-mail to ymm@yale.edu, and 
include a telephone number. 
Submissions may be edited for 
length, style and content. 
VISIT US ON THE WEB 
yalemedicine.yale.edu 
New state stem cell 
fund awards $7 million 
to Yale investigators 
As Yale Medicine was in produc¬ 
tion, Yale scientists received $7 
million in grants from the State 
of Connecticut Stem Cell Research 
Advisory Committee in November 
to study aspects of stem cell 
biology. The grants were the first 
awarded from the $100 million 
fund established by the state 
last year to promote stem cell 
research outside the restrictions 
of federal funding. The state 
also awarded grants totaling 
$12 million to investigators at 
the University of Connecticut 
and $900,000 to scientists at 
Wesleyan University.The total 
allocated for 21 research projects 
was $19.78 million. A state advi¬ 
sory panel awarded the grants 
after reviewing 70 applications. 
(See related story, page 7.) 
The lion’s share of the Yale 
funding went to Michael P. 
Snyder, ph.d., professor of 
molecular, cellular and develop¬ 
mental biology, to investigate 
the neural differentiation of 
human embryonic stem cells. 
He received $3.8 million. 
Haifan Lin, ph.d., director 
of the Yale Stem Cell Program, 
received $2.5 million to support 
a human embryonic stem cell 
core facility.The University of 
Connecticut received a similar 
amount for its core facilities as 
well. Diane S. Krause, m.d., ph.d., 
associate professor of laboratory 
medicine and pathology and 
co-director of Yale’s stem cell 
program, received $856,653 to 
study a leukemia gene using 
human embryonic stem cells. 
Yingqun Joan Huang, M.D., 
ph.d., assistant professor 
of obstetrics, gynecology and 
reproductive sciences, received 
$200,000 to study the Fragile 
X mental retardation protein in 
early human neural develop¬ 
ment. Eleni A. Markakis, ph.d., 
assistant professor of psychiatry, 
received $184,407 to direct the 
isolation of neuronal stem cells 
from human embryonic stem 
cell lines. And Erik Shapiro, ph.d., 
assistant professor of diagnostic 
radiology, received $199,975 
for using magnetic resonance 
imaging to study the directed 
migration of endogenous neural 
progenitor cells. 
“With this first allotment of 
money, Connecticut becomes 
a national leader in the area of 
stem cell research,” said Gov. M. 
Jodi Rell in a statement announc¬ 
ing the grants. "We have proven 
ourselves able to provide a 
place where such research can 
be done safely, ethically and 
effectively, in addition to provid¬ 
ing investment dollars for the 
growth of the bioscience indus¬ 
try in Connecticut and making 
an investment intended to 
improve the health of genera¬ 
tions to come.” 
Five other states—California, 
New Jersey, Maryland, Missouri 
and Illinois—have decided to 
fund stem cell research. 
"After careful consideration 
and review by both an inter¬ 
national panel of experts and 
this committee, we are confi¬ 
dent that Connecticut is invest¬ 
ing in stem cell research projects 
that will yield significant scien¬ 
tific findings in the long term,” 
said J. Robert Galvin, m.d., 
m.p.h., chair of the state’s Stem 
Cell Research Advisory Com¬ 
mittee and Commissioner of 
Public Health. 
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Water, a jumping gene and Paul Beeson 
This past spring we heard from Ariane Kirtley, m.p.h. ’04, who 
grew up in Africa and returned there after her graduation. 
Our cover story—her account in words and photographs— 
describes the life of the Tuareg and Woodabe inhabitants of 
; the Azawak, the remote and drought-stricken plains in Niger 
where life is a constant search for water. But Kirtley is not 
content with simply documenting living conditions there— 
1 she has also formed a foundation to help build wells in the 
region and save not only lives but a pastoral way of life as well. 
Closer to home, Tian Xu, ph.d., professor and vice 
I chair of genetics, has found a faster and cheaper way of 
making knockout mice. It involves a transposon, a “jump¬ 
ing gene” from a moth that can be inserted into the mouse 
genome, and a complex process that allows the laws of 
1 genetics to run their course with a little tweaking from 
human hands. This first transposon to be effectively used 
in mammals allows scientists to knock out known genes 
and discover others previously unknown. Freelance writer 
Pat McCaffrey spent some time with Xu to learn how 
he hopes to use his technology to help scientists find the 
causes of disease on a grand scale. 
Last August we learned of the passing of Paul B. 
Beeson, m.d., who served as chair of internal medicine 
from 1952 to 1965. During his tenure he hired new faculty, 
inspired his staff and residents and built the department 
into one of the best in the country. Renowned internationally 
as both a scientist and clinician, Beeson made fundamental 
contributions to the understanding of fevers and infectious 
diseases. Richard Rapport, m.d., author of Physician: The Life 
of Paul Beeson, has graciously allowed us to excerpt sections 























4 chronicle news from cedar street 
New funding paradigms 
reshape research 
Despite a tougher climate for nih 
dollars, school gets its largest grant 
ever as part of Roadmap initiative. 
Flat funding and a new research para¬ 
digm have turned federal funding of 
medical research on its head. After 
the recent doubling of the budget of 
the National Institutes of Health (nih), 
funding has leveled off, resulting in a 
net decrease thanks to inflation. And 
the nih is shifting the remaining dol¬ 
lars away from lone investigators to 
multidisciplinary teams of scientists. 
Both trends are being felt at the 
School of Medicine. In October the 
school received its largest nih research 
grant ever, a $57.3-million Clinical and 
Translational Science Award (ctsa), 
a new grant designed to encourage 
interdisciplinary research and the rapid 
movement of laboratory findings 
into human studies. 
The award, one of 12 made around 
the country, will “transform how 
clinical and translational research is 
conducted,” said nih Director Elias 
A. Zerhouni, m.d. 
The ctsa fits in with the nih Road¬ 
map for Medical Research, which 
calls for reshaping clinical research to 
accelerate medical discovery. It also 
fits in with the medical school’s own 
planning, said Dean Robert J. Alpern, 
m.d., Ensign Professor of Medicine. 
“A strategic planning initiative we 
launched in 2004 identified clinical 
research as a top priority and estab¬ 
lished the Yale Center for Clinical 
Investigation (ycci), a focal point for 
translational research,” Alpern said. 
“The ycci’s structure, which builds on 
Yale’s strengths in education, basic 
science and community-based research, 
is virtually identical to the vision put 
forth by the nih in this new program.” 
“With the ctsa grant we will be able 
to train many more clinical investiga¬ 
tors, known as ycci Scholars, who 
will be well-equipped to assemble the 
expert interdisciplinary teams they 
need to do top-quality translational 
research,” said Robert S. Sherwin, 
m.d., ycci director and principal inves¬ 
tigator on the ctsa grant. 
Meanwhile, scientists at Yale and 
other universities are finding grants 
harder to acquire. Over the last two 
years, said Carolyn W. Slayman, ph.d., 
deputy dean for academic and scien¬ 
tific affairs, Yale’s success rate has 
fallen, in line with national trends, but 
it is still above tire national average. 
“Some labs might have to cut back 
on the number of people in the lab, 
making it more difficult to complete 
projects,” said Lynn Cooley, ph.d., 
professor of genetics and cell biology 
and director of the Combined Program 
in the Biological and Biomedical 
Sciences. “Students and postdocs in 
training contribute enormously to 
research excellence in their labs. Both 
valuable research and the pipeline 
of new research talent are threatened 
by these budget cuts.” 
Slayman said the medical school’s 
Grants and Contracts Office, working 
with the development staff and with 
the Office of Cooperative Research, is 
providing information on alternative 
funding, including nonfederal granting 
agencies, foundations and corporations. 
She said these efforts have met with 
some success—direct grant dollars to 
Yale researchers increased by 5.9 per¬ 
cent last year. 
“We are working closely with de¬ 
partment chairs and program directors 
to provide as much help as possible to 
faculty members who run into difficulty 
with grant support,” Slayman said. 
—Pem McNemey and John Curtis 
University hopes to build 
on success in campaign for 
“Yale Tomorrow” 
Nearly a decade after the close of its last 
major fund-raising campaign, Yale has 
begun a five-year drive to raise $3 bil¬ 
lion, a major portion of which will be 
directed toward science and medicine. 
At the public launch of the “Yale 
Tomorrow” campaign on September 30, 
President Richard C. Levin announced 
that donors have already committed 
$1.3 billion in gifts and pledges dur¬ 
ing its quiet phase, which began in 
mid-2004. 
The public campaign kicked off with 
a day of presentations by noted faculty 
and alumni—including medical school 
professors Irwin M. Braverman, m.d. ’55; 
hs ’59, fw ’62; Christopher K. Breuer, 
m.d.; Carolyn M. Mazure, ph.d.; Milissa 
A. McKee, m.d.; R. Lawrence Moss, 
m.d.; W. Mark Saltzman, ph.d.; Bennett 
A. Shaywitz, m.d.; Sally E. Shaywitz, 
m.d.; and Tian Xu, ph.d.—followed by 
a multimedia program narrated by actor 
Sam Waterston, a 1962 Yale College 
alumnus, and a gala dinner in Univer¬ 
sity Commons. 
The campaign is organized around 
four major priority areas: “Yale College,” 
“The Arts,” “The Sciences” and “The 
World.” In the sciences Yale will seek 
support for programs focused on 
translating basic science insights into 
' clinically relevant work. Among the 
priorities are programs in neural degen¬ 
eration and repair, stem cell biology, 
translational immunology, functional 
genomics and clinical investigation. 
The ultimate goal is to find new and 
better methods of diagnosing and 
treating illness, said medical school 
Dean Robert J. Alpern, m.d., Ensign 
Professor of Medicine. 
According to Inge Reichenbach, 
Yale’s vice president for development, 
the campaign has set specific goals for 
the medical school, including the estab¬ 
lishment of new endowed professor¬ 
ships, financial aid for students, new 
buildings for research and clinical care, 
technology resources, educational inno¬ 
vation and support for the cancer hospi¬ 
tal addition to Yale-New Haven Hospital. 
The drive comes at a time when the 
university is enjoying record growth 
in its endowment, which grew from 
$3.8 billion in 1997, at the conclusion 
of the university’s "... and for Yale” 
campaign, to $18 billion for the fiscal 
year ending June 30. During that 
same nine-year period, the medical 
school’s endowment has risen from 
$446.6 million to $1.5 billion. The 
university has an operating budget of 
$1.67 billion for 2006-2007, of which 
$676 million is expected to come from 
the endowment. 
But the size of the endowment, sec¬ 
ond only to Harvard’s $29 billion nest 
egg, does not mean the university has 
all the resources it needs to grow in 
new directions, according to campaign 
leaders. “To expand Yale beyond its 
current scale and scope, to build the 
Yale of tomorrow, we will need new 
financial resources,” said President 
Levin. “Above all, we need to complete 
the transformation of Yale from a local 
to a regional to a national to an inter¬ 
national university.” 
Yale’s wealth is an issue that fund¬ 
raising staff must address directly with 
potential donors, said Jancy Houck, 
m.a., who became the university’s asso¬ 
ciate vice president for development 
and director of medical development 
and alumni affairs on September 18. 
Income from the current endowment 
was committed to specific items at the 
time of the original gift decades or more 
ago, she said. “It takes new resources 
to do new things,” said Houck. 
The same is true with grant dollars 
that come from the federal govern¬ 
ment, foundations and corporations, 
she added. For example, the $57.3- 
million Clinical and Translational 
Science Award (ctsa) that the medical 
school received in October (see related 
story), the largest grant ever received 
by the school, also presents an oppor¬ 
tunity to engage donors in conversa¬ 
tions about the medical school’s future. 
“This support from the National 
Institutes of Health doesn’t take 
away from our need for philanthropy, 
because grants are very, very specific. 
You have to use the funding in the 
exact manner outlined in the pro¬ 
posal,” said Houck. “The philanthropy 
that we would be looking for would 
be for items that are not included in a 
big grant, where people could really 
leverage their gift, knowing that there 
is a certain amount of activity that is 






















Years after gas attack, the 
horror lingers in an Iranian 
town, eph alumna finds 
After every bombing, people in Sardasht, 
a small town at the foot of Iran’s 
Zagros Mountains, ran outside to help 
the injured. On June 28, 1987, they 
rushed into a world that smelled of 
garlic. The air burned like acid. Bodies 
were covered with blisters. Children 
were crying, beyond comfort. When 
After an interview in Rabat, a Kurdish town in 
Iran that endured high-intensity warfare 
during the Iran-lraq war, Farnoosh Hashemian, 
right, posed with some of the women she 
interviewed. 
the blindness came, the villagers had 
no reason to expect that it would be 
temporary. For many, it was not. 
The physical effects of chemical 
weapons like the mustard gas that fell 
on this Iranian town during the 1980- 
1988 war between Iran and Iraq are 
well-documented: burns, respiratory 
problems and temporary or permanent 
blindness. A new Yale study now 
sheds light on the psychiatric effects. 
Farnoosh Hashemian, m.p.h. ’05, a 
research associate in the Department 
of Epidemiology and Public Health 
(eph), has documented severe and 
long-term mental health problems in 
Sardasht residents who survived a 
chemical attack. Her data were so com¬ 
pelling that the Iranian government 
made a psychologist, a scarce resource 
in the country, available to the 4,000 
chemical-attack survivors in Sardasht. 
Hashemian’s team published 
their findings in the August 2 issue of 
JAMA: The Journal of the American 
Medical Association. They collected data 
in three Kurdish towns in rural Iran: 
one was bombed 10 times; another 
was bombed 75 times; and a third, 
Sardasht, was bombed 60 times and 
also was attacked with chemical 
weapons. Hashemian did not antici¬ 
pate the magnitude of distress she 
found in Sardasht— 59 percent of 
those exposed to chemical weapons 
had experienced post-traumatic stress 
disorder, and 33 percent were still 
suffering from the disorder. She found 
that 65 percent had major anxiety 
symptoms and 41 percent had severe 
depressive symptoms. 
Growing up in Tehran during the 
war, Hashemian knew that Saddam 
Hussein had gassed civilians and 
Iranian troops. “Will he gas Tehran?" 
the adults whispered. Believing a 
chemical attack on the Iranian capital 
was imminent, her family fled the 
city, eventually settling in Canada. 
Three years ago Hashemian returned 
to Iran as an eph student on a Downs 
International Health Student Travel 
Fellowship. Although the program usu¬ 
ally sends students to countries unfa¬ 
miliar to them, Hashemian convinced 
the review committee that rural Kurdish 
areas would constitute a new culture 
for a woman raised in fast-paced 
Tehran. Her parents in Canada were a 
harder sell. The border region in 
northern Iran is known for smugglers 
and land mines. “They were very 
worried, but now they are proud of 
me,” she said. 
Hashemian collected data along 
with Farahnaz Falahati, m.d., a 
physician with the Janbazan Medical 
and Engineering Research Center, 
the Iranian equivalent of the Veterans 
Administration. The women stayed 
in spartan quarters with no showers or 
kitchen. But Hashemian said their 
main challenge was hearing the dread¬ 
ful and grim stories. 
Survivors reported nightmares, 
inability to work and relationships bro¬ 
ken under the weight of stress. They 
believed another attack would come at 
any moment. Their fear was height¬ 
ened during Hashemiarfs visit because 
the United States had just invaded Iraq. 
Many villagers expected that Saddam 
would gas them again in retaliation for 
the U.S. attack. Despite their fearful¬ 
ness, they invited the researchers into 
their small houses, offered them special 
meals and willingly told their stories. 
“They felt that they had been forgot¬ 
ten,” Hashemian explained, and she 
agrees. The international community 
was silent during and after the attacks, 
she said. 
Hashemian would like to see her 
work used by international organiza¬ 
tions seeking to eradicate chemical 
weapons. By documenting the suffer¬ 
ing of civilians—who account for most 
war casualties—Hashemian said, 
public health professionals can raise 
discussions of war and peace above 
the realm of politics. “War is a serious 
public health issue.” 
—Colleen Shaddox 
Stem cell program gets 
under way at Yale with 
arrival of cell biologist 
One of the nation’s leading stem cell 
biologists arrived at Yale last summer 
to lead a new program that will explore 
the unique properties and therapeutic 
potential of these cells. Haifan Lin, 
ph.d., and Associate Director Diane 
S. Krause, m.d., ph.d., an associate 
professor of laboratory medicine and 
pathology and an expert on bone mar¬ 
row stem cells, will lead the new Yale 
Stem Cell Program (yscp). They will 
oversee a group of a half-dozen scien¬ 
tists and an administrative and techni- 
, cal staff devoted to research on human 
embryonic and adult stem cells, as 
well as stem cells in the mouse, fruit 
; fly and roundworm. 
The new center comes as the State 
of Connecticut has allocated $20 mil¬ 
lion for the Connecticut Stem Cell 
1 Research Grants Program, making it 
one of three states to fund this research. 
! The yscp has applied for funding from 
I the state program and its applications 
were still under review this fall. 
Stem cells, which can differentiate 
1 into many of the myriad cell types that 
' form the body’s tissues and organs, 
j have been much in the news as a 
potentially powerful treatment for dia- 
j, betes, Parkinson’s disease, heart dis- 
I ease, spinal cord injury and other 
serious illnesses. The program will 
| provide a scientific hub for more than 
Haifan Lin is leading a new scientific center for 
faculty working on stem cell-related projects. 
30 faculty members across the medical 
school and university who work on 
stem cell-related topics. Over the next 
few years, the yscp will recruit four 
additional faculty members. 
Three core research facilities are 
now being put in place: a human 
embryonic stem cell culture laboratory 
directed by Lin and Krause; a cell 
sorting center directed by Mark J. 
Shlomchik, m.d., ph.d., professor of 
laboratory medicine and immuno¬ 
biology; and a confocal microscopy 
laboratory directed by Michael H. 
Nathanson, m.d., ph.d., professor of 
medicine and cell biology. The yscp 
will eventually occupy one floor of the 
Amistad Building on the southern 
edge of the medical school campus, 
which is now under construction and 
slated for occupancy next year. 
Lin comes to Yale from Duke Uni¬ 
versity, where he was co-founder and 
co-director of the Stem Cell Research 
Program. He received his undergradu¬ 
ate degree from Fudan University in 
Shanghai, China, and his ph.d. from 
Cornell University in 1990. He com¬ 
pleted his postdoctoral training at the 
Carnegie Institution of Washington 
before joining the Department of Cell 
Biology at Duke University Medical 
Center in 1994. 
Through his discovery of stem 
cells in the ovary of the fruit fly and his 
establishment of these cells as a research 
tool, Lin obtained direct evidence for the 
century-old hypothesis of asymmetric 
division as the means by which stem 
cells can both self-renew and produce 
daughter cells with the ability to differ¬ 
entiate into many distinct cell types. 
Lin has also discovered key genes that 
regulate stem cell division. 
“Haifan Lin is a pre-eminent scien¬ 
tist whose research on the most basic 
mechanisms of stem cell biology has 
had a tremendous impact on the field,” 
said Dean Robert J. Alpern, m.d., 
Ensign Professor of Medicine. “He has 
the broad perspective needed to lead 
this exciting new effort at Yale.” 
—Peter Farley 
YALE LICENSES AIDS DRUG 
Yale University concluded in June a license 
agreement granting Oncolys BioPharma of 
Tokyo exclusive rights to develop a new com¬ 
pound to treat hiv. Yale has also applied for 
a patent for the compound, Ed4T. Preclinical 
studies have already begun, and Oncoiys 
BioPharma hopes to begin Phase I/ll clinical 
trials in 2008. 
Ed4T is a thymidine analogue that blocks 
reverse transcriptase, an essential enzyme 
for viral replication. The compound was dis¬ 
covered and developed jointly by researchers 
in Japan and Yung-Chi Cheng, ph.d., the 
Henry Bronson Professor of Pharmacology 
at Yale. 
Pharmacological studies have shown that 
Ed4T has more potent anti-Hiv activity than 
existing nucleoside-analogue reverse tran¬ 
scriptase inhibitors (nrtis) and is active 
against viruses that are resistant to the exist¬ 
ing nrti and non-NRTi drugs. Further, Ed4T 
does not affect dna synthesis in mitochon¬ 
dria, a toxic side effect of some nucleotide 
analogues. These findings suggested that 
Ed4T might offer unique therapeutic advan¬ 
tages over existing anti-Hiv drugs. 
—John Curtis 
NEW MR SYSTEM AT YALE 
Yale will receive a $2 million High-End Instru¬ 
mentation (hei) grant from the National 
Center for Research Resources (ncrr) to buy 
a 7-Tesla human magnetic resonance (MR) 
system that will facilitate ultra-high resolu¬ 
tion studies of diabetes, epilepsy, psychiatric 
disease and learning disorders. The ncrr 
makes one-time awards to support the pur¬ 
chase of sophisticated instruments costing 
more than $750,000 to advance biomedical 
research and increase knowledge of the 
underlying causes of human disease. Douglas 
L. Rothman, ph.d., professor of diagnostic 
radiology and biomedical engineering, will 
oversee the MR system, a shared resource for 
several investigators funded by the National 
Institutes of Health. Yale has recruited two 
new faculty members to develop new meth¬ 
ods of biochemical image-guided neurosur¬ 





















Rounds MEDICINE AND HEALTH AT YALE 
Consistency lacking in 
transfer of patient data 
Many hospitals don’t have protocols 
for passing patient information among 
doctors, Yale study finds. 
No matter how swift the runners, a 
relay race is lost if they don’t pass 
the baton properly. A new Yale study 
finds that patient care is a baton at 
increasing risk of being dropped 
because too many internal medicine 
residency programs lack systems 
for transmitting patient information 
from shift to shift. 
Communication failure is one of 
the chief causes of medical errors, stud¬ 
ies have found, and the transfer of 
care is a weak link in the chain. But the 
Yale study, published in the Archives 
of Internal Medicine in June, finds that 
many hospitals lack an established pro¬ 
tocol for passing on patient informa¬ 
tion, even though transfers, also known 
as sign-outs, are becoming more com¬ 
mon as residents work fewer hours. 
“Communication is not something 
that the layman thinks is a problem,” 
said Leora I. Horwitz, m.d., a post¬ 
doctoral fellow in internal medicine 
and the study’s lead author. However, 
patients are now under the care of 
more doctors, due to limits on residents’ 
workweeks. Transfers “happen routinely 
and have the potential for catastrophe,” 
she said. 
Hospitals should have a standard¬ 
ized system each time a doctor 
hands off a patient to another doctor, 
Horwitz said. 
Horwitz’s team investigated the sign- 
out practices at 202 internal medicine 
residency programs in the United 
States and the impact of the reduced 
workweek on patient transfer proto¬ 
cols. Patient transfers, they found, rose 
11 percent—to an average of twice 
daily in a four-day hospital stay—since 
the regulations took effect in 2003. 
The procedures for those handoffs 
varied widely, though. Fifty-five percent 
of the programs didn’t require doctors 
to pass on key patient information in 
both oral and written form, which 
Horwitz said would curtail the risk for 
errors. In six of 10 programs, nurses 
were not informed that a transfer had 
occurred, and in many programs no 
workshops or lectures on sign-out 
skills were offered. In 34 percent of the 
cases, the handoff was left to interns 
alone. And fewer than a fifth of the 
programs used a Web-based program, 
or forwarded pager messages in the 
transfer process. 
“If you’re the primary doctor, you’re 
much less likely to make a preventable 
error than if you’re covering that per¬ 
son just for a day and you don’t know 
that [patient] well,” Horwitz said. An 
oral transfer allows the new doctor to 
ask questions or give “readback"— 
like a pilot would give to an air traffic 
controller. Written information can 
be referred to later if needed. 
The sign-out can differ from hospi¬ 
tal to hospital, but it needs to be con¬ 
sistent within the health care organiza¬ 
tion, said Paul M. Schyve, m.d., senior 
vice president of the Joint Commission 
on Accreditation of Healthcare Organi¬ 
zations, which made sign-outs one of 
its chief patient safety goals for 2006. 
“A standardized approach makes it 
easy for people to ask and respond to 
questions,” he said. 
The survey didn’t examine whether 
the various approaches to sign-outs 
actually prevent medical errors, espe¬ 
cially in light of the shorter workweek. 
“There’s a lot of anxiety around work- 
hour limitations in terms of whether 
they increase discontinuity enough 
that it overwhelms the benefits of 
physicians being rested,” Horwitz said. 
Future studies will decide “whether 
that’s clinically significant or not.” 
—John Dillon 
9 
New forum offers a place for 
doctors and nurses to discuss 
issues of patient care 
On a Thursday afternoon last fall, 23 
physicians, nurses and social workers 
at Yale-New Haven Hospital (ynhh) 
i met to discuss a case that made 
everyone uncomfortable: a patient 
with colon cancer suffered serious and 
eventually fatal complications follow¬ 
ing surgery, and the patient’s daughter 
i: refused to leave her side or her room 
during the two-month hospital stay. 
The daughter would not allow staff to 
communicate directly with her mother 
and slept much of the day in the hospi- 
i tal room, denying access to nurses 
even when they attempted to adminis- 
[ ter medications or other care. 
The discussion was part of the 
Schwartz Center Rounds, a program 
that creates a forum for caregivers to 
discuss complex emotional and social 
[ issues involved in caring for patients. 
In 1995, Kenneth B. Schwartz, a health 
care attorney in Boston, was dying 
of lung cancer. He was fortunate to 
receive not just top-notch medical care, 
but also an attention to his comfort 
and quality of life that made his illness 
easier to cope with for himself and his 
Health care professionals at ynhh can discuss 
complex issues of patient care during Schwartz 
Center Rounds, a national program. 
family. Shortly before his death, he 
established the Kenneth B. Schwartz 
Center, a nonprofit organization that 
has been helping caregivers provide 
compassionate care to their patients 
since 1997. The Schwartz Center 
Rounds now operate in approximately 
100 hospitals in 25 states; the program 
was brought to the Yale Cancer Center 
last February as part of a larger effort 
to increase the focus on supportive 
care for patients with severe illness. 
“It’s a unique forum for talking 
about difficult and challenging situa¬ 
tions in a nonmedical fashion,” said 
Kenneth D. Miller, m.d., assistant pro¬ 
fessor of medicine (medical oncology), 
director of supportive care programs 
at the Center and the rounds leader for 
the program. Open to all ynhh staff, 
the rounds take place once a month 
and feature a presentation by a medical 
team followed by a group discussion. 
Past topics of the Schwartz Center 
Rounds have included obtaining 
informed consent from mentally ill 
patients; keeping hope alive; and 
what to do when the patient, doctor 
and family are not on the same page. 
“We’re trying to develop a broader 
view on how different patients, and 
different families cope with really diffi¬ 
cult situations that may be different 
than what we might have chosen for 
ourselves or what we think we’d 
choose,” Miller said. 
According to Marjorie Stanzler, 
director of programs for the Schwartz 
Center, the ability of caregivers to 
voice their concerns in a safe environ¬ 
ment translates into new insights into 
caring for patients, an appreciation 
of the problems faced by colleagues in 
other disciplines and the realization 
that they are not alone in dealing with 
troublesome circumstances. 
—Jill Max 
STROKE, HEART ATTACK AND FIRING 
Losing a job just as retirement approaches 
more than doubles the chances of a heart 
attack or stroke, according to a Yale study 
published in Occupational and Environmental 
Medicine in June. 
For over to years researchers observed 
more than 4,000 people who were between 
the ages of 51 and 6t when the study began 
in 1992. During that period 582 lost their 
jobs. An earlier six-year study of the same 
people had suggested a higher risk of stroke, 
but didn’t make a definitive link between 
job loss and heart attacks. “With longer 
follow-up ... on heart attack and stroke events 
we were able to better assess the associa¬ 
tion between employment separation and 
the medical outcomes,” said William T. 
Gallo, ph.d., the lead author and an associ¬ 
ate research scientist in the Department 
of Epidemiology and Public Health. 
“We do a lot of downsizing in our coun¬ 
try and older individuals are often affected,” 
said co-author Elizabeth H. Bradley, M.B.A., 
ph.d., professor of public health. “We need 
to recognize not only the economic conse¬ 
quences, but also the health consequences.” 
—John Curtis 
KIDNEY PATIENTS LEFT OUT OF TRIALS 
Although at high risk for cardiovascular 
death, patients with chronic kidney disease 
(ckd) are frequently left out of cardiovascu¬ 
lar trials, School of Medicine researchers 
reported in the September 20 issue of 
jama: The Journal of the American Medical 
Association. 
The researchers’ review of 153 clinical 
trials published between 1985 and 2005 
found that patients with kidney disease 
were excluded from 56 percent of the trials 
and were more likely to be excluded from 
multicenter trials. Cardiovascular death 
is the leading cause of death in patients 
with CKD. 
“Inclusion and reporting of kidney dis¬ 
ease patients in cardiovascular trials must 
improve,” said senior investigator Chirag 
Parikh, m.d., assistant professor in the Section 
of Nephrology. “Alternatively, we need 
to design separate trials for cardiovascular 




















Findings from the bench 
An early start for the 
thinking brain 
Yale scientists discover predecessor 
cells that pave the way for the 
cerebral cortex. 
The cerebral cortex, a layer of cells just 
a few millimeters thick on the outer¬ 
most surface of the brain, is largely 
what makes humans noble in reason 
and infinite in faculties. New research 
from the School of Medicine shows 
that developing embryos, in their haste 
to become quintessentially human, 
generate the first neurons of the cortex 
only 31 days after fertilization—much 
earlier than previously thought. 
The cerebral cortex is an evolution¬ 
ary marvel. Its distinctive convoluted 
shape arose because the size of the cor¬ 
tex expanded disproportionately in 
relation to the rest of the brain during 
evolution. The 20 billion neurons 
packed within the cortex’s smooth gray 
folds account for about 40 percent of 
the brain’s weight, and the connections 
among them are largely responsible 
for the functions considered unique to 
humans, such as memory, thought, 
perceptual awareness, language, intel¬ 
lect and consciousness. 
Using precise cellular markers, 
Pasko Rakic, m.d., ph.d., the Dorys 
McConnell Duberg Professor of 
Neurobiology and professor of neurol¬ 
ogy, and chair of neurobiology and 
colleagues have discovered “predeces¬ 
sor” neurons that first appear in 
human embryos before the neural 
tube, the precursor of the central 
nervous system, has completely 
closed and before eyes, arms and legs 
begin to bud. According to Rakic, 
these predecessors could well be one 
type of neural stem cell of the “think¬ 
ing brain.” 
Until recently, researchers thought 
that all cortical neurons arose within 
a rudimentary cortical nexus and then 
migrated radially, like spokes jutting 
out from an axle, into place. However, 
Rakic’s findings show that the prede¬ 
cessor neurons arise from basal layers 
within the developing brain and then 
travel through inner cell layers to reach 
the cortex. The precocious cells gener¬ 
ate long extensions that pull them 
to different locations as the brain de¬ 
velops. These extensions may also act 
as scaffolds to guide late-blooming cor¬ 
tical neurons to their proper locations. 
In the July issue of Nature Neuro¬ 
science, the researchers wrote that 
studying how predecessor cells help 
to wire the billions of neurons of the 
adult human cortex may provide new 
insights into how humans differ from 
more primitive species and may shed 
light on the causes of mental illness. 
“Unraveling the early development 
of this complex structure,” the team 
wrote, “might provide the key to 
understanding both the mechanisms 
underlying its expansion during evolu¬ 
tion and the pathogenesis of many 
cognitive disorders.” Rakic added, “If 
we want to repair the human brain, 
we have to know how the human cor¬ 
tex develops; we have to know the 
timing, the sequence and the type of 
cells involved.” 
Rakic said that the next goal is to 
determine which genes are switched 
on in predecessor cells to control early 
cortex development. If the predeces¬ 
sors are indeed neural stem cells, iden¬ 
tifying the genes responsible for early 
Yale scientists have identified the first neurons 
(the golden area in the image) in the embryonic 
human cerebral cortex, which appear only 31 
days after fertilization. This is much earlier than 
previously thought, and the discovery of these 
predecessor cells in the part of the brain respon¬ 
sible for such human attributes as memory, lan¬ 
guage and intellect may provide insights into 
mental illness. 
cortex formation could provide insight 
into ways to generate new cortical neu¬ 
rons to repair brain injury. The team 
also plans to identify the source of 
predecessor cells by performing experi¬ 
ments in nonhuman primates that 
will enable them to visualize neuron 
migration using modern microscopy 
techniques. 
These findings will bring researchers 
one step closer to understanding the 
developmental mechanisms responsible 
for creating the thinking brain. “I am 
fascinated with the idea that I use my 
cortex to look at the cortex itself to deter¬ 
mine what makes it possible for me to 
think,” said Rakic. 
The project, supported by the Kavli 
Institute for Neuroscience at Yale, 
involves collaborations with societies in 
England and Russia. 
—Kara A. Nyberg 
Lacking an enzyme linked to 
diabetes and obesity, mice stay 
slim on a high-carb diet 
Even on a “supersize” diet, mice bred 
to lack a certain enzyme remained 
more svelte than mice with the enzyme, 
according to a study by Yale scientists 
in the July 2006 issue of the journal 
Cell Metabolism. Moreover, in a finding 
that surprised the research team, the 
mice’s blood sugar levels remained 
under control. 
The study’s senior author cautioned 
against premature talk of an elixir that 
prevents diabetes or does away with the 
need for exercise. “The long-term goal, 
I think, would be to figure out how this 
enzyme is working under normal cir¬ 
cumstances,” said Anton M. Bennett, 
ph.d., associate professor of pharma¬ 
cology. “But I think we’re a long ways 
away from this as an obesity target.” 
Bennett’s laboratory studies mitogen- 
activated protein kinase phosphatases 
(mkps), important players that have 
been implicated in numerous cellular 
functions such as cell growth and cell 
survival. For a better understanding of 
these enzymes, mice were bred to lack 
one of them, mkp-i. “There was no 
preconceived hypothesis that it would 
necessarily be involved in regulating 
body mass,” Bennett explained. 
At first there appeared to be no obvi¬ 
ous differences between the mice lack¬ 
ing mkp-i and the control mice. “If you 
looked in the cage and had the mice 
side by side, they would be indistin¬ 
guishable,” Bennett said. Both groups 
ate a typical chow diet—“the equivalent 
of three squares a day.” Soon, the 
knockout mice showed that they were 
less likely to put on the ounces. 
“Then we put them on a McDonald’s 
‘supersize’ equivalent, where 55 per¬ 
cent of the calories was from carbohy¬ 
drates,” he continued. “The differences 
in weight were extremely pronounced.” 
The mice without the enzyme were, 
on average, 15 to 20 percent leaner 
than the control group. “The enzyme 
seems to act as a brake on how fast you 
burn energy. When you remove that 
enzyme, energy expenditure seems to 
go up dramatically.” 
The mice without the enzyme were 
also better able to control their glucose 
levels. Because they were leaner, they 
also should have exhibited signs of 
increased insulin sensitivity. “But it 
was normal,” Bennett said. “That was 
somewhat of an unexpected result.” 
The knockout mice also were less likely 
to show signs of metabolic syndrome, 
a constellation of risk factors for heart 
disease and diabetes. One of the hall¬ 
marks of metabolic syndrome is a fatty 
liver, and the mice without the enzyme 
were resistant to that symptom. 
While the study shows that mkp-i 
“may contribute to obesity and dia¬ 
betes,” it is far from certain whether 
turning it off will prevent or ameliorate 
those conditions. There is also concern 
about the overall effect of turning off 
the enzyme in the body. Bennett said 
studies have found knockout mice to 
be more susceptible to infection. 
“That’s not a good thing,” he said. 
“Everything is connected.” 
—John Dillon 
SMOKING AND NICOTINE RECEPTORS 
Smokers may have a hard time quitting 
because their brains have significantly more 
nicotine receptors than those of nonsmokers, 
according to a study by Yale researchers 
published in August in the Journal of Neuro¬ 
science. The study, funded by the National 
Institute of Drug Abuse, is believed to be the 
first to offer direct evidence in living smokers 
that the numbers of the most common 
nicotine brain receptors are higher during 
early abstinence from smoking. 
“Nicotine craving is an important factor 
associated with relapse,” said Julie K. Staley, 
ph.d., associate professor of psychiatry 
and diagnostic radiology and lead author of 
the study. “This study paves the way for 
determining whether medications normalize 
the number of receptors and why some 
smokers, such as women and those with 
neuropsychiatric disorders, have more diffi¬ 
culty quitting smoking.” 
Staley said the team used spect imaging 
to see how the nicotine receptors adapt 
in response to the repeated stimulation of 
smoking a cigarette. 
—John Curtis 
TESTOSTERONE VS. NERVE CELLS 
A study by Yale scientists has shown that 
a high level of testosterone—such as that 
caused by the use of steroids—can lead to 
the death of brain cells. “Next time a muscle- 
bound guy in a sports car cuts you off on 
the highway,” said senior author Barbara E. 
Ehrlich, ph.d., professor of pharmacology 
and cellular and molecular physiology, “don’t 
get mad, just take a deep breath and realize 
that it might not be his fault.” 
Previous studies have shown that large 
doses of steroids can cause hyperexcitability, 
an aggressive nature and suicidal tenden¬ 
cies, which could mean alterations in neu¬ 
ronal function caused by the steroids. “In the 
present study we have demonstrated for the 
first time that the treatment of neuroblas¬ 
toma cells with elevated concentrations of 
testosterone for relatively short periods, six 
to 12 hours, induces a decrease in cell viabil¬ 
ity by activation of a cell death program,” 
said Ehrlich, whose study appeared in the 





















Books & ideas bookshelf 
Bruce Wexler’s new book explores 
neural processes and how they 
influence psychological and social 
processes. 
Culture and the brain 
A new book explores the links between neural networks, 
feelings and culture. 
Bruce E. Wexler, m.d., professor of psychiatry, believes that 
understanding how our brains work can illuminate human 
experiences small and large—from why our favorite letters 
in the alphabet are those in our own names to why we must 
struggle to adjust when a loved one dies. In his new book, 
Brain and Culture: Neurobiology, Ideology, and Social Change, 
he summarizes contemporary research into the brain and 
how it explains why we resist the unfamiliar and the alien— 
whether it’s a colorful tattoo on our teenager’s biceps or the 
rhetoric of those who insist theirs is the only true religion. 
“The aim of this book is to look at what we know about 
neural processes to see if that can increase our understand¬ 
ing of the psychological and social processes that rest 
upon this neurobiological platform," said Wexler, a clinician 
and researcher at the Connecticut Mental Health Center. 
“Our appreciation of the neurobiology can help us to under¬ 
stand—and eventually deal with—both psychological and 
social issues.” 
The connections between neurons that create networks 
derive not only from our genes but also from sensory input 
when we’re young. And human neural networks remain 
plastic into the third decade of life, much longer than those 
of any other animal. 
The less flexible adult human brain strives to see the 
world in a way that “agrees with internal structures.” That’s 
why physicians evaluating a sick patient may choose a com¬ 
mon diagnosis even when the patient’s problems don’t quite 
fit. “We complete perceptions in keeping with our expecta¬ 
tions, and those expectations are based on past experience, 
but not necessarily on the facts at hand,” Wexler observed. 
It is the comfort of the familiar that motivates some immi¬ 
grants to settle in ethnic enclaves, Chinatowns and Little 
Pakistans that recreate their former homes. The generation 
gap is especially poignant for immigrants, whose children 
are shaped by a very different world from the one in which 
they grew up. And for all parents, the world changes from 
generation to generation. “Most children in the world today 
are raised almost entirely in human-made environments,” 
Wexler said. Because each new generation has different 
brains from those of their parents, they in turn raise their 
children differently—leading to what Wexler calls “transgen- 
erational shaping of brain function.” But the generation 
gap discomfits all parents, because children loom large in 
parental neural networks. 
“We don’t like our children to turn into foreigners, because 
our children are so richly represented within us,” said 
Wexler. Similarly, we have trouble adapting when a loved one 
dies, because that person occupied a central place in our 
neural networks. “It’s a very arduous task to restructure, and 
it takes adults about a year.” 
What he calls “the neurobiological antagonism to differ¬ 
ence” can help explain violent cultural clashes: genocide 
in Armenia, Germany and Bosnia; massacre in Rwanda; 
Christians warring against Muslim “infidels;” and Muslims 
attacking Western “infidels.” 
Understanding our resistance to differences can point 
the way to reconciliation. Wexler now spends most of his 
spare time working for a nonprofit group he started called 
A Different Future. Its aim is to “amplify the voices” of 
Arabs and Israelis advocating peace—delivering a message 
of mutual respect that will embed itself into the neural 
networks of young Israelis and Palestinians. 
Wexler admits that even his own neural networks may 
balk at the unfamiliar. On a trip though Ohio he saw a 
building that looked out of place. He remembers thinking, 
“What is a mosque doing here?” 
—Cathy Shufro 
Bookshelf focuses on books and authors at the School of Medicine. 
Send suggestions to Cathy Shufro at cathy.shufro@yale.edu. 
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Play Ball with Me! 
by Lynn Reiser, m.d. ’70, clinical 
professor of psychiatry (Alfred 
A. Knopf) This interactive picture 
book of guessing games intro¬ 
duces young readers to various 
ballgames through the recogni¬ 
tion of simple objects. 
Social Structures, Aging, and 
Self-Regulation in the Elderly 
with contributions by Becca R. 
Levy, ph.d., associate professor 
of epidemiology and psychol¬ 
ogy; edited by K. Warner Schaie, 
ph.d., and Laura L. Carstensen 
(Springer Publishing Company) 
Contributors to this book explore 
how societal contexts influence 
aging and how self-regulation 
at the most basic levels of func¬ 
tioning influences the physical 
health and economic circum¬ 
stances of people as they age. 
Principles of Molecular 
Medicine, 2nd ed. 
with contributions by Jean 
' Bolognia, m.d. ’66, professor 
and vice chair of clinical affairs 
(dermatology), Daniel Gold¬ 
stein, ph.d., assistant professor 
of medicine (cardiology), and 
Stephen M. Strittmatter, m.d., 
the Vincent Coates Professor 
of Neurology and professor of 
neurobiology (Humana Press) 
This volume contains new sec¬ 
tions on genetics, oncology 
and metabolic and infectious 
diseases.The authors discuss 
the latest findings about links 
I between genetic mutations and 
j diseases; genomic approaches I to a variety of diseases; the 
potential of stem cells to regen¬ 
erate muscle, heart and neural 
cell populations; and advances 
in the understanding of the 
I biology of such previously un¬ 
beatable neurodegenerative 
diseases as Huntington’s. 
Aglow in the Dark: 
The Revolutionary Science 
of Biofluorescence 
by Vincent A. Pieribone, ph.d., 
associate professor of cellular 
and molecular physiology and 
neurobiology, and David F. 
Gruber (Belknap Press) This 
book describes the human fasci¬ 
nation with bioluminescence, or 
“living light.” It follows the path 
to one of the groundbreaking 
discoveries of the 20th century— 
green fluorescent protein, the 
glowing compound that has revo¬ 
lutionized molecular biology. 
dna Vaccines: Methods and 
Protocols, 2nd ed. 
by W. Mark Saltzman, ph.d., the 
Goizueta Foundation Professor 
of Chemical and Biomedical 
Engineering and professor of 
cellular and molecular physiol¬ 
ogy, Janet L. Brandsma, ph.d., 
associate professor of compara¬ 
tive medicine and pathology, 
and Hong Shen, ph.d. (Humana 
Press) This five-part volume 
contains state-of-the-art infor¬ 
mation about dna vaccine 
technology. Part I contains dna 
vaccine design protocols, focus¬ 
ing on methods that achieve 
optimal expression in host cells. 
Part II presents methods for 
dna delivery. Part III discusses 
methods for enhancing the 
potency of dna vaccines. Part IV 
describes several key areas of 
application in the field, includ¬ 
ing allergy, avoidance of autoim¬ 
munity, and neonate and infant 
vaccine response. The book con¬ 
cludes with a review of proto¬ 
cols for vaccine production and 
purification, and quality control 
methods. 
College Life 102: The No-Bull 
Guide to a Great Freshman Year 
by Andrew G. Kadar, m.d. ’73 
(iUniverse) The author offers 
advice to newly arrived college 
students on how to succeed 
both inside and outside the 
classroom. Tips include how to 
dodge the stress of deadlines, 
enroll in classes after they’re 
officially filled, avoid the “fresh¬ 
man 15” and get better grades 
by studying smarter rather than 
harder.The book also provides 
information about nutrition, ille¬ 
gal drugs, contraception and tat¬ 
toos and piercings. 
Immunology of Pregnancy 
by Gil Mor, m.d., associate pro¬ 
fessor of obstetrics, gynecology 
and reproductive sciences 
(Springer) This text reviews cur¬ 
rent knowledge about the role 
of the immune system during 
pregnancy and the interactions 
between the maternal immune 
system and the placenta. Mor 
analyzes studies related to 
the immunology of implanta¬ 
tion and provides a practical 
approach for the application of 
basic reproductive immunology 
research to such pregnancy 
complications as pre-eclampsia 
and preterm labor. 
“Shrink”: On Becoming 
a Psychotherapist 
by Louis B. Fierman, m.d., asso¬ 
ciate clinical professor of psychia¬ 
try (Blue Dolphin Publishing) 
Fierman, now retired, recounts 
his “only-in-America” journey 
as the son of uneducated immi¬ 
grant parents and how, with their 
support, he pursued a career 
as a maverick psychiatrist and 
psychotherapist at Yale and 
elsewhere. 
Hematology: Basic Principles 
and Practice, 4th ed. 
by Edward J. Benz Jr., M.D., fw 
’79, Ronald Hoffman, M.D., 
Sanford J. Shattil, m.d., Bruce 
Furie, m.d., Harvey J. Cohen, 
m.d., ph.d., Leslie E. Silberstein, 
m.d., and Philip McGlave, m.d. 
(Churchill Livingstone) This book 
covers the basic scientific foun¬ 
dations and clinical aspects of 
hematology. It provides practi¬ 
tioners with comprehensive and 
up-to-date information on hema¬ 
tology that reflects the rapid 
change in the molecular and cel¬ 
lular areas of the specialty. 
The Profession of Ophthalmol¬ 
ogy: Practice Management, 
Ethics and Advocacy 
edited by David W. Parke II, 
m.d., associate clinical professor 
of ophthalmology and visual sci¬ 
ence (American Academy of 
Ophthalmology). This three-part 
volume contains blueprints for 
business skills to develop and 
manage successful practices; a 
review of ophthalmology’s Code 
of Ethics and real-life case stud¬ 
ies illustrating ethical behavior 
in ophthalmic-related situations; 
and a discussion of the impor¬ 
tance of advocating on behalf of 
patients and the profession, 
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INFECTIOUS 
DISEASE CLINICS 
*' Of-NORTH AMERICA ■ 
Blogging saves doctors time 
Travel and Tropical Medicine: 
Infectious Disease Clinics of 
North America 
by Frank J. Bia, m.d., professor 
of medicine and laboratory medi¬ 
cine, and David R. Hill, m.d. 
(Saunders) Topics covered in this 
guide include new vaccines 
against yellow fever and Japa¬ 
nese encephalitis, the current 
prevention of malaria and treat¬ 
ment of such common syn¬ 
dromes as traveler’s diarrhea 
and cutaneous leishmaniasis. 
Other chapters address pre¬ 
travel screening of high-risk 
travelers, problems associated 
with airline travel, sexual 
tourism and the interactions 
between hiv infection and 
tropical diseases. 
Understanding Cancer: 
A Patient’s Guide to Diagnosis, 
Prognosis, and Treatment, 
2nd ed. 
by C. Norman Coleman, m.d. ’70 
(Johns Hopkins University Press) 
This book describes new treat¬ 
ments that target specific types 
of cancer and explains how to 
gather and interpret information 
when making decisions about 
treatments. It also provides 
guidance for preparing for visits 
to doctors and the hospital. 
Topics include biomarkers, novel 
imaging techniques, molecular 
signatures and profiling and 
molecular-targeted therapy. 
Some of these therapies are cur¬ 
rently available only through 
clinical trials, and the author 
includes a detailed discussion of 
what is involved in participat¬ 
ing in such trials. 
Kelley’s Textbook on 
Rheumatology, 7th ed. 
by Clement B. Sledge, m.d. ’55, 
Edward D. Harris Jr., M.D., Ralph 
C. Budd, M.D., Gary S. Firestein, 
m.d., Mark C. Genovese, m.d., 
John S. Sergent, m.d., and Shaun 
Ruddy, m.d. (Saunders) This 
book provides encyclopedic cov¬ 
erage not only of the etiology 
and pathogenesis of rheumatic 
diseases, but also of the biology 
of the normal joint, immune 
and inflammatory responses, 
evaluation of the patient and 
diagnostic tests and procedures. 
The book includes a bound-in 
dvd with chapter-by-chapter 
multiple-choice questions for 
board review. 
The descriptions above are based on 
information from the publishers. 
SEND NOTICES OF NEW BOOKS TO 
Cheryl Violante, Yale Medicine, 
300 George Street, Suite 773, 
New Haven, CT 06511, or via e-mail 
to cheryl.violante@yale.edu 
With all the information on the Web already, why would 
anyone want to add to the volume by reading blogs? To save 
time, according to librarians at Yale’s Cushing/Whitney 
Medical Library. 
Yale reference librarian Charles J. Greenberg, m.l.s., m.ed., 
for example, maintains a blog for surgeons at http://surgery- 
update.blogspot.com. “Surgeons don’t have time to look at 
all the journals,” said Greenberg, the library’s coordinator 
of curriculum and research support. He describes his blog 
as “the equivalent of a newsstand for information on certain 
emerging surgical topics.” Greenberg assembles his “news¬ 
stand” by combing 30 leading medical and surgical journals 
each month and posting entries on surgical news two or 
three times a week. 
Greenberg’s blog can be reached from the home page of 
the medical library, which maintains its own blog (http:// 
elibrary.med.yale.edu/blog/) to inform visitors of library 
news. Postings include descriptions of two newly acquired 
electronic databases offered by the library, one containing 
l, 800 online journals (The ScienceDirect Freedom Collection), 
and the other listing drug eruptions and interactions. 
The library website lists links to two other blogs by Yale 
medical librarians. Education services librarian Jan Glover, 
m. l.s., uses hers to dispense advice about doing online 
research (http://janstips.blogspot.com/). Glover posts research 
tips and entries that highlight databases. “Someone might 
not know a database existed, and it might be perfect for their 
topic,” she said. 
Janene Batten, m.l.s., reference librarian for the School 
of Nursing, started a blog about 18 months ago that focuses 
on items of interest to nurses (http://ysnlibrary.blogspot.com/), 
and she posts something new several times a week. 
Blogging took off during the run-up to the 2004 general 
election, said Web Services Librarian Hongbin Liu, m.l.s., 
who coordinates the library’s blogs. With blogs, said Liu, 
“everybody can be a freelance journalist.” Liu uses Technorati, 
a blog search engine, to monitor the growth of blogs. As 
of October there were 56.4 million blogs worldwide, not 
counting some of those that are written in languages other 
than English. Blogging, says Liu, is here to stay. 
—Cathy Shufro 
In Circulation focuses on activities at the Cushing/Whitney Medical 
Library. Send suggestions to Cathy Shufro at cathy.shufro@yale.edu. 
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Changing the ethical culture 
of pharma 
The last five years, said Arthur 
Caplan, ph.d., have seen the 
demonization of the pharmaceu¬ 
tical industry. Conflicts of inter¬ 
est, censored scientists, flawed 
drugs and devices placed on the 
market and the failure to pro¬ 
tect subjects of clinical trials 
have been “flat-out ethical dis¬ 
asters," said Caplan, chair of 
the Department of Medical Ethics 
at the University of Pennsylva¬ 
nia School of Medicine. 
Nevertheless, he told an 
audience at the School of 
Management in September, this 
demonization is irresponsible. 
"The pharmaceutical industry is 
not the tobacco industry,” he 
said.“The pharmaceutical indus¬ 
try produces medicines that 
relieve pain, save lives and cure 
patients. The pharmaceutical 
industry does do a lot of good.” 
How, he asked, can the indus¬ 
try change its ethical culture? 
He called for mandatory reg¬ 
istries of all clinical trials that 
would make data—and reports 
of adverse events—public. 
Epidemiology, he said, must 
trump marketing. He also called 
for tougher Food and Drug 
Administration monitoring of 
Phase IV, when drugs are in 
the marketplace. 
“I think pharmaceuticals 
need to commit to the scientific 
foundations of the industry,” 
he said. 
—John Curtis 
An ongoing disaster 
stemming from neglect 
For Roberto Johansson, m.d., 
ph.d., Hurricane Katrina was a 
disaster that didn’t have to 
happen. During a talk at the 
Department of Epidemiology 
and Public Health in October, 
he described what he saw in 
his hometown of New Orleans. 
“Roads were out. Telephone 
lines were out. The fire depart¬ 
ment broke down, ems totally 
broke down.The hospitals were 
marginal at best,” he said. 
But a long history of neg¬ 
lect—of the levees, of the city’s 
schools and of the city’s poor— 
compounded the problem, he 
said. And the order to evacuate 
came late. "Many of the people 
who stayed couldn’t get out 
because they were medically 
disabled or poor,” he said, noting 
that doctors, nurses and other 
health care workers stayed on 
their jobs. 
Disasters, he said, follow five 
stages. First comes knowledge 
of a possible disaster, followed 
by a warning phase.Then comes 
impact. In the rescue phase 
first responders try to save lives, 
and those outside the strike 
zone mobilize to help. The recov¬ 
ery phase, in which New Orleans 
finds itself, tries to keep survivors 
at a functioning level. 
“Katrina,” he said, "is a story 
that must not be forgotten.” 
—J.C. 
Tracing the history 
of medical education 
In the mid-igth century, medical 
schools were faculty-owned, for- 
profit operations that churned 
out doctors after just a few 
months of lectures. 
With the Flexner Report of 
1910, medical educators realized 
that medical schools should be 
integral parts of universities, 
said Kenneth M. Ludmerer, m.d., 
professor of medicine and his¬ 
tory at Washington University in 
St. Louis, in his address at the 
30th Annual Yale Affiliated Hospi¬ 
tals Symposium in November. 
By the 1920s, medical schools 
had become academic centers 
that emphasized research and 
clinical care.The fee-for-service 
era of the 1960s to 1980s also 
afforded rich learning opportuni¬ 
ties because hospital stays were 
longer. But that learning envi¬ 
ronment has been threatened by 
managed care, with its emphasis 
on seeing as many patients as 
possible. 
Today, Ludmerer sees a need 
for a social contract that funds 
and values medical education 
and research, while medical 
schools teach and practice cost- 
effective medicine. Despite the 
faults of the current system, 
Ludmerer said he wouldn’t trade 
today’s problems for those of a 
century ago. “It’s better to have 
problems financing treatment 
for Alzheimer’s disease and can¬ 
cer than to watch children die 
of diphtheria,” he said. 
—Jill Max 
Baboons, humans and stress: 
the cost of being an sob 
Baboons in Africa’s Serengeti 
Plain spend just three hours a 
day finding food, said Robert 
Sapolsky, ph.d.“That leaves nine 
hours of daylight for them to 
be really crappy to the other 
baboons,” Sapolsky said, adding 
that such behavior carries a cost. 
“Physiologically, it’s very expen¬ 
sive to be a bastard all day long.” 
In his keynote talk at a sym¬ 
posium in October sponsored by 
the Department of Psychiatry, 
Sapolsky, a professor of biologi¬ 
cal sciences and neurology and 
neurological sciences at Stan¬ 
ford University, described how 
chronic stress—in humans as 
well as baboons—can cause or 
contribute to physical and 
mental afflictions ranging from 
heart disease, ulcers and memo¬ 
ry loss to infertility and even 
diminished growth. "If stress 
goes on too long, it becomes 
pathogenic,” he said. 
But Sapolsky, who studies 
the relationship between 
personality and stress-related 
disease in wild baboons, found 
cause for optimism. Male 
baboons have "pungent individ¬ 
ualistic personalities,” he said. 
Some handle stress well; others 
don’t.There is compelling 
evidence that the same is true 
for humans.“If some baboons 
see the watering hole as half 
full, so can we,” he said. 
—Jennifer Kaylin 
capsule 
bottom In the United States the Spanish 
influenza pandemic of 1918 struck 28 percent of 
the population, killing 675,000 and depressing 
the average life span by 10 years. In Kansas, 
Camp Funston, built during World War I as a 
training camp, also served as an emergency 
hospital during the epidemic. 
below When Milton Winternitz came to 
Yale as chair of pathology in 1917, he brought 
with him a commitment to the U.S. Army to 
study the poison gases being used in the war. 
During the pandemic the Army Laboratory 
School at Yale, which studied human pathol¬ 
ogy, autopsied flu victims in New Haven. 
Yale’s Army Medical Laboratory and 
the 1918 Influenza Pandemic 
Studies undertaken during World War I led to breakthroughs in chemotherapy, 
providing a new understanding of the pathology of the deadly influenza virus. 
By Jennifer Kaylin 
The two facilities established at Yale 
during World War I for training 
lab technicians for fieldwork and for 
studying the effects of poison gas were 
in existence for only three years, but 
during that brief period they created 
a legacy of teaching and patient care 
that is still relevant to students at 
the School of Medicine and to health 
practitioners around the world. 
“In the early 20th century, Yale 
wasn’t a leader. There was no full-time 
faculty, and the teaching was mostly 
rote memorization followed by an 
apprenticeship,” said Michael Kashgar- 
ian, m.d. ’58, hs ’63, professor of 
pathology and molecular, cellular and 
developmental biology. 
That changed in 1917, when Milton 
C. Winternitz, m.d., became chair of 
Yale’s Department of Pathology. Winter¬ 
nitz brought with him the conviction 
that the study of medicine needed 
to be supported by science. He also 
brought a commitment to the U.S. Army 
that he would investigate the pathol¬ 
ogy of the poison gases that were being 
used in the Great War. 
The Army set up the Medical Divi¬ 
sion of the Chemical Warfare Service at 
Yale and the Army Laboratory School 
at Yale, both to be overseen by Winter¬ 
nitz. The first facility focused on experi¬ 
mental animal pathology. Using dogs 
as experimental subjects, researchers 
counted red and white blood cells and 
examined the organs after the dogs 
were repeatedly exposed to poison gases. 
They described how these chemicals 
kill cells, and they made the significant 
observation that nitrogen mustard is 
particularly lethal to lymphoid tissues. 
Researchers at the second facility con¬ 
centrated on human pathology, exam¬ 
ining in autopsy the lungs of patients 
who had been exposed to mustard gas. 
Together, the two facilities provided the 
ideal setting for Winternitz to introduce 
his new scientifically based pedagogy. 
In the midst of their work on gases 
used in war, researchers were hit with a 
new challenge: the influenza pandemic. 
In the autumn of 1918, this acute respi¬ 
ratory infection made its first appear¬ 
ance on the New England coast. 
“Terrible as has been the war, the 
cost of life and distress ... has been 
infinitesimal compared to the havoc 
caused by the late epidemic of influ¬ 
enza,” reads a passage from the New 
Haven Health Department’s 1918 
annual report. From October through 
December of that year, the department 
recorded 777 deaths from influenza 
and its complications. 
“People were healthy in the morn¬ 
ing and dead by nightfall,” said Martin 
E. Gordon, m.d. ’46, clinical professor 
of medicine and chair of the board 
of trustees of the Cushing/Whitney 
Medical Library Associates. 
The Army Laboratory School at Yale, 
located in the Brady Laboratory and 
one of several such schools around the 
country, was also set up to train labora¬ 
tory technicians in bacteriology and 
pathology before dispatching them to 
medical field units. After the flu out¬ 
break, the Laboratory School assumed 
the task of performing autopsies of the 
victims. They found that the pathology 
produced by influenza pneumonia 
closely resembled that produced by the 
inhalation of certain types of poison 
gas. Illustrators made a series of water- 
colors and drawings of the characteris¬ 
tic lesions. These pictures were part of 
an exhibit produced by Gordon called 
“The Flu and You: Old and New Threats” 
that appeared in conjunction with a 
lecture last spring by Harvey Fineberg, 
m.d., president of the Institute of 
Medicine of the National Academies 
of Science. 
The work of both the poison gas 
and influenza researchers is also 
preserved in three monographs: The 
Pathology of War Gas Poisoning, Lethal 
War Gases—Physiology and Experimental 
Treatment and Pathology of Influenza. 
By the standards of the time, Kashgarian 
said, the biochemical and pathological 
observations presented in these vol¬ 
umes were state of the art, but even 
by today’s standards, they provide a 
“strong basis” for additional studies. 
“Given the tools they had, the infor¬ 
mation they present is very complete 
and thorough,” said Kashgarian. 
One observation stands out—the 
researchers noticed that lymphatic 
and bone marrow tissue are destroyed 
by mustard gas. The therapeutic 
potential of this observation wasn’t 
explored until years later, but even¬ 
tually researchers found that nitrogen 
mustard, derived from the family 
of chemicals used in battle, caused 
tumors in mice to shrink. Human 
trials were equally encouraging and 
paved the way for treating cancer 
with chemicals. 
Jennifer Kaylin is a contributing editor of Yale 
Medicine and a freelance writer in New Haven. 
Studies of the pathology of the 1918 influenza 
pandemic in New Haven yielded three publica¬ 
tions, and illustrations of diseased tissue by 
Armin Hemberger. His images appeared in Experi¬ 
mental Treatment and Pathology of Influenza, 
which counted Winternitz as one of its authors. 
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FROM A MOTH, A TOOL TO DECODE GENE FUNCTION IN MAMMALS 
Transposons are snippets of dna that are also known as jumping genes because they move around a genome. 
Their movements are random, but they typically insert themselves into other genes and disrupt their 
functions, causing a mutation. For more than 50 years scientists have been looking for a transposon that can 
efficiently work in mammals. Tian Xu has modified a transposon from the cabbage looper moth and uses 





The piggyBac transposon, found in 
the cabbage looper moth, is split 
into two modified dna plasmids. 
One, the transposon lacking the 
gene that expresses the jumping 
enzyme transposase, carries a red 
fluorescent protein (rfp) marker. 
The other is the modified transpos¬ 
ase gene, plus a gene that causes 
a mouse's coat to turn black. 
2 
Each plasmid is injected into a 
different mouse embryo. As 
the mice grow, their appearance 
reflects their genetic status— 
mice that carry the transposon 
gene glow pink under ultraviolet 
light; black mice carry transposase, 
the jumping enzyme. A black 
mouse and pink mouse are bred. 
3 
Some of their offspring—identified 
by a black coat and a pink glow— 
carry both the transposon and 
transposase and have actively 
jumping genes. 
4 
These mice are bred with normal 
mice. 
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Little mouse, big science 
How fruit fly geneticist Tian Xu is transforming the mouse into story begins on page 20 
a genetics workhorse to reveal the causes of human disease. 
5 
I Some of their offspring will inherit 
j a mutation but not the jumping 
enzyme. Without the enzyme, the 
| transposon remains in place, and 
| polymerase chain reaction will 
j reveal which gene has been dis¬ 
rupted. Other offspring will inherit 
both the mutation and the jump¬ 
ing enzyme and can be bred with 
normal mice, as in step 4, to pro- 
i duce mice with different mutations. 
6 
Mutant mice are bred with normal 
mice to produce offspring that 
have the same stable mutation. 
7 
Mice, each carrying one copy of 
the same mutation, are bred.The 
breeding of these two hetero¬ 
zygous mice will produce a homo¬ 
zygous mouse with identical 
copies of the same gene mutation. 
8 
The offspring with two copies of the 
same mutation can be identified by 
a red glow because they also carry 
two copies of the rfp gene. If a defect 
results, researchers can discern the 
function of that gene by the conse¬ 
quences of the mutation. Xu's goal 
is to determine the cause of single¬ 
gene diseases by doing this type of 
analysis for each of the 20,000 mouse 
genes that have not been analyzed. 




















20 Little mouse, big science 
by Pat McCaffrey 
Sitting in a standard-issue clear plastic cage among hundreds 
of other white laboratory mice, the piggyBac mouse looks 
absolutely ordinary, not a bit like an animal poised to turn 
human genetics research on its head. But when Tian Xu, 
ph.d., professor of genetics, switches on an ultraviolet lamp, 
the mouse emits a faint pink glow—an aura that holds the 
secret of its transformative power. If Xu, professor and vice 
chair of genetics and the mouse’s inventor, has his way, he 
will breed up to a million more pink animals. Those ani¬ 
mals, he says, will reveal the causes—and in some cases the 
cures—for myriad human diseases. 
What is pigg}’Bac’s secret? Xu knows, because he engi¬ 
neered the mouse to carry a small piece of moth dna, 
a “jumping gene” called the piggyBac transposon, which in 
Tian Xu has found a method of 
making knockout mice that is 
faster and far less expensive than 
conventional technology. 
turn carries a genetic marker to turn the mouse pink for easy 
identification. The jumping gene makes the mouse a mutant 
factory: when the animal breeds, the transposon causes 
random genetic mutations in the mouse’s offspring—one 
gene per mouse is disabled. Compared to current methods 
for making experimental mice, known as knockouts, using 
piggyBac is 100 times quicker and cheaper. 
Xu eventually plans to produce 100,000 new strains of 
mice with missing genes. Among them, he expects to find a 
knockout for the majority of the estimated 25,000 to 30,000 
genes in the mouse genome. More than 99 percent of mouse 
genes have direct equivalents in humans, and so these mice 
will provide the first glimpse of the functions of many of our 
genes, most of which remain mysterious half a decade after 
the human genome project first cataloged their existence. 
From China to Yale 
Tian Xu came to New York City from China in 1983, a 21-year- 
old refugee from the Cultural Revolution pursuing graduate 
work in genetics at City College. After six months of living on 
a partial teaching assistant’s stipend in an abandoned build¬ 
ing in Harlem, he received an offer he couldn’t refuse: a full 
scholarship to Yale. He was soon in New Haven, studying the 
development of the fruit fly Drosophila melanogaster with cell 
biologist Spyros Artavanis-Tsakonas, ph.d. 
His good fortune did not impress his mother in China. 
“It was the first time she’d heard from me in six 
months, because I couldn’t afford to call home. But this was 
big news.” When Xu’s mom asked what he intended to 
study, Xu replied, “I’m gonna work on flies, Mom.” After a 
very long silence, his mother spoke: “Son, we have a lot of 
flies right here in our hometown.” 
For a geneticist, fruit flies are a model organism for 
figuring out what genes, and the proteins they encode, actu¬ 
ally do. The ability to produce hundreds, even thousands, 
of mutant flies quickly by using chemicals, radiation or even 
transposons lets researchers look for traits they are inter¬ 
ested in, such as slow growth or crippled wings. 
This kind of large-scale mutagenic analysis, called 
a forward genetic screen, has been a staple of fly research 
for decades. And at his lab in Yale’s genetics department 
Xu has used the technique to unravel the biochemical 
pathways involved in cancer cell growth and metastasis 
in Drosophila. 
Forward genetic screens have played a pivotal role in 
our understanding of modern biology in lower organisms, 
including bacteria, yeast, flies, worms, plants and zebrafish. 
But the lack of comparable genetic screens in mammals has 
impaired our ability to understand many aspects of human 
biology and disease. Xu felt that his fly work could only 
begin to approximate human disease because of the wide 
evolutionary distance between the two organisms. Moving 
his research closer to humans meant moving to the mouse. 
Are you a mouse or a man? 
Like humans, mice are mammals, with similar anatomy, 
physiology and developmental stages. They breed rapidly 
and can be inbred to produce large numbers of identical ani¬ 
mals. Their care and feeding are more complicated and 
costly than that required for fruit flies, but as higher animals 
go, they are small and inexpensive. 
For years, the obstacle to genetic studies in mice 
was a lack of tools for mutating genes en masse for forward 
genetic screening. Starting in 1981 with Frank H. Ruddle, 
ph.d., Sterling Professor of Molecular, Cellular and Develop¬ 
mental Biology at Yale, researchers developed genetic engi¬ 
neering methods that allowed them to add and subtract 
genes from mice, and these methods revolutionized the use 
of mice for targeted genetic research. 
Today, researchers can selectively mutate mouse genes 
at will. Typically, they use genetically altered embryonic stem 
cells to create embryos, which mature and pass the altered 
genes on to their offspring. The process is investigator- 
driven—scientists decide which genes to add or eliminate. 
From choosing a gene and designing a piece of dna to dis¬ 
rupt it, to creating embryonic stem cells and injecting the 
cells into embryos to produce mice, to breeding out the final 
mutants, each new knockout is a custom product that takes 
a year and approximately $100,000 to bring to life. But 
the goal of large-scale systematic mutations in the mouse 
genome has remained elusive. Efforts to use chemical 
mutagens or viruses to disrupt large numbers of genes have 
been abandoned as too expensive and unpredictable. 
Xu had a different idea. He wanted to create mutant 
mice as easily as he had made mutant fruit flies. He didn’t 
want one or two or even 10 mouse mutants—he wanted a 
complete collection, one mouse strain for each gene, that 
would allow him and scientists around the world to discover 
the roles of genes in human disease. “I thought if we could 
do the kind of work in mammals that we do in flies, that 
would be tremendous.” 
For that, he needed a new tool. 
Finding piggyBac 
Based on his experience with Drosophila, Xu believed a 
transposon could do the trick for wide-scale mutagenesis in 
mice. Transposons, also known as jumping genes, were 
first described in corn in the 1950s by Barbara McClintock, 
ph.d., who won the 1983 Nobel Prize in physiology or 
medicine for her discovery that the varied colors of Indian 
corn kernels arise from the disruption of pigmentation 
genes by transposons. 
Mere snippets of genetic material, transposons insert 
themselves at random in the middle of the long dna mole¬ 
cules that make up chromosomes. If they happen to land in 
the middle of a gene, the sequence becomes hopelessly gar¬ 
bled and the gene becomes nonfunctional. Over the course 
of evolution, transposons have remained active in plants and 
insects, presumably because they generate genetic diversity. 
For reasons that aren’t entirely understood, the abundant 
transposons in mammalian genomes (they make up as much 
as 40 percent of human dna) have been “disabled,” per¬ 
haps to protect organisms from unwanted mutations. 
Despite decades of efforts by many researchers, no one had 
succeeded in discovering or engineering an efficient trans¬ 
poson in mammals. 
Xu imagined using transposons like buckshot to 
pepper the mouse genome, where they would randomly 
insert themselves into genes and generate large numbers 
of mice with uniquely altered outward characteristics, or 
phenotypes. “People said I was crazy,” Xu recalls. “They 
said, you’ve never trained in mouse genetics. You’ve never 
even touched a mouse.” 
Xu didn’t give up his day job; he kept his lab pushing 
ahead with its regular Drosophila work. On the side, though, 



















22 Little mouse, big science 
he applied for funding from the Howard Hughes Medical 
Institute, a foundation known for supporting risky but 
promising ventures. With its support, over the last eight 
years he has tested a succession of transposons and viruses 
from plants, insects and wherever he could find them. 
Finally, he tried a strange-looking transposon known 
as piggyBac, found in the cabbage looper moth. It was dif¬ 
ferent from anything else he had seen, and it was so exotic 
Xu figured it might work. PiggyBac had been discovered 
several years earlier by Malcolm Fraser, ph.d., at the Univer¬ 
sity of Notre Dame in Indiana, and it had already been 
shown to suppress gene activity in insects. 
After engineering the piggyBac transposon to adapt 
it for mammalian cells, Xu found that it worked, and Xu’s 
mutant mice were featured on the cover of the journal Cell 
on August 12, 2005. “We don’t know why this one works 
while others don’t,” Xu said at the time, “It just works. We 
have a magical tool now." Xu and colleagues further engi¬ 
neered a red fluorescent protein gene from jellyfish, which 
they added to the transposon, allowing them to identify visu¬ 
ally which mouse carries a mutation and which is a mutant. 
Mutants-R-Us 
With quick and easy generation and recognition of mutants, 
the mammalian piggyBac transposon system is ideal for the 
large-scale project Xu envisioned. Besting the standard time 
requirement of one year per mutant mouse, within months 
the researchers had created 460 unique mutant mice. 
Among the first batch of 95 mutants they examined 
in depth were mice with tusks, mice with neurodegenera¬ 
tion, mice that could not sense pain, mice that turn only 
leftward, mice that don’t grow and mice with bad manners. 
Then there were the sterile mice, and mice never even 
born because their defects were lethal early in development. 
In each case, these afflicted mice will lead the researchers 
to single genes critical for growth and development, auto¬ 
immune disease, social behavior, spinal cord defects and 
neurodegeneration. 
“This is only looking at the first 95—imagine if we 
mutate every gene and look through them all, what we will 
find,” Xu says. The hit-or-miss nature of piggyBac mutations 
gives researchers a decided advantage over knockouts pro¬ 
duced using embryonic stem (ES) cells, he says. PiggyBac 
allows scientists to study genes they didn’t even know existed. 
“We don’t pick which genes to get rid of. We just make the 
mutants randomly and let the animals tell us which ones 
are important. This is a critical difference, because scientists 
are not that smart that they always pick the right gene to 
knock out.” 
Richard P. Lifton, m.d., ph.d., chair and Sterling 
Professor of Genetics, an expert on hypertension genes and 
a Howard Hughes Medical Institute investigator, agrees. 
Lifton says, “That’s the power of forward genetic screens. 
They allow us to find genes that affect these phenotypes that 
up to now we’ve had no idea about at all.” 
So unlike the ES cell method, which focuses exclu¬ 
sively on known genes, the unbiased approach of transposon- 
based mutagenesis can open up exploration of the entire 
genome, including areas of the genome previously dismissed 
as “junk” dna. 
Time for a new mouse 
Xu’s development of the piggyBac mouse came as the draw¬ 
backs of the knockout technique were holding back mouse 
genetics, despite international support for a centralized 
program to knock out every gene in the mouse. First, the 
process of producing knockout mice via ES cell engineering 
is slow and expensive. According to the National Institutes 
of Health (nih), about 11,000 mouse knockouts have been 
generated since the late 1980s, but that number is less 
impressive than it seems. Many genes have been knocked 
out more than once by different labs—one gene was 
knocked out independently at least 28 times. Of the esti¬ 
mated 25,000 mouse genes, only about 4,000 have been 
published, and studies of those genes have been limited 
to specific areas. 
And not all mouse mutants are available to all 
researchers. Given the time and resources invested in mak¬ 
ing knockouts, some researchers want to keep their own 
mice close to home, impeding the sharing of reagents and 
increasing the chances for redundancy and waste. 
To solve some of these shortcomings, the nih has set 
aside $50 million to establish a central repository for 10,000 
mutant ES cell lines. The lines, which will be produced over 
the next five years, will be freely available to all researchers, 
who can request the ES cells and then use them to produce 
their own knockout mice in their labs. A parallel effort, 
using different strains of mice and creating a different type 
of knockout, is being started by an international consortium 
that includes Canada and several European countries. 
Xu thinks that the key is to produce mutant animals 
that will reveal defects and diseases. Producing mutant 
animals from ES cells is a long process. The piggyBac mouse 
system can reach the goal faster and cheaper because it 
produces mutant animals in a highly efficient and cost- 
effective fashion, and allows rapid identification of mutants 
for analysis. His plan is to produce up to 100,000 mutant 
strains, each of which carries a single transposon mapped 
to a known site. A bank of frozen piggyBac mutant embryos 
would then be generated for distribution to researchers 
around the world. The resource would enable researchers in 
all fields of medicine to study the genes regulating the disor¬ 
ders they encounter, Xu says. 
Going with piggyBac for genome-wide mutagenesis 
has other advantages, too. Transposons may be the only way 
to generate mutants in dozens of strains of mice for which 
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ES cell cultures are not available. There are more than 200 
breeds of mice used by researchers, each with its own per¬ 
sonality. Some are preferred by immunologists, while others 
are better for neurological studies. To move a mutation 
between strains takes two or three years, which might be 
skipped altogether by utilizing transposon technology. 
Transposons could theoretically be used in other species, too, 
like the rat. 
From Yale back to China 
To produce the million mice it will take to find 100,000 
mutants, Xu and the School of Medicine have embarked on 
a joint research project with his alma mater, Fudan University 
in Shanghai. The mutagenesis of the mice will be done at 
Fudan, where Xu and his colleagues have set up a state-of- 
the-art mouse facility and production lab supported by 
Chinese government funds. Researchers in China have pro¬ 
duced the first 500 mutants already, including the 460 
Xu’s team produced. But finishing the job will require much 
more funding, and Xu is on the stump for that now. 
Fie has applied for nih funding for the research at 
Fudan, to produce 500 more mouse mutants in a pilot 
project. Xu wants to demonstrate that piggyBac can work in 
a different strain of mouse, and specifically in the strain 
that was selected for the nih ES cell-based knockout project. 
One way or another, the mutants will all be made within 
five years, according to Xu. “We hope that our project will 
be supported by the nih so that the mutants will be avail¬ 
able to the scientific community throughout the world as 
soon as possible.” 
Making the mutants is just the first step of Xu’s plan, 
and not even the most ambitious part. Once the mutants 
are created, the real work begins. Every one of the million 
mutant mice will need a thorough physical exam. The proj¬ 
ect, which Xu envisions carrying out at Yale, calls for a full 
workup for each mouse, and could include a CT scan, blood 
work and measures of immune, kidney, lung and cardiovas¬ 
cular function, as well as of behavior. Not all the mice will 
appear sick—many will seem perfectly normal until 
researchers take a closer look. 
“Now, researchers generate their own mutant mice 
and study only the processes they are interested in,” Xu 
explains. “For example, they make one or a few mutations 
and look for hypertension. If they see hypertension, that’s 
great. But if they do not see hypertension, that’s the end 
of the story, and they will most likely abandon the mice. 
But those mice could easily have diabetes, a very significant 
piece of information that would be totally missed. Further¬ 
more, researchers working on different diseases and biologi¬ 
cal processes are now repeatedly mutating the same genes 
in ES cells and/or taking the same ES cell line to repeatedly 
produce the same mutant mice. There is a significant waste 
of resources.” 
The centralized and comprehensive phenotyping will 
allow researchers to choose only the genes of interest for in- 
depth mechanistic studies and ensures that the mice rapidly 
make their way into the labs of experts who can best utilize 
them to discover new treatments for disease. Right now, 
Yale scientists are defining a scientifically solid and practical 
panel of phenotyping procedures that will cover the widest 
possible range of diseases. 
They believe their integrated approach will provide the 
biggest return on the piggyBac investment. They plan to make 
their results—and their mice—freely available to researchers 
all over the world. Xu wants to see all data posted on the 
Web, where interested scientists can troll for new genes for 
their favorite disease, then order off-the-shelf mice for 
their experiments. 
Besides having an impact on the most common major 
diseases, the mouse studies will advance research into orphan 
diseases—neglected conditions affecting so few people that 
they do not attract interest from for-profit drug companies. 
“There are about 6,000 orphan diseases. While each one 
affects only a small part of the population, all together they 
affect many people. We have a solution to the problem of 
lack of interest, because by the process of systematically 
mutating every gene and screening through our mice, we 
will identify many of the genes that are responsible for 
these diseases,” says Xu. 
Ultimately, Xu hopes to create more than just mice. 
“I want to make Yale the premier international center 
for human disease studies. The aim is to set up a center, 
based on these mice, which will attract researchers from all 
over the world. Each one can focus on a disease, and identify 
the causes of that disease right here. Then, they will move 
on to develop a career studying the mechanism of each dis¬ 
ease and finding a cure,” Xu says. “When I came to the 
United States 23 years ago, I had $50 to my name. Yale gave 
me a research fellowship and changed my fife. Now, we have 
a chance with these mice to cultivate a new generation of 
physician-scientists, who will mushroom out to solve disease 
and help millions of patients. That would really be my 
dream come true.”YM 
Pat McCaffrey is a freelance writer in Boston. 
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A LETTER FROM NIGER 
Water is life 
The 500,000 inhabitants of the Azawak plains of Niger wage a daily 
struggle to find enough water for their basic needs. Through her 
photographs, an alumna of epidemiology and public health hopes to 
draw attention to their plight and improve their lives. 
Text and photographs by Ariane Kirtley, m.p.h. ’04 
In the Tuareg camp of Tchintaloukan, 
18-year-old Againakou gives her 10- 
month-old son, Agoubouley, a drink 
of marsh water. Such water can be 
deadly—10 of 120 children in another 
camp visited by author Ariane Kirtley 
died of diarrheal diseases caused by 



















26 Water is life 
hen I threw a pebble into Mohammed and Gonda’s 
well, I heard a faint thump, not the splashing of water. “How 
deep is it?” I asked. Two hundred feet, I was told, and no 
sign of water. 
For six years Mohammed and Gonda’s families from 
neighboring villages and camps in the Azawak plains of 
the Republic of Niger pooled their resources to dig an adobe 
well. Then they abandoned their efforts. There was no more 
money to dig deeper or to line the well with cement—the 
adobe well threatened to cave in. Even if the families had had 
the resources, it would take six more years to reach water. In 
the Azawak the first water table typically lies 430 feet under¬ 
ground, and renewable aquifers are at 700 to 1,400 feet. 
Because the people of the Azawak cannot afford pumps and 
pipes, there are few sources of water, and none are perma¬ 
nent or reliable because they dry up from overuse. 
Finding water occupies the lives of the 500,000 mem¬ 
bers of the Tuareg and Woodabe Fulani ethnic groups who 
make their homes in the plains’ 200,000 square kilometers. 
Most of the year there is no water. During the rainy season 
from July through September, the pastures turn green, the 
animals grow fat, milk is plentiful and water overflows from 
marshes that reappear after nine months of drought. The 
water, fouled by animal and human waste, may be darker 
than coffee and dirtier than a New York City mud puddle, 
but people drink and bathe to their hearts’ content. Dysentery 
and diarrhea soon follow. 
While in the Azawak, Kirtley stayed 
with families in their homesteads, 
camps and villages. In January 
2006, during a Muslim festival, she 
posed with children of Tantigellay 
Teckniwen, a Tuareg camp. 
Most of the inhabitants of Niger’s 
Azawak plains belong to the Tuareg 
and Fulani ethnic groups. Pastoral- 
ists, they graze livestock, driving 
them as far as 350 miles in search 
of water. Author Ariane Kirtley 
describes the region as a “rich and 
diverse land of extremes: extreme 
kindness, extreme heat, extreme 
beauty and extreme challenges.” 
When the marshes dry up, people travel by foot or 
donkey to find water. Prevented by local populations from 
settling near the few sources of water that exist on the out¬ 
skirts of the territory, they repeat their search every day. 
The men travel up to 350 miles south seeking water for their 
livestock, and the search for water becomes a daily chore 
for women and children. Children as young as 9 or 10 may 
travel—with temperatures topping 100 degrees—10 to 17 
miles to the nearest well, only to wait for hours for their turn 
to fetch water. Often their turn comes too late, as the other 
people and their livestock sharing the well have left it dry. 
The children may stay at the marsh as long as three days 
while the water is replenished. 
Water consumption in these plains, less than a gallon 
and a half per person per day, is well below the World Health 
Organization’s recommendation of 6.5 gallons. During the dry 
season, water is reserved for drinking and cooking—personal 
washing awaits the return of the rains. In the Azawak almost 
half the children die before their fifth birthday. 
Despite the hardships, people stay in the Azawak. It is 
their traditional home, but on a practical level, they have no 
place to go. Their numbers are too large for relocation, and 
moving elsewhere could lead to strife with other ethnic groups. 
Finding water 
Although I spent the first 10 years of my life in Africa, I had 
never seen an area as poor as the Azawak. With my brother 
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the nomadic Bozo fishermen in Mali, the Ibadite Muslims of 
central Algeria, the animist Guere “panther men” of western 
Ivory Coast and the Inadan Tuareg artisans of Niger’s Air 
Mountains in the Sahara Desert. 
I studied public health at Yale and for my internship 
returned to Niger to work on a hygiene and sanitation pro¬ 
gram with care. After graduating in 2004, I went back to 
Niger as a Fulbright Scholar to build upon my work with 
care. My Fulbright research revealed significant variations 
in knowledge, attitudes, behaviors and resources relating to 
health and nutrition among seven ethnic groups living in 
rural Niger. (For example, of 700 men I interviewed in the 
Azawak, only three had heard of aids, and all three believed 
it resulted from women having sex with dogs.) With this 
information I created a database that allows health organiza¬ 
tions to tailor their programs to their target populations’ 
unique needs and attributes. 
During my Fulbright research I discovered the Azawak. 
My research assistant, Moustapha, whose family had aban¬ 
doned the plains during the drought of 1974, persuaded 
me to visit his homeland. Little did I know that my visit in 
September 2005, which was to last only a month, would 
consume me professionally ever since. I spent October 
and November 2005 attempting to interest humanitarian 
organizations in the Azawak. With a team of Nigerien 
employees from a large international humanitarian agency. 
we wrote a proposal to fund a water and food program. It 
was rejected because the Azawak is “too vast and remote”— 
the organization did not want to risk its employees in a 
region without water. 
Realizing that I had to take the first step if humani¬ 
tarian aid is to reach the Azawak, I have founded Amman 
Imman, which means “water is life” in Tamachek, the 
Tuareg language. Amman Imman has been raising money 
since February 2006, with a goal of $280,000 for a pilot 
program to build two borehole wells, each of which could 
provide water for 25,000 people. With more funding, we 
hope to sink even more such wells. Once water is available, 
humanitarian organizations may safely send workers to 
improve the lives of one of the most vulnerable populations 
on earth. (More information about the project is available 
at www.waterforniger.org.) 
The people of the Azawak 
Most people of the Azawak are pastoral nomads of the 
Tuareg and Woodabe Fulani ethnic groups. The Tuaregs of 
the Azawak have retained a nomadic existence, herding 
cattle, camels, goats and sheep, and living in tents of red- 
dyed goat hide in camps of 50 to 150 people. During the 
rainy season, they move every three to four days in search 
of pastures. In the dry season they move often within 
their “home territories,” land occupied by their families 
for generations. 
Gonda and Mohammed spent 
six years trying to dig a well, with 
money raised from their Tuareg 
families and neighbors. They aban¬ 
doned their efforts over a lack 
of money and worries that the 



















28 Water is life 
Throughout her travels in the 
Azawak, Kirtley captured images 
of daily life and portraits of the 
Woodabe and Tuareg peoples. 
The Woodabe are nomadic cattle herders who live in 
camps of one or two families and move frequently to greener 
pastures. Their homesteads consist of a traditional wooden 
bed (covered with a plastic sheet when threatened by rain or 
sun) and a wooden table covered with 20 to 30 calabashes— 
bottle gourds hollowed out and dried for use as containers. 
Only a few of these calabashes hold grain or milk—the rest 
are on display as a sign of the woman’s wealth. 
Sedentary villages grow more common as drought 
takes its toll on livestock. Without animals for their liveli¬ 
hood, the nomads settle into villages of between 100 and 
300 people and try to survive through subsistence agricul¬ 
ture, mostly growing millet and sorghum. But even they 
abandon their villages to search for water during the harsh¬ 
est months of the dry season. 
Hospitality and hope 
Sadouan was the first to greet me as my research assistant, 
Moustapha, and I arrived at our Tuareg host camp in Sep¬ 
tember 2005. She invited me to her tent, prepared a tradi¬ 
tional bed of large wooden poles and woven mats, and gave 
me a mosquito net and elaborate leather pillows for armrests. 
Late into the night her relatives came bearing bowls of 
camel milk. Sitting on a pillow and sipping the frothy liquid, 
with Moustapha as my interpreter, I had a conversation with 
Sadouarfs husband, Alhassan. The camp and its herds, he 
said, had recently returned from salt licks in the north. He 
right Tackawel, a Tuareg woman 
who lives in a sedentary village 
called Intatolen, pounded grain in 
September 2005. Many inhabi¬ 
tants of the Azawak are turning to 
raising grain instead of livestock 
in order to feed their families. 
far right Muddy marsh water 
is all that’s available for drinking, 
bathing, cleaning and washing 
dishes. In September 2005 in Tanti- 
gellay Teckniwen, a Tuareg woman, 
Zeinabou, washed her bowls. 
opposite left The Woodabe, 
a subgroup of the Fulani ethnic 
group, move their camps of one or 
two families every two or three 
days. Their homesteads include a 
wooden bed, which they cover 
with a plastic sheet when it rains 
or the sun is too harsh. 
opposite right In the region 
of Inagar in January 2005, a 
Woodabe Fulani family moved 
camp with their belongings 
carried on donkeys. 
lamented losing 80 percent of his herd to drought that year. 
“Around 100 of my camels died because they didn’t have 
enough food and water. When we ourselves had no more food, 
we also had to eat some of them. I sold others to buy millet for 
Sadouan and the kids,” he said. “Ten years ago, only the poor¬ 
est families in our camp owned fewer than 300 animals. With 
only 20 animals left, what can I count on to survive? Maybe 
if I grow enough millet this year, we’ll have enough to eat." 
After putting her children to bed, Sadouan gently ran 
her fingers through my hair. “Why haven’t you braided your 
hair?” she asked, implying that she would never leave her 
hair uncovered and unbraided. “If you want, I can wash it 
with ochre, and give you the festivity braids.” 
A wild harvest to fill empty bellies 
The sun was setting as 1 arrived in the Tuareg village of 
Intatolen to greetings from men and women returning from 
a day planting millet. Two women waved me over to their 
thatched hut to share their supper of wild squash and a 
grain I didn’t recognize. After several minutes of silence, 
I introduced myself and asked their names. They giggled. 
I had committed senti by speaking while eating. A faux 
pas in Tuareg tradition, senti is nonetheless covertly appreci¬ 
ated as a sign that the food was so good that it made your 
mind wander from matters of etiquette. 
“We would have liked to serve you meat, but all our 
animals have died,” said Issibit, the elder of the two co- 
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wives, after dinner. “We ran out of rice a few weeks ago, and 
so now we are eating wild grains until they too run out. 
And the lacada, we are very embarrassed to have served you 
the wild zucchini, but we have nothing else to eat.” 
I later learned that earing wild grains and vegetables 
is a sign of famine—they are eaten only when every other 
food source has run out. My research revealed that 71 per¬ 
cent of the households that I interviewed went from eating 
one or two meals a day supplemented with milk to one or 
no meals a day, sometimes supplemented with far less milk. 
And 91 percent reported resorting to eating wild grains, 
squash and bitter berries. 
From school to Guerwuls 
Fada, about 14, adorned with charm talismans, a round feather- 
topped hat and a Tuareg saber, came bouncing toward me 
as I struggled through prickly burrs. “Hey, follow me, I’ll show 
you where it’s best to step,” he said. “Come to my camp. It’s 
just over that dune.” Two hours and about 2,000 prickly burrs 
later, with a herd of long-homed cows following, we arrived at 
his home: a wooden bed and a table covered with calabashes. 
The camp was deserted. “Oh, I forgot—everyone has 
left to prepare for the Guerwul tomorrow.” I had heard of 
Guerwuls, beauty competitions held by the Woodabe people, 
a subgroup of the Fulani. “Can you come?” Fada asked. 
I asked Fada about life as a herder. Had he ever been 
to school? At first he laughed and then answered that the 
Fulani reject formal education because they believe that 
schools steal their children away from their pastoral lifestyle. 
A child who attends school is considered dead because he or 
she no longer understands magic or the art of herding. 
This is how Fada’s uncle, Ali, came to go to school 35 
years ago. French colonists demanded that his grandfather, 
the chief of his camp, send the children to school in Tchinta- 
baradene, the capital of the Azawak. He sent only his own 
grandchildren to their “death,” Ali among them. Ali ran away 
and hid in the bush for three weeks, traveling by foot through 
unknown prairies. When he reached his camp, the white men 
were waiting. He ran away five more times before accepting 
his fate. Ali never returned to life as a herder. Instead, he trav¬ 
eled to Morocco and France to obtain a degree in sustainable 
agriculture. Ali now works on crop productivity projects for a 
nonprofit organization in southern Niger. 
After I refreshed myself with a bowl of curdled cow 
milk and promised to see Fada at the Guerwul, he said, 
“I’d like to go to school someday and become like my Uncle 
Ali. Maybe when I have children, there will be schools in 
the Azawak for them to attend.” ym 
Ariane Kirtley, m.p.h. ’04, grew up in Africa and has founded the nonprofit 
organization Amman Imman to build permanent water sources in the 





















internal medicine and 
Paul Beeson 
by Richard Rapport, m.d. 
Paul B. Beeson, m.d., former chair of internal medicine at Yale 
and an internationally renowned physician and scientist, died 
on August 14 in Exeter, N.H., at the age of 97. 
Beeson held leadership posts at major academic medi¬ 
cal centers, was an editor of two major textbooks on internal 
medicine, advanced the study of fever and infection and was 
a member of the National Academy of Sciences. Among the 
honors he received was the Kober Medal, the highest award 
given by the Association of American Physicians. In 1973, Oueen 
Elizabeth II named him an Honorary Knight Commander of 
the Most Excellent Order of the British Empire, a rare honor 
for an American, in recognition of his service as the Nuffield 
Professor of Medicine at Oxford University. 
While at Yale Beeson conducted groundbreaking research, 
transformed the Department of Internal Medicine into a 
national model and cemented his own reputation in medicine. 
“When he came it was a relatively small department,” recalled 
Arthur Ebbert Jr., m.d., professor emeritus of medicine, who was 
hired by Beeson as an instructor in 1953. “He apparently had a 
mandate to expand the department and to encourage patient 
referrals from around the state. Before he came and reorganized 
the department, if doctors had a patient they wanted advice 
on, the patient went to New York or Boston.” 
Beeson the scientist was the first to identify proteins 
in white blood cells now recognized as cytokines, signaling 
compounds used for intercellular communications, that also 
During his 13 years as chair, Paul Beeson made 
internal medicine at Yale one of the best depart¬ 
ments in the country. He is remembered for his 
skill in the laboratory, his compassion for patients 
and his nurturing of students and residents. 
play a role in the body’s response to infections. With one of 
his residents, Robert G. Petersdorf, m.d. ’52, hs ’58, Beeson 
subsequently wrote a paper on patients with persistent fevers 
of 101 degrees or more. Published in the journal Medicine in 
1961, the article is considered a “landmark,” said Lawrence S. 
Cohen, m.d., hs ’65, the Ebenezer K. Hunt Professor of Medicine 
and Special Advisor to the Dean. Cohen, an intern and resident 
under Beeson, told The New York Times that the paper is “as 
relevant in 2006 as in 1961, in pointing out causes that were 
not obvious and teaching clinicians what they should be 
thinking about in making a differential diagnosis.” 
Beeson grew up in Anchorage, Alaska, where his father, 
John Beeson, m.d., was a general practitioner and surgeon for 
the Alaskan Railway. When he was 19, Paul Beeson followed 
his older brother to McGill University, where both received 
their medical degrees. After an internship at the University of 
Pennsylvania, Beeson joined his father and brother in practice 
in Ohio. The lure of research drew him to Rockefeller University, 
and he subsequently took appointments at some of the most 
prestigious academic and medical centers in the country. 
He came to Yale in 1952 from Emory University. When 
he left New Haven 13 years later to become the Nuffield 
Professor of Medicine at Oxford, internal medicine at Yale 
was regarded as the premier department in the country. 
In 1981, the Paul B. Beeson Professorship in Internal Medicine 
was established at Yale, endowed by a former colleague, 
Paul Beeson was widely regarded 
as a scientist and a caring 
physician, teacher and mentor. 
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Elisha Atkins, m.d., and his wife, Elizabeth. In 1996, the School 
of Medicine named its medical service in Beeson’s honor. 
In this article adapted from Physician: The Life of Paul 
Beeson (Barricade Books, 2001), author Richard Rapport, m.d., 
describes Beeson’s tenure at Yale. 
Beeson sat behind a glass-topped desk, rolling a letter opener 
around in his fingers, while the patients admitted during 
the night were presented to him by the residents. Laboratory 
tests had become more sophisticated since Beeson’s own 
house officer days, but history and physical examination 
remained central to the process of diagnosis. The impact 
of technological innovation was slight, in spite of cardiac 
catheterization and even early angiography. Laboratory 
values, X-ray results and physical examination were expected 
to be reported efficiently by the sleep-deprived residents. 
Long-windedness was abbreviated by an impatient tapping 
of the letter opener. The house staff soon learned that, 
while their new chair didn’t like mistakes, he tolerated them 
as a function of learning. What he could not tolerate was 
thoughtlessness. When it was uncovered that a patient had 
been treated unkindly or misused, as happened the day 
a resident referred to a homeless, alcoholic patient as “a 35- 
year-old bum,” the letter opener snapped unhappily to the 
desk and the room quieted while the offending resident 
searched in vain for an escape. This happened rarely, a 
testimony to both residents and chief, but when it did occur 
it was remembered for the life of the perpetrator. 
Teaching on the wards 
Tuesdays and Thursdays, after morning report, Beeson left 
his office with the residents and students assigned to his 
service, walked past the Fitkin Amphitheater and climbed 
upstairs to the wards where he consulted for two hours—all 
year long. Beeson approached the bedsides of the patients, 
who were exposed on all sides and confronted by a crowd of 
people they barely knew, and immediately sat down. He had 
come to believe, possibly from his practice experience in 
Ohio, that standing by a patient’s bedside places the doctor 
in a position of dominance that makes many ill people want 
to be somewhere else. He wished to place them at ease and 
so he reduced the distance between them by sitting unhur¬ 
riedly, an act that suggested interest in each patient, rather 
than the disease being discussed. As the resident presented 
the history, physical examination, laboratory and X-ray find¬ 
ings, a task that sometimes took a while, Beeson said noth¬ 
ing. He allowed the younger doctors to discuss the problem 
themselves, develop a differential diagnosis, and argue about 
what made one possibility more likely than another. If specu¬ 
lations behind the curtains drawn around the bed grew too 
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outrageous, Beeson gently guided the discussion back 
toward reason. Sometimes he said nothing at all, or simply 
agreed with the diagnosis and what was being proposed to 
manage the illness. Occasionally he differed altogether, as in 
the case of a third-year medical student admitted late one 
night in 1953. 
The student was Sherwin B. Nuland, m.d. ’55, hs ’61, 
later a Yale surgeon and gifted writer, who had been brought 
to the emergency room with a very high fever and, the admit¬ 
ting resident thought, an enlarged spleen. The temperature 
elevation alone wasn’t a great worry, but Nuland was clearly 
sick, and a spleen that can be palpated expands the possibili¬ 
ties in several nasty directions. Because they didn't know 
what was the matter with him, the residents did what they 
often did then (and now)-—they gave him antibiotics and 
started to work up the fever. Nuland later noted, “I was evalu¬ 
ated from one end of myself to the other, carrying a diag¬ 
nosis of either mononucleosis or hepatitis—no one being 
sure which. After about three days like this the Professor 
came to make rounds, examined me briefly, looked at his 
retinue and pronounced, ‘This boy had a strep throat a few 
days ago, but he’s fine now. He can be discharged.’ I don’t 
suppose this is a major triumph diagnosed by Dr. Beeson, 
but what impressed me most was the gentleness with which 
he treated his residents when he had shown them to be in 
error, and his certainty.” 
A growing faculty and more specialists 
The tendency toward subspecialization had begun, and 
the Department of Medicine was forced to add faculty 
members with more focused interests than only general 
internal medicine. While recognizing this requirement, 
Beeson was reluctant to abandon his lifelong view that 
internists should be generalists. But by 1954, this position, 
learned from both his father and Soma Weiss, m.d., the 
legendary Harvard physician and mentor, was difficult 
to defend, and new fellowship-trained faculty members 
were hired. With support from Vernon W. Lippard, m.d. 
’29, dean of the medical school, Beeson and the Yale 
department were now in a position to recruit from the best 
talent available. 
As the department added more faculty, it also grew 
in other dimensions. Space was always an issue (one car¬ 
diologist’s lab was in a remodeled coat closet off the Fitkin 
Amphitheater), and was relieved only slightly when the 
West Haven Veterans Hospital opened. The private Memorial 
Unit was constructed, allowing department attending staff 
to admit insured private patients and residents an opportu¬ 
nity to care for them, as well as for the nonpaying patients 
admitted to the Grace-New Haven Hospital. All of the fac¬ 
ulty, with the exception of the dean, were entirely indifferent 
to the funding sources for the care of any of these sick peo¬ 
ple. The faculty and house staff were paid a salary by the 
medical school; this income was not linked to nor influenced 
by months spent attending on the wards, number of patients 
seen or procedures performed, number of research papers 
published nor volume of work done as measured by any other 
scale. Patients were admitted through the clinics, emergency 
room or privately, and they were taken care of by the same 
attending physicians and the same house staff regardless of 
their type of insurance—or its lack. 
Such administrative issues always impose on the time 
of a department chair, and Beeson expected them. What he 
did not necessarily expect was the growing line of petitioners 
that never seemed to shrink outside his office door. 
Beeson still ran the entire department with only 
a secretary. Of course, the tasks were far beyond those of a 
routine secretarial job. His secretary, Betsy Winters, who 
would later have an award, the Betsy Winters House Staff 
Award, named in her honor, was responsible not only for 
scheduling appointments, phone calls, typing and mimeo¬ 
graphing—the general business of running the office— 
but also for managing grant applications to the National 
Institutes of Health (nih), intern and resident applica¬ 
tions and medical student evaluations and monitoring the 
queue outside Beeson’s door. Whenever people showed 
up, regardless of their rank, Winters found a way to coax 
a few more minutes out of the chair’s schedule for them. 
OPPOSITE In 1952, his first year 
as chair, Paul Beeson posed with 
the faculty in front of the Sterling 
Hall of Medicine. Beeson is fifth 
from left in the front row. To his 
immediate left is nephrologist 
John Peters, who made significant 
contributions to the study of 
renal disease. 
ABOVE In May 2003, Paul Beeson 
was reunited with nine of his 
former residents when he came 
to Yale for the unveiling of his 
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A caring mentor 
Dedication to the careers of students, residents and faculty is a 
labor-intensive activity. The students, who often entered medi¬ 
cal school with no idea about what clinical medicine really 
involved, were sometimes overwhelmed when they found out. 
Patients admitted to teaching centers in the late 1950s were 
often so sick they could not be cared for in a community hos¬ 
pital, and the mortality rate was as high as 10 percent on the 
Yale medicine wards. These patients were hospitalized for 
long periods, and the house staff and students developed rela¬ 
tionships with them not available in today’s technology-rich 
day-surgery and outpatient environment. 
An intern from 1958 remembers his young female 
patient with meningitis being treated with the new technique 
of injecting intrathecal penicillin, the drug infused into 
spinal fluid through a lumbar puncture needle in order to 
achieve high concentration at the site of infection. This was 
a procedure advocated by Beeson, who recommended that, 
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INTRODUCTION 
In 1868 Wunderlich, a German clinician, pub¬ 
lished in monograph form a convincing demon¬ 
stration of the value of measuring the body tem¬ 
perature in various diseases. This work was soon 
translated into other languages (1), and the prac¬ 
tice of making regular measurements of body 
temperature quickly became standard through¬ 
out the world. Thus the thermometer became the 
first instrument of precision to be used in medical 
practice. Long before Wunderlich, of course, phy¬ 
sicians had known that illness was sometimes 
manifested by increased body warmth: in fact 
the word “Fever" came to be used to designate 
a certain form or forms of illness. Benjamin Rush 
maintained that there was “only one fever,” but 
by the early part of the nineteenth century clini¬ 
cians were able to distinguish between some of 
them, such as typhoid and typhus fevers, purely 
on clinical grounds. The introduction of clinical 
thermometry happened to come at the same time 
as the discoveries of Pasteur and the beginning of 
the Golden Age of Bacteriology; soon, therefore, 
it was no longer acceptable to say that a patient 
•Present address: Dept, of Medicine, Univer¬ 
sity of Washington and King County Hospital, 
Seattle. 
In 1961 Beeson and Robert Peters- 
dorf, his chief resident, published 
their landmark paper on Fever in 
the journal Medicine. (See sidebar 
on opposite page.) 
even though she was improving, the spinal taps be continued 
until the patient was completely without fever. An arithmeti¬ 
cal error was made by the nurse preparing the infusion, and 
instead of 10,000 units of penicillin, the intern pushed in 1 
million. The patient convulsed and died. The intern, who had 
been taking care of the young woman since her admission, 
also collapsed. Beeson was called by someone still left stand¬ 
ing, and immediately came to the ward, gathered both nurse 
and intern and took them into an empty room. After the tears 
slowed and a little calm had been restored, he explained to 
the two young people that errors are certain to be made in the 
care of the desperately ill, and that everyone involved in their 
care assumes part of the responsibility for what happens on 
the wards—the triumph and the loss. By involving himself in 
the accident, and reminding them that it was he who chose 
the treatment, Beeson comforted the nurse and intern at least 
a little, and helped them to know that they were supported. 
Next, they told the family exactly what had happened. There 
was no lawsuit. 
In the first rank of internal medicine 
By i960, the administration of a major department of medi¬ 
cine such as Yale’s had become much more than the chair 
and one secretary could manage. A business manager was 
added to the staff and took over fiscal responsibility for the 
department, as well as management of the growing volumes 
of reports that the nih and other funding agencies expected. 
Even this increased manpower did little to allow Beeson the 
freedom for laboratory research and unhurried individual 
meetings with students he had so valued at Emory and dur¬ 
ing his first years at Yale. He became a clever and capable 
administrator, but never the kind of merciless program direc¬ 
tor consumed by competition for money, faculty and patients. 
The Department of Medicine had joined the first rank, 
competing with Harvard, Johns Hopkins and Columbia. 
A 1964 article about Yale in Newsweek describing the medical 
school as “good, if not outstanding,” brought this quietly out¬ 
raged response from John Bowers, m.d., who had been dean 
at two medical schools, member of the Atomic Bomb Casualty 
Commission and later president of the Macy Foundation: 
“The medical school at Yale has consistently ranked as one of 
the top schools in the country, with an excellent faculty and 
students. ... Recently a distinguished colleague at a New York 
medical school told me the Department of Medicine at Yale 
was unquestionably the most outstanding in the country— 
and neither he nor I are sons of Old Eli.” 
Beeson’s students make their mark 
While the department expanded both in depth and scope, 
some people left, of course. The vast majority of Beeson- 
trained academics found careers in the best medical schools 
in the country: 27 went on to hold major administrative posi¬ 
tions at other universities. All of these academic physicians 
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was suffering from ‘a fever’: the challenge was to 
determine the cause of that fever. It was also 
recognized that although infectious processes 
were the commonest causes of fever, other kinds 
of disease could also affect temperature regula¬ 
tion, and that a great variety of causes required 
consideration in the differential diagnosis of fe¬ 
brile illness. This became one of the main fields 
in differential diagnosis, and many of the great 
clinicians of the first half of the twentieth cen¬ 
tury, such as Horder and Libman, owed their 
reputations in some part to successes in diagnosis 
of febrile disease. 
Fever of unknown origin (F.U.O.) is a com¬ 
mon clinical problem, encountered frequently 
in nearly all branches of practice. Fortunately the 
cause is oftenest an acute infection, which soon 
becomes evident and responds to treatment, or 
runs its course. In the present article we are not 
concerned with such short-term problems, but 
are restricting the discussion to cases of pro¬ 
longed febrile illness of obscure cause. This is 
likely to be a source of perplexity and frustra¬ 
tion to the physician, and for the patient the dis¬ 
comforts of illness are compounded by the anxi¬ 
ety of uncertainty. These unhappy victims 
understandably tend to seek additional medical 
continued to train their own students and house staff in the 
image of their teacher, valuing patient care, instruction of 
house staff and clinical research above their own advancement. 
As the success and size of the department continued 
to grow, so did Beeson’s own prestige, both at Yale and nation¬ 
ally. This was not the result of self-promotion, but happened 
as a natural function of his unassuming manner and what 
Lewis Landsberg, m.d. ’64, hs ’70, and the rest of the house 
staff called the “Beeson mystique.” 
“What was it, we wondered, that contributed to the 
aura of greatness that surrounded this man? When Beeson 
walked into a room everybody stood up. His very presence 
imbued the Department of Medicine at Yale with an organic 
unity that was felt by third-year clerks and full professors 
alike. No one wanted to appear unworthy in behavior, 
demeanor or medical knowledge in the eyes of Dr. Beeson,” 
Landsberg recalled in a letter. 
At Yale, Beeson continued to take morning report him¬ 
self in his office at 8 o’clock, he still attended on the wards 
throughout the year and he gave the introductory lecture to 
the third-year medical students annually as they began their 
clinical training. At this lecture, a gravely ill person was cho¬ 
sen from among the hospitalized patients and brought to the 
Fitkin Amphitheater. As students who had studied only basic 
sciences, these 24-year-olds about to enter the wards for the 
first time had little understanding of the disease being pre¬ 
sented. Neither was it their professor’s intent to teach them 
details of that specific illness or class of diseases as he care¬ 
fully and slowly interviewed and then examined the patient 
on those fall afternoons. What a comfort it was to these bewil¬ 
dered students when they were then told: 
"As your acquaintance with clinical teachers grows, you 
will observe that although each of them has special knowledge 
and experience in some area of clinical medicine, they make 
no pretense of knowing it all. You will also find that clinicians 
frequently disagree, and that each of them comes to wrong 
conclusions from time to time. ... Biochemists and pharma¬ 
cologists have ‘hard’ facts to propound. We, on the other hand, 
deal with such commodities as pain and nausea. We must 
accept any kind of problem. We cannot insist on working with 
inbred strains of people, we cannot control the environment 
from which they come, we know that their recollection of past 
events is faulty and we cannot reduce them to subcellular 
fractions to determine what is going on. ... We live, therefore, 
in an atmosphere of doubt and uncertainty, and make our 
decisions and take our actions on the basis of probabilities. ... 
So these are some precepts you must consider: Give each 
patient enough of your time. Sit down; listen; ask thoughtful 
questions; examine carefully. ... Be appropriately critical of 
what you read or hear. ... Follow the example set by William 
Osier: ‘Do the kind thing and do it first.’”ym 
Richard Rapport, m.d., is a neurosurgeon in Seattle. 
As head of the Association of 
American Medical Colleges, 
Robert Petersdorf believed that 
medicine had become too 
specialized and tried to increase 
the number of primary care 
physicians entering general inter¬ 
nal medicine and family practice. 
Alumnus Robert Petersdorf, former 
aamc president, dies in Seattle at 80 
While this issue of Yale Medicine 
was in production, we learned 
of the passing of 
, m.d. ’52, hs ’58, 
former president of the Associa¬ 
tion of American Medical Colleges 
(aamc), as well as chair of the 
University of Washington Depart¬ 
ment of Medicine, dean of the 
School of Medicine at the Univers¬ 
ity of California, San Diego, and 
president of Brigham and Women’s 
Hospital in Boston. It seemed 
fitting to remember him on the 
same pages as Paul B. Beeson, 
M.D., former chair of internal 
medicine, who mentored Peters¬ 
dorf early in his career. 
The two met in 1952, when 
Beeson had just begun his tenure 
as chair and Petersdorf was in his 
last year of medical school. In 
1996, when Petersdorf accepted 
the Kober Medal from the Associa¬ 
tion of American Physicians, he 
remembered what Beeson had 
told him that day: "The secret to 
success in [academic medicine is] 
to get one’s hands dirty in the 
laboratory.” 
Five years after they met, when 
Petersdorf was chief resident, 
Beeson asked him to begin work¬ 
ing on a paper describing 100 
patients who had been ill for more 
than three weeks, had episodic 
fever of more than 101 degrees and 
had remained undiagnosed after 
one week in the hospital. This 
work was published under both 
their names in the journal Medicine 
in 1961 as "Fever of Unexplained 
Origin,” an article that remains 
one of the most frequently cited 
papers in medical literature. 
Petersdorf went on to lead pre¬ 
mier medical centers and depart¬ 
ments around the country, as well 
as several medical organizations. 
He died on September 29 in 
Seattle of complications of strokes 
at the age of 80. Colleagues 
remembered him as a mentor to 
young physicians and as one of 
the foremost infectious disease 
experts in the United States. 
As aamc president from 1986 
to 1994, Petersdorf sought to 
improve the nation’s system of 
medical education through efforts 
to increase the number of pri¬ 
mary-care physicians, strengthen 
efforts to enroll underrepresented 
minorities, support the role of 
teaching hospitals, encourage aca¬ 
demic physicians to devote more 
time to teaching and advocate for 
limits on the demands of resi¬ 
dency training. He also succeeded 
in improving communication 
between medical educators and 
Congress, in an era when national 
health policies and budgets increas¬ 
ingly affected medical schools 
























named to iom 
RICHARD A. FLAVELL, PH.D., 
Sterling Professor of Immunobiol¬ 
ogy, and chair of immunobiology 
was named to the Institute of 
Medicine (iom) in October. The 
iom was established by the 
National Academy of Sciences and 
is recognized as a national resource 
for independent, scientifically 
informed analysis and recommen¬ 
dations on issues related to human 
health. Election to the institute 
recognizes people who have made 
significant contributions to the 
advancement of the medical sci¬ 
ences, health care and public 
health and is considered one of 
the highest honors in the fields 
of medicine and health. 
Dean Robert J. Alpern, M.D., 
Ensign Professor of Medicine, said, 
“Richard’s research is outstanding, 
clearly placing him among the 
best immunologists in the world. 
This is combined with a talent 
for leadership that has allowed 
him to cultivate an immunology 
program that is unsurpassed any¬ 
where. His wisdom and experi¬ 
ence should prove valuable to the 
Institute of Medicine.” 
FlavelPs research primarily 
concerns the molecular basis of 
T cell differentiation in the im¬ 
mune system. His research team 
has used genomic approaches to 
identify the genes that are selec¬ 
tively expressed in T cell linea¬ 
ges, and has used gene targeting, 
transgenic mice and retroviral 
technology to elucidate the func¬ 
tion of these genes and their 
target sequences. 
Flavell, a Howard Hughes Medi¬ 
cal Institute investigator, studies 
effector mechanisms of pro¬ 
grammed cell death using mice 
lacking caspases and investi¬ 
gates the molecular and cellular 
basis for autoimmune disease. 
Jack Elias Fred Volkmar 
New chairs named 
at School of Medicine 
Several new appointments at the 
medical school were announced 
last summer and fall, with new 
leadership in the Department of 
Internal Medicine, the Child Study 
Center, the Department of Oph¬ 
thalmology and Visual Science and 
the Department of Laboratory 
Medicine. 
JACK A. ELIAS, M.D.,the 
Waldemar Von Zedtwitz Professor 
of Medicine and chief of the 
Section of Pulmonary and Critical 
Care Medicine, was named chair 
of the Department of Internal 
Medicine, effective October 1. Elias, 
a leading authority on the molecu¬ 
lar basis of asthma and other lung 
disorders, will lead the school’s 
largest department, with 351 full¬ 
time faculty, $83 million in research 
funding and $45 million in clinical 
activity. Elias, who came to Yale 
in 1990, is the author of more than 
160 original journal articles and 
200 abstracts. He is also a co¬ 
editor of the fourth (2007) edition 
of the leading textbook in the 
field, Fishman’s Pulmonary Diseases 
and Disorders. His research focuses 
on the cellular and molecular 
biology of the lung and processes 
related to both injury and repair 
of lung tissue. Elias has studied 
asthma, emphysema, pulmonary 
fibrosis, respiratory syncytial virus 
infection and acute lung injury. 
Elias succeeds David L. Coleman, 
m.d., hs ’80, former interim chair, 
who left Yale to become chair of 
medicine at Boston University. 
FRED R. VOLKMAR, M.D., 
a leader in the field of autism 
research, was named director of 
the Child Study Center and 
chief of the Department of Child 
James Tsai Brian Smith 
Psychiatry at Yale-New Haven 
Hospital for a three-year term, 
effective July 1,2006. The center 
is a national and international 
leader in the field of children’s men¬ 
tal health. Its programs in early 
childhood development, child¬ 
hood trauma,Tourette syndrome, 
obsessive-compulsive disorder, 
mental retardation, autism and 
other pervasive developmental 
disorders are national models. 
Volkmar, the Irving B. Harris Pro¬ 
fessor in the Child Study Center 
and professor of child psychiatry, 
pediatrics and psychology, came 
to Yale as a fellow in 1980 and 
joined the medical school faculty 
two years later. 
An editor of the Handbook 
of Autism and Pervasive Develop¬ 
mental Disorders (3rd ed., 2005), 
Volkmar was the primary author 
of the autism section of the Diag¬ 
nostic and Statistical Manual of 
Mental Disorders, 4th ed. (dsm-iv), 
published in 1994.This month he 
became editor of the Journal of 
Autism and Developmental Dis¬ 
orders, the field’s oldest academic 
journal. Volkmar has also made 
major contributions to the 2001 
monograph, Educating Children 
With Autism, written for the Com¬ 
mittee on Educational Interven¬ 
tions for Children with Autism of 
the National Research Council. He 
succeeds Alan E. Kazdin, ph.d., who 
had served as director since 2002. 
JAMES C. TSAI, M.D., M.B.A., 
was named chair of the Depart¬ 
ment of Ophthalmology and 
Visual Science, effective October 1. 
Tsai was associate professor of 
ophthalmology and director of the 
glaucoma division at the Edward 
S. Harkness Eye Institute of the 
Columbia University College of 
Physicians and Surgeons. He suc¬ 
ceeds M. Bruce Shields, M.D., who 
had served as chair since 1996. 
Tsai’s goal for the department 
is to make it an internationally 
recognized leader in patient care, 
vision research and medical edu¬ 
cation. He plans to recruit clini¬ 
cians and basic scientists with a 
focus on translational studies. 
His investigations have concen¬ 
trated on three areas related to 
glaucoma: the search for molecules 
with the potential to protect the 
optic nerve from damage directly 
without lowering intraocular pres¬ 
sure, the evaluation of surgical out¬ 
comes in glaucoma patients and 
the development of advanced tech¬ 
niques of vision testing. 
Tsai is a fellow of the American 
Academy of Ophthalmology, the 
American College of Surgeons and 
the Royal Society of Medicine in 
the United Kingdom. 
BRIAN R. SMITH, M.D., has 
been named chair of the Depart¬ 
ment of Laboratory Medicine 
and chief of laboratory medicine 
at Yale-New Haven Hospital. His 
three-year term began on July 1. 
Smith has served on the Yale 
faculty since 1989. His research 
interests in basic and translational 
science center on the biology of 
the inflammation-coagulation 
interface. Since 1997, Smith has 
served as vice chair of the depart¬ 
ment, which is a major center for 
research, patient care and teach¬ 
ing in laboratory medicine. The 
department has one of the few 
National Institutes of Health 
research training grants in trans¬ 
fusion medicine and hemato- 
pathology. The department 
performs nearly 5 million clinical 
tests each year. 
Smith succeeds Peter I. Jatlow, 
m.d., hs ’65, who had headed the 
department since 1984. 
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Tarek Fahmy and Erin Lavik 
Three Yale School of Medicine 
researchers investigating schizo¬ 
phrenia, depression and Tourette 
syndrome recently received Dis¬ 
tinguished Investigator Awards 
from the National Alliance for 
Research on Schizophrenia and 
Depression. The one-year grants 
are intended to encourage study 
of areas of neuropsychiatric 
research that present special 
opportunities for discovery. 
Angus C. Nairn, PH.D., profes¬ 
sor of psychiatry and pharmacol¬ 
ogy, is studying brain-derived 
neurotrophic factor, which has 
been implicated in several psy¬ 
chiatric disorders, including 
schizophrenia and depression. 
Paul J. Lombroso, M.D., the 
Elizabeth Mears and House 
Jameson Professor of Child Psy¬ 
chiatry in the Child Study 
Center, will use an animal model 
to investigate the molecular 
events associated with Tourette 
syndrome, a childhood disorder 
characterized by repetitive 
movements and vocalizations. 
John H. Krystal, M.D., the 
Robert L McNeil Jr. Professor of 
Clinical Pharmacology and pro¬ 
fessor of psychiatry, will use 
functional magnetic resonance 
imaging to collect pilot data on 
20 healthy human subjects to 
determine whether certain brain 
receptors are related to the cog¬ 
nitive deficits in schizophrenia. 
Two assistant professors have 
received Wallace H. Coulter 
Foundation Early Career Transla¬ 
tional Research Awards in Bio¬ 
medical Engineering. Erin Lavik, 
sc.D., was granted the award 
for developing, in collaboration 
with scientists at the University 
of Iowa, a long-term delivery 
system for medications to lower 
intraocular pressure in glaucoma 
Myron Cenel Andres Martin Michelle Bell Sven-Eric Jordt 
patients. Tarek Fahmy, PH.D., in 
collaboration with Joseph Craft, 
m.d., professor of medicine and 
immunobiology, developed a 
platform technology that prom¬ 
ises to detect, through magnetic 
resonance imaging, cells that 
cause autoimmune disease, and 
to deliver drugs to those cells. 
Two Yale environmental scien¬ 
tists were among eight who will 
share $3.6 million in grants from 
the National Institute of Envi¬ 
ronmental Health Sciences. The 
Outstanding New Environmental 
Scientist Award supports early- 
career scientists who make long¬ 
term commitments to environ¬ 
mental health research. 
Michelle L. Bell, PH.D., assist¬ 
ant professor of environmental 
health and of epidemiology and 
public health, will study the rela¬ 
tionship between outdoor con¬ 
centrations of ozone and the 
incidence of respiratory disease 
and death in exposed popula¬ 
tions. Sven-Eric Jordt, PH.D., assist¬ 
ant professor of pharmacology, 
will study the ways in which air¬ 
borne pollutants interact with 
sensory nerve cells to cause eye, 
nose and throat irritation. 
Jonathan S. Bogan, M.D., assistant 
professor of medicine (endocri¬ 
nology), has been named one of 
five Distinguished Young Scholars 
in Medical Research for 2006 
by the W. M. Keck Foundation. 
Bogan studies the way in which 
insulin triggers cells to take up 
glucose from the blood. 
Myron Cenel, M.D., professor 
emeritus of pediatrics and past 
chair of the Association of 
American Medical Colleges’ 
Council of Academic Societies, 
was appointed in July to the 
Health and Human Services 
Secretary’s Advisory Committee 
on Human Research Protections. 
The 11-member committee 
meets three times a year to pro¬ 
vide recommendations to the 
secretary on the responsible 
conduct of research involving 
human subjects. 
Andres S. Martin, M.D., M.P.H. ’02, 
has been named editor of the 
Journal of the American Academy 
of Child and Adolescent Psychiatry, 
effective January 2008. Martin, 
an associate professor of child 
psychiatry and psychiatry in the 
Yale Child Study Center, is also 
the medical director of the 
Children’s Psychiatric Inpatient 
Service at Yale-New Haven 
Children’s Hospital. 
Annette M. Molinaro, PH.D., 
assistant professor of public 
health (biostatistics), was 
awarded a three-year, $500,000 
grant by the National Cancer 
Institute in July to develop 
statistical methods for search¬ 
ing large sets of genomic, epi¬ 
demiologic and pathological 
data for variables that predict 
cancer outcomes. 
Marvin Moser, M.D., clinical 
professor of medicine, was hon¬ 
ored for “Outstanding Contribu¬ 
tions to the Advancement and 
Promotion of Scientific Research 
and Clinical Investigations 
Into Blood Pressure Related to 
Cardiovascular Health" at the 
annual meeting in May of the 
American Society of Hyperten¬ 
sion in New York. 
Annette Molinaro 
Barry L. Zaret, M.D., the Robert W. 
Berliner Professor of Medicine, 
received the Distinguished 
Service Award of the American 
Society of Nuclear Cardiology at 
its annual meeting in Montreal 
in September. The award was 
based on Zaret’s contributions 
to the field of nuclear cardiology 
and his 10-year term as the 
founding editor in chief of the 
Journal of Nuclear Cardiology. 
Heping Zhang, PH.D., professor of 
biostatistics in the Department 
of Epidemiology and Public 
Health, was named a fellow of 
the Institute of Mathematical 
Statistics at their annual meet¬ 
ing in Rio de Janeiro in August. 
Hongyu Zhao, PH.D., the Ira V. 
Hiscock Associate Professor of 
Public Health, has been elected 
a fellow of the American Statis¬ 
tical Association, a scientific and 
educational society established 
to promote excellence in the 
application of statistics. 
SEND FACULTY NEWS TO 
Claire M. Bessinger, Yale Medicine, 
300 George Street, Suite 773, 





















Beyond the white coat: 
training great doctors 
The deputy dean of education discusses 
outstanding physicians and what they 
must be able to say to their patients. 
In his welcoming speech to 100 mem¬ 
bers of the Class of 2010 at the White 
Coat Ceremony on August 29, Richard 
Belitsky, m.d., reminisced about his 
own introduction to medical school. 
His role models, he said, were the tele¬ 
vision doctors of his youth. “I wanted 
to be smart like Dr. Casey. I wanted 
to be compassionate like Dr. Welby. 
I wanted to be good-looking like Dr. 
Kildare,” he said, provoking laughs 
from the audience. 
Turning serious, Belitsky, the deputy 
dean for education and associate pro¬ 
fessor of psychiatry, acknowledged that 
the students have much to learn. “But 
so much of what you need to be 
really good doctors, you already know,” 
he said. 
Belitsky went on to list the quali¬ 
ties he believes are essential to being 
a good doctor. “Becoming a great doc¬ 
tor begins not with what you know, 
but who you are. Being someone’s 
doctor is about a relationship. That 
relationship is built on trust,” he 
said. “Being a great doctor begins not 
with what you have to say, but your 
ability to listen.” 
He concluded with what doctors 
need to be able to say. “First, ‘I’m 
sorry,’” he said. “Things go wrong. 
Sometimes it’s your fault. Sometimes 
it’s nobody’s fault. ... Things go 
wrong. Sometimes the most healing 
thing that you can do is to acknowl¬ 
edge that by saying ‘I’m sorry.’ ” 
The other things doctors need to 
know how to say include “ ‘I don’t 
know,’ ” he said. “Being great doctors 
doesn’t mean you have to know every¬ 
thing. You can’t. What is the main 
thing you need to know? The limits 
of what you know. You can't just say 
‘I don’t know.’ Something else has to 
happen. ‘I don’t know ... yet. But I 
will find out.’ ” 
—John Curtis 
ABOVE Jonathan Belman, Marie Bewley, 
Adriana Blakaj and Gregory Blanton watch as 
their classmates don white coats. 
top RIGHT Deputy Dean Richard Belitsky 
welcomes students and parents at a reception 
after the ceremony. 
BOTTOM right The Class of 2010 gathers in 
the rotunda of the Cushing/Whitney Medical 
Library for a group photo. 
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“You are the guardians of 
your profession/' speaker 
tells new Physician Associates 
Twenty-nine students in the Physician 
Associate Class of 2006 received 
their degrees at Commencement in 
September, entering a profession that 
has grown from small beginnings in 
the 1960s to more than 60,000 practi¬ 
tioners with their own national and 
specialty organizations. In his address, 
Commencement speaker Jerome P. 
Kassirer, m.d., noted advances in the 
profession but sounded a note of cau¬ 
tion for all health care practitioners, 
including physician assistants. They 
face challenges, he said, over conflicts 
of interest, the influence of the phar¬ 
maceutical industry and ethical stan¬ 
dards not designed for what he called a 
“market-driven” health care system. 
“What is the antidote to all of these 
threats? How do we respond as indi¬ 
viduals?” asked Kassirer, editor in chief 
emeritus of the New England Journal 
of Medicine. “The only antidote I know 
for these threats is professionalism.” 
He defined professionalism as a 
combination of technical competence, 
a commitment to self-improvement 
and a requirement to use knowledge 
and competence in the best interests 
of patients. “You alone,” he said, “are 
the guardians of your profession.” 
Dean Robert J. Alpem, m.d., Ensign 
Professor of Medicine, then pre¬ 
sented a challenge to the new physi¬ 
cian associates. 
“I challenge you to strive to be great. 
There will be many times in your 
careers when you will make a choice, 
when you strive to be your best or 
just try to get by. I hope you will strive 
to be the best,” he said. “You can be 
smart. You can be hard-working. But 
you have to care for your patients.” 
Student awards went to Maura 
Brenniclc, m.m.sc., pa ’06, who 
received the Academic Achievement 
Award, Anne Flitner, m.m.sc., pa ’06, 
who received the Clinical Excellence 
Award, and Scott McKay, m.m.sc., pa 
’06, who was given the Dean’s Humani¬ 
tarian Award for his work with the 
Student-Run Free Clinic. 
The Didactic Instruction Award for 
dedication and excellence in the class¬ 
room went to Kalpana Gupta, m.d., 
m.p.h., assistant professor of medicine 
(infectious diseases). The Clinical 
Instructor Award, for a clinical rotation 
site that provides exemplary clinical 
teaching, was given to two preceptors 
in geriatric medicine, Chandrika Kumar, 
m.d., of Harborside Healthcare Arden 
House in Hamden, Conn., and assist¬ 
ant clinical professor at Yale Geriatric 
Services, and Gerard Kerins, m.d., sec¬ 
tion chief of geriatric medicine at the 
Hospital of Saint Raphael. The Jack 
Cole Society Award, for significant con¬ 
tributors who support the physician 
associate profession, was given to Claire 
Hull, pa-c, a former academic coordina¬ 
tor of the program who is now at 
Oregon Health & Science University. 
—J-C. 
top Jerome Kassirer, former editor in chief 
of the New England Journal of Medicine, urged 
graduates to use professionalism to confront 
the challenges facing health care practitioners. 
middle Rebecca Pooley, Catherine Rabbitt 
and Anne Flitner pose for a photo before the 
Commencement ceremony. 
bottom Kolby Vaughan, with his daughter, 
































40 Alumni faces 
Juan Lubroth believes avian flu’s real threat 
to humans is its ability to disrupt people’s 
livelihoods and deny them a source of food. 
Avian influenza— 
it’s strictly for the birds 
A Yale alumnus who investigates 
animal diseases for the UN believes 
a human pandemic is unlikely. 
Sitting in his Rome office, gazing at 
cypress trees and terra cotta rooftops, 
Juan Lubroth, d.v.m., m.phil. ’92, 
ph.d. ’95, sighs when he hears the 
words “avian influenza pandemic”— 
not because he foresees the demise of 
the human race in a terrifying display 
of sickness and death, but because he 
believes that such concerns currently 
have little merit. 
“After over two years of looking at 
avian influenza, I do not see an immi¬ 
nent pandemic occurring in humans. 
Yes, we have had a little over 100 deaths 
in humans attributed to this virus, but 
this pales in comparison with deaths 
from other pathogens in humans, such 
as hiv, tuberculosis and childhood 
diarrhea,” Lubroth said during an 
interview last spring. And he should 
know. As the senior officer and head 
of the Emergency Prevention System 
(empres) livestock component at the 
Food and Agriculture Organization of 
the United Nations since 2002, Lubroth 
and his team have contained numer¬ 
ous avian influenza outbreaks. From 
their analysis of the viral sequence, 
they don’t believe we are any closer to 
a human pandemic. 
“Avian influenza needs to be put 
into perspective. Today, I have an epi¬ 
demic in poultry, and people’s liveli¬ 
hoods and source of protein are at 
stake. That is my battle right now— 
in poultry,” Lubroth said. To shore up 
this form of food security, he and his 
team are trying to teach poultry han¬ 
dlers how to improve their hygienic 
practices in order to reduce the spread 
of avian influenza among chickens 
and, in turn, among humans. These 
responsibilities fall under Lubroth’s 
mandate to track the international 
animal trade and ensure that food 
products are safe and free from such 
infectious agents as those that cause 
foot-and-mouth disease, swine fever, 
Rift Valley fever and avian influenza, 
among others. Lubroth jokes that 
he lives in Alitalia—Italy’s national 
airline—given his frequent travels 
to Thailand, Egypt, Turkey, Vietnam 
and China. 
As a veterinarian, Lubroth is the 
self-described “black sheep” in a 
family of architects—his father, grand¬ 
father, one of his two brothers, his 
sister, an uncle and a cousin are all 
architects. Even his only child, 28-year- 
old Gregorio, is in his third year at 
the Yale School of Architecture mas¬ 
ter’s program. Yet during his childhood 
in Madrid, Lubroth found himself 
drawn to a different calling. His family’s 
large verdant garden, full of animals, 
formed a pastoral oasis amidst the 
high-rises of the bustling city. Born the 
youngest of four children in 1957, it 
fell to him to clean up after the family’s 
dogs, cats, chickens and ducks. Lubroth 
demonstrated an aptitude for caring 
for animals, and when he was 12 he 
began volunteering at a local veteri¬ 
nary clinic. As he matured, Lubroth 
increasingly appreciated the relation¬ 
ship between human health and 
animal health, and he felt that investi¬ 
gating that link represented an ideal 
strategy for improving the lives of 
individuals in developing countries. 
To further his education and escape 
the political unrest in Spain during 
the transition from the dictatorship of 
Francisco Franco to democratic rule, 
Lubroth accepted a scholarship at 
Whitman College in Walla Walla, Wash., 
where he studied biology and played 
on the college's soccer team. At the 
University of Georgia he earned a mas¬ 




























Louis Kirchhoff has spent his career studying 
Chagas disease and recently developed an assay 
for screening the U.S. blood supply for the 
debilitating disease. 
and worked as a wildlife biologist. 
While there he met his wife of 24 years, 
Adriana, a native of Colombia, at a 
concert by the B-52’s. As he puts it, 
Lubroth married both Adriana and her 
young son, Gregorio. Lubroth stayed 
on at the university to earn his veteri¬ 
nary degree, fulfilling a longtime dream. 
Since then, Lubroth’s professional 
pursuits have led him far and wide: 
to New York to study foreign animal 
diseases, to Mexico City to prevent 
foot-and-mouth disease and to Brazil 
for more studies of foot-and-mouth. 
Before his appointment to empres, 
which is based in Rome, Lubroth 
headed the Reagents and Vaccine Sec¬ 
tion and Diagnostic Services Section 
at the Plum Island Animal Disease 
Center of the U.S. Department of 
Agriculture in New York. During his 
travels and many jobs, Lubroth picked 
up a second master’s degree along 
with a ph.d. from Yale’s Department 
of Epidemiology and Public Health, 
where he focused his interests in infec¬ 
tious diseases, specifically foot-and- 
mouth disease. 
Through it all, Lubroth’s mission 
has remained the same: “It is my pas¬ 
sion to work with developing countries 
to help with their strife by providing 
better health, both in animals and in 
humans.” Although his nonstop travel 
limits his time with his wife and pre¬ 
vents him from weeding through the 
stacks of articles and files cluttering 
his office, Lubroth is delighted with his 
position. “I feel that there is only one 
medicine, there is only one health. 
Whether it is environmental or wildlife 
or livestock, we are dealing with the 
same world,” he said. 
—Kara A. Nyberg 
A road trip in Latin America 
and a lifelong interest in a 
debilitating endemic disease 
In 1966 a young Harvard graduate 
with a B.A. in Romance languages and 
literature set out on a three-month 
drive through Mexico and Central 
America. The part-time interpreter for 
the U.S. Department of State never 
imagined that his road trip would lead 
to a career in medical science. 
“The culture was fascinating, the 
poverty oppressive, and I got hooked 
on Latin America,” recalled Louis V. 
Kirchhoff, m.d. ’77, m.p.h. ’77. In 
1967, determined to use his fluency 
in Spanish and Portuguese to improve 
lives, Kirchhoff, the son of a Chicago 
insurance agent, became the lone Peace 
Corps volunteer in drought-prone 
Apodi, a Brazilian town without run¬ 
ning water, electricity or paved streets. 
Kirchhoff set out to demonstrate 
that vegetables could be grown out of 
season—a project that would require 
irrigation. He rented 2.5 acres of land, 
then organized sharecropper families 
to build an irrigation system. That led 
to year-round crops—and income. By 
the early 1970s, Apodi, in the north¬ 
eastern state of Rio Grande do Norte, 
was nicknamed the “Tomato Capital” 
of the westernmost region. 
Despite the agricultural improve¬ 
ments, Kirchhoff recognized that the 
sharecroppers of Apodi had few options. 
“They had no access to education, better 
jobs or even birth control information,” 
he said. Health care consisted of two 
pharmacists dispensing informal diag¬ 
noses and prescription drugs. 
“Everyone had parasites, so I got 
a book on them,” recalled Kirchhoff. 
That’s when he learned about Chagas 
disease, a major cause of morbidity and 
death in Latin America that is associ¬ 
ated with poverty and a semi-arid cli¬ 
mate. The Chagas parasite (Trypanosoma 
cruzi) is transmitted when infected 
reduviid bugs (also known as triato- 
mine or kissing bugs for their habit of 
attacking the face) gorge themselves 
on blood drawn from sleeping people 
and deposit parasite-laden feces near 
the site of the bite wound. The para¬ 
sites enter the wound when the victim 
scratches the bite. Chagas causes 
debilitating, sometimes fatal, cardiac 
and gastrointestinal manifestations 
in 10 to 30 percent of those who have 
it, even decades after transmission. 
Convinced that infectious diseases 
were the biggest health problem in 
poor tropical regions, Kirchhoff left 
Brazil with a reawakened childhood 
career goal. His Russian-born mother 
had always urged him to become a 
doctor, one of her own criteria for 
success in America. He returned to 
school and took undergraduate as 
well as graduate science and epidemi¬ 
ology courses only to discover—at 
26—rampant age discrimination at 
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Yale admitted Kirchhoff to its m.d./ 
m.p.h. program. 
In 1976 he found himself back in 
Brazil because his thesis advisor, 
Alfred Evans, m.d., was studying links 
between Epstein-Barr virus (ebv) and 
tumors in Brazil. After a lengthy initial 
interview, Evans asked, “You don’t 
happen to speak Portuguese, do you?” 
Kirchhoff spent four months in 
Sao Paulo studying a possible Hodgkin 
lymphoma-EBV link. Collecting and 
organizing data solidified Kirchhoff’s 
love of research and earned him 
Yale’s Harold Lamport Biomedical 
Research Prize at graduation. 
After a residency in internal medi¬ 
cine at Michigan and a four-year fellow¬ 
ship at the National Institutes of Health’s 
National Institute of Allergy and 
Infectious Diseases, in 1985 he became 
an assistant professor at the University 
of Iowa College of Medicine and began 
studying Chagas genetics and diagnos¬ 
tics. Between 12 and 14 million people 
(including about 100,000 residents of 
the United States) harbor the Chagas 
parasite; about 25,000 die annually, 
typically of premature heart disease. 
Asymptomatic in 70 to 90 percent of 
cases, Chagas is easily transmitted 
by blood transfusion. Kirchhoff wanted 
to develop an accurate seriodiagnostic 
tool to avoid transmission of the para¬ 
site by transfusion. 
His appointment in 1990 as associ¬ 
ate professor of internal medicine, 
infectious diseases and epidemiology 
at the University of Iowa brought 
him nearer to his goal. “Getting tenure 
brought more freedom to explore 
less traditional avenues of academic 
research, in technology transfer and 
commercialization,” said Kirchhoff. He 
had already developed a radioimmune 
precipitation assay, still the gold stan¬ 
dard for confirmatory testing, yet 
slow and complicated to use. With co¬ 
inventor Keiko Otsu, he employed 
recombinant dna technology to develop 
chimeric antigens as the basis of a 
test that is accurate and easy to use. 
Last year the company he founded 
in 1998, Goldfinch Diagnostics, signed 
a licensing agreement with Abbott 
Laboratories to use the chimeric anti¬ 
gens as the basis of an automated 
assay for screening the United States 
blood supply for Chagas. The assay 
may eventually be marketed in Latin 
America as well. And in September 
Kirchhoff received a national Tibbetts 
Award for the development of the 
chimeric antigens. 
Settled in Iowa City, Kirchhoff, who 
is divorced, continues to attend on 
internal medicine and infectious dis¬ 
ease services. His children, Alicia, 
29, and Aaron, 26, are both artists. 
Kirchhoff’s favorite pursuits include 
foreign films, National Public Radio 
and jogging. (In June, he ran his 
sixth marathon—in Argentina.) 
“I get an enormous sense of accom¬ 
plishment thinking about what my 
technology may do,” Kirchhoff reflected. 
“When the automated assay comes to 
market, it will be very satisfying that I 
could have an original idea, bang away 
at it in my lab for 10 years and finally 
be able to more effectively protect trans¬ 
fusion recipients. I will be delighted.” 
—Carol Milano 
Sharing a home, a family 
and science—two alumni try 
to make a difference 
Jonathan and Bonnie Rothberg share 
not only a home and family but also a 
passion for probing the mysteries of 
the human genome. Together and sepa¬ 
rately, they attempt both to untangle 
genetic differences among individuals 
that can affect disease and to develop 
novel treatments that target disease at 
the genetic and molecular levels. 
In 1993, when many scientists were 
trying to decipher the human genome, 
Jonathan Rothberg, ph.d. ’91, had a 
vision: to mine the genome for drug 
targets. He founded CuraGen, a com¬ 
pany that uses information systems, 
automation and robotics to develop 
drugs that target specific genes. In the 
company’s early years, Jonathan would 
bring home sets of newly generated 
differential gene expression (dge) pro¬ 
filing data sets and ask his wife, Bonnie 
Gould Rothberg, m.d. ’94, m.p.h. ’05, 
to apply her medical background to 
make sense of the data. By January 
1997, midway through her internal 
medicine residency at Yale-New Haven 
Hospital and with Jordana, the first of 
their three children, still an infant, she 
decided to place her clinical training 
on hold and assume a full-time posi¬ 
tion designing and analyzing dge data. 
So she joined Jonathan at CuraGen, 
where she developed a pharmacoge- 
nomics program to understand the 
mechanisms that underlie differing 
responses to drugs. CuraGen developed 
five drugs (all in preclinical and clinical 
development) for treating cancer, the 
adverse effects of chemotherapy, kid¬ 
ney inflammation and type 2 diabetes. 
Bonnie Gould-Rothberg and Jonathan 
Rothberg share an interest in science and 
medicine, which they advance through 
their companies and foundation. 
As CuraGen grew, so did the Roth¬ 
berg family. The birth of their second 
child, Noah, in 1999, led Jonathan 
to start another company. Noah turned 
blue the night he was born and the 
doctors had no idea what was wrong. 
“I wished I could just read off his 
genome,” said Jonathan. “I had a 
computer magazine with me and I 
thought that since the computer guys 
have been able to make things a mil¬ 
lion times faster and a million times 
cheaper by putting them on a chip, 
why not the genome?” Noah quickly 
turned a healthy pink, but nonetheless 
Jonathan created a new company, 454 
Life Sciences, to pursue his vision of 
sequencing genomes. 
454 Life Sciences is also attempting 
to reconstruct the genome of Neander¬ 
thals, an evolutionary predecessor and 
possibly a subspecies of modern Homo 
sapiens. “The wonderful thing about 
the Neanderthal project is that we may 
uncover the molecular basis for the 
mind,” Jonathan said. Since the genetic 
difference between modern humans 
and Neanderthals is only one-twentieth 
of 1 percent and the main distinction 
between the two species is largely 
cognitive, it’s possible that just a hand¬ 
ful of genes are involved in human 
brain function. 
But that’s not the Rothbergs’ only 
project. In 2002, Jonathan formed The 
Rothberg Institute for Childhood Dis¬ 
eases, a nonprofit organization dedi¬ 
cated to finding a cure for tuberous 
sclerosis, a genetic disorder that causes 
benign tumors to grow in the brain 
and other vital organs throughout the 
body, as well as cures for other orphan 
diseases of childhood. With three chil¬ 
dren under the age of five, Bonnie 
joined the institute as director of clinical 
development. Although her medical 
degree served her well, she felt that she 
needed formal training in clinical 
research design and analysis to conduct 
large-scale clinical research. While earn¬ 
ing an m.p.h. at Yale, she rediscovered 
genomics as a subdiscipline of molecu¬ 
lar epidemiology and is now pursuing a 
doctorate in chronic disease epidemiol¬ 
ogy. She is working with David L. 
Rimm, m.d., hs ’91, ph.d., associate 
professor of pathology, using tissue 
microarrays to find proteins that could 
serve as prognostic markers for the 
speed of growth in melanoma tumors. 
Her work has also come full circle: at 
CuraGen she participated in the dis¬ 
covery of a drug for melanoma, a dis¬ 
ease that she is now studying at Yale, 
where the drug is currently being tested. 
With 25 U.S. patents, work featured 
on the covers of Cell, Science and Nature 
and election to the National Academy of 
Engineering in 2004, Jonathan has 
moved on to his next project, which he 
calls the culmination of his life observa¬ 
tions. “If you walk into a lab, it’s very 
inefficient,” he said. “So I decided that 
instead of just miniaturizing gene 
sequencing, why not create a general- 
purpose machine very much like a com¬ 
puter but that would move chemicals or 
lab components around?” In 2004, he 
founded RainDance Technologies to 
develop a system for testing, profiling or 
sorting samples used in chemistry, 
molecular biology and biochemistry on 
disposable chips. The company expects 
to ship its first machine, which it calls 
the Personal Laboratory System, or pls, 
in 2007. 
Although Jonathan and Bonnie are 
both fascinated by science, it wasn’t 
their shared academic interests that 
brought them together. The two met at 
a party in 1993, but only began dating 
three months later when Bonnie found 
an opening in her on-call schedule. 
They were married in 1995. Jonathan 
acknowledges that hundreds of dedi¬ 
cated people have helped him turn his 
groundbreaking ideas into commercial 
successes. But he recognizes that his 
most important partnership, in life and 
in work, is with Bonnie. 
—Jill Max 
Familiar Faces 
Do you have a colleague who is making 
a difference in medicine or public 
health or has followed an unusual path 
since leaving Yale? We’d like to hear 
about alumni of the School of Medicine, 
School of Public Health, Physician 
Associate Program and the medical 
school’s doctoral, fellowship and 
residency programs. Drop us a line at 
ymm@yale.edu or write to Faces, 
Yale Medicine, 300 George Street, Suite 




















Aaron Beck Elizabeth 
Blackburn 
Joseph Call 
Three Yale alumni received Lasker 
Awards in September for out¬ 
standing research in medicine. 
For 61 years the Albert Lasker 
Medical Research Awards, among 
the most coveted in science, 
have honored scientists, physi¬ 
cians and public servants who 
have made major advances in 
the understanding, diagnosis, 
prevention, treatment and cure 
of many of the great crippling 
and killing diseases of the 20th 
and 21st centuries. 
This year's recipients include 
Aaron T. Beck, m.d. ’46, who on 
September 17 received the 2006 
Albert Lasker Award for Clinical 
Medical Research, "for the 
development of cognitive 
therapy, which has transformed 
the understanding and treat¬ 
ment of many psychiatric condi¬ 
tions, including depression, 
suicidal behavior, generalized 
anxiety, panic attacks and 
eating disorders.” 
Beck is university professor 
emeritus of psychiatry at the 
University of Pennsylvania, where 
he joined the faculty in 1954. His 
initial research dealt with the 
psychoanalytic theories of depres¬ 
sion, but he subsequently de¬ 
veloped a different theoretical- 
clinical approach that he called 
cognitive therapy. Since 1959 
he has directed research into the 
psychopathology of depression, 
suicide, anxiety disorders, panic 
disorders, alcoholism, drug abuse 
and personality disorders, as well 
as the application of cognitive 
therapy to these disorders. His 
most recent work has focused on 
reducing the number of suicide 
attempts among chronic attempt- 
ers and patients diagnosed with 
borderline personality disorder. 
The two other Yale alumni 
to receive Lasker awards were 
colleagues here in the 1970s. 
Elizabeth H. Blackburn, PH.D., 
fw ’77, sc.D.H. ’91, the Morris 
Herzstein Professor of Biology 
and Physiology in the Depart¬ 
ment of Biochemistry and 
Biophysics at the University of 
California, San Francisco, shared 
in the Albert Lasker Award for 
Basic Medical Research. She won 
the award, along with Carol W. 
Greider, ph.d., of Johns Hopkins, 
and Jack W. Szostak, ph.d., of 
Harvard, for the prediction and 
discovery of telomerase, an 
enzyme that contains rna and 
synthesizes the ends of chromo¬ 
somes, protecting them and 
maintaining the integrity of the 
genome. Blackburn began her 
research in this area while she 
was a postdoctoral fellow at Yale. 
Blackburn earned her doc¬ 
torate from the University of 
Cambridge in England in 1975 
and did her postdoctoral work 
at Yale from 1975 to 1977 in 
molecular and cellular biology 
in the laboratory of another 
2006 Lasker honoree, Joseph C. 
Call, PH.D. ’52. 
“As a postdoctoral fellow in 
my lab at Yale,” Gall recalled, 
"Liz identified the short dna 
sequence that defines the 
telomeres, or ends of chromo¬ 
somes. Later when she and her 
student, Carol Greider, found 
the enzyme (telomerase) that 
adds these sequences to 
chromosomes, everyone knew 
immediately that they had 
made a monumental discovery. 
Since then, the importance of 
their discovery has only grown.” 
Among other honors and 
awards, Blackburn was named 
California Scientist of the Year 
in 1999, elected President of 
the American Society for Cell 
Biology for the year 1998 and 
served as a board member of 
the Genetics Society of America 
(2000-2002). Dr. Blackburn is an 
elected fellow of the American 
Academy of Arts and Sciences 
(1991), the Royal Society of 
London (1992), the American 
Academy of Microbiology (1993) 
and the American Association 
for the Advancement of Science 
(2000). She was elected Foreign 
Associate of the National Acad¬ 
emy of Sciences in 1993, and was 
elected as a member of the 
Institute of Medicine in 2000. 
Gall received the Albert Lasker 
Award for Special Achievement 
in Medical Science,“for a distin¬ 
guished 57-year career—as a 
founder of modern cell biology 
and the field of chromosome 
structure and function; bold 
experimentalist; inventor of in 
situ hybridization; and early 
champion of women in science.” 
Gall, now at the Carnegie 
Institution (Department of 
Embryology at Baltimore), ranks 
among the most distinguished 
cell biologists in the history of 
the discipline. 
Among Gall’s awards are the 
2004 Society for Developmental 
Biology Lifetime Achievement 
Award and the 1996 American 
Association for the Advance¬ 
ment of Science Mentor Award 
for Lifetime Achievement. In 
1988 he received the Wilbur 
Lucius Cross Medal, the highest 
honor bestowed by the Yale 
Graduate School on exception¬ 
ally distinguished alumni. 
195OS 
Eiji Yanagisawa, M.D., HS ’59, clini¬ 
cal professor of otolaryngology, 
received the Presidential Citation 
from the American Laryngologi- 
cal, Rhinological and Otological 
Society at its 109th annual meet¬ 
ing in Chicago in May. The award 
was given in recognition of his 
contributions to otolaryngology 
and head and neck surgery. 
197OS 
Deborah Rose, M.P.H. ’77, PH.D. ’89, 
has been selected by the Asso¬ 
ciation of Yale Alumni (aya) to 
receive the Yale Medal, the high¬ 
est award presented by the aya 
and conferred in recognition of 
outstanding service to the uni¬ 
versity. Since its inception in 
1952, the Yale Medal has been 
presented to 257 individuals, 
all of whom not only showed 
extraordinary devotion to the 
ideals of the university, but also 
demonstrated their support 
of Yale through extensive and 
exemplary voluntary service on 
behalf of Yale as a whole or one 
of its many schools, institutes or 
programs. Rose has served her 
class as secretary, class council 
member and reunion chair. Her 
dedication extends beyond 
her class to many areas of the 
university and the surrounding 
community, including the Ster¬ 
ling Memorial Library, Jonathan 
Edwards College and the new 
Rose Center that houses both 
the Yale Police Department and 
the Dixwell Community Center. 
45 
Kate Lally and Antony Chu 
She initiated computerization of 
the branch libraries of the New 
Haven Free Public Library. A 
longtime supporter of Yale’s ini¬ 
tiatives to help revitalize the city 
of New Haven, Rose has worked 
since her earliest days at Yale 
with community outreach 
programs through Dwight Hall, 
the Yale-affiliated student-run 
public service organization. 
Robert E. Steele, m.p.h. ’71, PH.D. 
’75, president of the Association 
of Yale Alumni in Public Health 
(ayaph), has received the 2006 
Nathan Hale Award for his 
efforts in establishing a Nathan 
Hale Scholarship in 2006, which 
is being named the Association 
of Yale Alumni in Public Health 
Board Scholarship.The scholar¬ 
ship will be awarded to a stu¬ 
dent in the Department of 
Epidemiology and Public Health 
(eph). Steele has made fund¬ 
raising one of the top priorities 
of the ayaph board. During his 
presidency Steele has ensured 
that the eph Alumni Fund 
reaches its goal by writing 
letters, calling alumni, nego¬ 
tiating with major donors and 
contributing his own funds. 
198OS 
Christiane Nockels Fabbri, PA-c 
’84, received a doctorate in his¬ 
tory from the Graduate School 
of Arts and Sciences in May 
2006. Her dissertation, a survey 
of medieval and early modern 
treatises on the plague, analyzes 
continuity and change in plague 
medicine from 1348 to 1599. 
Fabbri was associate director of 
the Yale Physician Associate 
Program from 1991 to 2000, and 
was voted Distinguished Alumna 
in 2004. She currently practices 
family medicine in West Haven, 
Alejandro Necochea and 
Lauren Smith 
Conn., and continues her research 
on early modern health care. She 
and her husband, Remo Fabbri Jr., 
m.d. ’64, look forward to hearing 
from any alumni visitors when 
in town. 
Justin O. Schechter, m.d., hs ’85, 
assistant clinical professor of 
psychiatry, has been appointed 
by Gov. M. Jodi Rell to serve on 
the Psychiatric Security Review 
Board (psrb) in the state of 
Connecticut.The psrb is a state 
agency to which the Superior 
Court commits persons who are 
found not guilty of a crime by 
reason of mental disease or 
mental defect.The psrb reviews 
the status of acquittees through 
an administrative hearing 
process and orders the level of 
supervision and treatment for 
the acquittee considered neces¬ 
sary to protect the public. 
Schechter, who has a special 
interest in forensic psychiatry, has 
also been appointed an associ¬ 
ate fellow of Silliman College. 
199OS 
Jonathan N. Grauer, M.D. ’97, was 
married in August to Jane S. 
Merkel, PH.D. ’00, in New Haven. 
Grauer is a director of the ortho¬ 
paedic spine service and an 
assistant professor of orthopae¬ 
dics and rehabilitation at the 
School of Medicine. Merkel is 
director of chemical genomics at 
the Center for Genomics and 
Proteomics at Yale. 
Vicki Shi and Edward Poon 
Joanne N. Ouinones, m.d. ’98, 
Bryon P. Wenrich, pa '98, and big 
sister Elena Sofia proudly 
announce the arrival of William 
Carlos Wenrich-Quinones, born 
December 29,2005. Quinones 
is an attending physician in 
maternal-fetal medicine at Lehigh 
Valley Hospital in Allentown, Pa., 
and Wenrich is a cardiothoracic 
surgery physician assistant at 
Lankenau Hospital in Wynne- 
wood, Pa. Yale classmates can 
reach the Wenrich-Quinones 
clan atjqwenrich@yahoo.com. 
2000S 
Kate M. Lally, M.D. ’02, and Antony 
F. Chu, m.d. ’02, were married in 
July in Bedford, N.H. Lally is an 
internist at a group practice in 
Radnor, Pa. Chu is a cardiology 
fellow at the University of 
Pennsylvania. Both were Howard 
Hughes Medical Institute fel¬ 
lows. Lally studied melanoma at 
the National Institutes of Health 
and Chu did work in vascular 
biology at Yale. 
Stephanie M. Marticello, M.P.H. 
’04, was married in June to 
Christopher M. Poulin in Thomas- 
ton, Conn. Marticello works as 
an epidemiologist with the state 
Department of Public Health. 
Alejandro J. Necochea, M.D. ’04, 
was married on July 1 to Lauren 
B. Smith, m.p.a., in Philadelphia. 
Necochea is a third-year resi¬ 
dent in internal medicine at the 
Hospital of the University of 
Pennsylvania. Smith is a policy 
analyst fellow with joint 
appointments at the Robert 
Wood Johnson Foundation in 
Princeton, N.J., and the Center 
for Health and Wellbeing at 
Princeton University. The two 
met in Lima, Peru, Necochea’s 
hometown, when he was on 
leave from medical school to 
study tuberculosis in shanty¬ 
towns and she was there on a 
Fulbright scholarship, studying 
microfinance, the provision 
of small loans to women entre¬ 
preneurs. 
Rahul Rajkumar, J.D. ’06, M.D. 
’06, was married in May to 
Usha-Kiran Ghia, j.d., in Cincin¬ 
nati. Rajkumar recently began an 
internship in internal medicine 
at Brigham and Women’s Hospi¬ 
tal in Boston. Ghia began clerk¬ 
ing in October for a Federal 
District Court judge in Boston. 
Vicki Shi, m.p.h. ’00, manager in 
strategic marketing for Johnson 
& Johnson’s pharmaceuticals 
division in New Jersey, was mar¬ 
ried in August to Edward Poon, 
m.d., a radiologist also based in 
New Jersey. Fellow eph grads 
who attended included Sobin 
Chang, m.p.h. ’97, Nicole Durbin, 
m.p.h. '00, Scott Durbin, m.p.h. 
’99, and Greg Kruse, m.p.h. ’01. 
send alumni news to 
Claire M. Bessinger, Yale Medicine, 
300 George Street, Suite 773, 
New Haven, CT 06511, or via e-mail 
to claire.bessinger@yale.edu 
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John L. Binder, M.P.H. ’85, a 
colonel in the U.S. Air Force, died 
on September 7 following a 
battle with cancer. He was 49. 
A resident of Yorktown, Va., 
Binder served 21 years in the Air 
Force, most recently as chief of 
the Expeditionary Medical Opera¬ 
tions Division, Headquarters Air 
Combat Command at Langley 
Air Force Base in Hampton, Va. 
His duties included directing 
functions for medical readiness 
operations, providing medical 
forces and support to planners 
throughout the world. His career 
took him all over the world and 
he served in Korea,Turkey, 
Germany, Hawaii and the conti¬ 
nental United States. As an 
executive officer at Ramstein Air 
Base in Germany, Binder was 
instrumental in the November 
1991 repatriation of Terry Waite 
and Thomas Sutherland, who 
had been hostages in Beirut in 
the late 1980s and early 1990s. 
Colonel Binder recently received 
the Legion of Merit Medal signi¬ 
fying meritorious and distin¬ 
guished service. 
Charles R. Cavanagh Jr., M.D. ’47, 
died on May 6 In Spokane, Wash. 
He was 83. Cavanagh served in 
the Navy Reserve while in medi¬ 
cal school and in the Air Force, 
where he was chief of surgery at 
Fairchild Air Force Base in 
Washington. After his military 
service he formed the Spokane 
Surgical Group. 
William L. Donegan, M.D. ’59, died 
on July 17. He was 73. An aca¬ 
demic and athletic standout in 
high school in Florida, Donegan 
earned scholarships to Exeter 
Academy, Yale University and 
the School of Medicine. He com¬ 
pleted his residency at Barnes 
Hospital-Washington University 
School of Medicine in St. Louis. 
At Ellis Fischel State Cancer 
Hospital in Columbia, Mo., he 
developed his expertise in surgi¬ 
cal oncology. In 1974 he joined 
the faculty of the Medical 
College of Wisconsin, where he 
spent the next 29 years. 
Richard K. Friedlander, M.D. ’47, 
died on June 3 in Geyersville, 
Calif. He was 82. After serving as 
house physician at the American 
Hospital in Paris, Friedlander 
went to San Francisco to train as 
a psychiatrist at the Langley 
Porter Neuropsychiatric Institute 
at the University of California, 
San Francisco (ucsf). He also 
worked in emergency psychiatric 
services at San Francisco General 
Hospital and the student health 
service at ucsf. He retired in 1983. 
Howard H. “Howdy” Groskloss, 
m.d. ’35, died on July 15 at vna 
Hospice House in Vero Beach, 
Fla. He was 100. While at the 
School of Medicine, Groskloss 
also played professional baseball 
for the Pittsburgh Pirates, from 
1930 to 1932. He practiced 
gynecology for more than 25 
years and during World War II he 
was a Navy flight surgeon. 
Terry L. Hatmaker, M.P.H. '74, died 
on July 30 in High Point, N.C. 
He was 59. Born in LaFollette, 
Tenn., Hatmaker grew up in 
Oregon. He worked at the Center 
for Life Cycle Analysis (lca) at 
Oak Ridge National Laboratory 
in Tennessee, helping to develop 
an lca system for the U.S. 
Department of Energy (doe) to 
assist in making decisions about 
decontamination at various doe 
sites. The lca system is intended 
to minimize risks to human 
health and added insults to the 
environment. 
Jay G. Hayden II, m.d. ’66, died on 
May 20 after a struggle with 
pulmonary fibrosis. He was 66. 
An anesthesiologist, Hayden 
served in the U.S. Air Force at 
Andrews Air Force Base, then 
worked at the Lahey Clinic in 
Massachusetts. In 1982 he 
moved to Maine and worked 
at the Maine Medical Center’s 
Spectrum Medical Group. 
Gueh-Djen (Edith) Hsiung, PH.D., 
an internationally recognized 
virologist and professor emeri¬ 
tus in the Department of 
Laboratory Medicine, died of 
cancer on August 20, at Con¬ 
necticut Hospice in Branford. 
She was 87. Hsiung was a pio¬ 
neer in the field of diagnostic 
virology and known for the 
techniques she invented to 
detect and characterize viruses. 
She authored a landmark text¬ 
book, established laboratories 
and trained generations of new 
professionals in the field, even 
into her early 80s. She was also 
known for her development 
of animal models to study the 
pathogenesis and treatment of 
viral infections. Hsiung was born 
in Hupei, China, and graduated 
with a degree in biology from 
Ginling College in Chengdu in 
1942. During World War II she 
tested bacterial and viral vac¬ 
cines for use in animals at the 
Ministry of Public Health in 
Lanzhou. After the war, she 
came to the United States and 
obtained her doctorate in micro¬ 
biology from Michigan State 
University in 1951. She applied 
for admission to medical school 
at Yale but was told she was too 
old. Instead she was offered a 
postdoctoral fellowship in 1953, 
working under Joseph L. 
Melnick, ph.d. ’39, on poliovirus 
and related enteroviruses. She 
joined the faculty the next year 
and, aside from a two-year 
sojourn at New York University, 
spent her entire professional 
career at Yale. 
John K. Joe, M.D., HS ’00, assistant 
professor of otolaryngology, died 
suddenly on August 8. He was 36. 
Joe came to Yale in 1995 as an 
intern in the Department of 
Surgery and completed his resi¬ 
dency in otolaryngology in 2000. 
After a fellowship at Memorial 
Sloan-Kettering Cancer Center 
and an assistant professorship at 
the Medical University of South 
Carolina, Joe returned to Yale in 
2003 to join the faculty of the 
Section of Otolaryngology in the 
Department of Surgery. He rapidly 
established himself as a premier 
head and neck surgeon and de¬ 
veloped one of the largest head 
and neck surgical oncology prac¬ 
tices on the East Coast. He spe¬ 
cialized in treating patients with 
advanced and complex cancers 
and offered the highest level of 
technical and compassionate care. 
Frederick F. Krauskopf, M.D. ’44, 
died on August 7 in Florida. 
He was 87. Born in Germany, 
Krauskopf came to the United 
States when he was 5. After a 
residency at Jackson Memorial 
Hospital in Miami, he served in 
a U.S. Medical Corps m.a.s.h. 
unit in Korea. He subsequently 
served as chief of surgery at 
Fort McClellan, Ala., and at the 
Walter Reed Army Hospital in 
Washington. He also served 
as chief of surgery and deputy 
commander of the Medical 
Center of the European Theater 
in Landstuhl, Germany. After 
serving as chief of surgery at 
Martin Army Hospital at Fort 
Benning, he retired to private 
practice in Stuart, Fla. 
Victor A. Machcinski Sr., M.D. '47, 
died of cancer in West Chatham, 
Mass., on May 11. He was 82. 
Machcinski interned at Grace- 
New Haven Community Hospi¬ 
tal and completed a surgical 
residency at New Britain Hospi¬ 
tal. He served in Korea with the 
U.S. Army Medical Corps and 
was awarded the Bronze Star. A 
fellow of the American College 
of Surgeons, he practiced at 
Danbury Hospital for 31 years. 
Ralph C. Maurer, M.D. ’67, died 
on May 12. He was 62. Maurer 
served as a major in the Medical 
Corps, U.S. Air Force Reserve, at 
the School of Aerospace Medi¬ 
cine in San Antonio. For the last 
26 years he was on the faculty 
at the University of Florida 
College of Medicine, where he 
was an associate professor of 
psychiatry and director of the 
Center for Autism and Related 
Disabilities. 
Iwao M. Moriyama, M.P.H. ’34, 
ph.d. ’37, died on June 10 in 
Cheverly, Md., of complications 
from injuries sustained in a fall. 
He was 97. In 1940 Moriyama 
joined the U.S. Public Health Ser¬ 
vice in Washington, where he 
worked for more than 30 years. 
He served on the National Com¬ 
mittee on Vital and Health 
Statistics and the World Health 
Organization’s Expert Panel on 
Health Statistics. During his 
retirement he spent three years 
studying health risks from radia¬ 
tion exposure in Hiroshima, 
Japan. 
Richard M. Peters, M.D. ’45, died 
of metastatic melanoma on 
September 1 at his home in Palo 
Alto, Calif. He was 84. Peters was 
born in New Haven, the son of 
John P. Peters, m.d., a distin¬ 
guished professor of medicine at 
the School of Medicine. After 
graduating, Peters served as a 
medical officer in the Army, and 
in 1952 he became assistant pro¬ 
fessor of surgery and head of 
cardiothoracic surgery at the 
University of North Carolina 
at Chapel Hill. In 1954 he was 
instrumental in opening the 
first intensive care unit in the 
United States for postsurgical 
patients at North Carolina 
Memorial Hospital. Eight months 
later it became the first desegre¬ 
gated ward in the hospital, a 
precedent that led to the even¬ 
tual desegregation of the entire 
hospital. In 1963 Peters’ research 
on pulmonary mechanics led 
him to recognize the need to 
use computer and physiology 
methodologies to collect and 
analyze pulmonary mechanics 
and work done on the lungs. He 
also established a postgraduate 
curriculum in bioengineering, 
one of the first of its kind in the 
country. In 1961 he was elected 
to the Chapel Hill School Board 
and was instrumental in deseg¬ 
regating the city’s public schools, 
making it the first totally deseg¬ 
regated school system in the 
South. In 1969, Peters became 
head of the division of cardio¬ 
thoracic surgery and bioengi¬ 
neering at the new University of 
California, San Diego, School of 
Medicine.Throughout his career, 
Peters was very interested in the 
teaching of medical students, 
residents and fellows. He served 
as head of the examination 
committee for the American 
Board of Thoracic Surgery and 
developed the automated sys¬ 
tem for construction of the writ¬ 
ten examination. He published 
250 articles and a book on respi¬ 
ratory mechanics; was senior 
editor of five textbooks, includ¬ 
ing a comprehensive text on car¬ 
diothoracic surgery published in 
China; and was a contributing 
author to books on pulmonary 
mechanics,fluid management 
and thoracic surgery. 
Hannah C. Russell, R.N., M.P.H. 
’60, died on September 13 in 
Avon, Conn. She was 95. Russell 
worked as an operating room 
nurse at Columbia Presbyterian 
Hospital in New York. She also 
worked at the Visiting Nurse 
Association in New Haven. She 
was an assistant professor of 
nursing at the University of 
Bridgeport and a Red Cross 
instructor during World War II. 
She was on the Planning and 
Zoning Commission in Orange, 
Conn., and served as a state rep¬ 
resentative in the Connecticut 
legislature. 
Bradford Simmons, M.D. ’39, died 
on July 13 at Marin General 
Hospital in California. He was 
94. An athlete, Simmons played 
football, rowed crew and was a 
heavyweight boxer. During 
World War li he was a Navy 
flight surgeon, and after the war 
he practiced at Southern Pacific 
Hospital, Marin General Hospital 
and San Quentin Prison. After 
retiring he served on the ship 
Hope in Brazil, at a Quaker hos¬ 
pital in Kenya, at a hospital in 
Samoa and on the Navajo Indian 
Reservation at Shiprock, N.M. 
Charles A. Slanetz Jr., M.D. ’57, 
died on June 12 in Locust Valley, 
N.Y. For 41 years Slanetz prac¬ 
ticed genera! surgery in Glen 
Cove, N.Y. He also had staff posi¬ 
tions at North Shore Hospital 
and at the University Hospital at 
Stony Brook, N.Y. His research on 
colon cancer was published in 
several journals. 
Lester J. Wallman, M.D. ’38, died 
on July 23 in Burlington, Vt., 
where he lived and practiced 
medicine since 1947. Wallman 
was born in New York City and 
received his undergraduate and 
medical degrees from Yale. He 
trained in pathology in Sweden, 
in general surgery in Delaware 
and in neurology and neurosur¬ 
gery in Connecticut. After leav¬ 
ing the U.S. Army in 1946 as a 
captain, Wallman completed his 
neurosurgery training in 
Vermont. He joined the faculty 
of the University of Vermont in 
1948. Wallman was named 
professor emeritus in 1992. He 
wrote a chapter in the univer¬ 
sity’s bicentennial history and 
established the Beaumont 
Medical History Lecture Series. 
He also served as chair of the 
Vermont State Board of Health 
and on many civic boards, 
including that of the Vermont 
chapter of the American Red 
Cross. 
Paul B. Beeson, M.D., and Robert 
G. Petersdorf, m.d. ’52, HS ’58, are 
remembered on pages 30-35. 
SEND OBITUARY NOTICES TO 
Claire M. Bessinger, Yale Medicine, 
300 George Street, Suite 773, 




















48 F0ll0W-Up Archives 50 and 25 years ago 
Ovarian cancer screening to reach patients 
Physicians refer to epithelial ovarian cancer as "the silent 
killer.” With few early symptoms, the disease often goes unde¬ 
tected until it has spread to other parts of the body and it’s 
too late for curative treatment. It ranks as the deadliest of all 
gynecological cancers, claiming approximately three of every 
four women in the United States diagnosed with the disease. 
Now a scientific team led by Gil Mor, m.d., ph.d., associate pro¬ 
fessor of obstetrics, gynecology and reproductive sciences, has 
found a way to detect the disease in its earliest stages, and 
has teamed with biopharmaceutical companies to transfer 
this technology from the bench to the bedside. 
In May 2005, Mor and colleagues, in an article in the 
Proceedings of the National Academy of Sciences, showed that 
abnormal concentrations of four cancer-related proteins— 
leptin, prolactin, osteopontin and insulin-like growth factor 
II—in blood samples could indicate the presence of epithelial 
ovarian cancer with 95 percent accuracy and 95 percent speci¬ 
ficity. [See “Biomarkers Warn of a ‘Silent Killer’,” Autumn 2005.] 
Since then they have added two other protein markers 
and the accuracy rate has risen to 98 percent and the speci¬ 
ficity rate to greater than 99.6 percent. This means that only 
20 of every 1,000 women screened will be mistakenly diag¬ 
nosed as being cancer-free, while only four of every 1,000 
screenings will yield false positives. 
Now the research team is pursuing partnerships with 
biotech companies throughout the world to develop this tech¬ 
nology commercially. Yale recently signed a licensing agree¬ 
ment with SurExam Life Science & Technology Co., a Chinese 
company founded in part by scientists trained at Yale, and 
negotiations are under way to license the technology to a new 
diagnostic company in Israel. 
Mor predicts that the test will be available in the 
United States early this year, following the completion of a 
pivotal Phase II trial being conducted by the National Cancer 
Institute in partnership with Laboratory Corporation of 
America. He hopes that his blood screen will be routinely used 
to detect epithelial ovarian cancer. “At the beginning, we 
thought this test may be appropriate only for women at high 
risk, but we now see this test as becoming a more routine 
diagnostic for screening,” he said. 
—Kara A. Nyberg 








“A record-setting grant of 
$3,600,000 to the Yale School of 
Medicine from the Ford Founda¬ 
tion was announced in March as 
part of the Foundation’s program 
to strengthen instruction in the 
nation’s private medical schools. 
The Ford Foundation is making 
awards totaling $90,000,000 to 
the nation’s 45 private medical 
schools. The money is to be held 
as invested endowment for at 
least 10 years. The income from 
endowment may be used for 
instructional purposes but not for 
construction or research needs. 
After the 10-year period, Yale and 
the other recipient medical 
schools are free to use the princi¬ 
pal sum as well as endowment 
income. ... 
‘‘Dean [Vernon W.] Lippard, in 
commenting on the Ford Founda¬ 
tion award, said: ‘This is the 
largest gift ever received by the 
Yale School of Medicine. Its impor¬ 
tance is not related to its size 
alone but rather to the fact that it 
is designated for unrestricted 
endowment. The income will be 
used in support of the basic opera¬ 
tion of the school and improve¬ 
ment of its educational program. 
Yale will be forever grateful to the 
Ford Foundation.’ ” 
“The first patients moved into the 
Yale-New Haven Hospital’s new 
seven-story patient-care facility on 
April 21, culminating nearly 20 
years of planning and three years 
of construction. The enormous 
task of moving patients, staff and 
equipment from the outmoded 
New Haven Unit and parts of the 
Memorial Unit was launched amid 
balloons, flowers and a spirit of 
festivity in the pristine, attractive 
new facility. ... 
“The $73 million project replaces 
outdated facilities located across 
the street in the New Haven Unit 
with a modern, comfortable and 
integrated patient-care area. The 
project also includes renovation of 
the childbirth facilities in the 
Memorial Unit. 
“The building has enabled the 
Hospital to consolidate the depart¬ 
ments of radiology, pediatrics, 
the operating rooms, admitting 
and discharge offices and the 
cafeterias. The new emergency 
room located on the first floor 
has doubled in size. Patient rooms 
on floors five through seven have 
been designed with privacy and 
comfort in mind.” 
Stay connected 
Yale Medicine can help you stay connected with fellow alumni 
of the School of Medicine, School of Public Health, Physician 
Associate Program and the medical school's doctoral, fellowship 
and residency training programs. Share your personal and pro¬ 
fessional news for publication in the Alumni Notes department 
of Yale Medicine and on the Web, using this card or the online 
form at info.med.yale.edu/ayam. 
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House Staff (hs) 
□  
Other Yale degree(s) and year(s) 
Share your news on the reverse of this card and mail to: 
Claire M. Bessinger 
Institutional Planning and Communications 
Yale School of Medicine 
300 George Street, Suite 773 
New Haven, CT 06511 
Please include a photograph. 
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“A SURGERY TO PREVENT HIV” 
Since Kyeen Mesesan, an m.d./ph.d. candidate at the School of 
Medicine, began her dissertation project in South Africa in 2003, 
she has received accolades and invitations to present at confer¬ 
ences. But nothing was quite like the 16th International aids 
; Conference in Toronto in August, where she presented a paper on 
adult male circumcision programs and hiv. 
“I had an idea it would be a bit contentious,” said Mesesan. 
“We’re talking about a surgery to prevent hiv.” Indeed, activists at 
the conference raised pointed questions about genital mutilation, 
race and gender. But the idea has gained currency as the notion of 
a single magic bullet against aids gives way to multiple measures 
to prevent hiv infection. 
Circumcision was not originally part of Mesesan’s research— 
she was exploring a hypothetical question. “What does a country 
like South Africa do 10 years from now if a partially effective 
vaccine comes out—say 30 percent effective—and they have to 
decide whether they’re going to use it on their population?” she 
asked. Mesesan put this question in the context of other risk 
factors, such as sexual behavior and condom use. “Although in 
most scenarios such a low-efficacy vaccine would be beneficial, in 
some scenarios you could actually make the epidemic worse.” 
Her research took a detour in July 2005 when, in a study in 
South Africa, French researchers linked male circumcision to a 
61 percent reduction in female-to-male transmission of the virus. 
Mesesan took that number and, applying statistical modeling 
techniques, estimated that in the township of Soweto, a five-year 
prevention program that boosted the current 35 percent circumci¬ 
sion rate by io percent would prevent 53,000 infections. 
“While even a low-efficacy hiv vaccine may be decades 
away, circumcision is effective and the technology is available 
immediately,” Mesesan stated. In December trials in Kenya 
and Uganda showed that circumcision reduced the risk of aids 
from heterosexual sex by half. 
—John Curtis 
o 
Kyeen Mesesan used statistical modeling to 
determine how many new hiv infections adult 
male circumcision could prevent in a township 
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Reminisce with classmates 
See what's new. 
Stroll down Cedar Street. 
Reconnect. 
Classes ending in 2 and 7 will be holding special celebrations this year. 
All alumni are welcome to attend Alumni Reunion Weekend. 
To learn more about this year’s program, please call (203) 436*8551 
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Town and gown come 
together for science 
education 
An arrest, birth control 




The virtual patient 
How digital simulators, actors 
and mannequins have 










ON THE COVER 
The goal of the Hasbro board game 
“Operation” is to complete a deli¬ 
cate procedure, using tweezers to 
remove a “body part” successfully, 
without tripping a buzzer. In the 
more serious matter of physician 
training, advances in computer 
technology combined with a game¬ 
like approach have changed the 
way skills are taught. Now medical 
students and residents can prac¬ 
tice surgical techniques on com¬ 
puter simulators and mannequins 
and with standardized patients, 
actors who help students develop 
their clinical interview skills. 
BACKGROUND 
Body parts from “Operation” must 
be removed without touching 
the metal edges of a cavity in the 
game board. 







Books & Ideas 
Capsule 
Simulated cases, real skills 
Increasingly, medical schools such as Yale are using 
standardized patients, lifelike mannequins and virtual 
reality to teach clinical skills. 
By Jennifer Kaylin 
From the potion to the pill 
By characterizing and quantifying the active ingredients in 
traditional Chinese herbal remedies, Yale scientists hope 
to improve treatment and reduce toxicity for cancer patients. 
By John Dillon 
A fascination with violence 
Dorothy Lewis has spent her career trying to understand 
murderers. Her ideas, once considered outrageous, now 
influence Supreme Court decisions. 








On the Web 
yalemedicine.yale.edu 
On our website, readers can submit class notes or a change of address, 
check the alumni events calendar, arrange for a lifelong Yale e-mail alias 








































HOW TO REACH US 
Yale Medicine welcomes news 
and commentary. Please send 
letters (350 words or less) and 
news items to Yale Medicine, 
300 George Street, Suite 773, 
New Haven, CT 06511, or via 
e-mail to ymm@yale.edu, and 
include a telephone number. 
Submissions may be edited for 
length, style and content. 
VISIT US ON THE WEB 
yalemedicine.yale.edu 
“Who among us 
would share?” 
Please pass on my thanks to 
Ariane Kirtley for her article 
"Water is Life” [Yale Medicine, 
Winter 2007]. 
I was especially moved by 
her account of being invited to 
share a meal by two women in 
one of the villages she visited. 
Despite having had to scavenge 
for wild zucchini and wild grains 
during a time of famine, they 
were eager to share what they 
had with someone who to them 
must have seemed unimagi¬ 
nably prosperous. 
Who among us would share 
what we had if we had so little? 
And who among us will share 
what we have, since we have 
so much? 
Michelle Sanders, m.d. ’99 
West Westford, Mass. 
I wanted to congratulate the 
photographer Ariane Kirtley on 
the amazing cover photographs 
she took for the most recent 
edition of Yale Medicine. Simply 
amazing. 
Kevin A/I. Johnson, m.d. '03 
St. Louis, Mo. 
Beeson article brings 
back memories 
I read with more than passing 
interest the piece by Richard 
Rapport, m.d., on Paul Beeson, 
who was one of my real-life 
heroes ["Fever, Internal Medicine 
and Paul Beeson,” Yale Medicine, 
Winter 2007]. In it, he mentions 
the tragic case of the young 
woman who died from an over¬ 
dose of intrathecal penicillin. 
I am certain that from that inci¬ 
dent came the study that led 
to the paper by Elihu Schimmel, 
m.d. ’54, hs ’61, fw ’64, titled 
"The Hazards of Hospitalization,” 
which appeared in the Annals of 
Internal Medicine in January 1964. 
Each of Beeson’s chief resi¬ 
dents had a yearlong project 
that usually became the subject 
of medical grand rounds toward 
the end of the academic year. 
Schimmel’s project was titled 
"The domp Syndrome,” the 
acronym referring to diseases of 
medical progress, perhaps the 
precursor of the Institute of 
Medicine’s volume To Err is 
Human. In-hospital complica¬ 
tions of all sorts, including iatro¬ 
genic deaths, are front-burner 
items today. I hesitate to think 
of the reams of regulations that 
have been generated hoping 
to prevent, or at least minimize, 
these untoward occurrences. 
As medicine becomes more 
technology-driven, the pace of 
hospital practice quickens and 
the severity of illness of those 
patients who are hospitalized 
increases, the health care profes¬ 
sionals who battle to reduce in- 
hospital complications will be 
working against a considerable 
gradient. I wish them good luck 
in this difficult and worthwhile 
endeavor. 
I enjoy Yale Medicine and 
read it regularly. Keep up the 
good work! 
James B.D. Mark, m.d., hs '60 
Stanford, Calif. 
The obituary for Paul Beeson 
brought back many memories 
for me, and one of the anec¬ 
dotes certainly rang a bell. When 
I started my internship in 1963, 
I learned that there were more 
interns than slots for residents 
and one intern would not be 
kept on. 
One of my patients, who 
had alcoholic hypoglycemia, 
was chosen to be the subject 
of grand rounds that summer. 
Tom Ferris, my chief resident, 
told me to write the history 
and physical examination and 
then to come to his office 
to rehearse.The next day, the 
auditorium was packed. In the 
first sentence I extempora¬ 
neously described the patient 
as "an alcoholic bum.”There 
was an audible gasp from the 
audience and I knew I had 
done something wrong. On 
Monday, Tom told me that 
Beeson wanted me to know 
that there may have been bums 
at Bellevue but there were no 
bums in New Haven. I imagined 
then that my fate was sealed— 
I would be the intern who was 
cut because I was not enough 
of a New England gentleman. 
Fortunately that did not happen. 
Before the year was out, how¬ 
ever, I received a draft notice and 
went to see Beeson. He was able 
to get me reassigned to the Public 
Health Service at the Communi¬ 
cable Disease Center (which 
later became the Centers for 
Disease Control and Prevention), 
and he apologized to me for 
not being able to keep me 
out of the service altogether! 
His advice was to make 
an opportunity out of what 
appeared to be adversity. I did, 
and that began my career in 
infectious diseases. I sub¬ 
sequently went to visit him in 
Oxford to ask his advice about 
where to do a fellowship. We had 
lunch at a pub; he was generous 
with his time and advice. He was 
so happy at Oxford, working on 
the immunology of eosinophilia 
in rats with trichinosis. He said he 
had left Yale so that he would 
have time to do research, rather 
than doing only administration 
for a department that had grown 
too large for his taste. I only 
regret not having had more time 
directly under his tutelage. He 
was a great teacher and a terrific 
role model. 
Joshua Fierer, m.d., hs ’68 
San Diego, Calif. 
Thank you very much for the 
magnificent article about Paul 
Beeson’s tenure at the School 
of Medicine. The author, Richard 
Rapport, m.d., could not possibly 
express the awe that Dr. Beeson 
inspired in our entire class. It 
is no accident that a majority of 
my classmates chose internal 
medicine as their career choice— 
inspired, of course by the great 
physicians and teachers that 
surrounded Dr. Beeson. 
We were thunderstruck by 
the fact that one of our class¬ 
mates actually died as a compli¬ 
cation of an infectious disease 
while a patient of Dr. Beeson’s at 
the Grace-New Haven Medical 
Center! We could not imagine 
that Dr. Beeson could permit 
such a tragedy to occur! 
Fred M. Palace, m.d. ’60, hs '64 
Basking Ridge, N.J. 
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For our cover story this issue we asked writer Jennifer Kaylin to explore the ways in which 
simulation is used to train physicians. Simulation techniques range from mannequins 
that talk, breathe and even “die,” to sophisticated computer simulators that let residents and 
students test their skills at intubation and colonoscopy, to actors who take on the characters— 
and ailments—of patients in order to teach interview skills. These techniques have become 
standard training tools in medicine and, as medical education increasingly emphasizes 
clinical skills, a new way of evaluating students and residents. 
We also focus on the meeting of mainstream medicine and traditional Chinese 
medicine. Since ancient times and all around the world, humans have found remedies in 
herbs and plants. As writer John Dillon reports, Yung-Chi Cheng, ph.d., the Henry Bronson 
Professor of Pharmacology, has taken the lead at Yale in seeking out Chinese herbal medicines 
that can enhance the effects of chemotherapy while mitigating toxic side effects. 
Finally, writer Colleen Shaddox takes us into the world of Dorothy O. Lewis, m.d. ’63, 
hs ’70, who has spent her career studying killers. Since her childhood Lewis has been driven 
by a desire to know what makes society’s outcasts tick. Although her initial theories fell out¬ 
side what was then the psychiatric mainstream, her ideas have become accepted and even 
cited in Supreme Court decisions. Among those she has studied are serial killer Ted Bundy, 
John Lennon's assassin Mark David Chapman and Washington sniper John Muhammad. 
In all violent offenders she has found three elements that add up to a recipe for violence. 
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4 chronicle news from cedar street 
pet Center opens on 
Howard Avenue 
New tools for diagnosis 
and treatment are available to 
clinicians and patients. 
Despite recent advances in molecular 
medicine, physicians are still in the dark 
about many diseases, gleaning clues to 
a therapy’s effectiveness only by study¬ 
ing changes in symptoms. Even as doc¬ 
tors seek the best treatment, patients 
may deteriorate. At Yale’s new Positron 
Emission Tomography (pet) Center, 
researchers hope to bring light into 
this darkness by discovering novel 
diagnostic tools for otherwise hidden 
molecular abnormalities and speeding 
development of new medications. 
pet imaging, said George Mills, m.d., 
director of the Division of Medical 
Imaging and Radiopharmaceutical 
Drug Products at the Food and Drug 
Administration’s Center for Drug 
Evaluation and Research, is “tire essen¬ 
tial foundation” of the agency’s efforts 
to modernize the process of developing 
new medicines. Mills spoke at the 
January 18 opening ceremony for 
the new 22,000-square-foot facility, 
located at 801 Howard Avenue. 
pet is a noninvasive imaging tech¬ 
nique that scans for minute amounts 
of radioactive material—radiotracers— 
that have been injected into a patient’s 
body to bind to specific organ sites, 
providing images of molecular func¬ 
tion. Researchers and clinicians use 
this information to study changes in 
organ function as a result of disease 
or in response to treatment. The 
radiotracer can also label a drug to 
determine whether and how much of 
the compound has reached its target. 
Labeling enables researchers to study 
the safety and efficacy of different dose 
levels and identify biological markers 
of disease that can aid in diagnosis. 
“The work we do here will build 
the knowledge we need to develop 
diagnostic imaging agents coupled to 
therapy,” said J. James Frost, m.d., 
ph.d., professor of diagnostic radiol¬ 
ogy and psychiatry, chief of nuclear 
medicine at Yale-New Haven Hospi¬ 
tal and director of the pet Center. 
Joining Frost as co-directors are lead 
physicist Richard E. Carson, ph.d., 
professor of diagnostic radiology and 
biomedical engineering; and lead 
radiochemist Yu-Shin Ding, ph.d., 
professor of diagnostic radiology. 
Completing the senior faculty team 
is Henry Huang, ph.d., a radio¬ 
chemist and associate professor of 
diagnostic radiology. 
Tire development of the center was 
made possible, in part, by Pfizer, the 
pharmaceutical company, which con¬ 
tributed $5 million to establish it and 
provides $2 million annually to sup¬ 
port pet imaging studies of mutual 
research interest to both parties. Most 
research at the center will be supported 
by federal grants. The company has 
already used the pet facilities to study 
a small group of patients to determine 
how much of a new drug for depres¬ 
sion would be required to reach its tar¬ 
get in the brain, and how much would 
generate unacceptable side effects, said 
Diane K. Jorkasky, m.d., Pfizer’s vice 
president of clinical pharmacology. 
Researchers are usually required to 
give dosages that escalate over several 
months to large numbers of patients to 
establish the safest and most effective 
Robert Alpern, Diane Jorkasky, Richard Levin 
and Pfizer CEO Jeffrey Kindler cut the ribbon 
at a ceremony marking the opening of the 
medical school’s new pet Center. 
dose of a drug. “If we are able to avoid 
the need to do large-scale clinical stud¬ 
ies like that, we’ll be saving tons 
of money and time, and most impor¬ 
tant, we won’t expose patients need¬ 
lessly to a drug that may not have any 
benefit,” said Jorkasky. 
Frost said the center will serve as a 
core facility for the entire School of 
Medicine. Some biomarkers discovered 
in the course of research projects 
with Pfizer or other companies will be 
available for faculty research projects. 
Along with cardiology and oncol¬ 
ogy, other major areas of focus are 
Alzheimer’s disease, schizophrenia, 
depression, obesity, post traumatic 
stress disorder and other conditions 
that are difficult to diagnose and treat. 
Frost hopes that the center’s research 
will help to identify biomarkers for 
subtypes of these diseases, which can 
help determine the best treatment 
for a given individual. “Ultimately this 
will benefit our patients,” Frost said. 
“That’s the key." 
—Marc Wortman 
5 
Hands-on science program for 
local students brings town and 
gown together 
The students who were asked to iden¬ 
tify and explain the function of a muscle 
in the cadaver they’ve been working 
with in the School of Medicine’s anato¬ 
my lab aren’t enrolled at Yale, but they 
can take advantage of the school’s offer¬ 
ings. They are high school students 
participating in the Anatomy Teaching 
Program, one of several ways in which 
the medical school collaborates with 
Hill Regional Career High School, 
a magnet school located just a stone’s 
throw from campus. 
Ten years ago Yale formalized a 
partnership with Career High that has 
enabled its students to benefit from 
the university’s expertise and resources. 
The magnet school attracts students 
from New Haven and its surrounding 
suburbs who are interested in a career 
in health, business or computer tech¬ 
nology. The partnership began infor¬ 
mally with the anatomy program in 
1993 and has expanded to include a 
variety of offerings. 
Yale students and faculty instruct 
and mentor Career High students in 
a number of settings. In the medical 
careers class, for example, Yale public 
health students come to Career High 
to speak about medical career options 
during the first semester, while the 
high school students complete an 
internship at Yale in the second semes¬ 
ter. The Department of Epidemiology 
and Public Health donated a research- 
quality electron microscope to help 
Career students understand molecular 
structures; it also recommended the 
types of equipment that would be most 
appropriate for a certified nurse’s aid 
room set up to look like a clinic. Another 
learning opportunity is offered to 
advanced biology students who come to 
Yale twice a month after school with 
their teacher, Shirley Neighbors, to work 
with medical students who help them 
with course material. 
In the anatomy course, which is 
also taught by Neighbors, two classes 
meet twice each month in Yale’s anato¬ 
my lab, where first- and second-year 
med students overseen by William B. 
Stewart, ph.d., associate professor 
of surgery and chief of the Section of 
Anatomy and Experimental Surgery, 
volunteer as instructors. In small 
groups, the students explore such 
topics as cardiovascular health, energy 
metabolism and infectious diseases. 
“One of the ideas is that these kids will 
become community ambassadors for 
health,” said Stewart. For the students, 
it’s a rare opportunity to see firsthand 
the effects of disease. “We actually get 
to touch the [cadavers] and feel what 
we’re looking for,” said Career High 
junior Lorraine Gabriel. 
In the scholar (Science Collabora¬ 
tive for Hands-On Learning and 
Research) program, a three-week sum¬ 
mer residential science program for 
students entering grades 10 through 
12, Career students have a chance to 
become fully immersed in campus 
life. They not only study science sub¬ 
jects at the college level and conduct 
research under the supervision of 
Yale faculty, but they also get a taste of 
college life by living in the dorms. The 
students normally participate in the 
scholar program for three years. For 
Minerva Ruiz, who now works in 
the Family Support Services section of 
the Yale Child Study Center, the sum¬ 
mer program was an eye-opening expe¬ 
rience. Attending classes in which 
professors treated her as a college stu¬ 
dent, conducting a study on the ways 
in which smoking affects the brain 
and tasting ethnic food at local restau¬ 
rants helped make her a more open 
person, she said. “We were able to 
First-year medical student Terri Huynh leads 
students from Hill Regional Career High School 
through an exploration of the human body 
in the Anatomy Teaching Program. 
go off to college and be comfortable 
with that.” 
Like many of her classmates, Ruiz, 
who graduated from Florida Interna¬ 
tional University and plans on getting 
a ph.d. in psychology, takes education 
seriously. More than 96 percent of 
Career graduates went to college in 
2005 (the college-bound rate for New 
Haven students in general is 83 per¬ 
cent); for those who participate in the 
scholar program, the college atten¬ 
dance rate is 100 percent. 
The collaboration between Yale and 
Career High doesn’t benefit only the 
high school students, however. As 
Neighbors watched second-year med 
student Rebecca Bruccoleri explain 
how food is converted to energy, she 
observed, “If they can find time to do 
this as a med student, you can imagine 
























ways of teaching in a changing 
medical landscape 
For the past 32 years, Yale faculty from 
the Department of Internal Medicine 
have taught at 10 hospitals throughout 
Connecticut through the Yale Affiliated 
Hospitals Program (yahp). Begun in 
1975, yahp is currently the largest con¬ 
sortium of internal medicine training 
programs in the United States. Its goal 
has always been to improve the quality 
of medical education throughout the 
state. With 446 full-time faculty among 
nine residency programs and more than 
6,500 attending physicians, the pro¬ 
gram trains more than 450 residents 
in internal medicine each year. It also 
provides opportunities for collaborative 
clinical and educational research as 
well as selected subspecialty clerkships 
at Yale for affiliated medical residents. 
Each year 100 residents from other 
hospitals take electives at Yale-New 
Haven Hospital. Member hospitals 
include the Hospital of St. Raphael 
in New Haven, Bridgeport Hospital, 
Waterbury Hospital, Greenwich 
Hospital, Norwalk Hospital, Griffin 
Hospital in Derby, St. Mary’s Hospital 
in Waterbury, Danbury Hospital 
and Lawrence & Memorial Hospital 
in New London. 
“This is a very robust relationship," 
said Silvio E. Inzucchi, m.d., profes¬ 
sor of medicine (endocrinology) and 
director of the program, speaking 
at yah p’s 30th annual symposium in 
November. “After 30 years, the pro¬ 
gram is still evolving—it is clearly of 
mutual importance to both the depart¬ 
ment and our affiliates.” Asghar 
Rastegar, m.d., professor of medicine 
(nephrology) and associate chair for 
academic affairs, called it a “unique 
network.” Yale’s collaboration with 
smaller, community-based hospitals, 
he said, allows them to attract better 
faculty as well as trainees to their pro¬ 
grams, enhance training of their resi¬ 
dents and maintain academic links 
that serve as a resource. And, noted 
Peter N. Herbert, m.d. ’67, hs ’69, 
vice president and chief of staff at 
Yale-New Haven Hospital, a vigorous 
educational program strengthens the 
overall enterprise. “Training programs 
are critically important to the retention 
of our faculty,” he said. 
But all is not well in the training 
of new doctors. More than a dozen 
speakers cited new challenges to medi¬ 
cal education, not only in Connecticut 
but also in other parts of the country. 
Among those challenges are young 
doctors’ desires for a less stressful and 
demanding lifestyle, lack of financial 
support for education and the shrink¬ 
ing emphasis on the hospital as the 
primary training setting. As Herbert 
noted, patient contact typically takes 
up an hour or two of a resident’s day, 
while another six to seven hours are 
spent “doing largely clerical things 
that, in a practice setting, would be 
done by someone else.” 
Dean Robert J. Alpem, m.d., Ensign 
Professor of Medicine cited inadequate 
funding for education as a major prob¬ 
lem, observing that tuition covers only 
half the cost of a medical education. 
Clinical practice, which has traditionally 
brought in money to fill that gap, is 
increasingly under financial pressure 
itself. “The ability of the clinical practice 
to subsidize education is going away,” 
he said. “You can’t run a medical school 
without a clinical practice, but what is 
optimal for education is not necessarily 
optimal for clinical practice.” 
Also of concern, said Jack A. Elias, 
m.d., the Waldemar Von Zedtwitz 
Professor of Medicine and chair of 
medicine, is the aging of the physician- 
scientist population, whose unique 
perspective bridges the lab and the 
bedside. Ten years ago, he said, 57 per¬ 
cent of the physician-scientists who 
received grants from the National 
Institutes of Health were 45 or older. 
“We are losing ground in this area 
at a time when translational research 
is blossoming.” 
Panelists also cited the importance 
of mentorship for medical students 
and young doctors. Mary E. Tinetti, 
m.d., the Gladys Phillips Crofoot Pro¬ 
fessor of Medicine (geriatrics) and 
professor of epidemiology and public 
health, said that in the past students of 
either gender were linked with experi¬ 
enced older men, because the majority 
of available mentors were men. Today, 
however, there are women who can 
mentor other women and members of 
minority groups who can guide others 
from their respective backgrounds— 
even from afar—because they are “peo¬ 
ple who share many life experiences.” 
Despite their concerns about the 
future of medical education, speakers 
also noted cause for optimism in 
efforts to address the challenges. Elias 
cited a one-year master’s program in 
public health at Yale that is geared to 
practicing physicians. Alpern said that 
while the financing of medical educa¬ 
tion is built on a shaky foundation, 
“each school figures out a way to get 
around it.” And Rastegar, in an inter¬ 
view after the symposium, said that the 
education at Yale rests on a core belief 
shared by faculty. 
“Everyone feels that there are sig¬ 
nificant structural challenges we are 
facing,” said Rastegar. “A great deal of 
education depends on an environment 
that nurtures the trainees. Yale’s power 
has always been that.” 
—John Curtis and John Dillon 
Two decades after its 
founding, immunobiology 
becomes a department 
Ever since Edward Jenner injected a 
young English boy with cowpox virus in 
the 1790s to prevent smallpox, scientists 
have tried to conquer infectious diseases 
by understanding and strengthening the 
human body’s immune response. Yet as 
recently as three decades ago, the most 
basic principles of modem immunology 
eluded researchers. 
All that would change, however, 
when the medical school decided to 
continue the work of the late Richard 
Gershon, m.d., who had established an 
immunology group within the pathol¬ 
ogy department. In 1988, a visionary 
scientist was recruited to create one of 
the first free-standing immunobiology 
sections in the world. 
Almost 20 years later, Richard A. 
Flavell, ph.d., Sterling Professor 
of Immunobiology, remains chair, but 
in January the section became a full- 
fledged department in the School of 
Medicine. The group that started out as 
a handful of scientists has grown to 
include 13 world-renowned researchers, 
whose publications appear regularly 
in top-ranked scientific journals. “We 
strategized about it and planned very 
carefully what we wanted to build, and 
that’s what we built,” said Flavell. 
Almost 20 years ago Richard Flavell created 
one of the first free-standing immunobiology 
sections in the world. Now it is a department 
at the School of Medicine. 
Representative of the group’s far- 
reaching influence is the discovery of 
the workings of the innate immune 
system in the 1990s. While most 
researchers focused on the adaptive 
immune system, which creates B and 
T cells that target specific bacterial 
or viral invaders, the late Charles A. 
Janeway Jr., m.d., wondered how these 
immune responders are able to act 
so effectively and precisely every time 
the body is invaded by an infectious 
microbe. In a scientific tour de force, 
he and Ruslan M. Medzhitov, ph.d., 
professor of immunobiology, showed 
that components of the innate system 
known as toll-like receptors provide 
the adaptive system with the necessary 
advance intelligence to do its job. 
“It was like saying there are only 
four planets in the solar system and 
then one day somebody comes along 
and says no, there are eight,” said 
David G. Schatz, ph.d., professor of 
immunobiology. 
Uncovering the role of to//-like recep¬ 
tors in the innate immune system is just 
one of the advances made by the depart¬ 
ment. Flavell’s lab has identified mol¬ 
ecules that are involved in activating and 
differentiating T cells and that could 
have implications for hiv and cancer. 
Other areas of research are the simi¬ 
larities between allergens and microbes 
that jump-start the immune system; 
how proteins get broken down and then 
“presented” by antigen-presenting cells 
that allow T cells to recognize them; 
proteins that are involved in antibody 
production; and a protein that allows 
toll-like receptors to send signals and is 
involved in every inflammatory process. 
The explosive growth of knowledge 
coming from the department over 
the last two decades has increased the 
awareness that the clinical relevance 
of immunobiology goes far beyond 
protection against disease. Immune 
mechanisms may lie at the root of 
numerous chronic diseases, including 
cancer, congestive heart failure and 
Alzheimer’s disease. 
—Jill Max 
NEW GRANT FOR RICKETS STUDY 
Yale University has received a five-year, $5 
million grant from the National Institute of 
Arthritis and Musculoskeletal and Skin Dis¬ 
eases to form a Center of Research Transla¬ 
tion (cost), one of four in the country, to 
provide models of translational research in 
academic medical centers. The Yale cort 
will focus on X-linked hypophosphatemic 
rickets (xlh), the most common form of 
inherited rickets in the United States, xlh 
can lead to deformed bones, fractures and 
debilitating arthritis. 
The Yale Center for xlh, directed by 
Thomas O. Carpenter, m.d., professor of pedi¬ 
atrics, and co-directed by Karl L. Insogna, m.d., 
professor of medicine (endocrinology), has 
as its goals the identification and validation 
of mediators of skeletal disease in xlh and 
the development of therapeutics based on 
this knowledge. The center will support an 
educational program, a pilot projects pro¬ 
gram and three scientific studies, as well as 
a research core. 
—J.C. 
FOUR NAMED AAAS FELLOWS 
Four Yale faculty members have been elevat¬ 
ed to the rank of fellow by the American 
Association for the Advancement of Science. 
Arthur L. Horwich, m.d., professor of 
genetics and pediatrics, was honored for con¬ 
tributions to the understanding of the role 
of chaperonins in mediating protein folding. 
John R. Carlson, ph.d., the Eugene 
Higgins Professor of Molecular, Cellular and 
Developmental Biology, was cited for 
contributions to the molecular neurobiology 
of olfaction. 
Oswald J. Schmitz, ph.d., the Oastler 
Professor of Population and Community 
Ecology in the School of Forestry & Environ¬ 
mental Studies, was named a fellow for 
his contributions to the understanding the 
emergence and maintenance of ecosystem 
structure and functioning, and for relating 
ecosystem patterns to individual behaviors. 
Kurt W. Zilm, PH.D., professor of chem¬ 
istry and chemical engineering, was named 
a fellow for his applications of solid-state 
nmr spectroscopy to molecular structure 






















ROUnds MEDICINE AND HEALTH AT YALE 
Medicare coverage 
leads to more screening 
With a change in federal policy, the 
number of early diagnoses of colon 
cancer has risen. 
The expansion of Medicare in 1998 to 
cover colonoscopies appears to have led 
to both an increase in demand for the 
screening procedure and a rise in early- 
stage colon cancer diagnoses, according 
to a study by Yale researchers. 
“We found that after the Medicare 
policy change, the use of colonoscopies 
went up and there was a corresponding 
increase in the likelihood that patients 
with colon cancer would be diagnosed 
at an early, curable stage,” said lead 
investigator Cary P. Gross, m.d., associ¬ 
ate professor of medicine. His study 
appeared in the December 20 issue 
of JAMA: The Journal of the American 
Medical Association. 
In 1998 the Medicare reimburse¬ 
ment policy was changed to cover the 
procedure, which costs roughly $800, 
for older patients with increased colon 
cancer risk. The policy was expanded 
again in 2001 to cover colonoscopy 
screenings for everyone 65 and older. 
As a general internist at the Primary 
Care Center at Yale-New Haven Hospital, 
Gross sees firsthand how reluctant 
patients are to undergo a colonoscopy. 
“I thought it was important to test 
the assumption that reimbursement 
had been a major barrier to obtaining 
a colonoscopy,” he said. 
The researchers studied patients in 
the Surveillance, Epidemiology and 
End Results Medicare-linked database 
between 1992 and 2002. They adjusted 
for such factors as the increasing aware¬ 
ness of colon cancer screening during 
the study period, given the high-profile 
efforts of TV anchorwoman Katie Couric 
to draw attention to the importance of 
the procedure with an on-air colonoscopy 
in March 2000. (Couric’s husband had 
died of colon cancer two years earlier.) 
Gross’ team found that the new 
Medicare policies were associated with a 
substantial increase in colonoscopy use 
among beneficiaries without cancer, as 
well as an increased likelihood of early 
diagnosis for patients who developed 
cancer. Before Medicare started covering 
the screening procedure, 22.5 percent of 
Medicare beneficiaries who developed 
colon cancer were diagnosed at an early 
stage. After Medicare began providing 
coverage for older at-risk patients, that 
number rose to 25.5 percent. When cov¬ 
erage was expanded again, to include all 
Medicare recipients over 65, 26.3 per¬ 
cent of patients diagnosed with colon 
cancer were diagnosed at an early stage. 
“Our analysis suggests that the 
new Medicare policy was associated 
with improved health by identifying 
more patients with early-stage disease,” 
Gross said. But he was quick to add 
that, despite these encouraging signs, 
nearly three-quarters of all patients 
diagnosed with colon cancer still 
receive the diagnosis after the disease 
has spread beyond the early stage. 
Although his study suggests that cost 
had been a barrier for some patients, 
Gross said it also showed that “the 
new reimbursement policy was not 
a sufficient intervention to alter the 
decision process about having a 
colonoscopy for many older people.” 
Noting that colonoscopies can 
also prevent colon cancer by removing 
precancerous lesions, Gross said the 
next step is to assess the impact of 
Medicare colonoscopy reimbursement 
on the incidence of colon cancer and 
to develop strategies to increase the 




After 10 years of research, a 
rare skin disease is traced to a 
chemical used in mris 
In 1997 investigators in California 
came across a mysterious skin disease. 
It often started with redness of the 
skin and warmth, but as it progressed, 
the skin swelled, tightened and turned 
brown, becoming almost “woody.” 
The unnamed disease led to disability, 
reduced mobility of the joints and 
could be fatal. 
After almost 10 years of research, 
Shawn E. Cowper, m.d., assistant pro¬ 
fessor of dermatology and pathology, 
has provided additional evidence that 
the disorder affects a small number 
of patients with kidney disease who 
undergo magnetic resonance imaging 
(mri) scans with contrast. The disease 
that he identified in 2001, with Philip 
LeBoit, m.d., of the University of 
California, San Francisco, is now called 
nephrogenic systemic fibrosis (nsf). 
Cowper started a registry of the disease 
that now numbers about 235 cases. 
At first Cowper thought the disor¬ 
der affected only the skin. It turns out 
that it is mediated by a cell involved 
in wound healing that was originally 
identified in 1992 by Richard Bucala, 
m.d., ph.d., professor of medicine 
(rheumatology), pathology and epi¬ 
demiology (microbial diseases). 
While pondering its causes, Cowper 
noticed that most of the patients in 
his registry had undergone vascular 
imaging. Working with investigators 
in Bridgeport, Conn., he examined 
the records of 467 patients receiving 
dialysis. Three developed nsf follow¬ 
ing mri, and all three had received the 
contrast agent gadolinium. Another 
84 patients received gadolinium but 
did not develop the disease. In March, 
Cowper published a study in the 
Clinical Journal of the American Society 
of Nephrology, linking gadolinium 
to nsf, which occurs only in patients 
with advanced kidney disease. 
Based on Cowper’s work and a 
Danish study, the Food and Drug 
Administration issued a public health 
advisory last year warning of the dan¬ 
gers to kidney patients who receive a 
contrast-enhanced mri. “What’s really 
key now, and what everybody is excited 
about finding, is what makes these 3 
percent different than the other 97 per¬ 
cent who have renal failure and have 
been exposed to gadolinium without 
developing nsf,” said Cowper. 
Understanding the mechanism 
behind nsf may explain why it occurs. 
In contrast agents, gadolinium is bound 
to a chelate, a molecule that keeps it 
from interacting with the body and 
allows it to be quickly eliminated by the 
kidneys. But patients with advanced 
kidney disease can’t efficiently rid them¬ 
selves of such toxins as gadolinium, 
which may build up, dissociate from the 
chelate and do damage. 
Unfortunately, all contrast agents 
used for routine mris in the United 
States contain gadolinium. Kidney 
patients who must undergo an mri 
with contrast are advised to undergo 
dialysis immediately afterward, but no 
one is certain that this will decrease 
the chances of developing nsf. “There 
are a lot of questions that need to be 
answered before anyone declares this 
disease gone, or even this technique 
safe,” said Cowper. 
—Jill Max 
HIGHER RISK FOR CARDIAC PATIENTS 
About a third of heart attack patients also 
have an active, noncardiac condition that 
could warrant admission to the hospital, 
Yale researchers reported in the American 
Journal of Medicine in October. And patients 
who have acute conditions such as stroke, 
kidney failure and pneumonia may have 
poorer outcomes, according to first author 
Judith H. Lichtman, m.p.h. ’88, ph.d., assist¬ 
ant professor of epidemiology. “Relatively 
little is known about the care and outcomes 
of heart attack patients who arrive at the 
hospital with an additional, active noncar¬ 
diac condition. 
Lichtman and colleagues studied 1,145 
patients with acute myocardial infarction 
who were discharged from Yale-New Haven 
Hospital between January 1997 and June 
2000, and rated the additional noncardiac 
conditions in these patients by severity. 
Life-threatening conditions included active 
bleeding, major stroke, metastatic cancer, 
abdominal aortic aneurysm rupture, acute 
psychosis, major trauma and others. 
“More research is needed to describe 
these complex patients to identify opportu¬ 
nities to improve their clinical management,” 
said Lichtman. 
—John Curtis 
HIV SCREENING SHOULD BE ROUTINE 
Voluntary screening for HIV should be rou¬ 
tine for all adults, not just those at high 
risk, according to a study by Yale researchers. 
The team reports in the December 5 issue 
of the Annals of Internal Medicine that rou¬ 
tine hiv screening is cost-effective, even in 
communities where as few as two in 1,000 
people have undiagnosed HIV infection. 
Early identification of hiv leads to better 
health outcomes and longer life expectan¬ 
cies in Hiv-infected persons. 
The study provides strong support for the 
Centers for Disease Control and Prevention 
guidelines issued in September 2006 that 
recommend routine hiv screening of all per¬ 
sons age 13 to 64 in all health care settings. 
“Early identification of hiv saves lives,” 
said principal investigator A. David Paltiel, 
m.p.p.m., ph.d., professor of public health 























Findings from the bench 
A clear solution 
to a protein puzzle 
An enzyme’s structure plus 
oil and water may yield a clue 
to Alzheimer’s disease. 
Several years ago, when researchers 
discovered intramembrane proteases— 
a class of hydrophilic enzymes that 
seemed to work despite being sur¬ 
rounded by cells’ oily membranes— 
many scientists were perplexed. Some 
were downright skeptical. After all, 
oil and water don’t mix. 
Ya Ha, ph.d., assistant professor of 
pharmacology, and colleagues may 
have revealed the intramembrane pro¬ 
teases’ recipe for success with their 
publication in October in the journal 
Nature of the protein’s structure. In 
addition to providing a solution to a 
slippery biological mystery, Ha’s work 
could shed light on the mechanisms 
underlying Alzheimer’s disease. 
The chewing up of proteins, a pro¬ 
cess known as proteolysis, is the job 
of proteases. But protein-splitting 
reactions require water, not normally 
found in the greasy interior of cell 
membranes. In 1997, Nobel laureates 
Joseph L. Goldstein, ph.d., and 
Michael S. Brown, ph.d., suggested 
in an article in Cell that a protease 
involved in regulating cholesterol 
somehow did its work within the cell 
membrane. This protease must be 
“unusual,” they acknowledged, but 
they proposed that gamma-secretase, 
the enzyme that cleaves amyloid 
protein into the toxic fragments 
seen in the brains of Alzheimer’s 
patients, might also operate in the 
same manner. 
When he came to the School of 
Medicine from Harvard University five 
years ago, structural biologist Ha was 
convinced that gaining structural infor¬ 
mation through X-ray crystallography 
was the key to understanding intra¬ 
membrane proteases. He started with 
gamma-secretase. But despite his best 
efforts, it could not be coaxed into 
forming crystals, the first step in deter¬ 
mining a protein’s molecular structure 
by X-ray crystallography. 
When a family of bacterial enzymes 
with similar activity known as rhom¬ 
boid proteins was discovered in 2001, 
Ha seized on those as an alternative. 
Over the next four years, Ha worked 
with postdocs Yongcheng Wang, ph.d., 
and Yingjiu Zhang, ph.d., to obtain 
the first X-ray data of the rhomboid 
enzyme molecules and created a visu¬ 
alization of the structure. 
At last, they saw how an intramem¬ 
brane enzyme is built: in the middle 
of a sea of fat, the rhomboid protease 
creates a protective bubble to shelter 
water molecules (whose source is 
unknown; they may come from a sur¬ 
rounding aqueous solution) in its 
active site. The enzyme is serpentine, 
crisscrossing the cell membrane six 
times. Five of these segments bundle 
together to create a water-filled cham¬ 
ber within the membrane. 
However improbable this enzyme’s 
mechanics, they are medically impor¬ 
tant because the enzyme belongs to the 
family that includes human gamma- 
secretase. “Compounds that inhibit the 
production of toxic amyloid peptides 
are now believed to be one of the most 
promising approaches to the develop¬ 
ment of drugs for Alzheimer’s dis¬ 
ease,” says Vincent T. Marchesi, m.d., 
ph.d., the Anthony N. Brady Professor 
of Pathology and an expert on both mem¬ 
brane protein structure and Alzheimer’s 
disease. “Ha’s findings are an important 
contribution to this effort.” 
Ha says that the rhomboid pro¬ 
tease is a good model system for 
intramembrane proteases in general, 
but he confesses that he still has his 
eye on gamma-secretase. “I would 
love to see it,” he says. While the two 
enzymes are not related by their pro¬ 
tein sequence or by evolution, Ha 
believes that they share common fea¬ 
tures because they face the same 
challenge of mixing water with oil. 
“Once you have a few structures, 
you’ll see a pattern start to emerge,” 
Ha explains. “That will give us a bet¬ 
ter understanding of how inhibitors 
might work. And then maybe we can 
design better inhibitors, and maybe 
those inhibitors can be used as drugs.” 
—Pat McCaffrey 
Structural biologist Ya Ha produced this image 
of a hydrophilic enzyme that functions in a cell’s 
oily, and hydrophobic, membrane. 
Yale scientist finds two 
genetic anomalies linked to 
macular degeneration 
In late 2004, Josephine J. Hoh, ph.d., 
associate professor of epidemiology 
and of ophthalmology and visual sci¬ 
ence, used new dna chip technology to 
identify a gene for age-related macular 
degeneration (amd). She found a sin¬ 
gle nucleotide polymorphism (snp)— 
in this case a variant in the coding 
region of complement factor H (cfh) 
gene on chromosome 1—that is linked 
to an increased risk of developing both 
wet and dry forms of amd. 
Now, in findings published in the 
journal Science in October, Hoh has 
reported finding an independent snp 
in a section of chromosome 10 that 
regulates the htrai gene. The variant 
appears to increase the expression of 
the protein htrai in the eyes of homo¬ 
zygotes, and people carrying two 
copies of the risk allele have a much 
higher risk of wet amd. 
“We found that patients with the 
htrai snp in both chromosomes were 
10 times more likely to have wet amd 
than those who have it in just one 
chromosome or no snp,” said Hoh. 
“This may point to possible directions 
for effective treatment of wet amd.” 
amd causes light-sensitive cells in 
the retina to break down, resulting in 
progressive loss of central vision. Of 
the two forms of amd, the dry form is 
more common than the wet form. Wet 
macular degeneration can lead rapidly 
to blindness, while the dry form of 
amd progresses more slowly. 
The discovery marks the first time 
that a cross-ethnic approach was used to 
efficiently decipher a complex disease 
such as amd. Hoh exploited differences 
in the progression of amd in Caucasian 
and Chinese patients. In Caucasians, 
the proliferation of abnormal blood ves¬ 
sels is compounded by the development 
of large waste deposits called drusen. 
Chinese patients, she said, develop little 
or no drusen and progress directly to 
wet AMD. 
Using dna samples from Chinese 
patients with amd, Hoh discovered the 
disease-causing variant in the control 
section of the htrai gene. She then 
hypothesized that this same genetic 
variant causes wet amd in Caucasians. 
“Finding a gold mine is very much 
easier if you have a good map showing 
where to dig. The discovery in the 
Hong Kong Chinese samples gave me 
the map,” she said. The confirmation 
of her hypothesis that the htrai vari¬ 
ant causes wet amd in Caucasians was 
done in collaboration with Kang Zhang, 
m.d., ph.d., of the University of Utah 
School of Medicine. 
These studies demonstrate that each 
of these two major genes, cfh and 
htrai, affects the risk for a distinct 
component of the amd phenotype: cfh 
influences the production of drusen 
associated with dry amd, whereas 
htrai influences blood vessel develop¬ 
ment, the hallmark of the wet disease 
type. When the two processes are com¬ 
bined, they lead to the composite char¬ 
acteristics seen in some cases of amd. 
“The marker variant we have identi¬ 
fied in htrai is very much associated 
with amd, but function of the gene 
that causes wet amd is unknown. We 
need to conduct further functional 
studies in order to understand the bio¬ 
logical mechanisms,” said Hoh. 
—Robin Orwant 
et cetera ... 
CANCER MUTATIONS COMMON 
Cancer gene mutations are found in about 
1 percent of the general population, more 
frequently than previously thought, accord¬ 
ing to Yale researchers. 
The study published in the December 6 
issue of the Journal of the National Cancer 
Institute looked for the presence and rate of 
brcai and BRCA2 mutations in women with 
newly diagnosed ovarian cancer. Those muta¬ 
tions have been linked to elevated lifetime 
risks for breast, ovarian and other cancers. 
The scientists screened for the most 
common mutations as well as rare or hard- 
to-distinguish variants. They then calcu¬ 
lated the incidence of those variants in the 
general population and in individuals with 
family members who have had cancer. 
The Yale team found that the lifetime risk to 
age 80 is not the same for all mutations. 
‘‘The exact nature of the level of risk for 
the particular mutations needs to be further 
explored,” said lead researcher Harvey A. 
Risch, m.d., ph.d., professor of epidemiology. 
“This study is an important first step in 
that direction.” 
—John Curtis 
A GENE FOR NICOTINE ADDICTION 
The World Health Organization estimates 
that more than 1 billion people smoke 
worldwide, and that smoking causes nearly 
5 million premature deaths every year. 
Crowing scientific evidence suggests a 
genetic link to nicotine addiction. 
In findings published in the January issue 
of Biological Psychiatry, Joel E. Gelernter, 
m.d., professor of psychiatry, genetics and 
neurobiology, and colleagues reported on 
the risk of nicotine dependence in 634 small 
nuclear families with members who were 
also dependent on cocaine or opioids. In 
507 of the African-American or European- 
American families, at least two members 
were nicotine-dependent. The researchers 
identified one significant genome-wide 
linkage on chromosome 5 for the African- 
Americans and a strong linkage on chromo¬ 
some 7 for the European-Americans. “These 
data add to the growing evidence for spe¬ 
cific locations for genes that influence risk 






















Books & ideas bookshelf 
A doctor learns to cope with death 
In her new book, a surgeon explores the ways in which 
physicians respond to dying patients. 
Pauline Chen’s study of doctors 
and death began with her own 
difficulties in responding to the 
terminally ill. 
Pauline W. Chen, m.d., hs ’98, often recalls the words of 
the late Yale surgeon C. Elton Cahow, m.d. She once heard 
him remonstrate with an exhausted resident for thinking 
he could head home without checking on a certain patient. 
“Once you put your hands on a patient,” Cahow said, 
“they’re yours.” 
Chen liked to think she was keeping close watch over all 
her patients. But something was still wrong: “As early as 
internship,” she said, “when patients were dying, I found it 
difficult to go into their rooms, to talk to their families, to 
discuss their diagnoses and prognoses.” She even shunned 
a dear friend with terminal cancer. 
And her fellow physicians generally shared her anxiety 
about death. “We’re all susceptible to this,” she said in 
a recent telephone interview from her home near Boston. 
“Dying is frightening.” 
This fundamental human anxiety, she said, is ratified by 
medicine’s “hidden curriculum.” When a patient’s death 
was imminent, Chen often saw attending physicians close 
the curtain around the patient and the grieving family, and 
then depart. Chen did the same. “We thought that family 
members wanted to be alone at the end,” she recalls. “It 
never occurred to most of us that the actual process might 
be frightening, and that we could alleviate that fear by being 
present. And perhaps too, some of us—I include myself 
here—did not have the insight to realize that we were also 
leaving them alone because it was easier for us to stay away 
from the dying altogether.” 
“This deeply rooted angst about death,” she later wrote, 
was being passed on by doctors from one generation to the 
next “like some tragic hereditary disease.” 
Chen said that physicians recognize their limitations. 
Almost half the oncologists in one study described them¬ 
selves as only “poor” or “fair” at breaking bad news. Chen 
herself abandoned a favorite patient to painful and futile 
end-of-life care because she could not bear to see him 
diminished by his cancer. In the idiom of her Taiwanese 
heritage, the young man became a wan ong kuci, a restless 
soul who haunted her. 
Five years ago, pregnant with twins, she took time off 
from her work as a transplant surgeon at ucla to care for 
her daughters and write about the ways in which physicians 
cope with death. Her book. Final Exam: A Surgeon's Reflections 
on Mortality, was published by Alfred E. Knopf in January. 
Chen begins Final Exam at the moment when she 
unveils the cadaver that she will dissect as a medical student. 
Through anecdotes from medical school at Northwestern 
and residency at Yale, she traces her growing awareness of 
the extent to which doctors deny death, and tells of the 
moment midway through residency when an attending sur¬ 
geon provided a better model. The surgeon closed the bed 
curtain around a dying patient but did not leave. He remained 
inside the curtain, sitting with the patient and family dur¬ 
ing the final hour of the patient’s life. “It was a major turn¬ 
ing point,” Chen recalls. “I realized that I could do more 
than just cure. I could be there for my patients and their 
families.” She might offer what the medical anthropologist 
Arthur Kleinman, m.d., calls “empathic witnessing.” 
“My greatest hope for the book,” she said, “is to get peo¬ 
ple to talk about the issue and to share their anxieties.” 
Although she recognizes that complex cultural, psychologi¬ 
cal and institutional forces determine how we cope with 
death, “the more awareness there is, the greater the chance 
that we’ll improve end-of-life care for all of us.” 
Chen now works full-time as a writer, lecturer and con¬ 
sultant. Her blog carries a link to an excerpt from the 
book, which was published in The New York Times Magazine 
last December: www.paulinechen.com. 
—Cathy Shufro 
Bookshelf focuses on books and authors at the School of Medicine. 
Send suggestions to Cathy Shufro at cathy.shufro@yale.edu. 
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Joyce Tombran-Tink, w>o 
Colict J. Barhsfable, 0*w . 
Complications in Surgery 
and Trauma 
edited by Stephen M. Cohn, M.D., 
with contributions by Edward 
Lubin, m.d., ph.d., Deepak 
Narayan, m.d., m.b.b.s., assistant 
professor of surgery, John A. 
Persing, m.d., professor of sur¬ 
gery (plastic) and neurosurgery, 
Michael J. Robbins, Joseph H. 
Shin, m.d., hs ’97, associate pro¬ 
fessor of surgery, and Raymond 
S. Sinatra, m.d., ph.d., professor 
of surgery (Informa Healthcare) 
This text offers practical, detailed 
information on avoiding and 
managing complications result¬ 
ing from surgical interventions 
in the operating room, emer¬ 
gency room and intensive care 
unit. It covers a variety of pre-, 
intra- and postoperative events, 
analyzing complications in all 
surgical disciplines and suggest¬ 
ing protocols for preventing 
them. 
Colorectal Cancer: Evidence- 
Based Chemotherapy Strategies 
edited by Leonard B. Saltz, m.d., 
with contributions by Edward 
Chu, m.d., professor of medicine 
and pharmacology, Richard 
Kim, m.d., fw ’06, and M. Wasif 
Saif, m.b.b.s., associate professor 
of medicine (Humana Press) 
This evidence-based and data- 
driven guide presents reviews 
of cutting-edge therapies for 
colorectal cancer. The opening 
chapters outline contemporary 
thinking about the biology of 
colorectal cancer, screening and 
potential methods of chemopre- 
vention. Subsequent chapters 
present uses of cytotoxic chemo¬ 
therapy and weigh the potential 
for incorporating innovative bio¬ 
logical therapy.The concluding 
chapter explores emerging drug 
paradigms and their potential 
for treating colorectal cancer. 
Obstetric and Gynecologic 
Anesthesia: The Requisites 
by Feme R. Braveman, m.d., pro¬ 
fessor of anesthesiology and of 
obstetrics, gynecology and repro¬ 
ductive sciences (Mosby) This 
text discusses anesthesia for 
female patients during common 
surgical procedures, including 
oncologic and nonobstetrical 
procedures and fetal surgery. 
Other topics include pain man¬ 
agement for high-risk obstetric 
patients and pharmacology. 
Each chapter includes case 
studies. 
Management and Treatment 
of Scars: Procedures in Cosmetic 
Dermatology Series 
by Kenneth A. Arndt, m.d. '61, 
hs ’62 (Saunders) This reference 
presents practical guidance for 
revising scars using medical 
treatments, light/laser treat¬ 
ment and surgical and nonsurgi- 
cal procedures.The book offers 
step-by-step guidance on proper 
techniques, pitfalls and "tricks 
of the trade,” along with photo¬ 
graphs and illustrations of cases 
discussed. 
Counseling and Psychotherapy 
Essentials: Integrating Theories, 
Skills and Practices 
by Glenn E. Good, ph.d., and 
Bernard D. Beitman, m.d. ’68 
(Norton Professional Books) 
This textbook aligns students’ 
classroom experience with 
the demands of actual clinical 
practice, in which clinicians 
do not hew to a single theoreti¬ 
cal line but, rather, mix schools 
and methodologies in order 
to address their clients' needs. 
Ocular Angiogenesis: Diseases, 
Mechanisms and Therapeutics 
by Colin J. Barnstable, d.phil., 
professor of ophthalmology and 
visual science and of neurobiol¬ 
ogy, and Joyce Tombran-Tink, 
ph.d. (Humana Press) This book 
surveys current clinical and basic 
knowledge concerning abnormal 
growth of blood vessels in the 
eye.The authors also identify 
and assess the most promising 
approaches and discuss the 
challenges encountered in devel¬ 
oping therapeutics for ocular 
neovascular diseases. This text 
includes a CD with color ver¬ 
sions of figures used in the book. 
Visual Development, 2nd ed. 
by Nigel W. Daw, ph.d., profes¬ 
sor emeritus of ophthalmology 
and visual science (Springer) 
Written for medical students, 
graduate students and postdocs, 
this book describes the develop¬ 
ment of the visual system, the 
effects of visual deprivation and 
the mechanisms by which visual 
deprivation produces its effects. 
Menstrual Disorders: 
A Practical Guide 
edited by Deborah B. Ehrenthal, 
M.D., Matthew K. Hoffman, M.D., 
and Paula J. Adams Hillard, m.d., 
with contributions by Henry M. 
Rinder, m.d., associate professor 
of laboratory medicine (The 
American College of Physicians) 
Designed for the primary care 
clinician, this book is divided 
into three sections. The first dis¬ 
cusses the adolescent patient, 
the second covers the range of 
disorders that patients may 
experience from adolescence 
through menopause and the 
third examines the relationship 
between menstrual disorders 
and other medical illnesses. 
Extreme Prematurity: Practices, 
Bioethics and the Law 
by Geoffrey Miller, m.d., profes¬ 
sor of pediatrics and neurology 
(Cambridge University Press) 
This book examines issues sur¬ 
rounding the clinical manage¬ 
ment of extremely premature 
neonates in the context of mod¬ 
ern neonatal intensive care. 
The text covers the epidemiol¬ 
ogy of extreme prematurity and 
patient care practices in differ¬ 
ent parts of the world; bioethics 
considerations, including ethical 
theories, moral principles and 
quality-of-life issues; national 
and international guidelines; 
and medical law in the United 
States and elsewhere. 
Field Guide to Bedside 
Diagnosis, 2nd ed. 
by David S. Smith, m.d., associ¬ 
ate clinical professor of medicine 
(Lippincott Williams & Wilkins) 
This book enables students and 
physicians to navigate the path 
from collecting information on 
the patient’s symptoms and pre¬ 
senting signs to reaching a diag¬ 
nosis. The guide is organized to 
parallel the diagnostic reasoning 
process, providing a differential 
overview of probable causes, 
a diagnostic approach for each 
differential diagnosis, and the 
specific clinical findings that 
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A digital treasure trove 
Metabolic Syndrome and 
Cardiovascular Disease: 
Epidemiology, Assessment and 
Management 
edited by Nathan D. Wong, 
m.p.h. ’87, and Andrew J. Krentz, 
m.d. (Informa Healthcare) This 
text addresses the epidemiol¬ 
ogy, diagnosis, assessment and 
management of patients with 
metabolic syndrome—focusing 
on implications for cardiovascu¬ 
lar disease risk. With tables, 
flowcharts and practice guide¬ 
lines, this resource analyzes 
recent clinical trials, compares 
and assesses new and emerging 
therapies and provides recom¬ 
mendations for improving 
the assessment and treatment 
of patients. 
Principles and Practice of 
Geriatric Psychiatry 
edited by Marc E. Agronin, m.d. 
’91, and Gabe f. Maletta, m.d., 
ph.d. (Lippincott Williams & 
Wilkins) This book describes in 
detail the neurologic and neuro¬ 
psychiatric patient assessment 
and the use of all treatment 
modalities, both psychothera¬ 
peutic and pharmacologic, in 
elderly patients. The contribu¬ 
tors discuss the treatment of 
disorders in all clinical settings: 
inpatient, outpatient, emer¬ 
gency, primary care, assisted liv¬ 
ing and long-term care. The 
book includes case studies and 
personal accounts by patients 
and care providers. Appendices 
provide drug information and 
list additional resources. 
Weight Bias: Nature, 
Consequences and Remedies 
by Kelly D. Brownell, ph.d., 
professor of psychology and epi¬ 
demiology, Rebecca M. Puhl, 
ph.d., Marlene B. Schwartz, 
ph.d., and Leslie Rudd (The 
Guilford Press) The authors 
explore the nature, causes 
and consequences of weight 
bias and present a range of 
approaches to combat it. They 
discuss topics including the 
barriers facing obese adults and 
children in health care, work 
and school settings; theories 
on how stigma develops; the 
impact on self-esteem and 
health; and strategies for reduc¬ 
ing prejudice and bringing 
about systemic change. 
The descriptions above are based on 
information from the publishers. 
SEND NOTICES OF NEW BOOKS TO 
Cheryl Violante, Yale Medicine, 
300 George Street, Suite 773, 
New Haven, CT 06511, or via e-mail 
to cheryl.violante@yale.edu 
James D. Jamieson, m.d., ph.d., professor of cell biology, 
knew that he had a piece of history in his closet: lantern slides 
made by the pioneering cell biologist George E. Palade, m.d., 
and colleagues. Those images of cells seen through the elec¬ 
tron microscope had laid the groundwork for Palade’s 1974 
Nobel Prize in physiology or medicine. “Palade and his peo¬ 
ple really formulated, invented and provided the informa¬ 
tion that started the field of cell biology in the 1940s,” said 
Jamieson, who did his doctoral work at Rockefeller Univer¬ 
sity with Palade and came with him to Yale. 
Jamieson knew that his mentor, who was at Yale from 
1973 until 1990, wanted the images to be available to students 
and scientists around the world. And so Jamieson cleaned 
the 3.25- by 4-inch glass slides, which Palade left at Yale. 
Jamieson then digitally scanned 191 slides. Arthur R. Belanger, 
m.s., project manager of academic media and technology, 
indexed the slides and placed them on the website of the 
Cushing/Whitney Medical Library. 
The Palade slides are among several digitized collec¬ 
tions now available on the website. Other collections include 
engravings of historic figures and oil portraits of Chinese 
patients with tumors and other deformities from the mid- 
19th century. The digital collection will expand, said Daniel 
M. Dollar, m.l.s., associate director of collection development. 
Palade’s slides helped biologists to relate what they 
were learning about cell morphology through the electron 
microscope with what was being discovered about cellular 
biochemistry through cell fractionation, the process of sepa¬ 
rating a cell into its distinct parts with a centrifuge. 
This holistic understanding of cell function and struc¬ 
ture provides the foundation for contemporary understand¬ 
ing of disease processes, because, Jamieson said, “you need 
to know what’s going on in the normal cell before you begin 
to figure out what’s going on in the diseased cell.” 
The Medical Digital Library can be accessed at http:// 
www.med.yale.edu/library/subjects/digital.html. An exhibit 
by the Yale Medical Historical Library charting the life of pio¬ 
neering neurosurgeon Harvey Cushing, m.d., is now available 
online at http://www.med.yale.edu/library/historical/cushing/. 
—Cathy Shufro 
In Circulation focuses on activities at the Cushing/Whitney Medical 
Library. Send suggestions to Cathy Shufro at cathy.shufro@yale.edu. 
ON CAMPUS 15 
Physician-assisted suicide is the 
wrong solution 
At a time when life is devalued, 
when people are killed over 
necklaces or iPods, physician- 
assisted suicide ill serves patients, 
physicians and society, said 
Michael H. Levy, m.d., ph.d., dur¬ 
ing a talk at internal medicine 
grand rounds in January. 
"If we look at physician- 
assisted suicide as an act of has¬ 
tening death,” said Levy, vice 
chair of the Department of Medi¬ 
cal Oncology at the Fox Chase 
Cancer Center in Philadelphia, 
“then it is an act of harm.... Do 
we really need to kill the patient 
to kill the pain?” 
Levy said physician-assisted 
suicide violates key tenets 
of medical ethics; erodes trust 
in health professionals; and 
diminishes what he called "the 
miracle of life.” It also denies a 
patient’s loved ones the chance 
to provide care at the end of 
life. If legitimized, he said, it 
could force doctors to provide 
a service they oppose. And, he 
continued, it could stifle the 
search for alternate ways to 
relieve suffering. 
“I think the risk to society 
far outweighs the benefits,” 
Levy said. 
—John Curtis 
Is sleep no more than a cure 
for sleepiness? 
In 1989, when scientists kept 
rats from sleeping, the rats 
started to die by the nth day. 
By the 32nd day, they were all 
dead."We are still clueless as to 
why the rats died,” said Robert 
Stickgold, ph.d., associate pro¬ 
fessor of psychiatry at Harvard 
Medical School and an expert on 
sleep, speaking at internal medi¬ 
cine grand rounds in November. 
“It happens in rats,” he con¬ 
tinued."It happens in humans.” 
For 2,000 years we have 
understood other basic drives, 
such as hunger and sex, he said, 
but the need for sleep remains 
a mystery. Among early candi¬ 
dates for its apparent benefits, 
said Stickgold, were restoration 
and recovery, energy conserva¬ 
tion and avoidance of nocturnal 
predators. "When you try to 
parse those out,” Stickgold said, 
"none of those make sense. You 
end up back at the point that 
sleep is to cure sleepiness.” 
Yet more recent studies have 
confirmed that a good night’s 
sleep confers numerous bene¬ 
fits. Without it, the immune sys¬ 
tem produces fewer antibodies 
to fight infection. And it is dur¬ 
ing sleep that the brain consoli¬ 
dates the day’s memories and 
learning. 
“It does matter how much 
sleep you get,” Stickgold said. 
—J.C. 
The teachings of Maimonides 
and a moral imperative 
The 12th-century physician 
Maimonides, who lived in Spain 
and Egypt, achieved fame as a 
rabbi and philosopher yet helped 
to establish a moral imperative 
that guides medicine to this day: 
the obligation to make every 
effort to heal the patient. 
Although best known for his 
Guide for the Perplexed, which 
proposed ways to reconcile reli¬ 
gion and science, the scholar 
also proposed an alternative to 
the prevailing Christian view 
of a doctor’s role, said Sherwin B. 
Nuland, m.d.’55, hs ’61, clinical 
professor of surgery and author 
of a biography of Maimonides. 
In a December talk, Nuland told 
members of the Interdisciplinary 
Center for Bioethics that Mai¬ 
monides saw medical care not 
as a prayer but as "something 
physical that needs to be done.” 
Healing remained linked to faith, 
nonetheless, because renewed 
health would allow the patient 
to resume his study of God. 
As a physician, Maimonides 
believed that “you are to make 
any sacrifice other than another 
human life to save someone you 
can possibly save,” Nuland said. 
“There is no credit to be given to 
a physician for doing his work. 
It is an obligation.” 
—C.S. 
Environment and society: which 
determines health risks? 
A two-story house has peeling 
paint and no yard. Behind it 
loom industrial smokestacks. 
Mark R. Cullen, m.d. ’76, hs ’79, 
professor of medicine and of 
epidemiology and public health, 
and director of the Yale Occupa¬ 
tional and Environmental Medi¬ 
cine Program at the School of 
Medicine, used a photograph to 
frame a lecture in March at the 
School of Forestry & Environ¬ 
mental Studies. Do children in 
that house face health risks 
because of toxins from factories 
and lead from peeling paint or 
because they live in an over¬ 
crowded, high-crime neighbor¬ 
hood with a crummy school and 
no recreational facilities? 
Environmental epidemiolo¬ 
gists focus on the physical 
environment, while social epi¬ 
demiologists look at patterns 
of psychological and social stress. 
Both inquiries, Cullen said, are 
too narrow. "Neither side explains 
it all.” Historically, however, the 
two fields haven’t shared infor¬ 
mation. Cullen says researchers 
need to "deal with their agendas 
in tandem,” because that’s the 
only way to get a full under¬ 
standing of a population’s health 
status.That knowledge can lead 
to the creation of such initiatives 
as more recreational space on 
the street or tougher air pollu¬ 
tion standards, which will better 























An arrest in New Haven, contraception 
and the right to privacy 
In 1961 a Yale physician joined with Planned Parenthood to challenge 
a state law banning contraceptives. Their case reached the U.S. Supreme Court 
and opened the door to the acceptance of contraception. 
By Lori Ann Brass 
above On June 7,1965, Estelle Griswold, left, 
and Cornelia Jahncke, executive director and 
president, respectively, of the Planned Parent¬ 
hood League of Connecticut, celebrated a 
decision by the U.S. Supreme Court that struck 
down the state’s law banning the use of 
birth control. That decision paved the way for 
later decisions, including Roe v. Wade, which 
legalized abortion in the United States. 
right Estelle Griswold and C. Lee Buxton, center, 
in police headquarters on November 10,1961. 
The two were arrested after opening a clinic in 
New Haven that offered birth control counseling 
and prescribed contraceptives—violations of 
an 1879 statute that barred the use of any drug 
or instrument for preventing conception. 
When police raided a Trumbull Street 
clinic on November 10, 1961, it came 
as no surprise. The Planned Parent¬ 
hood League of Connecticut (pplc) had 
opened the clinic days earlier to offer 
birth control counseling and to pre¬ 
scribe contraceptives—deliberate viola¬ 
tions of an 1879 statute prohibiting the 
use of “any drug, medicinal article or 
instrument for the purpose of prevent¬ 
ing conception.” 
Estelle Griswold, the feisty execu¬ 
tive director of the pplc, and C. Lee 
Birxton, m.d., the medical director of 
the clinic and chair of the Department 
of Obstetrics and Gynecology at the 
School of Medicine, were arrested, 
convicted and fined $100 each. The 
pplc had spent decades lobbying the 
Connecticut General Assembly to 
repeal or amend the statute, one of 
the “Comstock laws” promoted by 
anti-obscenity crusader Anthony 
Comstock in the late 19th century. 
For 21 years the pplc had operated 
only as a transport service, shuttling 
patients to clinics in Rhode Island and 
New York, where contraception was 
legal. In Connecticut married women 
with private physicians could often 
obtain birth control information and 
devices, but poor women, or women 
without connections, could not. Two 
previous attempts to challenge the 
statute, in 1943 and 1961, had been 
dismissed by the U.S. Supreme Court, 
in the first case because the doctor 
involved lacked standing to sue on 
behalf of patients, and in the second 
case, also involving Buxton, because 
the plaintiffs had not been threatened 
with prosecution. 
Police charged Griswold and 
Buxton with aiding and abetting the 
commission of a crime—anyone 
who prescribed and advised women 
about contraceptives was as culpable 
as the women who used them. The 
resulting case, Griswold v. Connecticut, 
had far-reaching consequences for 
women’s health and reproductive 
rights. “Women and families were 
moving eagerly to adopt birth control 
17 
across the country,” said Susan Lloyd 
Yolen, vice president of public affairs 
and communication for Planned 
Parenthood of Connecticut. “The birth 
control pill came out in i960, but 
Connecticut was a holdout on birth 
control at that point.” 
In 1965 the case reached the U.S. 
Supreme Court. Thomas Emerson, 
j.d., dean of the Yale Law School, and 
Catherine Roraback, j.d. ’48, repre¬ 
sented the pplc. On June 7, 1965, the 
court ruled 7-2 that the Connecticut 
law violated the constitutional right to 
marital privacy. “It paved the way 
for the nearly unanimous acceptance 
of contraception that now exists in 
this country,” said Yolen. 
“The ruling meant the police had 
no right to raid your house to look 
for contraception,” said Gary L. Gross, 
m.d. ’65, hs ’70, an instructor at 
Harvard Medical School and the medi¬ 
cal director of federally funded family 
planning clinics in Boston. Gross, who 
worked with Buxton as a student and 
resident, said that Buxton believed in 
women’s rights, the importance of con¬ 
traception for all women and providing 
good health care free from interference. 
After Griswold, the pplc opened 
clinics throughout the state, physicians 
no longer feared arrest for dispensing 
contraception. It meant, said Gross, 
that people could decide the number 
and spacing of their children. 
Griswold also laid the groundwork 
for later reproductive-rights deci¬ 
sions. In its 1972 decision in Eisenstadt 
v. Baird, the U.S. Supreme Court 
extended the right to privacy to indi¬ 
viduals, effectively legalizing birth 
control for unmarried women, said 
Gross. A year later, in Roe v. Wade, 
the court recognized a woman’s right 
to choose abortion. 
“In 1957, the wife of a Yale Law 
School student couldn’t obtain a 
diaphragm at the student health serv¬ 
ice,” said Gross. “But when the first 
women were admitted to Yale College 
in 1969, the health service provided 
lectures about birth control and 
where to obtain it as part of fresh¬ 
men women’s orientation.” 
Lori Ann Brass is a freelance writer in 
Woodbridge, Conn. 
The fight to legalize birth control had a long 
history in Connecticut. In 1941 supporters 
of birth control took a lunch break during a 
























Increasingly, medical schools such as Yale are using standardized patients, 
lifelike mannequins and virtual reality to teach clinical skills. 
By Jennifer Kaylin 
Photographs by Frank Poole 
High-fidelity human patient 
simulators, such as Sim-Man at 
right, talk, breathe and can even 
“die.”The computerized and 
programmable polymer figures 
can simulate just about any 
condition in the human body. 
Their vital signs can change to 
create medical emergencies 
that allow students to practice 
procedures such as intubation 
and order X-rays or CT scans. 
A new curriculum, which began 
this year, requires third-year 
medical students to participate 
in 24 scenarios over a 12-week 
surgery clerkship. 
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n a conference room down 
the hall from his office, Frederick D. Haeseler, m.d., is talk¬ 
ing to three visitors about a patient named Noah Savage. 
“Noah was short of breath when he exerted himself, 
so he stopped taking his daily walks. After his feet began to 
swell, he was given a prescription for a diuretic called Lasix, 
and the symptoms got better,” Haeseler says. “But then 
an echocardiogram revealed that he had severe idiopathic 
dilated cardiomyopathy, an uncommon, but not rare, heart 
condition. In this case it’s progressive. Medication can help 
relieve symptoms, but ultimately Noah would need a heart 
transplant to survive.” 
If Noah, an attractive middle-aged man with a ruddy 
complexion and bright eyes, appeared remarkably relaxed 
given the seriousness of his diagnosis, it was for good reason. 
He doesn’t really have a life-threatening heart condition— 
he’s a character being portrayed by an actor named Jeff 
Savage. The three visitors Haeseler was addressing are other 
actors preparing to begin work at the School of Medicine 
as standardized patients—actors trained to assume the lives 
and symptoms of patients in order to help students take 
medical histories, conduct physical examinations and hone 
the interpersonal skills necessary to be effective physicians. 
Training through simulation—whether by such stand¬ 
ardized patients as Savage, by mannequins or by virtual 
computer technology—has become an increasingly accepted 
methodology in medical education. Medical schools, includ¬ 
ing Yale, are devoting significant resources to exposing stu¬ 
dents to these training opportunities. In addition to Haeseler’s 
program, Yale now has an array of human-patient simula¬ 
tors, or mannequins, for students to “treat,” as well as a 
simulation laboratory equipped with computers that allow 
students to practice everything from suturing techniques 
to performing a colonoscopy. 
Instructors say these simulation tools are useful for 
both teaching and assessment. Students can practice and 
make mistakes without harming real patients; these tools 
can simulate unusual cases students wouldn’t often see in 
practice; and the tools are ideal for comparative evaluations 
of clinical skills, because each student faces an identical 
set of patient challenges. 
The use of actors is the oldest of these patient- 
simulation techniques. Yale’s program, which was launched 
in 1993 with eight actors, was part of the primary care 
clerkship. The early response from students was resound¬ 
ingly positive, says Haeseler, associate clinical professor 
of medicine and director of the Yale Standardized Patient 
Program. “Their only complaint was that it wasn’t offered 
until the fourth year.” Today, students begin working with 
standardized patients in the second or third week of medi¬ 
cal school in the longitudinal communication skills program 
directed by Auguste H. Fortin VI, m.d., m.p.h., associate 
professor of medicine, and taught by a multidisciplinary fac¬ 
ulty. Haeseler has trained 30 actors and written 75 scripts 
that represent a range of medical disorders and psychosocial 
issues. All are designed for the small-group workshops 
with standardized patients that occur throughout the four- 
year medical curriculum. In their first year students learn 
basic interview skills and advance to more challenging 
interactions in subsequent years. 
Savage, who’s been involved for about a year, is a 1961 
Yale College alumnus, antiques dealer and professional actor 
who most recently appeared in Our Town at the Thomaston 
Opera House in Thomaston, Conn. He has played the same 
patient about a dozen times, his medical condition growing 
increasingly dire with each performance. On the day Haeseler 
described Noah Savage’s illness to the other actors, they 
were preparing for a workshop on breaking bad news. This 
scenario required Savage to tackle his most challenging 
medical school role to date—getting the news that he needs 
a heart transplant. 
“Breaking bad news is one of the most challenging 
things physicians need to do. It is important for students to 
learn a structured, patient-centered approach that they can 
practice without causing discomfort for themselves or their 
patients,” says Haeseler. 
The rehearsal began with Haeseler role-playing a stu¬ 
dent. Following the model for breaking bad news that Fortin 
introduces to students just before their sessions with the 
actors, Haeseler asked Noah some general questions about 
how he was feeling and what he knew about his illness. 
Speaking in a slow soothing voice, he gently told Noah 
that his heart muscle had weakened and that he would likely 
need a heart transplant to survive. The news hardly seemed to 
register. “I’ve heard of those,” Noah said quietly, “but I never 
thought it would be something I’d ever need.” He appeared 
dazed, as though he needed to go home, talk with his family 
















20 Simulated cases, real skills 
Afterward, Haeseler said Savage’s reaction would provide stu¬ 
dents with an opportunity to listen, respond empathically to 
emotion and offer continuing support. 
The use of standardized patients, also known as simu¬ 
lated patients, programmed patients, surrogate patients, pro¬ 
fessional patients and patient instructors, has proven to be 
such an effective tool for teaching and assessing medical stu¬ 
dents that the United States Medical Licensing Examination 
(usmle) has added a clinical-skills assessment that includes 
standardized patients. The technique has become so widely 
accepted that now almost every medical school in the coun¬ 
try uses it. 
This acceptance could hardly have been predicted, 
given the early reaction to bringing actors into the classroom. 
In the early 1960s, when tire technique was introduced by 
Howard S. Barrows, m.d., it was dismissed as maligning the 
dignity of medical education and being too “Hollywood.” 
Barrows, a neurologist at Montefiore Hospital in the Bronx, 
N.Y., stumbled onto the technique inadvertently. He used to 
enlist patients on his floor to be examined by students. One 
day a patient told him that a student had been so unpleasant 
to him that in order to get back at the offending student, the 
patient began inventing symptoms. The incident led to an 
epiphany for Barrows: why not recruit healthy people to act 
as patients? Real patients wouldn’t be inconvenienced by 
gruff or incompetent students; students could be exposed to 
uncommon clinical events; and it would be an ideal assess¬ 
ment tool, because every student would get the same case. 
Barrows’ timing was fortuitous. At around the same 
time, medical schools were looking for more precise and less 
arbitrary ways to evaluate students during their clerkships. 
Until then students generally received satisfactory or better 
evaluations, because faculty members almost never directly 
observed them interacting with patients. 
The first standardized patient was developed by 
Barrows when he was at the University of Southern California. 
An artist’s model played a patient named Patty Dugger, a 
paraplegic woman with multiple sclerosis. After creating the 
case, Barrows needed to figure out a way to assess students’ 
interactions with her. Rather than using a one-way mirror 
or peeking through a curtain, he decided to give the actress a 
checklist to fill out after each encounter. 
Haeseler trains the actors to respond to students’ 
open-ended questions, reflections, summaries and empathic 
statements that they learn from Fortin’s introductory demon¬ 
strations. “Facilitative behaviors such as these build trust 
that in turn helps patients to express themselves and tell a 
more complete story of illness that includes biological, 
personal and emotional dimensions,” Haeseler says. 
Characters are developed using many sources, includ¬ 
ing literature, the actors’ own life experiences and real cases. 
During a standardized-patient encounter, a student is observed 
by one faculty member and two other students. What enhances 
the educational value, Haeseler says, is that students may 
call a time-out at any time during the session and freeze the 
action. This option gives the student a chance to get feed¬ 
back and advice, or to get some expert information that might 
be helpful. 
“Everyone has a memory of a doctor who didn’t seem 
to care or who didn’t explain things well,” says Savage, 
adding that through his work as a standardized patient, he 
feels he’s “helping future doctors acquire skills that are 
extraordinarily important.” 
A mannequin with human ailments 
Elsewhere on campus, simulated patients of a different sort 
are being used to help students master other important skills. 
Last June, Leigh V. Evans, m.d., hs ’02, director of health 
care simulation for the Section of Emergency Medicine in the 
Department of Surgery, launched a program using high-fidelity 
human patient simulators for third-year medical students 
during their surgery rotations. The lifelike polymer figures are 
computerized and programmable, so they can simulate just 
about any condition that occurs in the human body. 
The simulators can talk and breathe, their vital signs 
can change and they can even “die,” although Evans, an 
assistant professor in the Section of Emergency Medicine, 
says she’s never made a simulator do that because she wor¬ 
ries it would be too traumatic for the students. The major 
advantage a simulator has over actors is that you can create 
a medical emergency or practice such procedures as intuba¬ 
tion that you wouldn’t perform on a real person. 
During a recent session, a white male mannequin lay 
on an examining table surrounded by six students. Evans, 
who watched through a one-way mirror, used a microphone 
and a computer to alter the patient’s vital signs and talk to 
the students, either as the patient or as an expert consultant. 
This type of simulation has advanced significantly, thanks 
to the work of anesthesiologist David M. Gaba, m.d. ’80, at 
Stanford University. A researcher committed to refining 
simulator-based teaching techniques, he and his colleagues 
have developed a program that creates lifelike situations in 
clinical settings. Gaba’s program has been adopted at Yale, 
Harvard, Penn State, the University of California, San 
Francisco, and abroad. [See “A Safer OR,” Yale Medicine, 
Summer 2003.] 
The “patient” in Evans’ class was a 47-year-old man 
with severe abdominal pain and bloating. The students’ job 
was to figure out what was wrong with him and prescribe 
a course of treatment. As they began asking him questions, 
he complained of feeling nauseated; then he vomited. When 
he told the students that he still felt “horrible,” they decided 
to insert a nasogastric tube. 
The students then ordered X-rays, which showed 
that the patient had a large bowel obstruction. When Evans, 
assuming the role of a consultant, asked what the rectal 
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exam had revealed, the students realized they’d forgotten to 
perform one. A CT scan finally revealed the problem: sig¬ 
moid volvulus—a twist in the colon that caused everything 
moving through it to back up. Although this condition 
can sometimes be treated with a rectal decompression, the 
patient had already had two similar episodes, so surgery 
was recommended this time. 
Simulators can cost between $40,000 and $200,000, 
says Evans, depending on the sophistication of the software. 
The current curriculum, which requires third-year students 
to participate in 24 scenarios over a 12-week block, began 
this academic year. 
“We’re not dependent on what comes through the 
door, and students can treat much sicker ‘patients,’” says 
Evans. The simulators are ideal for clinical decision mak¬ 
ing and developing teamwork skills, she says, but are less 
effective for teaching physical diagnostic skills, because 
regardless of the sophistication of their computer programs, 
they’re still just plastic dolls. 
Evans’ students work in groups of six, with a faculty 
member overseeing the session. During the exercise, partici¬ 
pants can call a consultant, talk to a surgeon, order X-rays or 
request any service that would be available during an emer¬ 
gency. The simulations are videotaped so that participants 
can review their performances afterward. The Department of 
Pediatrics now has an infant mannequin, and the Yale New 
Haven Center for Emergency Preparedness and Disaster 
Response is also using mannequins to teach students. The 
next step, says Evans, is to set up a simulation center with a 
simulated operating room, an intensive care unit, a trauma 
bed and other hospital settings. 
“It’s helpful to be able to see serious cases, unstable 
cases, and think through everything on your own,” says 
Kathryn Hogan, m.d., a third-year resident in emergency 
medicine who led the group that treated the patient with sig¬ 
moid volvulus. She says that during the first few scenarios 
in which she participated, she and the group forgot to ask 
key questions as they tried to diagnose the patients. But she 
says they’ve gotten better. “When you learn by doing, you 
learn fast because it feels like you’re treating a real patient. 
It’s very dynamic.” 
“See one, do one, teach one”—virtually 
Another variation on the simulated-patient model—the 
computer simulator—is now in wide use at the surgical 
simulation laboratory run by Andrew Duffy, m.d., assistant 
professor of surgery, director of the surgical simulation cen¬ 
ter and assistant program director of the surgical residency. 
Launched last March, the surgical simulation center 
resembles a video arcade without all the flashing lights 
and electronic noises. Several box trainers designed to help 
students with such skills as performing endoscopic proce¬ 
dures, manipulating remote instruments, developing spatial 
During her acting career Kris 
Montgomery had the starring role 
in Evita in national and interna¬ 
tional touring companies and 
performed Off Broadway and in 
motion pictures with Harrison 
Ford, Tom Hanks and Meg Ryan. 
As a standardized patient at the 
School of Medicine she plays 
the role of a Manhattan execu¬ 
tive whose hip problems stem 
from a high-stress job. During 
interviews with medical students, 
she drops clues to her physical 
and psychological states, hoping 






















22 Simulated cases, real skills 
Last March the surgical simulation 
center opened at the medical 
school, with computer simulators 
that allow students and resi¬ 
dents to master such skills as per¬ 
forming endoscopic procedures, 
manipulating remote instruments, 
developing spatial relationships, 
hand-eye coordination and sutur¬ 
ing. Andrew Duffy, assistant pro¬ 
fessor of surgery, director of the 
surgical simulation center and 
assistant program director of the 
surgical residency, demonstrates 
on a simulator that can replicate 
both the inside of an abdomen 
and a full colonoscopy procedure. 
“You can watch yourself zipping 
around the colon on the video 
screen. The machine even groans 
if you’ve hurt the patient,” Duffy 
says. About 100 surgical, ortho¬ 
paedic and ob/gyn students 
and residents use the lab on a 
regular basis. 
relationships, hand-eye coordination and suturing are located 
in a suite of rooms near Yale-New Haven Hospital, so that 
residents can stop in and practice in between their duties at 
the hospital. 
One trainer replicates the inside of an abdomen. 
Another is a full colonoscopy procedure simulator. “You 
can watch yourself zipping around the colon on the 
video screen. The machine even groans if you’ve hurt the 
patient,” Duffy says. 
The surgical simulation laboratory grew out of the 
need to teach students and residents more skills in less time. 
“With an 8o-hour limit imposed on surgical residents’ train¬ 
ing, and so many new laparoscopic procedures, residents have 
to learn twice as much in 20 percent less time,” Duffy says. 
About 100 surgical, orthopaedic and ob/gyn students 
and residents use the lab on a regular basis. The machines, 
which came into use in medical schools about five years 
ago, are now so popular that some of the hand pieces have 
worn out. “These machines are essential tools,” Duffy says. 
He says the next generation of simulators, which are now 
in development, will include gall bladder and hernia models. 
Duffy contrasts this type of training with his own, 
when the mantra was “see one, do one, teach one” and the 
main way in which residents honed their skills was by 
observing experienced doctors at work. “I vividly remember 
how bad I was and how quickly the surgeon took over," 
he says. “We want students to learn and practice on our 
machines, so that when the time comes to treat real patients, 
they’ll already be proficient.” In fact, all residents are 
now required to complete this training before they assist in 
laparoscopic and endoscopic procedures on patients. 
For laparoscopic surgeons, simulators help them 
learn how to manipulate instruments in a three-dimensional 
space while looking at a two-dimensional screen. “Dissec¬ 
tion combined with computers helps surgeons look at two 
dimensions, but ‘see’ in three,” says Lawrence J. Rizzolo, 
ph.d., associate professor of surgery and of ophthalmology 
and visual science, and director of medical studies in the 
anatomy section in the Department of Surgery. 
Computer software and patient narratives also help 
build a clinical correlation between patients and the study of 
anatomy by transforming the cadaver into a simulated patient. 
All course activities become centered on clinical problems 
and procedures. “The software allows us to see internal organs 
and rotate the images,” Rizzolo says. “In our dissection lab, 
there’s a computer at every table. The idea is to make it so the 
software can’t be used without the cadaver and the cadaver 
can’t be used without a computer,” says Rizzolo. 
Assessing clinical skills 
Although it’s accepted that clinical skills are central to the 
practice of medicine, prior to the introduction of standard¬ 
ized patients into the usmle there was no national approach 
for objectively evaluating students’ competency in clinical 
skills. “It was always pointed to as a gap in the medical 
licensing program,” says Gerard F. Dillon, ph.d., associate 
vice president for the usmle at the National Board of 
Medical Examiners. That gap was filled in 2004 when stand¬ 
ardized patients were introduced as part of the usmle 
system. “To introduce it into the examination program was 
an enormous step forward,” he added. 
With this new assessment tool, examiners have been 
better able to identify students who are deficient in clinical 
skills. These students, who previously might have flown 
beneath the radar, now get feedback, and their schools are 
notified so that they can get help to remedy the deficiency. 
The other benefit, Dillon says, is that since the usmle has 
begun assessing clinical skills, medical schools have put 
more emphasis on teaching these skills and ensuring that 
students have mastered them. 
As the usmle assessment program develops, the hope 
is that it will expand beyond standardized patients to include 
such other technologies as patient simulators. “With live 
actors, you can’t assess all of the skills that you would like,” 
Dillon says. “Our plan is to introduce some other technol¬ 
ogies that will allow an even broader assessment, but first 
we have to make sure that such technologies are reliable and 
that their presentations are consistent.” 
Money is another consideration. At a cost of $1,000 
per assessment, which students pay, Dillon says the usmle 
program has a responsibility to consider the expense of any 
additional assessment tools. 
Still, despite the considerable investment and inevitable 
growing pains that come with the introduction of a new pro¬ 
gram, it’s clear that standardized patients, mannequins and 
increasingly sophisticated computer trainers are going to 
become a key methodology in medical education. 
“I like it very much. It’s a great addition to the pre- 
clinical education. It gives students the chance to develop the 
skill of eliciting medical histories and physical findings,” 
says Peter N. Herbert, m.d. ’67, hs ’69, chief of staff and 
senior vice president for medical affairs at Yale-New Haven 
Hospital. Herbert says that unlike real patients, actors are 
able to objectively assess the student’s technique and offer 
feedback, which he says is “extraordinarily useful.” 
For example, if a student makes the common mistake 
of lapsing into med-speak (“Is your child febrile?” rather 
than “Does your child have a fever?”), a standardized patient 
will quickly point that out. 
“I can only say that I wish there had been standard¬ 
ized patients when I was a medical student,” Herbert says. 
“It would have saved me and my early patients a lot of 
embarrassment.” ym 
Jennifer Kaylin is a freelance writer in New Haven. 
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26 From the potion to the pill 
By John Dillon 
Illustrations by Mark Gagnon 
estern physicians, who demand clinical 
proof of a drug’s efficacy, and propo¬ 
nents of alternative remedies, who point 
to anecdotal evidence that their prod¬ 
ucts work, have carved out distinct but 
neighboring territories in the world 
of medicine. Although the inhabitants of these territories 
have often regarded each other with suspicion, their borders 
have become increasingly porous. According to a 2004 sur¬ 
vey by the National Center for Complementary and Alterna¬ 
tive Medicine (nccam) of the National Institutes of Health 
(nih), 36 percent of Americans 18 or older have tried an 
alternative remedy. That survey also found that 26 percent 
of the respondents used alternative treatments based on a 
recommendation from a mainstream medical practitioner. 
This wary and shifting relationship stems in part 
from differing world views. Practitioners of traditional or 
alternative medicine take a more holistic view of healing 
than their mainstream counterparts. And mainstream 
physicians see a lack of scientific rigor in published evalu¬ 
ations of traditional medicines whose recipes have been 
handed down over generations. Furthermore, how does a 
physician calculate a reliable dosage of a medicine that’s 
brewed in a tea and whose chemical makeup depends on 
how much water and how many leaves are used, where 
the plants were grown, when they were harvested and how 
much it rained that season? 
Now Yale scientists are attempting to bring traditional 
Chinese medicine into the mainstream. Working with two 
companies in New Haven and Taiwan, they have brought 
precision and consistency to a traditional Chinese remedy 
for headache, fever and gastrointestinal problems. Clinical 
trials have shown that the compound reduces the unpleasant 
effects of chemotherapy. Trials will soon begin to evaluate 
whether it also enhances the action of the chemotherapy. 
The researchers’ main accomplishment, however, is the 
development of a platform technology that combines quality 
control, a robust database, clinical trials and herbal resources 
to produce plant-based medicines with a biologically consis¬ 
tent result. 
“We’re in a new frontier," said Yung-Chi “Tommy” 
Cheng, ph.d., the Henry Bronson Professor of Pharmacol¬ 
ogy, who is leading efforts at Yale to advance the study of 
traditional Chinese medicine. 
Prehistoric origins of herbal medicine 
Most users of herbal remedies point to anecdotal rather 
than clinical evidence of efficacy—but that evidence, like the 
botanicals themselves, has firm roots in many countries 
around the world. 
Otzi the Iceman, the 5,300-year-old mummified human 
discovered in the Italian Alps in 1991, carried his own medi¬ 
cine kit, which contained birch fungus, a natural antibiotic. 
An autopsy showed that Otzi suffered from intestinal para¬ 
sites, so the birch may have come in handy to fight the 
infestation. Birch fungus also could have served as a styptic 
pencil to close minor cuts. 
In the Middle Ages, ergot, a fungus that grows on rye 
and other food grains, caused ergot poisoning in people 
who ate bread made from rye, barley or wheat infested with 
the parasite. Characterized by constriction of blood vessels, 
ergotism often led to gangrene. It was also marked by con¬ 
vulsions and hallucinations known as Saint Anthony’s fire. 
(The alkaloids in ergot were a key ingredient in the experi¬ 
ments performed by a Swiss chemist that led to the synthe¬ 
sis of lsd.) Ergot was also used in 16th-century Europe to 
stop postpartum bleeding and to induce abortions; its first 
recorded use as an oxytocic was 1582. 
And also in the 16th century, Western explorers like 
Sir Walter Raleigh were impressed by the way in which 
South Americans killed prey—and sometimes Europeans— 
with arrows poisoned with curare. Curare, which is con¬ 
cocted from several plants, kills by isolating muscle tissue 
from contact with nerves, eventually paralyzing the victim’s 
respiratory muscles. The powers of curare weren’t tamed 
until 1942, when two physicians converted it into a muscle 
relaxant that allowed lifesaving procedures to be performed 
more rapidly and effectively. 
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The coca leaf has been a chief target in the war on 
drugs, but it was woven into the fabric of Andean society 
thousands of years before its illicit use as the raw material 
of cocaine. To this day, indigenous people in South America 
chew on the leaf as a stimulant and appetite suppressant, 
helping them get through a day of hard labor on the moun¬ 
tainsides. Brewed as a tea, coca combats altitude sickness 
and settles the stomach. 
Since the Enlightenment, the healing ability of botani- 
cals has been rooted in hard science: the British physician 
William Withering, m.d., noted in a seminal 1785 paper that 
the garden herb foxglove, also known as digitalis, alleviated 
a deadly accumulation of fluid in the lungs and other body 
tissues—a condition then called dropsy—in patients with 
congestive heart failure. 
Humankind has also been wary of medicinal plants. 
They tend to trigger a bitter taste on the tongue, long recog¬ 
nized as a poison detector. They also vary in their potential 
to harm as well as heal. As Withering himself acknowledged, 
the perils of foxglove were well-known. 
Foxglove has long since been converted into a standard¬ 
ized drug known as digoxin, but controversy over its use— 
including its potential toxicity—continues to this day. But the 
disputes are based on numerous studies, something that 
can’t be said about many other botanicals with supposed heal¬ 
ing properties. The longstanding use of herbal preparations 
notwithstanding, they have a hard time getting a seat at the 
table dominated by Western pharmaceuticals, which rely 
heavily on the clinical trial, largely unheard-of until the 1920s. 
Star anise is a staple in Chinese spice cabinets, in part 
because of its licorice-like flavor and in part because it helps 
promote healthy digestion. Teas made from it have tradition¬ 
ally been used to treat colicky babies. However, in 2003 the 
Food and Drug Administration (fda) issued an advisory to 
warn consumers against drinking the tea—Chinese star anise 
was sometimes adulterated with Japanese star anise, a toxic 
species of the herb. It also provides the key ingredient for the 
anti-flu drug oseltamivir phosphate, marketed under the name 
Tamiflu by Roche. When reports of avian flu hit Asia in 2005, 
Chinese officials reported a run on star anise, both by people 
who wanted its protective properties and by those who wanted 
it to flavor their food. Eating the spice offers no protection 
against flu, however, because the active ingredient, shikimic 
acid, is obtained only after a laborious extraction process. 
For over two millennia herbal treatments have been a 
mainstay of Chinese medicine, whose techniques also 
include acupuncture and massage. Among the herbs used 
are yarrow, to treat the common cold, colic, indigestion and 
toothache; aloe, which has a laxative effect and is also used 
to treat wounds and burns; cardamom seeds for infections 
of the digestive tract as well as nausea and vomiting; and 
devil’s root, for chronic bronchitis. Traditional Chinese 
medicines are made of a blend of herbs, usually a principal 
ingredient and three others intended to reinforce the effects 
of the principal herb, mitigate its side effects or treat a coex¬ 
isting disease pattern. 
Finding a consistent dosage 
Complementary and mainstream medicine “have a different 
type of approach” to healing, but “eventually, they’re going 
to meet,” said Cheng. “Chinese medicine has been used for 
years and is still used today.” He knows full well that “main¬ 
stream medicine has always been suspicious” of such 
methods of healing, even if their popularity has risen in 
Western countries. By 1997, according to the nccam, spend¬ 
ing on complementary and alternative medicines totaled 
between $36 and $47 billion in the United States alone. By 
comparison, the major pharmaceutical companies registered 
$251.8 billion in sales in 2005, according to the most recent 
figures from ims Health, a consulting firm that tracks the 
drug industry. 
In 1999 Yale’s Office of Cooperative Research worked 
with Cheng to found PhytoCeutica, a company devoted to 
making cancer drugs out of herbs used in traditional Chinese 
medicine. That this project is connected with a leading 
research institution at all reflects a major shift in attitude, said 
James C. Whorton, ph.d., professor of medical history and 
ethics at the University of Washington School of Medicine in 
Seattle and the author of Nature Cures: The History of Alternative 
Medicine in America. “It would not have happened 25 or 30 
years ago,” he said. “A faculty member wouldn’t risk having 
his name associated with some group that was doing alterna¬ 
tive medicine. It was career suicide.” 
Cheng also hopes to advance the acceptance of tradi¬ 
tional medicines at the international level. In December 
2004 he founded the Consortium for the Globalization of 
Chinese Medicine, which counts as members 61 institutions 
around the world, including seven from industry. Member 
institutions include the School of Medicine; the Department 
of Intramural Research Affairs at the National Health Research 
Institutes of the nih; and academic and research institutes 
in Canada, China, Great Britain, Hong Kong, Singapore, 
Taiwan and the United States. The consortium’s goals are to 
develop platform technologies for producing Chinese medi¬ 
cines, to facilitate collaboration among institutions and to 
develop medicines based on Chinese herbal preparations as 
well as traditional medicines from other countries. “The 
spirit is to share the technology,” said Cheng, who chairs the 
consortium. “This is something no company or institution 
can do by itself." 
The key to success for producing Chinese herbal 
remedies, aside from showing that they work, is getting a 
consistent formula to deliver the drug. This concern for 
consistency is what separates PhytoCeutica from other pur¬ 
veyors of Chinese herbs. The alternative treatment landscape 




















28 From the potion to the pill 
cancer therapies but ultimately failed or were deemed dan¬ 
gerous. When such products are taken in their herbal form 
or as unregulated supplements, however, the bath water 
comes with the baby. “With two different preparations, you 
come up with a different result,” Cheng said. “The chemical 
composition is going to be different.” 
For example, pc-spes, a widely touted herbal concoc¬ 
tion for prostate cancer, was removed from the market after 
reports that it caused cardiovascular and other problems. 
“Different formulations were found to have different impuri¬ 
ties,” said Edward Chu, m.d., deputy director of the Yale 
Cancer Center. If the impurities had been removed, it might 
have worked, he said. 
For the past few years PhytoCeutica has been conduct¬ 
ing early-stage clinical trials of a traditional Chinese medi¬ 
cine formula that goes by the designation PHY906 and acts 
as an adjuvant to chemotherapy for cancer. For competitive 
reasons, the company, which has a patent for PHY906 in 
the United States and other countries to treat cancer, won’t 
release many details about the herbs used in the compound. 
Cheng said it is a traditional Chinese medicine derived from 
four different plants whose therapeutic ingredients work 
better together than each does alone. Unlike other plant- 
based drugs with a single active molecule, however, PHY906 
is multipronged. “Chinese medicine always claims to have 
multiple chemicals hitting multiple targets,” explained 
Cheng, referring to the traditional practice of blending sev¬ 
eral herbs to produce a single remedy. “There is a possibility 
this could be a shortcut to look for medicines which have 
a broad spectrum of usage, and also cover most patients.” 
The herbs used to make PHY906 are typically brewed 
as a tea or put in a blender, according to Chu, who was born 
in the United States, but whose great-grandfather practiced 
Chinese herbal medicine. The plants have been used histori¬ 
cally to treat headache, fever, swelling and a host of gastro¬ 
intestinal problems. 
Initial Phase I trials involving 17 patients found that 
PHY906, used in combination with a standard two-drug 
regimen for colon cancer, caused no adverse effects and 
appeared to reduce the toxicity of the chemotherapy. The 
next step of the trial, with 29 patients, is to determine whether 
PHY906 will enhance the action of the chemotherapy 
and shrink tumors as it did in animal models, Cheng said. 
Another trial tested the compound with capecitabine, mar¬ 
keted by Roche under the name Xeloda to treat liver cancer, 
and again found no adverse effects from PHY906. Data are 
still being gathered to assess the effects of the traditional 
formula on quality of life, but initial findings, said Cheng 
and Chu, are encouraging. 
“It seemed like the anti-tumor activity of Xeloda was 
improved upon the addition of the herb,” said Chu. “In 
Phase I, patients seemed to tolerate the combination pretty 
well, and there are some patients who are continuing to 
receive treatment for a lot longer than with chemotherapy 
alone.” In Phase II of that trial, the investigators will see 
“whether it can cause the tumors to shrink and allow the 
patients to be living with their cancer for a longer period of 
time,” Chu said. In addition, a new trial at Yale-New Haven 
Hospital is testing PHY906 in combination with Xeloda for 
treatment of pancreatic cancer. 
Chu and Cheng still don’t know how PHY906 works, 
but they suspect that it inhibits certain proteins or clears a 
path to allow cancer drugs to get into cells. “To be honest, 
as a patient you don’t really care how the compound works,” 
Cheng said. That people have used these herbs for nearly 
two millennia, and still do in the age of pharmaceutical 
plenty, makes for a tough-to-ignore case. “A number of our 
friends who have had cancer and who have taken these 
herbs have benefited,” Chu said. The point of the research, 
however, is to “take it out of the mystique and prove in fact 
that there is real clinical efficacy.” 
If proven effective, PHY906 could become the first 
botanical prescription medicine developed from multiple 
herbs to be approved for oral administration by the fda, said 
Cheng. (The fda recently approved an unrelated topical 
application based on herbal medicine for treatment of geni¬ 
tal warts, Cheng said.) 
While the trial results have looked good so far, this 
botanical-to-pharmaceutical therapy still faces an uphill battle. 
“So far, I have not seen any herb go beyond Phase III,” said 
Lixing Lao, m.d., ph.d., director of traditional Chinese medi¬ 
cine research at the University of Maryland School of 
Medicine. Another concern endemic to herbal medicines— 
and one that has ended trials in the past—is getting a consis¬ 
tently successful formula. “We have standards of chemical 
identities,” said Peter Goldman, m.d., professor emeritus of 
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pharmacology at Harvard, who has called for stronger research 
on medicinal herbs. “How sure are you that what you have 
from a chemical perspective could actually be reproduced?” he 
asked. Lao added that the potency of an herb can vary greatiy 
from sample to sample. “Different fields in different seasons 
may come up with different chemical compositions.” 
PhytoCeutica’s work on PHY906 stems from a col¬ 
laboration with SunTen Phytotech, a Taiwanese herbal 
medicine company that had manufactured the compound 
in pill form for years. What’s new is the application of 
PhytoCeutica’s platform technology, called Phytomics, and 
quality control methods to develop a standard consistency 
for the compound. Cheng said PhytoCeutica uses modern 
bioinformatics, “including chemical and biological finger¬ 
prints,” to obtain the same formula each time. “We com¬ 
pared our product with the company’s product that was 
made previously, not following current good manufacturing 
practices,” Cheng said. “As far as chemistry and biology are 
concerned, they are different. The manufacturing practices 
are a critical element to ensure the product’s consistency.” 
The success of PHY906, according to Nature Cures 
author Whorton, depends on whether “they’ve actually iden¬ 
tified the compounds present in the crude herbs and isolated 
that in pure form, the way you’d isolate morphine from 
opium.” If that works, then PhytoCeutica and its Taiwanese 
partner can separate from the large pack of herbal medicine 
companies. Paul Talalay, m.d. ’48, professor of neurology 
and pharmacology at Johns Hopkins School of Medicine, 
said that will be necessary because many products make 
bogus claims, are dangerous or both. A 1994 federal law 
allows sellers of alternative remedies to make health claims 
without adhering to the same strict standards as a pharma¬ 
ceutical drug. The law, the Dietary Supplement Health 
and Education Act (dshea), essentially deregulated the 
industry—the fda can’t remove a product until there is over¬ 
whelming evidence that it causes harm—and spurred more 
intense interest in readily available products, dshea was 
“a disaster” that “confuses our ability to handle disease prop¬ 
erly,” Talalay said. Everything should undergo the same 
standards of testing, he said. 
The program as developed by Yale may be an excellent 
model for raising standards, according to Jeanne A. Drisko, 
m.d., who developed an integrative-medicine program at 
the University of Kansas and served on an Institute of Medi¬ 
cine committee that wrote a report on alternative medicine. 
“The only way that we’re going to separate those [remedies] 
that work from those that don’t is to do the research,” she 
said. “And it has to be done in a partnership between the 
conventional practitioner and the complementary and alter¬ 
native practitioner.” ym 
John Dillon is a freelance writer in New Haven. 
Chinese herbal remedy 
found to work against 
kidney disease in mice 
The search for a treatment for 
polycystic kidney disease (pkd), 
a disorder in which genetic muta¬ 
tions lead to the formation of 
cysts that impair kidney function, 
has led a Yale team to a Chinese 
plant-based medicine used for 
centuries to treat cancer, inflam¬ 
mation and other conditions. 
“The active ingredient has been 
known for 30 years, but nobody 
knew how it worked,” said Craig 
M. Crews, ph.d., associate pro¬ 
fessor of chemistry, of molecular, 
cellular and developmental 
biology and of pharmacology. 
“We wanted to find out how 
this compound worked.” 
Crews and colleagues found 
that the compound, known as 
triptolide, binds to a calcium chan¬ 
nel encoded by the gene PKD2 
and implicated in polycystic kid¬ 
ney disease. Furthermore, the 
gene that encodes that channel 
had been cloned by Stefan Somlo, 
m.d., fw ’91, the c.n.h. Long 
Professor of Medicine and profes¬ 
sor of genetics. Triptolide is the 
active ingredient in the traditional 
Chinese medicine Lei Cong Teng, 
typically brewed as a tea. 
In March, Crews and his team, 
in collaboration with Somlo, 
reported in the Proceedings of 
the National Academy of Sciences 
that triptolide reined in the rogue 
calcium channel in mice and thus 
appeared to mitigate the symp¬ 
toms of pkd. "Our research 
shows that triptolide ... markedly 
decreases cyst formation in a 
mouse model of this most com¬ 
mon genetic lethal kidney dis¬ 
ease,” Crews said. 
pkd, Crews said, is the result 
of a gene mutation that con¬ 
fuses epithelial cells into think¬ 
ing they’re at an earlier stage 
of development. As a result they 
continue to generate tubules that 
turn into fluid-filled cysts in the 
kidney. "They accumulate cysts 
to the point where after 40 or 50 
years of life the kidneys are so 
full of cysts that they lose func¬ 
tion," he said. More than 12 mil¬ 
lion people worldwide suffer 
from the disease. 
“The next step with triptolide 
is that we want to see if this 






















above As a child growing up 
during World War II, Dorothy 
Lewis wondered what happened 
to shape Adolf Hitler’s character. 
As a psychiatrist, she has studied 
serial killers and murderers, find¬ 
ing three elements that occur 
consistently in the most violent 
offenders: brain dysfunction, child 
abuse and psychotic thinking, 
particularly paranoia. The three 
occurring simultaneously, she 
believes, are a recipe for violence. 
right Lewis’records include 
writing samples and drawings 
from the killers she has studied. 
The style of these records tells 
her as much as the substance— 
marked changes in handwriting 
can reveal as much as what 
is written. 
A fascination with 
violence 
Dorothy Lewis has spent her career trying to understand serial killers 
such as John Allen Muhammad and Ted Bundy. Her theory—that all 
violent offenders share three traits—was once considered outrageous 
but now influences Supreme Court decisions. 
By Colleen Shaddox 
Photographs by Terry Dagradi 
Dorothy Otnow Lewis, m.d. ’63, hs ’70, a clinical professor in 
the Child Study Center, recalls her childhood in New York 
City during World War II as painful and awkward. As children 
were choosing up sides for a game, she remembers praying, 
“Please God, let me be picked second to last, not last.” The 
little girl who was the object of so much teasing at school 
would once again see her prayers go unanswered. 
At home, things were not always easy. She was tangled 
in an ambiguous relationship with her older sister, who liked 
to hide in dark closets, jump out and scream, “The green 
witch will get you!” But at other times, she helped Dorothy 
with her French homework, keeping her a week ahead of her 
classmates. A serious, often sad, child, Dorothy was urged 
by her mother to be more social: “shorten your skirts; be a 
butterfly.” But young Dorothy never felt much like a butterfly. 
She felt like an outsider, and she credits that feeling of isola¬ 
tion with her lifelong interest in society’s pariahs. 
Her interest began in kindergarten, when a precocious 
desire to understand how a human being could be so cruel 
led her to try to figure out Adolf Hitler. After all, she was hor¬ 
rified when she watched her uncle slaughter a chicken on 
their farm in New Jersey. In Lewis’ memoir, Guilty by Reason 
of Insanity: A Psychiatrist Explores the Minds of Killers, she 
recalls stories of the Nazi dictator hanging over her childhood 
as “a source of fascination and fear.” She was the only student 
in her elementary school “who did not rejoice upon hearing 
of Hitler’s suicide. Now I could never know what made him 
tick. ... I was convinced, even as a child, that Hitler could not 
have been born that way. Something had to have happened 
to him. No one could be born that way. I still believe that.” 
Lewis has spent her career as a psychiatrist studying 
murderers and searching for scientific explanations for their 
behavior. Her work would take her away from her family as 
she flew to reform schools and prisons around the country 
to research cases or testify for the defense. It would put her 
in the company of such notorious murderers as Mark David 
Chapman, who shot John Lennon; serial killers Ted Bundy 
and Arthur Shawcross; and in 2005, John Allen Muhammad, 
the so-called “Beltway Sniper,” who examined her fingers and 
told her she should drink more water. Lewis’ work would 
place her on the stand as a defense witness where prosecu¬ 
tors would do their best to discredit her. It would even put her 
at odds with the mainstream of her profession as she chal¬ 
lenged conventional theories that attribute violent behavior to 
socioeconomic deprivation and lax discipline. 
Her findings, based on psychiatric and neurological 
evaluations coupled with reviews of medical records, have 
appeared in such publications as the American Journal of 
Psychiatry and the Journal of the American Academy of Child 
and Adolescent Psychiatry. Three elements, she has found, 
occur consistently in the most violent offenders: brain dys¬ 
function, child abuse and psychotic thinking, particularly para¬ 
noia. When all three occur simultaneously, Lewis believes, 
they become primary ingredients in a recipe for violence. 
Her theories, once considered outrageous, influenced 
Supreme Court rulings on capital punishment in 1988 
and 2005. The outsider has become the expert and even 
something of a butterfly. “She’s very petite, very feminine. 
The last person in the world you’d expect to be doing this 
work,” said Jonathan H. Pincus, m.d., hs ’64, her long¬ 
time collaborator, now chief of neurology at the Veterans 
Administration Medical Center and a member of the 
Center for the Brain Basis of Cognition at Georgetown 




















32 A fascination with violence 
Lewis believes that child abuse acts 
in several ways to turn people into 
violent adults. The abuse itself can 
cause brain damage that leads to 
a lack of control. Children also learn 
an unhealthy model of behavior. 
“Children do as they see," Lewis 
said. And the abuse engenders 
rage that is almost never directed 
toward the abuser, but is displaced 
onto others. 
In concentrating on violence, Lewis chose, to put it 
mildly, the road less traveled. Her husband, Melvin Lewis, 
m.d., hs ’59, professor emeritus and senior research sci¬ 
entist in the Yale Child Study Center, frequently ribs her, 
“Dorothy, with two basic drives why did you have to choose 
violence?” She has no regrets. “Violence is probably the 
single most important public health issue anywhere in the 
world,” Lewis said. 
A murder with no reason 
She is a master at separating the lurid side of her work 
from her family life. On a snowy afternoon last winter in 
her comfortable Tudor home in New Haven, a boom 
box flooded the house with Mozart. Lewis sat on the sofa 
thumbing through case records. 
Her records are full of drawings and writing samples 
from the murderers she has examined. There are sketches 
that they made of their own disjointed conceptions of their 
brains as well as scenes of sexual abuse they remembered 
from childhood. Lewis often saw as much in the style of their 
works as in the substance. “See. Here! And here again!” She 
tapped the pages wherever she saw marked changes in hand¬ 
writing—clues that the writer may periodically dissociate. 
Until 1984, when she recognized her first case of dis¬ 
sociative identity disorder (did), she questioned the phenom¬ 
enon’s very existence. It is still regarded with skepticism by 
some psychiatrists. 
Once known as multiple personality disorder, did is 
marked by two or more personalities coexisting in the 
same patient. While did has been listed in the fourth edition 
of the Diagnostic and Statistical Manual of Mental Disorders 
since 1994, the diagnosis remains controversial—some psy¬ 
chiatrists believe it is the product of therapist suggestion. 
Nevertheless, Lewis is now asked to lecture about did inter¬ 
nationally—evidence, in her view, that the profession is 
giving the diagnosis more credence. 
As she pored over records of Lee Anne Jameson, the 
first juvenile murderer Lewis ever evaluated, a small boy 
bounded into the room and asked, “Grandma, do you have 
any batteries?” Her grandson, Noah, held up an action figure. 
Lewis looked up from the book and grinned. She asked him 
a bit about his day, then directed him to the batteries. When 
Noah left the room, she returned to the Jameson case without 
■missing a beat. 
Lee Anne (a pseudonym to protect the girl’s identity) 
was 13 when she killed her best friend with a paring knife 
while waiting for a school bus. No one, least of all Lee Anne, 
could say why. Lewis got involved in the case because she 
was running a clinic in New Haven’s juvenile court at that 
time. Observing “normal” children in a preschool as a child 
psychiatry fellow at Yale didn’t interest her; she convinced 
the faculty that her evenings with her daughter, Gillian, then 
four, gave her ample opportunity to observe normal child 
development. She got permission to observe at the juvenile 
court in New Haven. After witnessing the severe psycho¬ 
pathology in children and families coming through the court 
and the lack of services available to them, she received a grant 
from the state of Connecticut in 1971 to open the first court 
clinic in the state. With psychologist David A. Balia, ph.d., a 
research associate at the Child Study Center, she published 
Delinquency and Psychopathology in 1976. The book was based 
on their work with children in the clinic. 
One of the first cases Lewis encountered was that of 
Lee Anne. The girl’s medical history was telling. She had 
made more than 30 visits to Yale-New Haven Hospital. While 
pregnant with Lee Anne, her mother suffered from syphilis 
and untreated hypothyroidism, conditions that limited Lee 
Anne’s intelligence. During a difficult delivery, the soft bones 
of the baby’s cranium had been squeezed together and her 
clavicle broken. The ensuing years saw a string of emergency 
room visits—cuts, burns, stomach pains and numerous 
accidents and injuries. Lee Anne was dismissed as a manipu¬ 
lative attention-seeker. No one paid attention to a medical 
student’s note: “she stared off into space and could not be 
aroused for several seconds. ... Get eeg.” Lewis suspected a 
neurologic problem and consulted Pincus, then also a faculty 
member at Yale. Pincus found some signs of neurologic 
problems and ordered an eeg, but it was normal. Never¬ 
theless, Lee Anne’s symptoms were consistent with complex 
partial seizures. She also was paranoid and sometimes 
heard voices that told her what to do. 
Lee Anne displayed the three traits that Lewis and 
Pincus would see again and again in murderers: brain injury, 
psychosis and a history of abuse. Their combined testimony 
was less conclusive than Lewis would have liked. But it was 
enough to get Lee Anne sent to a treatment center; it was also 
the start of a partnership that would alter the careers of both 
doctors, who often see things very differently. 
For example, Lewis has long been at odds with the 
conventional wisdom and often puts more trust in her own 
observations than in the literature. Pincus, however, has a 
deep respect for the literature. And when they began their 
second collaboration, in 1977, Pincus observed that the 
study was “a waste of time.” Lewis was studying the neuro¬ 
psychiatric characteristics of youths in Long Lane School in 
Middletown, then Connecticut’s detention facility for vio¬ 
lent juveniles. The state wanted detailed information about 
the children who would be housed in a proposed secure 
wing. Pincus did not believe that violence and neuropathol¬ 
ogy were linked—he opened one of the classic texts on 
crime and psychiatric disorders and read a list of factors 
not associated with criminal behavior, including such 
impairments as schizophrenia and brain damage. Pincus 
finally agreed to participate in the study after Lewis 
explained that her grant included a stipend for a neurolo¬ 




















34 A fascination with violence 
staggering. He told Lewis that he had never seen so many 
neurologically impaired children in one place. 
Their collaboration continued when Lewis joined the 
faculty of New York University (nyu) in 1979 as a professor 
of psychiatry. She made the move because her Yale appoint¬ 
ment as a clinical professor carried no salary. She also main¬ 
tained a small private practice in addition to her academic 
work. But when Melvin Lewis was diagnosed with angina, 
she faced the possibility of becoming the sole breadwinner 
for a family that now included two children. 
“I wanted to work in New Haven, and Yale was the 
obvious place to begin my job search,” Dorothy Lewis wrote 
in her memoir. “Yale was not interested. Yale had never in its 
history given a tenured faculty position in psychiatry to a 
woman psychiatrist; maybe once to a pediatrician, once to an 
epidemiologist; never to a woman psychiatrist. Yale was not 
about to break tradition for me.” After receiving offers from 
Columbia, Cornell and nyu, Lewis joined the faculty at nyu, 
because it had an inpatient adolescent unit and offered access 
to Bellevue Hospital’s prison ward. Lewis secured funding to 
study prisoners and again convinced Pincus to become the 
project neurologist. 
An interview four years later on the CBS Morning News 
brought her to the attention of a Florida public defender. 
The lawyer saw Lewis’ interview with Diane Sawyer on the 
subject of children who kill, and thought that the children 
she described sounded a lot like two of his clients on death 
row. He asked Lewis and Pincus to come to Starke, Fla., to 
evaluate his entire death row clientele. Tire only place to eat 
was a greasy spoon with an electric sign outside flashing 
"Burn Bundy Burn,” a reference to the serial killer Ted Bundy, 
due to be executed. Bundy was not on their list of convicts 
to examine, though Lewis would end up interviewing him 
many times before his execution in 1989. 
Lucky Larson (not his real name) was on their list. 
Larson was sentenced to die for two separate murders in 
which he’d hacked victims to death in the course of robberies. 
Tire death row inmate’s demeanor was remarkably cheerful. 
Larson explained that he’d adopted an optimistic attitude after 
a serious car accident he’d had years before the murders. 
Larson’s smile was lopsided, as was his gait. Tests revealed 
several brain injuries. An mri showed that his frontal lobes 
had been injured and could not perform their usual job of 
controlling impulses emanating from the deeper, more primi¬ 
tive parts of the brain. 
Meanwhile Lewis was probing Larson’s history for 
evidence of abuse. Interviews revealed nothing. He had no 
memory of maltreatment of any kind. Displaying a charac¬ 
teristic of many brain-damaged individuals, he would go 
off on verbal tangents and then ask, “Where’d I go? What 
was the question?” 
When Larson’s brother, Frank, was arrested for molest¬ 
ing his own children, the defense team got important clues 
about Lucky’s upbringing. Where, Lewis wondered, had 
Frank learned such behavior? A private investigator working 
for Lucky Larson’s lawyers found social service records docu¬ 
menting that Lucky’s mother had begun sexually abusing 
Lucky when he was six years old. His father, jealous of the 
relationship, was violent toward the boy. Once Lucky scram¬ 
bled up a tree to escape his enraged father. The man took 
an axe and chopped down the tree with Lucky in it. 
Larson won a new sentencing hearing, but the jury 
again condemned him to death. On death row, he talked 
almost constantly—happy chatter about very little. He would 
try to snap his fingers—even though his neurological prob¬ 
lems made the task impossible—to illustrate how little it all 
mattered. “The only comfort we could find,” Lewis wrote, “was 
in our knowledge that the very lesions that separated Lucky’s 
frontal lobes from the rest of his brain and caused him to act 
so ferociously also protected him from appreciating the reality 
of his situation and kept him in perpetual good spirits.” 
A scientific explanation for violence 
Over the past 25 years Lewis and Pincus have evaluated more 
than 100 juvenile and adult capital defendants. They are often 
asked to testify for the defense during the sentencing phase. 
That atmosphere is emotionally charged, and the scrutiny 
they receive can be intense. 
One of her best-known adversaries is forensic psychia¬ 
trist Park Dietz, m.d., m.p.h., ph.d. Dietz testified for the 
prosecution in the case of the New York serial killer Arthur 
Shawcross, for whom Lewis was a defense witness. In addi¬ 
tion to being a frequent prosecution expert witness, Dietz also 
runs Threat Assessment Group, a firm that advises employers 
on the risk of stalking, product tampering and other forms of 
violence in their workplace. 
Detailed and harsh in his criticism, Dietz has accused 
Lewis of interpreting “ambiguous symptoms” as psychosis. 
“I can’t escape the theory that Dr. Lewis has some position or 
a zealotry against the death penalty that influences her find¬ 
ings and judgment,” he said. 
Lewis, however, insists that she takes no sides on the 
morality or politics of the death penalty. She offers objective 
testimony on the mental health of accused killers, most of 
whom hide their illnesses and childhood traumas because 
“they’d rather be killed than called crazy. ... I just give you the 
facts. Then if you decide you want to kill him, you can kill 
him,” she said. 
Of course, her strictly clinical explanation for murder 
does not answer traditional questions of right and wrong. 
Fox News commentator Bill O’Reilly once asked her in a 2002 
interview, “But Dr. Lewis, what about evil?” 
“Evil is not a scientific term,” Lewis answered. “It’s a 
religious term.” 
In most cases, Lewis sees the defendant executed 
despite her testimony. But her work has changed the way the 
death penalty is applied nationally. Lewis’ research on juve¬ 
niles condemned to death in Texas became part of the record 
in a 1988 Supreme Court ruling that youths under the age of 
16 could not be executed, and in a 2005 Supreme Court rul¬ 
ing that murderers cannot be executed for crimes they com¬ 
mitted before the age of 18. (Justice Thurgood Marshall also 
cited her work in his 1991 dissent from a Supreme Court 
decision allowing the execution of the brain-damaged Ricky 
Ray Rector.) Her research cited in the 2005 case found the 
same three factors she had so often observed—a history of 
abuse along with psychiatric and neurological problems— 
and documented how little the courts had considered them. 
Her most important contribution, according to Pincus, 
is establishing the link between child abuse and violent 
behavior. It would be easy to see how their work together 
might have made Pincus and Lewis anti-death penalty 
crusaders, but they avoid association with groups trying to 
ban capital punishment. Instead they have become zealous 
about preventing child abuse. 
Preventing child abuse 
Lewis has retired from nyu but remains a clinical professor 
in the Department of Psychiatry and in the Child Study 
Center at Yale. She continues to evaluate violent offenders, 
conduct research on violence, supervise trainees and see pri¬ 
vate patients. She is currently studying the moral implica¬ 
tions of our knowledge about violence; the origins of the 
concept of the sociopath; and ethical issues surrounding the 
“lottery” of life that places some people at greater risk of 
becoming violent. She is also working with Jennifer S. Bard, 
j.d. ’87, m.p.h., professor of law at Texas Tech University 
(ttu) School of Law and adjunct associate professor of 
neuropsychiatry at the ttu School of Medicine, on a study of 
capital defendants who represent themselves. One of Lewis’ 
major interests continues to be the prevention of child abuse. 
Child abuse, says Lewis, acts in several ways. First, the 
abuse itself can cause brain damage that leads to a lack of con¬ 
trol in individuals. It exposes children to an unhealthy model 
of behavior. “Children do as they see,” she said. The stress 
resulting from ongoing physical and verbal abuse changes the 
structure of the brain. And finally, she said, “Abuse engenders 
rage that is almost never expressed toward the perpetrator of 
the abuse. That rage is displaced onto others. 
“I would give my right arm to get funding to do an 
early identification and prevention project,” she said. “We 
could identify kids early whose maladaptive behaviors reflect 
terrible violence at home.” The goal would be to offer support 
to parents—parenting education and mental health serv¬ 
ices—rather than remove children from the troubled home. 
But she believes that the program would be seen as intruding 
on families and therefore be a tough sell. 
Lewis’ childhood curiosity about humanity’s dark side 
launched her on a mission to understand the very people 
much of society would prefer to eliminate. Ted Bundy asked 
to see Lewis the day before his execution and even kissed 
her goodbye. “Everyone else wants to know what I did,” he 
explained. “You want to know why.” 
If violence is the most serious public health problem 
in the world, Lewis sees understanding killers as the key to 
devising a cure. The closest that Lewis comes to condemning 
the death penalty has less do to with arguments about justice 
and compassion than a thirst for answers. “How is it,” she 
asks in her memoir, “that we pour millions of dollars into 
Bundy books and the like, but are nevertheless willing to sac¬ 
rifice further knowledge about him and his ilk in the interest 
of doing away with them?” 
At 69, and after decades of study, Dorothy Lewis is no 
less fascinated by our pariahs than she was at age five, ym 
Colleen Shaddox is a freelance writer in New Haven. 
Among the murderers and serial schoolgirl who killed her best 
killers Lewis has studied are Ted friend for reasons she could 
Bundy, Mark David Chapman not explain. 
and “Beltway Sniper” John Allen 
Muhammad. The first murderer 






















New deputy director 
at Yale Cancer Center 
edward chu, m.d., was named 
deputy director of Yale Cancer 
Center (ycc), effective January 1. 
He succeeds Jose Costa, M.D., who 
has filled the post for the past 
10 years. Costa will remain on the 
faculty as a professor of pathology 
and of medicine, vice chair of the 
Department of Pathology and 
director of anatomic pathology in 
the department. Costa will also 
remain an active member of YCC. 
Chu, who is currently professor 
of medicine and pharmacology 
and chief of medical oncology, 
has held positions of increasing 
responsibility at the center since 
1996. In his new role, Chu will 
continue to lead the Section of 
Medical Oncology and will also 
direct the clinical research initia¬ 
tives for YCC. 
Chu is a graduate of Brown 
University, where he also received 
his medical degree and completed 
his residency training. He com¬ 
pleted a fellowship in medical 
oncology at the National Cancer 
Institute and served as a tenured 
senior clinical investigator. He 
came to Yale in 1996 as chief of 
medical oncology and director of 
the VA Connecticut Cancer Center 
Michael Cappello 
at the VA Connecticut Healthcare 
System in West Haven and as 
co-director of the Developmental 
Therapeutics Research Program 
at ycc. 
Chu is the author of Physicians' 
Cancer Chemotherapy Drug Manual, 
a comprehensive review of all 
major cancer drugs and treatment 
regimens used in daily clinical 
practice. The manual, which is 
now in its seventh edition and is 
updated annually, is recognized 
as a leading publication in the 
field of cancer therapy. Chu is also 
editor in chief of the journal 
Clinical Colorectal Cancer and chair 
of the International Colorectal 
Congress, an annual meeting that 
brings together leaders in oncol¬ 
ogy from the United States, Europe 
and Asia to present and discuss 
the latest developments in the 
management and treatment of 
colorectal cancer. 
Pediatrician named 
to research society 
A Yale pediatrician is among 27 
of the nation’s foremost experts 
in global health who will band 
together to advocate for greater 
U.S. investment in global health 
research, mich ael cappello, 
M.D., fw ’95, professor of pedi¬ 
atrics, microbial pathogenesis, 
and epidemiology and public 
health, joined the inaugural class 
of ambassadors in the Paul G. 
Rogers Society for Global Health 
Research in November. The Rogers 
Society, funded by the Bill and 
Melinda Gates Foundation, is 
named for the former congressman 
from Florida, a champion of health 
research. Rogers is the current chair 
emeritus of ResearchlAmerica, a 
nonprofit public education and 
advocacy alliance founded in 1989. 
Members of the Rogers Society 
team are leaders in medical and 
global public health research. 
The inaugural class of ambassa¬ 
dors will meet with opinion 
leaders and decision makers at 
the national level to convey the 
importance of global health 
research. Among the ambassadors 
are two former Yale faculty mem¬ 
bers,peter J. HOTEZ, PH.D., 
m.d., chair of microbiology and 
tropical medicine at The George 
Washington University Medical 
Center,and leon e. rosenberc, 
m.d., HS ’63, professor of molecu¬ 
lar biology at Princeton University 
and a former dean of the School 
of Medicine. 
Gerhard Giebisch 
Professor honored with 
prestigious award 
GERHARD H. GIEBISCH, M.D., 
professor emeritus and senior 
research scientist in cellular and 
molecular physiology, received 
the John P. Peters Award from the 
American Society of Nephrology 
at its annual meeting in November. 
Giebisch, a pioneer in the use of 
cellular and molecular approaches 
to elucidate mechanisms of electro¬ 
lyte pathophysiology, is the first 
Yale faculty member to receive the 
Peters Award. 
Established in 1983, this annual 
award is named for one of the 
fathers of the discipline of nephrol¬ 
ogy. Peters spent his entire faculty 
career at Yale, and was chief of 
the metabolic division in the 
Department of Medicine from 
1922 to 1955. 
Giebisch studied kidney func¬ 
tions at the micro level. He con¬ 
siders the kidney one of the body’s 
most complex control organs. 
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Robert Udeisman Linda Degutis 
The Yale Corporation made the 
following appointments in the 
Department of Surgery at its 
December meeting: the chair of 
the department, Robert Udeisman, 
m.d., m.b.a., was named the 
William H. Carmalt Professor of 
Surgery; John A. Elefteriades, M.D. 
'76, hs '81, fw ’83, chief of cardio- 
thoracic surgery, was named 
the William W.L. Glenn Professor 
of Cardiothoracic Surgery; and 
Ronald R. Salem, m.d., was named 
the Lampman Professor of Surgery. 
Sidney J. Blatt, PH.D., professor of 
psychiatry and psychology and 
chief of the psychology section in 
the Department of Psychiatry, has 
received the Mary S. Sigourney 
Award from the Mary S. Sigourney 
Award Trust, for distinguished 
contributions to psychoanalytic 
theory and research. The Sigourney 
Award, considered the most dis¬ 
tinguished international award 
for contributions to psychoanaly¬ 
sis, includes a prize of $50,000. 
Blatt’s research has focused on 
disruptions of normal psychologi¬ 
cal development as the core of 
many psychiatric disorders. 
James P. Comer, M.D., the Maurice 
Falk Professor of Child Psychia¬ 
try, is the winner of the 2007 
Grawemeyer Award for Educa¬ 
tion, the University of Louisville 
announced in November.The 
award carries a $200,000 cash 
prize, the highest in the field of 
education. Comer established 
the School Development Program 
in 1968, a whole-child develop¬ 
ment program that encourages 
collaboration among teachers 
and between schools and their 
communities. 
Michael Green Alan Kazdin Anthony Koleske Joel Rosenbaum 
David C. Cone, M.D., associate 
professor of surgery (emergency 
medicine) and epidemiology, 
was installed as president of the 
National Association of ems 
Physicians (naemsp) in January. 
The naemsp promotes excellence 
in emergency medical services 
in out-of-hospital settings. 
Linda Degutis, M.S.N. '82, DR.PH. 
'94, associate professor of sur¬ 
gery (emergency medicine) and 
public health (environmental 
health sciences), has been named 
president-elect of the American 
Public Health Association (apha). 
She will begin her term in the 
fall of 2007.The apha represents 
more than 50,000 members 
in more than 50 occupations 
within the field of public health. 
Degutis is the director of the 
Yale Center for Public Health 
Preparedness, whose work 
ensures that front-line workers 
are prepared to respond to 
public health emergencies. 
Michael Green, M.D., associate 
professor of medicine, has been 
selected as a Kimball Scholar by 
the American Board of Internal 
Medicine. Green will develop an 
Internet-based portfolio that 
allows the board’s diplomates to 
document the characteristics, 
pursuit and application of their 
clinical questions, in order to 
facilitate reflective evidence- 
based practice. 
Alan E. Kazdin, PH.D., the John M. 
Musser Professor of Psychology, 
has been named president of 
the American Psychological 
Association, the largest associa¬ 
tion of psychologists worldwide. 
Kazdin, who also directs the 
Yale Parenting Center and Child 
Conduct Clinic, began his leader¬ 
ship of the i50,ooo-member 
organization in January 2007 
as president-elect. He will take 
office as president in 2008. 
Anthony Koleske, ph.d., associ¬ 
ate professor of molecular 
biophysics and biochemistry 
and of neurobiology at the 
School of Medicine, received the 
$500,000 Established Investi¬ 
gator Award from the American 
Heart Association in January. 
The award will fund Koleske's 
research on the mechanisms 
that allow cells to sense differ¬ 
ences in their adhesive environ¬ 
ment and respond by redirect¬ 
ing migration. 
Richard P. Lifton, PH.D., M.D., 
Sterling Professor of Genetics, 
chair of genetics and a Howard 
Hughes Medical Institute inves¬ 
tigator, received the 2006 Robert 
Tigerstedt Award at the 21st 
Biennial Scientific Meeting of 
the International Society of 
Hypertension in Fukuoka, Japan, 
in October. Lifton was cited for 
his "pioneering work on the 
identification of mutations that 
cause human hypertension, 
which has identified the key role 
of renal salt handling in blood 
pressure regulation in humans.” 
Lifton was also selected to 
deliver the first Donald Seldin 
Lecture at the annual meeting 
of the American Heart Associa¬ 
tion in Chicago in November. 
Joel Rosenbaum, PH.D., professor 
of molecular, cellular and 
developmental biology, and a 
faculty member since 1967, 
received the 2006 E.B. Wilson 
Medal, the American Society 
for Cell Biology’s highest honor 
Thomas Steitz 
for scientific research in Novem¬ 
ber. The honor recognizes sig¬ 
nificant advances over a lifetime 
in the understanding of the 
assembly, maintenance and 
function of cilia and flagella, 
which are fine hair-like cell 
organelles that extend outward 
from the cell surface. 
Craig R. Roy, PH.D., associate 
professor of microbial patho¬ 
genesis, has received the 2007 
Eli Lilly and Company Research 
Award from the American 
Society for Microbiology. This 
award recognizes fundamental 
research of unusual merit in 
microbiology or immunology by 
an individual on the threshold 
of his or her career. 
Thomas A. Steitz, PH.D., Sterling 
Professor of Molecular Biophysics 
and Biochemistry, received the 
nth Keio Medical Science Prize 
on November 1 at Keio University 
in Tokyo, Japan. Steitz was 
honored for research that pro¬ 
duced the first X-ray crystallo¬ 
graphic imaging of the large 
50S ribosomal subunit in 2000. 
Robert I. White Jr., M.D., professor 
of diagnostic radiology, received 
the Leaders in Innovation Award 
from the Society of Interventional 
Radiology at the group's annual 
meeting in Seattle in March. The 
award recognizes society mem¬ 
bers who have originated and 
implemented an idea that has 
had an advantageous impact on 
the practice of interventional 
radiology. 
SEND FACULTY NEWS TO 
Claire M. Bessinger, Yale Medicine, 
300 George Street, Suite 773, 






















top The 2006 Downs International Health 
Student Travel Fellows reported on their health 
research and findings in October, in posters 
and oral presentations. Ten of the 12 fellows, 
students in medicine, public health, nursing and 
the Physician Associate Program, presented 
posters on their research in Africa, South 
America and the Caribbean. 
above Jennifer Lee, a second-year medical 
student, explained her research on sensory phe¬ 
nomena in Tourette syndrome and obsessive- 
compulsive disorder in Brazil. 
Downs fellows report 
on summer research 
hiv/aids, trauma of war and 
genocide are among the topics of 
last year’s presentations. 
For Christopher P. McManus, a student 
at the School of Public Health and 
the School of Forestry & Environ¬ 
mental Studies, doing research in 
South Africa’s Kwazulu-Natal province 
meant learning anew what is meant 
by family. “I didn’t even know what 
a household was,” said McManus, not¬ 
ing that polygamy leads to a different 
definition. 
McManus described his research 
in October at the annual fall sympo¬ 
sium of the Committee on Interna¬ 
tional Health. Every year students 
in nursing, medicine, public health 
and the Physician Associate Program 
report on research done the summer 
before. In 2006 a dozen students 
undertook research projects in Africa, 
South America and Jamaica. McManus, 
one of three students to make an 
oral presentation, studied the impact 
of hiv/aids on rural households. 
“There are a whole bunch of people 
in these households and everyone 
does a whole lot of stuff,” he said. 
“If you remove one member of a 
household it is very difficult for that 
household to maintain security.” aids, 
he said, tends to affect the most pro¬ 
ductive family members, and their 
absence can lead to a food shortage. 
He found that 42 percent of the 
households surveyed made up the 
difference with wild food, such as 
birds, hare or antelope. Coping strate¬ 
gies included watering down por- 
ridge or using pumpkin to stretch it, 
borrowing food and skipping meals. 
Eloise D. Austin, a second-year 
medical student, described the mental 
health effects of the Rwandan genocide 
of 1994 on children. She interviewed 
40 orphans and found that their prob¬ 
lems included grief, loneliness and fre¬ 
quent memories of traumatic events. 
According to past studies, “most 
children had seen the death of a close 
family member, had witnessed mas¬ 
sacres, had been forced to hide, had 
seen dead bodies or body parts,” 
she said. Her open-ended interviews 
suggested that the mental health 
burden from these traumatic events 
was still considerable. 
Amy L. Glick, a nursing student, 
examined perceptions of care by 
patients and providers at a new hiv/ 
aids clinic in Togo, in western Africa. 
In that region she found stigma to 
be pervasive. Some patients said that 
people in certain villages or tribes 
believed that aids was caused by sor¬ 
cery, or that discussing sex education 
and prevention with young adults 
would cause promiscuity. And in some 
hospitals, patients with aids described 
poor care, neglect and insults from 
staff. The AED-Lidaw Health Clinic, 
where the research was conducted, 
is working to combat these negative 
experiences and provide a positive 
experience for patients with hiv/aids. 
Other research topics included 
sand fly-vectored diseases in Peru, atti¬ 
tudes toward female condom use in 
Botswana and the willingness of medi¬ 
cal and nursing students to treat 
Hiv-positive patients in Sierra Leone. 
—John Curtis 
Hunger and Homelessness 
Auction raises $36,000 for 
community agencies 
The student-run Hunger and Home¬ 
lessness Auction raised $36,313 in 
November for seven community agen¬ 
cies in New Haven, an increase of 
$5,000 over tire previous year. 
This year’s auctioneer was Wade 
Brubacher, father of first-year student 
Jake Brubacher. State Attorney General 
Richard Blumenthal, j.d., made a guest 
appearance to auction his own dona¬ 
tion-—lunch in Hartford and a personal 
tour of the state capitol. 
Recipients this year are the Com¬ 
munity Health Care Van, haven Free 
Clinic, Community Soup Kitchen, 
Domestic Violence Services of Greater 
New Haven, Immanuel Baptist Shelter, 
Leeway, Loaves and Fishes and the St. 
Thomas More Catholic Chapel and 
Center at Yale University, which runs 
a soup kitchen. 
The fundraising began with a silent 
auction, from November 13 to 16, fol¬ 
lowed by a live auction in the Harkness 
Ballroom on November 16. Offerings 
included a dinner and wine tasting 
hosted by Dean Robert J. Alpern, m.d., 
Ensign Professor of Medicine, with 
samples from his private collection; 
lunch with University President Richard 
C. Levin at Mory’s; weekends in New 
York, New Hampshire and other choice 
locations; classic books; stargazing ses¬ 
sions; and lessons in art, athletics, cook¬ 
ing, dance and languages. 
Student organizers offered their 
thanks to faculty. “We owe a lot of our 
success to their help and generosity,” 
said Joshua I. Weiner. 
-J.C. 
top Wade Brubacher, a professional 
auctioneer and father of first-year student 
Jake Brubacher, offered his services to 
this year’s auction. 
middle Medical student Laura Tom enticed 
prospective buyers to bid on a gold and dia¬ 
mond necklace before the live auction. 
bottom Physician Associate students Melissa 
Studdard, Tamara Brining, Dan Heacock and 
Anthony Pazienza perused the list of available 



































4° Alumni faces 
Lee Goldman, executive vice president 
for health and biomedical sciences at 
Columbia University’s College of Physi¬ 
cians and Surgeons, is known for his 
work in combining epidemiology with 
clinical care in cardiology. 
Blending the clinical 
and the statistical 
Early in his career, Lee Goldman saw 
the value of applying epidemiology to 
clinical practice. 
For more than two decades physicians 
have carried in their pocket copies 
of the Goldman Index, a list of factors 
to determine whether a patient under¬ 
going surgery for noncardiac reasons 
is at risk of a heart attack or another 
major cardiac complication. The index 
is named for Lee Goldman, m.d. ’73, 
m.p.h. ’73, fw ’78, who developed 
it during his medical residency and 
published it during his cardiology 
fellowship at Yale by applying tech¬ 
niques derived from epidemiology 
and clinical practice. 
In recent years Goldman has also 
achieved renown for his leadership 
of the department of medicine at the 
University of California, San Francisco 
(ucsf), which he joined in 1995. In 
July 2006 Goldman moved to Colum¬ 
bia University’s College of Physicians 
and Surgeons as executive vice presi¬ 
dent for health and biomedical sciences 
and dean of the faculties of health sci¬ 
ences and medicine. 
Goldman traces his interest in sta¬ 
tistics to a class he took during his first 
semester at the School of Medicine 
with John D. Thompson, R.N., m.s., 
the legendary director of the program 
in hospital administration at the 
Department of Epidemiology and 
Public Health. That course convinced 
Goldman to enroll in Yale’s master 
of public health program, and a study 
he undertook there cemented his love 
of numbers and other data. In 1971, 
President Richard Nixon was pushing 
a plan for national health insurance. 
Goldman surveyed Yale medical stu¬ 
dents and faculty, deconstructing this 
bill and competing pieces of legislation 
to determine how his colleagues should 
perceive each proposal. Goldman then 
took his programming textbook to the 
beach over Labor Day weekend and 
came back ready to crunch numbers in 
the giant computers of the day. As the 
analysis came together, he was hooked. 
“I ended up publishing five papers 
out of my thesis,” he said, “and kind 
of got the bug.” 
He soon began to apply his new¬ 
found statistical and programming 
savvy to studies of cardiac risk. After 
an internship and residency at ucsf 
and a second residency at Massachu¬ 
setts General Hospital, Goldman 
became a cardiology fellow at Yale. As 
his fellowship ended, Goldman said, 
his interest in epidemiology propelled 
him toward nontraditional applications 
of cardiology. “Cardiology divisions 
weren’t really interested in me, and 
I didn’t really want to run an echo 
[cardiogram] lab,” he said. 
In the division of general internal 
medicine at Harvard’s Peter Bent 
Brigham (now Brigham and Women’s) 
Hospital, where he stayed for almost 
two decades, Goldman continued to 
focus on combining epidemiology 
with clinical care in cardiology. “Most 
of my work used the same kinds of 
methods an epidemiologist used, 
but applied it to patients we actually 
touched,” he said, describing his 
efforts to determine risk factors for 
heart attacks after surgery and among 
patients who came to emergency 
rooms with chest pain. “There were 
so many factors to consider that 
clinicians did not have a way of deter¬ 
mining which ones were the best 
predictors of a patient’s risk,” he said. 
“The concept was always to gather 
comprehensive data and to whittle it 
down to what might be important.” 
One of Goldman’s most enduring 
contributions was the Goldman Index. 
“It was the first systematic approach 
to that question,” said Lawrence S. 
Cohen, m.d., hs ’65, special advisor 
to the dean. “It has remained a bench¬ 
mark for the care of patients that 
are undergoing noncardiac surgery, 
and it has stood the test of time over 
three decades.” 
Goldman and his colleagues also 
started one of the first chest pain 
evaluation units at Harvard. Today, 
these are common at many hos¬ 
pitals nationwide. And Goldman 
developed the Coronary Heart Disease 
Policy Model, which sets priorities 
for preventing and treating heart 
disease. At Harvard, he also co¬ 
developed the Program in Clinical 
Effectiveness, which has trained 
David Kupfer’s meeting with a mentor in 
his second year of medical school set him 
on a path toward his career in psychiatry. 
over 1,000 young physicians in the 
basics of clinical research. 
“He really has been a pioneer,” said 
Harlan M. Krumholz, m.d., m.sc., the 
Harold J. Hines Jr. Professor of Medi¬ 
cine and professor of epidemiology and 
public health, and of investigative medi¬ 
cine, one of Goldman’s advisees at Yale. 
“He was one of the first people to 
develop large observational studies that 
drew knowledge from the real world 
and could be fed back into practice.” 
After becoming the chair of medi¬ 
cine at ucsf, Goldman and his col¬ 
league Robert M. Wachter, m.d., in 
1996 coined the term hospitalist for 
inpatient physicians, a concept that 
quickly produced a major movement 
in medicine. (Goldman and Wachter 
started the first hospitalist program in 
the country at ucsf.) With inpatient 
care changing rapidly, they argued, 
office-based doctors simply do not have 
time to monitor their hospital patients 
the necessary three or four times a day. 
Establishing a separate specialty of 
hospital medicine, they argued, would 
increase hospital efficiency and benefit 
patients. “The board is about to recog¬ 
nize it as a distinct discipline,” he said, 
referring to the American Board of 
Internal Medicine, which certifies sub¬ 
specialties in internal medicine. 
“Columbia is fortunate,” said his 
former advisee Krumholz, recalling his 
mentor’s seemingly limitless capacity 
to inspire students and colleagues. 
“When he walked into a room, the 
energy would just increase, the quality 
of conversation would go up. I think a 
whole generation of people was drawn 
to research because of their association 
with him.” 
—Alla Katsnelson 
From sleepless nights and a 
study of narcolepsy to chairing 
a leading program 
When most lights in the dormitory 
went out, David Kupfer’s stayed on. 
A history and economics major at Yale 
College, Kupfer, m.d. ’65, couldn’t 
understand why his peers needed so 
much sleep. At the time, he didn’t real¬ 
ize sleep would influence his career— 
that he would become a leader in 
sleep, depression and bipolar disorder 
research—and that observing two 
cases of narcolepsy would set him on 
this path. 
While in medical school and still 
undecided about a specialty, Kupfer 
saw two patients at Yale-New Haven 
Hospital (ynhh) who suffered from an 
extreme exhaustion called cataplexy 
that results in a complete loss of mus¬ 
cle control. Both were also diagnosed 
with narcolepsy. 
Seeing these two patients solidified 
Kupfer’s decision to study sleep, but 
two encounters with a Yale professor 
molded his career. As a second-year 
student he met Thomas Detre, m.d., 
then chief of psychiatry at ynhh, 
whose interests included recurrent 
depression, violence and aggression in 
children, biologic aspects of mental 
disorders and the budding fields of 
psychobiology and psychopharmacol¬ 
ogy. At a time when there was little 
understanding of mental diseases, 
Detre felt that understanding the body 
could lead to better treatment of men¬ 
tal illness. 
During Kupfer’s third year, a last- 
minute trade with a classmate led 
to a chance reunion with Detre and 
solidified Kupfer’s decision to pursue 
psychiatry. The night before beginning 
his psychiatry rotation at the VA hos¬ 
pital in West Haven, Kupfer agreed to 
switch rotations with a classmate who 
wanted to work at the VA. Kupfer was 
back at ynhh with Detre. They soon 
realized they had a lot in common— 
both were high-energy and stayed up 
late. Detre expected diligence and 
Kupfer delivered. 
“Some people have considered 
[Detre] a tough taskmaster because he 
was so persistent. I found him loyal 
and supportive and clever. He gave me 
freedom,” Kupfer said. 
After medical school, Kupfer trained 
at the National Institute of Mental 
Health (nimh), then returned to Yale 
in 1969 as an nimh investigator 
and assistant professor of psychiatry. 
Kupfer’s career was blossoming at 
Yale, but Detre asked him to join him 
at the University of Pittsburgh and 
its Western Psychiatric Institute and 
Clinic (wpic), which Detre felt he 
could transform to better treat patients 
with mental illness. In 1973, Kupfer 
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sor of psychiatry and director of 
research. In 1983, he became director 
of the wpic and chair of the Depart¬ 
ment of Psychiatry when Detre 
became senior vice chancellor for 
health sciences. In 1994, further 
cementing the connection between 
these remarkable colleagues, Kupfer 
was named the first Thomas Detre 
Professor of Psychiatry. 
Finally retired from his 23-year 
career as vice chancellor, Detre now 
serves as a professor emeritus of 
psychiatry and is teaching a course to 
residents on psychiatric diagnosis. 
He sits on the boards of two software 
companies in Pittsburgh and is also 
on the scientific advisory board of 
PsychoGenics, a New York-based com¬ 
pany that tests neurological drugs. 
At Pitt, Kupfer stressed the impor¬ 
tance of determining the biological 
underpinnings of psychiatric disease 
and led a research revolution by earn¬ 
ing a number of nimh grants for 
research on sleep disturbances, depres¬ 
sion and bipolar disorder. The number 
of faculty and beds increased, along 
with the reputation of Pitt’s psychiatry 
program. “From 1983 to 1993 the 
department went from Number 4 to 
Number 1 in federal research funding,” 
Detre explained. 
With his wife, Ellen Frank, ph.d., 
Kupfer co-directs the Bipolar Disorder 
Center for Pennsylvanians, created 
with a $5 million grant from the 
commonwealth. He is principal inves¬ 
tigator of several studies, including 
one on the pharmacogenetics of bipo¬ 
lar disease. 
“You’re going to laugh when I say 
this—writing is very difficult for me,” 
he said. He has written 800 articles, 
books and book chapters. His latest 
book, written for a general audience 
with Helena Chmura Kraemer, ph.d., 
and Karen Kraemer Lowe, m.s., is titled 
To Your Health: How to Understand 
What Research Tells Us About Risk, and 
stresses the importance, throughout 
medicine, of designing more rigorous 
clinical trials and clearly defining the 
results. As a case in point Kupfer cites 
media reports of studies that appeared 
to show a high risk of suicide among 
young children on antidepressants. 
According to Kupfer, many of the stud¬ 
ies poorly defined the risk. 
Kupfer hopes that someday more 
physicians will value the relationship 
between mental and physical illnesses. 
Research has shown that depression, 
for example, makes people more sus¬ 
ceptible to other illnesses, like dia¬ 
betes. Kupfer feels that many doctors 
treat the diabetes rather than exploring 
the link between the depression and 
diabetes. He hopes this paradigm 
changes soon—patients who receive 
poor mental health treatment face 
serious health risks, just like patients 
who receive the wrong medical care. 
It might keep Kupfer up at night, 
but that’s when he does his best work. 
—Meghan Holohan 
A rebel with “medicine in his 
veins” becomes a scientific 
researcher in India 
When Manohar V.N. Shirodkar, med 
’54, m.d., initially rebelled against a 
family tradition and rejected medical 
practice, his father, a famed gynecolo¬ 
gist in Mumbai, India, despaired. The 
young Shirodkar knew he had “medi¬ 
cine in his veins”—his father had 
developed the Shirodkar stitch, which 
is still used to treat cervical incompe¬ 
tence. But Shirodkar wasn’t interested 
in being a clinician. 
Shirodkar, however, found some¬ 
thing more exciting—the viral causes 
of illness. When he learned that his 
grandmother had died of cervical can¬ 
cer, Shirodkar was hooked. How did 
she get sick? Why would she have can¬ 
cer when others do not? Today, the 
medical community knows that some 
types of the human papilloma virus 
can cause cervical cancer, but at that 
time the young man simply knew that 
one way to understand illness was to 
study oncogenic viruses. 
To his father’s delight, Shirodkar 
begged to study medicine in the 
United States. After he completed his 
undergraduate work at Johns Hopkins 
University, he headed to the Yale 
School of Medicine in 1950. His clini¬ 
cal studies were interrupted when 
Shirodkar learned his wife was preg¬ 
nant. The couple returned to Mumbai, 
where their daughters, Renee and 
Diane, were born. With a growing 
family, Shirodkar didn’t have the funds 
to complete medical school. He 
accepted a position at Johns Hopkins’ 
school of public health, which gave 
him a stipend to pursue an sc.d. 
Manohar Shirodkar has spent his career, 
in India and the United States, studying 
oncogenic viruses. 
His detour from a traditional medi¬ 
cal education gave Shirodkar the 
opportunity he wanted. (He finished 
his m.b.b.s. in 1970 at the Seth G.S. 
Medical College in Mumbai.) And 
throughout a career filled with many 
twists and turns, his drive to under¬ 
stand viruses remains constant. 
As a graduate student at Hopkins 
in 1958, Shirodkar began investigat¬ 
ing the Rous sarcoma virus in chickens, 
the first virus discovered to cause a 
solid cancer. His research took him 
from Hopkins to the Virus Research 
Center of the Rockefeller Foundation 
in Pune, India, where he completed 
his doctoral thesis. In 1978 he found 
that West Nile virus, and later, rabies, 
blocked the Rous-produced sarcoma, 
and that the underlying mediator was 
not interferon, but his newly discov¬ 
ered anti-sarcoma, antiviral protein, 
called plasma factor. His research find¬ 
ings appeared in The Journal of 
Immunology in December 1965, the 
Journal of General Virology in 1973, 
The Indian Journal of Medical Research 
in 1978 and the Indian Journal of 
Experimental Biology in October 2006. 
“The most gratifying aspect of my 
career,” Shirodkar said, “is the fact that 
I have been a perpetual student—quite 
literally—and have been able to pur¬ 
sue, with some success, ... the search 
for scientific truth.” 
As a young man, Shirodkar turned 
away from a career as a clinician, yet 
he always admired his father. In 1976, 
Shirodkar and his wife, Sudha, founded 
the Dr. V.N. Shirodkar Memorial 
Research Foundation, an organization 
that embodies the dreams of both 
Shirodkar and his father. The organiza¬ 
tion screens underprivileged women 
for cervical cancer and investigates 
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John Harrington John Mayer Jr. Robert Diasio Ralph Horwitz Morris Wessel 
I94OS 
Morris A. Wessel, M.D. '43, has 
retired from the Clifford Beers 
Clinic, the oldest outpatient 
behavioral health clinic in the 
United States, after 35 years of 
service as a pediatrician and 
advocate for children and fami¬ 
lies. The clinic announced that 
their new national trauma center 
will now be named the Morris 
Wessel Child and Family Trauma 
Center of the Clifford Beers Clinic. 
Wessel cared for generations of 
New Haven children as a pedia¬ 
trician in practice from 1951 until 
his retirement in 1993. 
195OS 
Harry C. Miller, M.D. '54, writes to 
say, "In September 2006, Kari 
and I moved from Great Falls, Va., 
where we'd lived for 33 years, 
to a new home in Keswick, Va. 
It’s a lovely spot in a lovely devel¬ 
opment called Glenmore. Nice 
golf course, nice neighbors, lots 
of kids, six miles from Charlottes¬ 
ville. Gorgeous views of the 
Blue Ridge.” Miller still partici¬ 
pates in urology conferences 
at the University of Virginia in 
Charlottesville. 
Mary W. Schley, M.D. ’52, received 
an honorary doctor of humane 
letters degree from Columbus 
State University in Georgia, 
honoring her 45 years of profes¬ 
sional work in Columbus as 
well as her volunteer work in 
organizations devoted to educa¬ 
tion, health care and the per¬ 
forming arts. 
1960s 
TheTufts-New England Medical 
Center’s (nemc) Division of 
Nephrology celebrated the 70th 
birthday of John T. Harrington, 
m.d. '62, in January and noted 
his contributions to the medical 
center, Tufts University School 
of Medicine and the field of 
nephrology. Harrington began 
his association with nemc in 
1965 as a nephrology fellow, 
subsequently serving as direc¬ 
tor of the dialysis unit and chief 
of the division of general inter¬ 
nal medicine. In 1996 he was 
appointed dean of Tufts Univer¬ 
sity School of Medicine, a posi¬ 
tion he held until 2002. As dean 
emeritus, Harrington currently 
serves as a senior nephrologist 
and professor of medicine. The 
celebration also featured the 
inaugural "Dr. John T. Harrington 
Medical Grand Rounds,” and the 
announcement of the creation 
of an endowed fund in nephrol¬ 
ogy in Harrington’s name as well 
as the naming of the Dr. John T. 
Harrington Conference Room in 
the Division of Nephrology. 
Marc E. Lippman, M.D. ’68, a pio¬ 
neering breast cancer researcher, 
has been named chair of the 
Department of Medicine at the 
University of Miami Miller 
School of Medicine. Lippman 
currently chairs the Department 
of Internal Medicine at the Uni¬ 
versity of Michigan. He was pre¬ 
viously director of the cancer 
research center at Georgetown 
University and spent 18 years as 
a senior investigator with the 
National Cancer Institute. Lipp¬ 
man, who started in Miami 
on May 1, has five patents and 
author credit on more than 600 
articles, chapters and books. 
Lippman is currently studying 
biological markers that could 
predict which breast tumors will 
respond to hormone therapy. 
He will continue to see patients 
and, with his new post, will 
also chair the Department of 
Medicine at Jackson Memorial 
Hospital. 
John E. Mayer Jr., m.d. ’68, a sen¬ 
ior associate in cardiovascular 
surgery at the Children's 
Hospital in Boston and a profes¬ 
sor of surgery at Harvard 
Medical School, was elected 
president of the Society of 
Thoracic Surgeons (sts) at its 
annual membership meeting on 
February 5. Mayer has been 
involved with sts throughout 
his career, his principal interests 
being issues in government rela¬ 
tions and public affairs. 
197QS 
C. Gene Cayten, M.D., M.P.H. ’72, 
senior associate dean and pro¬ 
fessor of surgery at New York 
Medical College, received the 
Physician Achievement Award 
in September from Our Lady of 
Mercy Medical Center in the 
Bronx, N.Y. Cayten is the author 
of more than 100 publications 
and 36 book chapters and 
has been chair of surgery at the 
medical center for 23 years. 
Robert B. Diasio, m.d. ’71, began 
serving as director of the Mayo 
Clinic Cancer Center in Septem¬ 
ber. He will also oversee cancer 
center activities at the branches 
of the Mayo Clinic in Scottsdale, 
Ariz., and in Jacksonville, Fla. 
Diasio was previously a profes¬ 
sor of medicine, pharmacology 
and toxicology at the University 
of Alabama School of Medicine 
in Birmingham. He plans to con¬ 
tinue his pharmacogenomic 
research, which focuses on maxi¬ 
mizing the effectiveness of 
chemotherapy through new 
genetic diagnostic methods. 
Edward C. Halperin, M.D. ’79, vice 
dean of the Duke University 
School of Medicine, assumed the 
deanship of the University of 
Louisville’s School of Medicine in 
November. Halperin is also the 
Ford Foundation Professor of 
Medical Education and a profes¬ 
sor of radiation oncology and 
pediatrics at the medical school, 
as well as a professor of history 
in the university’s College of 
Arts and Sciences. 
Ralph I. Horwitz, M.D., FW ’77, the 
Arthur Bloomfield Professor and 
the chair of the Department of 
Medicine at Stanford University, 
is one of seven people named 
as members of the National 
Institute of Health's Advisory 
Committee to the Director.The 
committee has advised the 
director on policy and planning 
issues for more than 40 years. 
The seven new members join 13 
current committee members. 
Tom Smith, m.d. ’79, and Joann 
Bodurtha, m.d. ’79 (married in 
1982), report that their daugh¬ 
ter Anna has enrolled in Yale 
College in the Class of 2010. The 
Thomas Palliative Care Program 
at Virginia Commonwealth 
University (vcu), which Smith 
directs, won the American 
Hospital Association’s Circle of 
Life award for the best pallia¬ 
tive care program in 2005 and 
the International Association 
for Hospice and Palliative Care’s 
45 
Rock Positano Andrew Steele 
University Award for the best 
academic program in 2006. 
Smith is a professor of medicine 
at the vcu Massey Cancer Center 
in Richmond. Bodurtha is pro¬ 
fessor of human genetics, pedi¬ 
atrics and obstetrics-gynecology 
at vcu, and has been named 
interim chair of the Department 
of Human Genetics. Both have 
active ROi-funded research pro¬ 
grams as well as busy clinical 
practices—important now that 
they are empty nesters. 
Eliot Sorel, M.D., fw ’75, co¬ 
chaired the Pan American Health 
Organization Forum on Bioethics, 
Public Health and Health Policy 
at the World Congress of Public 
Health in Rio de Janeiro in Aug¬ 
ust. As part of that forum, he 
also presented "Modernising 
Health Systems, a 21st-Century 
Essential Prerogative.” Last May 
he served as a senior advisor 
to the Center for Strategic and 
International Studies in Wash¬ 
ington, on "Modernising Health 
Care Systems in Central and 
Eastern Europe.” 
198OS 
Robert L. Levin, M.D. ’89, and 
Karen Shaevel Gumer, M.s., 
c.r.n.p., were married in Septem¬ 
ber in Washington, Levin is a 
medical officer in the Division of 
Psychiatry Products of the U.S. 
Food and Drug Administration. 
Gumer is a family nurse practi¬ 
tioner in Rockville, Md. 
William A. Petit Jr., M.D., FW ’88, 
was installed as president of 
the Hartford County Medical 
Association in Cheshire, Conn., 
in November. He was also cited 
by Connecticut Magazine as 
one of the state’s top physicians 
for women. 
Rock G. Positano, D.P.M., M.SC., 
m.p.h. '89, was named director 
last fall of the Joe DiMaggio 
Sports Foot and Ankle Center at 
the Hospital for Special Surgery 
in New York City. The center is 
dedicated to nonsurgical man¬ 
agement of foot and ankle prob¬ 
lems as well as athletic injuries. 
Positano also writes the Tuesday 
health column for the New 
York Post. 
Andrew Steele, M.D. '86, M.P.H., 
has received a master’s degree 
in health informatics from 
the Royal College of Surgeons 
in Edinburgh, Scotland. 
199OS 
Duane A. Bryan, M.D. ’96, and 
Sarah E. O’Loughlin, r.n., were 
married in November at the 
Brooklyn Botanic Garden in New 
York. Bryan is a cardiologist and 
partner in Advanced Cardiovas¬ 
cular Care, a group practice in 
Valley Cottage, N.Y. O’Loughlin is 
a nurse anesthesiologist with 
Northeastern Anesthesia Services 
in Mt. Kisco, N.Y. 
Brian “Ari” Cole, M.D., M.P.H. ’95, 
has recently started his second 
master’s-degree program at 
Harvard’s Kennedy School of 
Government. He hopes to serve 
as a diplomat, perhaps in Scan¬ 
dinavia. Last fall he was also 
cross-registered at Harvard Law 
School “to better understand 
the problems between lawyers 
and physicians.” Cole practices 
medicine in Hawaii, Pennsylva¬ 
nia, Massachusetts and New 
York. He considers Prague and 
Stockholm his favorite European 
cities for vacation and work. 
Benjamin R. Doolittle, M.D. ’97, 
m.div. '97, hs ’02, assistant pro¬ 
fessor of medicine (general 
medicine) and pediatrics at the 
School of Medicine, was one of 
53 nominees for the 2006 
Association of American Medical 
Colleges Humanism in Medicine 
Award.The nomination by medi¬ 
cal students is recognition of a 
candidate as a positive and car¬ 
ing role model. Five characteris¬ 
tics are considered: mentoring 
skills, compassion and sensitiv¬ 
ity, collaboration, community 
service activity and observance 
of professional ethics. 
Rommel Nobay, m.p.h. ’99, was 
married on January 20 in 
Stamford, Conn., to Frances Wu. 
Nobay is an associate director 
of information technology at 
Genzyme, a biotech company. 
Wu is an account director in the 
direct marketing unit of the 
McCann Worldgroup, an interna¬ 
tional advertising agency head¬ 
quartered in New York City. 
2000S 
Aaryn Cohen Oleson, m.p.h. ’00, 
and her husband, Matthew, 
announce the birth of their first 
child, Wyatt Samuel, on August 
16. She is the pharmacovigilance 
consultant at the University of 
North Carolina in Chapel Hill 
and a doctoral candidate in 
pharmacoepidemiology. He is 
receiving his doctorate in physi¬ 
cal therapy from Duke University. 
Peter J. Mason, M.D., HS ’00, 
m.p.h., has joined the Wisconsin 
Heart and Vascular Institute 
in Madison. A cardiac and vascu¬ 
lar interventionist, Mason 
received his medical degree from 
the University of Massachusetts 
School of Medicine, where he 
was inducted into the Alpha 
Omega Alpha honor society. He 
completed his internal medi¬ 
cine internship and residency 
at Yale-New Haven Hospital, 
and fellowships in cardiovascu¬ 
lar epidemiology and peripheral 
vascular medicine and interven¬ 
tion at Brigham and Women’s 
Hospital in Boston. He also 
completed fellowships in cardio¬ 
vascular medicine and interven¬ 
tional cardiology at Boston 
Medical Center. Mason earned 
a public health degree at 
Harvard University School of 
Public Health. 
Peter M. Petrillo, PA '02, was 
married to Bridget Nester in 
Falmouth, Mass., in September. 
Petrillo is a physician’s assistant 
at the Hospital of St. Raphael 
in New Haven. Nester is a nurse 
anesthetist in New Haven. 
Curtis Weiss, m.d. ’05, was mar¬ 
ried to Alexandra Block, j.d. ’04, 
in Westbrook, Conn., on August 
27. Weiss is a resident in internal 
medicine at Yale-New Haven 
Hospital. Block is an associate in 
a New Haven law firm. 
SEND ALUMNI NEWS TO 
Claire M. Bessinger, Yale Medicine, 
300 George Street, Suite 773, 
New FTaven, CT 06511, or via e-mail 
to claire.bessinger@yale.edu 





















46 in Memoriam 
Richard N. Abbott, M.D. ’43, died 
on January 26 in Tilton, N.H. He 
was 88. Born in Lewiston, Maine, 
Abbott lived in Gilmanton, N.H., 
after his retirement in 1987. He 
completed his internship and 
residencies at New Haven Hospi¬ 
tal, Boston Children’s Hospital 
and the Boston Floating Hospital. 
Abbott was a captain in the Army 
Medical Corps during World War 
II, and served in the Philippine 
Islands and in the Army of the 
Occupation in Japan. He was the 
first pediatrician in Natick, Mass., 
where he practiced for more 
than 45 years. During that time 
he served as the school physician 
for elementary schools in Natick 
and Wellesley. 
George R. Barnes Jr., M.D. ’47, 
hs ’50, died on October 22 in 
Tacoma, Wash., following a short 
illness. He was 84. After a pediat¬ 
rics residency, Barnes served in 
the U.S. Army for five years. He 
subsequently entered academic 
medicine, teaching pediatrics at 
the University of Iowa. An inter¬ 
est in diagnostic medicine led to 
a second residency in radiology. 
In 1967 he joined a private prac¬ 
tice in Tacoma, practicing radiol¬ 
ogy. Upon his retirement he 
joined the faculty at the Univer¬ 
sity of Arizona Medical School 
in Tucson. 
Arnold M. Baskin, M.D., HS ’57, 
assistant clinical professor 
of surgery and a sponsor of a lec¬ 
tureship in the Humanities in 
Medicine at Yale, died on January 
9. He was 79. Baskin received his 
medical degree from Albany 
Medical College and completed 
his internship and residency at 
Yale-New Haven Hospital (ynhh), 
where he trained in general sur¬ 
gery and urology. He entered pri¬ 
vate practice after completing 
his residency, and he founded the 
urology practice in New Haven 
and surrounding areas now 
known as the Urology Center. 
Baskin participated in ynhh’s 
Recovered Medical Equipment 
for the Developing World pro¬ 
gram, which collects opened but 
unused surgical supplies for 
distribution to hospitals in the 
developing world. 
Francis L. Black, PH.D., professor 
emeritus of epidemiology 
(microbiology), an expert in the 
biochemistry of viruses and the 
third scientist to use the measles 
vaccine in humans, died on 
January 27. He was 81. Black was 
born in Taipei, Taiwan, one of 
four children of medical mission¬ 
aries. After receiving his ph.d. in 
biochemistry from the University 
of California, Berkeley, Black 
completed a research fellowship 
at the Rockefeller Foundation 
Laboratories and a postdoctoral 
fellowship under Joseph L. 
Melnick, ph.d. '39, a founder of 
modern virology, at the School 
of Medicine. Black went on 
to become a virologist at the 
Laboratory of Hygiene in 
Ottawa. In 1955, he returned to 
Yale to the departments of 
microbiology and epidemiology 
and public health, where he 
remained for 41 years. 
Maurice L. Bogdonoff, M.D. ’52, 
died on January 15 in Wheaton, 
III., of complications from esopha¬ 
geal cancer. He was 80. Born in 
Chicago in 1926, Bogdonoff grew 
up in Connecticut. He took two 
years off from Tufts University 
to serve in the U.S. Navy in the 
Philippines during World War II. 
After graduating from the School 
of Medicine with top honors, 
he spent his entire 35-year career 
at Rush University Medical 
Center in Chicago, where he was 
a professor of radiology and 
internal medicine. Bogdonoff 
was also a consultant for the 
Department of Energy’s Argonne 
National Laboratory outside 
Chicago and the U.S. Army’s 
Gorgas Hospital in the Panama 
Canal Zone. He retired and 
moved to Maine in 1988 when 
macular degeneration began to 
affect his eyesight; nonetheless, 
he was a guest lecturer in nuclear 
power engineering at the Maine 
Maritime Academy in Castine. 
He traveled the world, riding 
yaks along the Silk Route in Asia, 
visiting Tibetan monasteries 
and sleeping under the stars on 
the deck of a barge in Indonesia. 
James M. Cary, M.D., HS ’51, died 
on February 8 in Simsbury, 
Conn. He was 85. Cary received 
his medical degree from Case 
Western Reserve University. Dur¬ 
ing the Korean War he served 
as a captain in the U.S. Army in 
Alaska and in a Forward Army 
Hospital Unit. After his military 
service he came to Yale to com¬ 
plete a residency in orthopaedic 
medicine. He then began an 
orthopaedic surgery practice in 
Waterbury, Conn. In 1969 he 
became the assistant medical 
director and director of educa¬ 
tion at the Newington Children’s 
Hospital, where he remained 
until his retirement in 1983. He 
enjoyed auto racing and was the 
racetrack physician at Lime Rock 
Park in Lakeville, Conn., in the 
late 1950s and early 1960s. 
Norton G. Chaucer, M.D., M.P.H. ’51, 
died on January 17 in Milford, 
Conn. He was 90. Chaucer gradu¬ 
ated from Yale College in 1937 
and received his medical degree 
from Columbia University in 1941. 
During World War II he served in 
the U.S. Navy at several hospitals. 
After the war he became health 
director for Fairfield, Conn., and 
later served as health director for 
Hartford and West Hartford, Conn. 
Henry M. Gewin, M.D., HS ’51, 
died on February 1 in Mobile, Ala. 
He was 85. A1945 graduate of 
Vanderbilt University School 
of Medicine, Gewin completed 
his internship at Yale. He then 
moved to Tuscaloosa, Ala., where 
he was a U.S. Army medical 
officer. Upon leaving the Army, 
he returned to Yale to complete 
his training. At Yale he was a 
chief resident and instructor in 
medicine. In 1951 he moved 
to Mobile to begin practice at 
the Diagnostic & Medical Clinic, 
where he remained until his 
retirement in 1994. He was chair 
of the Mobile County Board 
of Health and served as president 
of the medical staffs of several 
local hospitals. Gewin was a 
fellow of the American College of 
Physicians, the specialty society 
for physicians in internal medi¬ 
cine and related subspecialties. 
Dennis Gilbert, m.p.h. ’83, died 
on December 8 in Roseville, III. 
He was 54. Gilbert was a profes¬ 
sor at Eastern Illinois University 
and author of the textbook Book 
on Health. 
Herbert Goldenring, M.D., former 
associate clinical professor of 
pediatrics and director of the 
Newborn Nursery at Yale-New 
Haven Hospital, died on January 
24,2006. He was 84. Goldenring 
received his medical degree from 
New York University and trained 
in pediatrics before serving as a 
general medical officer in Korea. 
He set up practice in Branford 
in 1954, the first pediatrician in 
private practice on the shoreline. 
He cared for thousands of 
children in his practice before 
retiring to academia in 1990. 
He retired from Yale in 2000. 
Edward H. Hon, M.D., HS ’55, died 
on November 6 at his home in 
Bradbury, Calif. He was 89. Hon 
worked with Orvan Hess, m.d., to 
invent electronic fetal heart rate 
monitoring at Yale in the 1960s. 
Born in China to Australian par¬ 
ents in 1917, he grew up in 
Australia and came to the United 
States in 1945 to attend Loma 
Linda Medical School, then 
known as the College of Medical 
Evangelists of the Seventh-Day 
Adventist Church. Hon com¬ 
pleted his residency in obstetrics 
and gynecology at Yale, hoping 
to return to China later as a 
medical missionary. After pub¬ 
lishing a landmark paper with 
Hess on fetal electrocardiogra¬ 
phy in the journal Science in 1957, 
Hon wrote more than 150 schol¬ 
arly papers and received numer¬ 
ous awards, including the 
Distinguished Service Award of 
the American College of Obste¬ 
tricians and Gynecologists 
and the 1999 Order of Australia 
Gold Medal. 
Francis J. Kalaman, M.D., M.P.H. 
’68, died on January 25 in Palm 
City, Fla. He was 93. Kalaman 
came to the United States from 
Hungary at the age of 8. During 
World War II he was a physician 
in the medical corps of the U.S. 
Army and received the Bronze 
Star for setting up and com¬ 
manding two hospitals on differ¬ 
ent fronts. In 1947 he began a 
private practice in Norwalk, Conn., 
where many of his patients 
came from the city’s Hungarian 
community. He served as health 
director for the city and physi¬ 
cian for the police department. 
Aaron B. Lerner, m.d., ph.D., the 
founding chair of Yale’s Depart¬ 
ment of Dermatology and an 
internationally renowned scien¬ 
tist, died on February 3. He 
was 87. Lerner, who was born in 
Minneapolis and received his 
graduate and professional 
degrees from the University of 
Minnesota, was one of the 
world’s leading authorities on 
skin pigmentation. He guided 
dermatology at Yale from its 
inception in 1956 as a small new 
section within the Department 
of Internal Medicine to its later 
status as a free-standing depart¬ 
ment in 1971. Lerner was the 
first dermatologist elected to the 
National Academy of Sciences. 
He is well-known for his 1958 
discovery of melatonin, a hor¬ 
mone secreted by the pineal 
gland that regulates circadian 
rhythms, and for his work with 
melanocyte-stimulating hor¬ 
mone, which he completed 
with colleagues at Yale and else¬ 
where. Previously he and a fel¬ 
low graduate student, G. Robert 
Greenberg, ph.d., had isolated 
the first monoclonal antibody, 
known as cryoglobulin. Lerner 
was a pioneering "translational 
scientist,” tightly coupling 
scientific insights with clinical 
advances. 
F. Eugene Martin, m.d. ’41, died on 
December 16 in Dayville, Conn. 
He was 90. During World War II 
Martin was a flight surgeon and 
lieutenant commander in the 
U.S. Navy. He practiced medicine 
in New Jersey and Pennsylvania 
after his discharge from the mili¬ 
tary in 1947. In 1961 he became 
chief medical officer at the 
Mansfield Training School, an 
institution for the mentally 
retarded in Mansfield, Conn. 
Martin retired in 1975. 
Ernest L. Sarason, M.D. ’39, died on 
November 28 in Syracuse, N.Y. He 
was 92. Sarason completed his 
internship and residency at Mt. 
Sinai Hospital in New York City 
and served during World War II 
as a major in the U.S. Army. Upon 
his return to Syracuse he prac¬ 
ticed surgery. He was best known 
in his community as a donor and 
fundraiser for hospitals, charities, 
museums and the Syracuse 
Symphony Orchestra. For his con¬ 
tributions to the community he 
received numerous awards, 
including the President’s Citizen¬ 
ship Award from the Medical 
Society of the State of New York. 
Lewis S. Solomon, M.D. ’67, died 
of a brain tumor on January 31 
in Santa Rosa, Calif. He was 65. 
Solomon worked in Sonoma 
County for almost three decades 
as a pulmonologist and critical 
care physician. After graduating 
from the University of California, 
Los Angeles, in 1963, he was a 
research student there and later 
received a research fellowship 
under Willard F. Libby, ph.d., who 
won the i960 Nobel Prize in 
chemistry for the use of carbon- 
14 to date archaeological arti¬ 
facts. After medical school 
Solomon served in the U.S. Air 
Force and was a researcher in 
the Armed Forces Radiobiology 
Research Institute in Bethesda, 
Md. In 1976 he moved to Santa 
Rosa to join a medical practice. 
Mattie L. Wade, R.N., M.P.H. ’59, 
died on November 30 in Atlanta. 
She was 94. Wade was a private- 
duty nurse in South Carolina 
and Florida before she moved to 
Atlanta to work as a public 
health nurse. After receiving her 
public health degree from Yale 
she became the assistant to the 
director of public health nursing 
in Fulton County, Ga. She later 
became the county’s director of 
public health nursing. 
William J. Waskowitz, m.d. ’57, 
died of congestive heart failure 
in Kensington, Conn., on Decem¬ 
ber 4. He was 75. Born in New 
Britain, Conn., Waskowitz fol¬ 
lowed in his father’s footsteps to 
Yale College as well as the School 
of Medicine. He completed a 
residency in orthopaedic surgery 
at the University of Oklahoma, 
and then returned to his home 
in New Britain to join his father’s 
practice as a sports physician 
and orthopaedist. He cared for 
children with hemophilia at 
Newington Children’s Hospital, 
as well as treating high school 
and college athletes. He was 
given the Moyer Award, the top 
honor of the National Athletic 
Trainers’Association, for his 
work in sports medicine in the 
1980s. An expert in treating knee 
injuries, Waskowitz pioneered 
the use of arthroscopy at New 
Britain General Hospital, where 
he was chief of orthopaedic sur¬ 
gery. He collected piano sheet 
music from the early 1900s and 
played the piano regularly, par¬ 
ticularly the music of Porter, 
Gershwin and New Orleans jazz 
composers. 
SEND OBITUARY NOTICES TO 
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Research in Iran yields clue to heart disease 
In 1998 Arya Mani, m.d., hs ’97, fw ’01, assistant professor of 
medicine (cardiology), returned to his native Iran to embark on 
a research project that linked modern genomics with his coun¬ 
try’s patterns of intermarriage [See “Journey of the Heart,” Yale 
Medicine, Spring 2004]. Working with Richard P. Lifton, m.d., 
ph.d., chair of genetics, Mani sought a genetic component to 
heart disease. He also believed that genetic mutations would 
be more prevalent in families where relatives intermarried. 
Although their initial research focused on patent ductus 
arteriosis (pda), in March the journal Science published Mani 
and Lifton’s research on metabolic disease, also involving coro¬ 
nary and carotid arteries.They identified a rare defect in a sin¬ 
gle gene that causes metabolic syndrome—a cluster of risk 
factors that include high ldl cholesterol, low hdl cholesterol, 
high triglycerides, hypertension and diabetes—and early heart 
disease. The paper relied on a study of an Iranian family with 
high rates of coronary artery disease (cad). Among 58 blood 
relatives, 28 were diagnosed with early cad—before the age of 
50 for men and 55 for women—and 23 of the 28 died at young 
ages. Relatives without cad died at an average age of 81. 
Mani and Lifton traced the mutation to a section of 
chromosome 12. There they found a mutation in a gene called 
lrp6. One change in an amino acid altered the activity of the 
protein encoded by the gene, which acts in the Wnt signaling 
pathway, a network of proteins that is involved in develop¬ 
ment and is altered in certain malignant tumors. 
“The main finding is the role of Wnt signaling in devel¬ 
opment of metabolic syndrome and cad; that is where science 
has to focus on now to understand the basic molecular 
mechanism of the disease,” Mani said. 
"We expect that studies of the Wnt signaling pathway 
in patients with early cad and metabolic syndrome will pro¬ 
vide new insight into the basic biology of disease causation 
and allow new approaches to disease prevention,” Lifton said. 
—John Curtis 
Archives 50 and 25 years ago 
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“The extensive growth of knowl¬ 
edge concerning the nervous 
system resulting from work in the 
fields of anatomy, physiology, 
psychology, biochemistry and 
pharmacology in recent years is 
causing many medical schools to 
re-evaluate the organization of 
basic science courses related to the 
nervous system.This problem has 
been under discussion at Yale for 
several years, and this winter an 
integrated program in the teaching 
of neuroanatomy and neurophysi¬ 
ology will begin with the initiation 
of a first-year course, ‘Introduction 
to the Nervous System.’ 
“This course will be presented 
jointly by the Departments of 
Anatomy and Physiology with the 
cooperation of the Sections of 
Neurology and Neurosurgery. The 
program will consist of lectures, 
demonstrations, laboratory exer¬ 
cises, conferences and correlation 
clinics covering the basic structure 
and function of the nervous sys¬ 
tem. In addition to the presenta¬ 
tion of fundamental concepts of 
normal morphology and activity, 
the program will endeavor to 
introduce the first-year medical 
students to the use of quantitative 
analytical methods and the rudi¬ 
ments of experimental design 
through laboratory experiments 
applied to the nervous system.” 
Yale Enters a Cooperative 
Research Agreement With 
Bristol-Myers for Develop¬ 
ment of Anticancer Drugs 
—Yale Medicine 
Fall/Winter 1982 
“Bristol-Myers Company and Yale 
University have entered into 
a $3 million cooperative research 
agreement to facilitate the pro¬ 
duction and availability of new 
anticancer drugs. 
“The agreement brings the 
investigative talents of Yale medi¬ 
cal scientists, who are recognized 
leaders in cancer chemotherapy 
research, together with the research 
and developmental resources of 
Bristol-Myers Company, a major 
producer and distributor world¬ 
wide of anticancer agents. Through 
ongoing technical and scientific 
interaction, they will seek to employ 
the unique resources and skills 
of university- and industry-based 
approaches to development and 
production of new effective and # 
safe drugs for the diagnosis and 
treatment of neoplastic diseases.... « 
“Yale is one of very few research 
institutions in the world where sci- c 
« 
entists involved in the development ■o 
(| 
of a new anticancer drug work 1 
together from the first experiments j! 
4> 
at the laboratory bench through to * 
treating patients in the clinic. They 1 
played a leading role in the devel¬ 
opment of several important drugs, £ 
and in addition, they have been 
conducting research to increase the S 
effectiveness and reduce the toxic 
side effects of a number of drugs * 
which have been used with some 
success, by revising the scheduling 
of their administration, and by uti¬ 
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Yale Medicine can help you stay connected with fellow alumni 
of the School of Medicine, School of Public Health, Physician 
Associate Program and the medical school’s doctoral, fellowship 
and residency training programs. Share your personal and pro¬ 
fessional news for publication in the Alumni Notes department 
of Yale Medicine and on the Web, using this card or the online 
form at info.med.yale.edu/ayam. 
□ _ 
Check box if new address Date 
Name 
Address 
City, State, Zip 
Home telephone with area code 
Office telephone with area code 
Fax 
E-mail 








House Staff (hs) 
□ 
Other Yale degree(s) and year(s) 
Share your news on the reverse of this card and mail to: 
Claire M. Bessinger 
Institutional Planning and Communications 
Yale School of Medicine 
300 George Street, Suite 773 
New Haven, CT 06511 
Please include a photograph. 
















































































































































































































































































































YALE RESEARCHERS CITED AMONG TOP 10 
Among the top 10 scientific breakthroughs of 2006, the journal 
Science has noted the work of two faculty members and a 
Yale alumnus for their research on the genetics of macular degen¬ 
eration, the capacity of stem cells to copy themselves and the 
decoding of the Neanderthal genome. 
The journal cited genomic studies of age-related macular 
degeneration (amd) led by Josephine J. Hoh, ph.d., associate 
professor of epidemiology and of ophthalmology and visual sci¬ 
ence, along with other studies as representing significant progress 
against the disease, the most common cause of blindness in 
people over the age of 50. In 2005, Hoh and colleagues linked a 
variant of a gene on chromosome 1 with the milder dry form 
of amd. Last year a group led by Hoh identified a single change 
in a gene on chromosome 10 that leads to a much greater risk 
of developing the more aggressive wet form of the disease. [See 
“Yale Scientist Finds Two Genetic Anomalies Linked to Macular 
Degeneration,” page 11.] 
Haifan Lin, ph.d., professor of cell biology and director of 
the Yale Stem Cell Center, was one of four scientists who con¬ 
tributed to breakthroughs in the understanding of small rna mol¬ 
ecules known as Piwi-interacting rnas, or piRNAs. Lin’s lab first 
discovered Piwi/Argonaute genes, which are essential for the self¬ 
renewal of stem cells, in 1998. But it was not understood what 
role these genes play in stem cell division until last year, when 
Lin’s group showed that Piwi/Argonaute proteins bind to piRNAs. 
Alumnus Jonathan Rothberg, ph.d. ’91, founded and 
chairs 454 Life Sciences, a Branford, Conn., company that created 
technology for the rapid sequencing of genomes. Two of the labs 
on the top 10 list used this technology, and Lin is using it in his 
work. Rothberg and collaborators in Europe analyzed DNAfrom a 
38,000-year-old Neanderthal fossil and found that the difference 
between the human and Neanderthal genomes is just one base 
pair in 2,000. 
—Jill Max 
The journal Science cited two 
Yale medical school faculty 
members and a Yale alumnus 
among the scientists behind the 
top 10 breakthroughs of 2006. 





PA I D 
Burlington, VT 05401 
Permit No. 696 




